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The primary aim of this thesis was to test the effect of two types of honey, a manuka 
honey and an Otago pasture honey, on a range of key cell types involved in the 
inflammatory response of wound healing. A range of in vitro assays were used to test 
the effect of honey on various cells with a view to the implications of the results for 
wound healing, focusing on the mechanisms by which honey has been observed to have 
beneficial effects on both scar formation and inflammation. 
To investigate whether honey could stimulate bovine T cells to proliferate in vitro, bot~ 
MTT and BrDU assays of proliferation and flow cytometry analysis were used. It was 
found that low concentrations of honey stimulated resting T cells to proliferate and 
express the IL-2 receptor in a dose-dependent manner with progressive dilution. This 
suggests that honey contains lymphomitogenic factors. Manuka honey was stimulatory 
at higher dilutions than pasture honey. Low concentrations of honey induced cell 
division profiles similar to those obtained with Con A-stimulated cells. The stimulatory 
activity of honey was found to be in a high molecular weight fraction. Sugars alone had 
no effect on T cell proliferation, as demonstrated by use of artificial honey (a syrup of 
sugars as in honey). 
The ability for honey to induce messenger RNA expression for key cytokines. involved 
in wound healing was investigated. Conventional reverse transcriptase-PCR was used 
to detect the production of mRNA for honey at 0.25% concentrations for various times 
(0-24 h). The more sensitive molecular technique, quantitative real-time RT-PCR was 
then used to quantify the abundance of cytokine mRNA transcripts expressed in bovine 
blood exposed to 0.25% manuka honey as compared with Con A or control cultures. 
Transcriptional activity of ten genes, IL-1, IL-5, IL-12, IL-18, IFN-y, HSP70, HSP90, i-
NOS, TNF-cx., and TGF-~ were studied at the mRNA level during a 0-24 h exposure of 
whole blood to honey. To test for any modulatory effects of honey on gene expression 
in an inflammatory model, whole blood was exposed to honey at the same time as LPS 
and the mRNA expression for the genes was measured. The results show that honey up-
regulates a wide range of mediators, including TNF-cx., IL-1 ~. and TGF-~. and this 
supports the hypothesis that honey induces cytokine release. Honey gave a transient and 
moderate induction of cytokine mRNA compared with a massive and prolonged 
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induction by the mitogens, Con A and LPS. The inclusion of honey with LPS led to a 
reduced expression of rnRNA for key inflammatory mediators, including iNOS and 
TGF-~, compared with LPS alone. This supports the hypothesis that honey modulates 
inflammation. 
To investigate whether honey could induce THP-1 monocytes to release TNF-a., 
bioassays using WEHI cells were carried out to measure TNF-a. production after the 
monocytes were exposed to honey. Honey was found to stimulate release of TNF-a. by 
the monocytes when at a range of concentrations between 0.000025-0.1 %, with no 
differences between the levels produced at the various concentrations of honey. At 
concentrations of honey from 0.25-1 % the TNF-a. production decreased as the 
concentration of honey increased. This may indicate that an anti-inflammatory action 
overrides the stimulatory effect at concentrations of honey greater than 0.25%. Sugar 
content had no effect upon TNF-a. release, as demonstrated by the artificial honey 
control. There were no differences between honey types (manuka honey and pasture 
honey) in induction of TNF-a. release. Time-course analysis confirmed that a 4-6 h 
incubation period of cells with 0.25% honey gave maximal TNF-a. production. A 2 h 
minimum exposure period of cells to honey was critical for TNF-a. production. 
Incubation of LPS-stimulated monocytes with honey had no effect on their subsequent 
TNF-a. production. A good correlation was found between the TNF measurements 
detected by ELISA and the WEHI Bioassay. 
To test whether honey could modulate LPS-stimulated NO production by THP-1 
monocytes and bovine peripheral blood mononuclear cells, Greiss assays were 
performed. Both manuka honey and pasture honey at 0.5% and 1 % concentrations 
suppressed LPS-induced nitrite release in a dose-wise manner, indicating modulation of 
nitric oxide production. Manuka honey had a more potent modulating effect on LPS-
driven nitrite production than pasture honey, and maintained activity at 0.25%. Sugars 
alone had no effect. High molecular weight dialysis fractions of either honey contained 
the activity, but some of the activity was lost by fractionation. An ether extract of 




To investigate whether honey has an effect on phagocytosis, whole blood was incubated 
with honey and the ability of neutrophils to take up fluorescent-labelled bacteria was 
measured using the Phagotest® assay. The artificial honey control provided clear 
evidence that low concentrations of honey (optimal at 0.25%) induce phagocytosis by 
neutrophils due to the supply of sugars. Manuka honey had an additional opsonizing 
effect on bacteria, which enhances the phagocytic response beyond that seen with 
sugars alone. 
The effects of honey on tight junction (TJ) resistance were assessed for MOCK cell 
monolayers subjected to an EGTA challenge. It was found that manuka honey and 
pasture honey have protective effects on TJ following the challenge, and enhance post-
challenge recovery of transepithelial resistance. Manuka h~ney had greater modulatory 
activity on TJ with increased concentration from 0.1-1 %, and 1 % concentrations of 
both honeys gave the greatest protective effects. Manuka honey appeared to have 
greater protective effects than pasture honey. Application of manuka honey (at 1 % 
concentrations) to both the apical and basolateral sides of the MOCK cell monolayer 
significantly enhanced TJ tightness beyond the control. Dialysis of the honey confirmed 
that the high molecular weight fraction contained the active component. Diffusate 
fractions from either honey type had no effect on TJ. Artificial honey had no effect. 
The effect of various honey concentrations on the proliferation of the 3T3-Ll fibroblast 
cell-line in vitro was investigated using MTT proliferation assays. Both manuka honey 
and pasture honey (0.25%) increased fibroblast proliferation. Artificial honey had no 
effect on fibroblast proliferation, indicating sugars have no role in mitogenic activity. 
This suggests that honey contains factors which directly promote cell division in 
fibroblasts. 
An in vitro model was used to test whether honey-induced factors produced by 
peripheral blood mononuclear cells (PBMC) could activate fibroblast proliferation. 
These assays were performed to examine whether honey could have an indirect 
stimulatory effect on fibroblasts. Incubating fibroblasts with supematants derived from 
honey-stimulated PBMCs (at 0.025% concentrations of honey) led to significant 
fibroblast proliferation. Low concentrations of honey (less than 0.1 % ) do not directly 
stimulate fibroblast proliferation, therefore factors produced by honey-stimulated 
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PBMCs must promote fibroblast proliferation. A high molecular weight fraction of 
manuka honey obtained from dialysis contained the active component. The diffusate 
obtained by dialysis (containing sugars) had no activity. 
To investigate whether honey could modulate the response of fibroblasts to an 
inflammatory agent, fibroblasts were exposed to honey for various times prior to and at 
the same time as IL-1 p. Honey did not augment fibroblast proliferation when added at 
the same time as IL-1 p. Prior incubation of fibroblasts with honey (0.25-1 % ) for 2 h 
before IL-IP-stimulation decreased the cell response to IL-IP, and this anti-
inflammatory active component was of a high mo.lecular weight. 
It is proposed, on the basis of this in vitro study, that honey provides a neatly controlled 
therapy for optimising tissue repair, with potential for use in inflammatory disorders. It 
is the central thesis of this study that the stimulatory agent in honey induces cytokine 
production necessary for healing to occur, but that the oxidant species produced by 
these cells are effectively regulated by a second agent, thereby creating a feedback-
regulated delivery system. The results presented in the current study suggest that honey 
can both stimulate and modulate cell activity, and show that honey interferes with a 
large number of regulatory steps in the inflammatory pathway, e.g. cell division, 
transcription, tight junction integrity, production of oxidant species. While the 
stimulatory activity was observed at lower concentrations, the modulatory effects 
required higher concentrations of honey. The dual ability for honey to stimulate 
moderate cellular activation in the absence of an immune stimulus, yet not augment 
mitogenic stimulation, and in some cases to modulate cell response to a mitogen, 
indicates that it will promote healing without setting up harmful inflammation. 
If further experiments confirm this to be the case, honey will have potential for 
therapeutic application. The work also identifies some new areas of research, which if 
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Chapter 1 begins with a brief introduction and concludes with a literature review 
comprising: 
1) A review of what was known about the tissue-healing properties of honey 
prior to the current study. 
2) A review of established knowledge of the inflammatory process, with an 
emphasis on wound healing. 
3) A review of the current understanding of the pathogenesis of some key 
inflammatory diseases, with a focus on fibrosis. 
4) A review of the existing treatments for keloid scars, with an emphasis on 
the need for new therapies. 
5) Primary aims of the current study. 
Chapter 2 describes the effect of honey on T cell cultures as measured by proliferation 
assays (BrDU and MTT), along with flow cytometry analysis of cellular activation 
markers. Chapter 3 describes the effect of honey on the kinetics of cytokine mRNA 
expression for several genes involved in wound healing, in whole blood cultures. The 
molecular techniques, conventional reverse transcriptase-PCR and quantitative real-
time reverse transcriptase-PCR, were used to examine both the direct effect of honey 
on mRNA amplicons and the effect of adding honey at the same time as 
lipopolysaccharide on mRNA amplicons. Based on the results obtained in Chapter 3, 
in Chapter 4 a WEHI bioassay was used to further examine the effect of honey on 
TNF-a production by peripheral blood mononuclear cells (PBMCs) and a THP-1 
monocyte cell line. 
In Chapter 5 the effect of honey on nitric oxide production by PBMCs and THP-1 
monocytes was measured using the Griess reagent. Based on the observation that 
honey down regulated the mRNA expression for iNOS in Chapter 3, the effect on 
nitroc oxide production of exposing THP-1 monocytes to honey at the same time as 
LPS, was further examined. In Chapter 6, the effect of honey on bead uptake by 
neutrophils was examined using both flow cytometry analysis and haemocytometry. 
\.\ 
Prolo!,!u.: Prcamhk 
After establishing that honey has effects on key cells functioning in the inflammatory 
pathway, the effect of honey on blood-tissue barriers was examined. In Chapter 7, 
measurement of transepithelial resistance across an epithelial cell monolayer was used 
to measure the effect of honey on tight junction integrity during an inflammatory 
challenge. Chapter 8 describes the effect of honey on fibroblast cultures as measured 
by MTI proliferation assays. Fibroblasts represent one of the key cell types 
functioning in the later inflammatory stage of wound repair. 
Finally, in Chapter 9, a discussion of the relevance and importance of the findings in 




All honey concentrations are expressed as% (v/v) unless otherwise stated (taking 1 ml 
honey as 1.37 g honey). Where the concentration of honey is expressed as the degree 
of dilution of the original honey, the dilution is by volume. All concentrations of 
honey are given as final concentrations unless otherwise stated. 
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Chapter One: General Introduction 
"Whether it's got reliable evidence is the key - not whether it's got a conventional or 
alternative label" (Rogers, 2003) 
The study in this thesis investigates the effect of honey on key cells involved in the 
inflammatory phase of tissue repair. Therefore this review will briefly examine the 
avenues of work which led to the acceptance in modem times of honey as a therapeutic 
agent, as well as the mechanisms by which honey was known to promote wound healing 
prior to commencement of this study. A section on the process of tissue repair will 
indicate steps where therapeutic agents may intervene. Finally a discussion of the aims of 
this study will be presented. 
1.1 DEFINING THE FIRST STEPS TO INVESTIGATE WHETHER HONEY 
HAS SCIENTIFIC VALIDITY AS A WOUND HEALING THERAPY 
The aim of current therapeutic discovery research is to identify drugs which are highly 
specific for a single target, do not produce side-effects, and are active in vivo. Generally 
major drug development programs screen thousands of compounds in order to identify an 
agent with some therapeutic activity. The exploration of honey as a therapeutic agent is 
being conducted in reverse. Having been a successful therapy for several millennia, the 
scientific research to understand how honey acts physiologically to promote wound 
healing is only now being done. Commonly, therapies which optimise tissue healing have 
effects upon receptors, enzymes or ion channels (Nicholson, 2000). Therefore, the 
immune system is a relevant place to begin a search for the mechanisms by which honey 
has these effects, as the inflammatory response to injury or infection is the start of the 
healing/repair process. Further, aspects of the immune system are easily modelled in vitro 
by culturing specific cell types and challenging them with inflammatory conditions. 
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The key objective of this thesis was to investigate the effect of honey on the immune 
system. The first step was to identify the cells upon which honey has a significant effect. 
Then, if honey provided encouraging results in these cell-based assays, more specific 
analyses would be performed to demonstrate how honey produced the biological 
response. While the study undertaken here was not the first of its kind to examine the 
effect of honey on immune cell function, previous research had been limited. The two 
published studies conducted prior to this thesis identified the potential for honey to 
stimulate lymphocyte cell division and to increase phagocytic activity of neutrophils 
(Abuharfeil et al., 1999), and also the potential for honey to increase cytokine production 
by monocytes and to reduce the production of oxygen radicals by these cells (Tonks et al., 
2001). These studies only tested a few concentrations of honey (0.1, 0.25% Jordanian 
wild flower honey and 1 % New Zealand manuka and Otago pasture honey). With this in 
mind, it was logical to commence research in this thesis by repeating the assays described 
in those studies, and extending the range of honey concentrations. 
1.2 CURRENT KNOWLEDGE ABOUT HONEY AS A TISSUE - HEALING 
AGENT 
Molan (2001) has comprehensively reviewed all that is currently known about the tissue -
healing properties of honey. Honey has been used as a folk medicine since ancient times 
(Adcock, 1962; Ransome, 1937). It appears in historical records as a pharmaceutical used 
to successfully treat a myriad of ailments from wounds to intestinal disorders (reviewed 
by Molan, 1992a). With the advent of bacterial resistance to antibiotics resulting from 
their widespread use in the 20th century, honey has been rediscovered as a medicine. The 
proven ability of honey to promote wound healing by removing bacteria, debriding, and 
by stimulating re-epithelialisation, growth of fibroblasts and new blood capillaries, has 
been reviewed by Molan (2001). Though there was limited scientific evidence to explain 
the mechanisms by which honey optimises wound healing prior to the present study, a 
wealth of anecdotal reports document the ability of honey to remove infection in cases 
where skin was broken or unbroken (Molan, 1998; Postmes et al., 1997; Subrahmanyam, 
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1993; Harris, 1994; Adesunkanmi and Oyelami, 1994; Suguna et al., 1993; Postmes et 
al., 1993; Ndayisaba et al., 1993; Efem, 1993; Gupta et al., 1992; Ankra-Badu, 1992; 
Subrahmanyam, 1991; Zumla and Lulat, 1989; Farouk et al., 1988; Efem, 1988; 
Dumronglert, 1983; Bergman et al., 1983; Bose, 1982; Armon, 1980; Cavanagh et al., 
1970; Bulman, 1955). While much of the evidence for honey as a wound healing agent is 
based on topical application of honey to the skin (Cooper et al., 2001; Vardi et al., 1998; 
Subrahmanyam, 1998; Wood et al., 1997; Harris, 1994; Subrahmanyam, 1994; 
Subrahmanyam, 1993; Phuapradit and Saropola, 1992; Subrahmanyam, 1991; Efem, 
1988; Bergman et al., 1983) there is evidence that honey has a protective effect on the gut 
mucosa (Ghosh and Playford, 2003; Bilsel et al., 2002; Gharzouli et al., 2002; Ali et al., 
1997; Haffejee and Moosa, 1985; Salem, 1981). The ability for honey to have direct 
activity on bacteria has been well documented (Kingsley, 2001; Moore et al., 2001; 
Dunford et al., 2000; Thomas et al., 1998; Vardi et al., 1998; Wood et al., 1997; 
Ndayisaba et al., 1993; Efem, 1988), and honey is allowed to be sold as a medicine in 
Australia based on this scientific evidence. Clinical observations that honey clears 
infection beneath unbroken skin is thought to be due to the existence of at least one of the 
following factors in honey: antibacterial activity, immunostimulatory activity or anti-
inflammatory activity (Ahmed et al., 2003; Biswal et al., 2003; Gheldof et al., 2003; 
Misirlioglu et al., 2003; Schramm et al., 2003; Swellam et al., 2003; Lusby et al., 2002; 
Mahgoub et al., 2002; Topham, 2002; Al-Waili, 2001; Ali et al., 1997; Duddukuri et al., 
1997). The present study sought to identify which of these factors was most likely to be 
responsible for observed effects on tissue healing in the absence of clinical infection. 
1.3 THERAPEUTIC BENEFITS OF HONEY 
1.3.1 Honey as an antibacterial agent 
Infection of wounds result from the presence of micro-organisms, and honey has been 
used successfully to clear bacteria from a variety of infected wounds (reviewed by Molan, 
2001). The most compelling evidence for the ability of honey to act as an antibacterial 
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agent is the clearance of antibiotic-resistant bacterial strains (Dunford et al., 2000; Vardi 
et al., 1998). A brief review of the known mechanisms by which honey has antibacterial 
activity is given here. Antibacterial activity of honey has been attributed to a number of 
factors: the osmotic effect of the sugars, acidity, and the presence of hydrogen peroxide 
along with other unidentified substances probably originating from the floral source 
(Wahdan, 1998). The "Unique Manuka Factor" (UMF) is an example of a floral-derived 
compound with antibacterial activity which is only found in manuka honey (Molan and 
Russell, 1988). The rating of the level of UMF has been adopted as a marketing tool for 
manuka honey to be sold as a medicine in many countries. Though, despite many years of 
research, UMF has not been isolated to identify its chemical structure (Weston, 2000). 
Evidence that antibacterial activity of generic honey types is conveyed by more than the 
osmotic effect is demonstrated by studies where honey gave complete bacterial inhibition, 
and sugars alone had no effect (Cooper and Molan, 1999). 
1.3.1.1 Osmotic effects 
One of the ways honey is known to inhibit microbial growth is due to its high sugar 
content. Honey is hypertonic, a saturated or supersaturated solution of sugars, fructose 
and glucose being the key components (Rilegg and Blanc, 1981). Honey only has a 15-
21 % water content (w/v), and the low water activity deprives bacteria of the water needed 
for cell function, resulting in bacterial inhibition (Molan, 1992a; Chirife et al., 1982. 
Honey may also draw water from bacterial cells (Majno, 1975). This has been 
demonstrated using artificial honey, made using the same proportions of sugars found in 
natural honey, and measuring bacterial inhibition (Postmes et al., 1993). 
Dilution of honey results in corresponding reductions of osmotic effect. The lowest 
concentration of sugar that inhibits Staphlococcus aureus growth has a water activity of 
0.86 (equivalent to a 29% v/v honey solution). Yet, much lower concentrations (2-4%) 
can completely inhibit S. aureu'!; indicating the antibacterial activity obtained by honey 
can not be attributed solely to osmolarity effects (Cooper et al., 1999; Chirife et al., 
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1982). This has important implications for potential use of honey as a topical treatment 
for infected wounds, due to the dilution effect which will occur with lymph or plasma 
(Molan, 2001). It will also be diluted by gastric fluid when taken orally (Molan, 2001). 
1.3.1.2 Hydrogen peroxide 
A key component of honey responsible for antibacterial activity is hydrogen peroxide 
(Weston, 2000; Molan, 1992a; 1992b). The hydrogen peroxide content of honey was first 
identified in 1962, and in 1963 its presence was attributed to the activity of the enzyme 
glucose oxidase in honey (White et al.,1963; Adcock, 1962). At that time, the 
antibacterial activity of honey was attributed to hydrogen peroxide for the first time, and 
it was observed that either light or catalase could remove its activity. 
Glucose + Oxygen ~ Hydrogen Peroxide + Gluconolactone 
Glucose oxidase jJ, 
Gluconic acid 
This reaction occurs when bees secrete the glucose oxidase enzyme from their 
hypopharyngeal glands into the nectar during the formation of honey (White, 
1975a;1975b). White et al. (1963) demonstrated that hydrogen peroxide is only produced 
after honey has been diluted, as glucose oxidase is almost inactive in full strength honey. 
This has important implications for its use as a topical treatment, again due to the dilution 
effects of lymph, plasma or stomach acids when orally administered. Further, it is 
important that hydrogen peroxide is only present at low concentrations as it has a 
cytotoxicity exceeding its bacterial potency at concentrations beyond 100 µM (Burdon, 
1995; Lineaweaver et al., 1985). 
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1.3.1.3 Acidity 
Due to the presence of gluconolactone/gluconic acid produced enzymically during the 
ripening of nectar into honey, honey has a characteristically low pH, typically 3.2-4.5 
(White, 1975b; Stinson et al., 1960). Though this means that honey has a lower pH than 
the minimum tolerated values for survival by some key wound-infecting bacteria species 
(e.g. Pseudomonas aeruginosa, pH 4.4), no correlation has been found between 
antibacterial activity and pH of honey (Molan, 1992a; Thimann, 1963). Again, dilution of 
honey applied to wounds will change the pH and this will affect the extent to which pH 
will negatively affect bacterial species. 
1.3.1.4 Non-peroxide antibacterial components 
Flavonoids, including chrysin, pinobanksin and pinocembrine (Marcucci et al., 2001), 
along with flavonone and pinocembrine (Bogdanov, 1984), have been isolated in small 
amounts from honey. While these substances have proven antibacterial activity (Rivera-
Vargas et al., 1993), they could not have significant antibacterial effects at the 
concentrations present in honey (Weston, 2000). The antibacterial activity of the phenolic 
acids, caffeic acid and ferulic acid, has also been identified (Cizmarik and Matel, 1970) 
and these have been isolated from honey (Wahdan, 1998), but these occur at 
concentrations well below those necessary for potent effects (Wes ton, 2000). The 
presence of UMF in manuka honey has already been described (Section 1.3.1). 
1.3.1.5 Variation between honey types 
The demonstrated variation in antibacterial activity between honeys obtained from 
different floral origins and geographical sources confirms that different honey types will 
have different therapeutic properties (Allen et al., 1991; Farouk et al., 1988; Molan, 
1992b). The knowledge that honey type could be matched to therapeutic useage was 
understood by the ancient physicians: Aristotle (384-322 BC) recommended pale honey 
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be used as a salve for sore eyes and wounds, and Discorides (c.50 AD) promoted pale 
honey from Attica as the best cure for ulceration (Molan, 1999). While manuka honey is 
likely to be rich in glycated proteins and antioxidants, it has a low hydrogen peroxide 
content compared with a pasture honey type, which has the reverse profile (Molan, 
1992b). The hydrogen peroxide content of individual honey types is likely to be related to 
the catalase content of that honey, and this is derived from the plant of origin (Dustmann, 
1971; Schepartz and Subers, 1966). The ascorbic acid content of host plasma, along with 
the presence of iron has also been documented to affect the rate at which hydrogen 
peroxide breaks down via chemical reactions (Savini et al., 1999). This highlights the 
importance of interactions between the host and the honey type in any observed variation 
of potency. Darker honeys have been found to have a higher antioxidant content (Molan, 
2001), which is a reflection of the high content of plant phenols (P. C. Molan; personal 
communication). While the white pasture honey type obtained from the Otago plains, is 
largely devoid of tree pollens due to the lack of tree cover, and therefore, antioxidant 
content is low, manuka honey has a high antioxidant content. 
1.4 MECHANISMS BY WHICH HONEY PROMOTES TISSUE REPAIR 
1.4.1 The existing evidence for honey as a cell growth stimulant 
Of direct relevance to the aims of this study, there are a number of anecdotal reports 
which suggest that honey promotes cellular anabolism (Lusby et al., 2002; Wood et al., 
1997; Ndayisaba et al., 1993; Somerfield, 1991; Efem, 1988). Though the mechanisms by 
which honey promotes cell growth have been speculated, they have not yet been 
identified (Molan, 1993). Acidification of wounds by lowering the pH has been 
determined experimentally to increase the rate of epithelialisation (Kaufman et al., 1985), 
and this may contribute to the observed stimulatory effects of honey on tissue repair. Of 
relevance to this study, 0.1 % manuka honey concentrations stimulated epithelial cell 
division in a respiratory epithelial cell line model and increasing the concentration beyond 
this had no effect (D. Adams, Child Health Research Institute, Adelaide; personal 
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communication). Honey has been demonstrated to: promote the development of new 
connective tissue around regenerating blood vessels (Subrahmanyam, 1998; Efem, 1993; 
Farouk et al., 1988; Efem, 1988), stimulate epithelial cover (Misirlioglu et al., 2003; 
Topham, 2002; Subrahmanyam, 1998; Efem, 1993; Efem, 1988), stimulate collagen 
synthesis (Kumar et al., 1993; Suguna et al., 1992) and stimulate development of new 
blood vessels to increase tissue oxygenation (Kumar et al., 1993; Gupta et al., 1992). 
Further, the osmotic outflow of lymph which occurs when honey is applied topically to 
wounds may increase nutrient supply to the tissues (Lusby et al., 2002). It would appear 
that honey has a superior ability to promote re-epithelialisation compared with sugar 
(Bose, 1982). In addition to its sugar content, honey has a direct nutrient effect on cell 
metabolism (Molan, 1999). Hydrogen peroxide has been demonstrated to have a direct 
stimulatory effect on fibroblast proliferation when added to cell cultures in vitro at low 
concentrations (Burdon, 1995; Chung et al., 1993; Schmidt et al., 1992; Rao and Berk, 
1992; Murrell et al., 1990). The role of hydrogen peroxide as an immune stimulant is 
discussed in Section 1.4.3. 
1.4.2 Cleansing and debriding action of honey on wounds 
Honey has been documented to provide cleansing action on wounds due to flushing 
which occurs as lymph is drawn out by the osmotic action of sugars (Topham, 2002; 
Molan, 1999). In addition to removing any potential contaminants from the wound bed, 
the osmotic activity lifts dead tissue eliminating the need for surgical debridement 
(Mcinerney, 1990; Efem, 1988; Farouk et al., 1988; Wadi et al., 1987). Debridement of 
the wound bed is critical because a contaminated wound cannot heal (Mcinerney, 1990) 
due to the propensity for dead tissue to support the growth of bacteria (Cavanagh et al., 
1970). The importance of maintaining a moist wound-healing environment for optimal 
tissue repair has been reported (Thomas et al., 1998). This is because protein-digesting 
enzymes function more efficiently in moist environments (Molan, 2001; Bradley et al., 
1999; Archer et al., 1990). Fibroblast proliferation is optimised by moist conditions, and 
such an environment is also necessary for keratinocyte migration across the wound bed to 
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restore epithelial cover, so that a scar is less likely to form (Misirlioglu et al., 2003; 
Niessen et al., 1999; Kirsner and Eaglstein, 1993). Evidence from Topham (2002), 
suggests that an additional contribution of honey to scar-free healing is its ability to 
enable wound-healing proteoglycans to function without excessive production of 
collagens. Furthermore, it was demonstrated that the ability of hyaluronic acid to be 
continually generated from glucose due to the presence of a glucose supply reduced the 
formation of fibre-forming collagens (Topham, 2002). These observations help to explain 
why honey is associated with scar-free healing (Molan, 1993; Topham, 2002; Tejero-
Trujeque, 2001). 
The ability of hydrogen peroxide to mediate the observed chemical and enzymic 
debriding processes imparted by honey on wounds has been postulated by Molan (2001). 
Metalloproteases are known to be activated by oxidants (van Wart and Birkedal-Hansen, 
1990), along with deactivation of inhibitors of tissue serine proteases (Flohe et al., 1985). 
Fibroblast collagenase, normally present in tissues in the latent form, can be activated by 
oxidants, enabling breakdown of collagen so that tissue remodelling can proceed (Weiss 
et al., 1985). The ability of honey to reduce post-operative peritoneal adhesions has been 
speculated to be due to inhibition of peritoneal plasminogen activator (Aysan et al., 
2002). They postulated this may have been achieved through antioxidant activity (Section 
1.4.4.1), or because of the physical properties of honey including its hygroscopicity, 
hypertonicity and low pH (Sections 1.3.1.1, 1.3.1.3) which inhibits mechanical contact 
between the cecal and ileal surfaces (Aysan et al., 2002) so that adhesion could not occur. 
1.4.3 Evidence that honey is an immune stimulant 
In addition to the proven antibacterial activity of honey, and the clinical observations that 
it stimulates re-epithelialisation and minimises scar formation, there is limited evidence 
that honey may act on immune cells in the first phase of inflammation. Studies conducted 
by Abuharfeil et al. (1999), have shown that honey stimulates B- and T-lymphocytes , 
and activates neutrophils. A study by Al-Waili (2003) showed that oral ingestion of honey 
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increased both the number of circulating monocytes and lymphocytes in blood. 
Investigations by Blair (2000) and Tonks et al. (2003), have demonstrated that honey 
stimulates monocytes in vitro to release tumour necrosis factor a (TNF-a) and 
interleukins 1 and 6 (IL-1 and IL-6). Further, Simuth et al. (2004) have reported that the 
presence of royal jelly proteins in honey stimulated macrophages to release TNF-a. These 
cytokines play a crucial role in activation of the immune response (Nathan, 2002). There 
are a number of mechanisms which have been hypothesised to account for immune 
stimulation by honey. The direct supply of glucose to macrophages has been 
demonstrated to enhance their respiratory burst (Ryan and Majno, 1977). Incubation of T 
cell lymphocytes with low concentrations of hydrogen peroxide has been reported to 
stimulate cell proliferation in vitro (Reth, 2002) and stimulate fibroblast mitosis in vitro 
(Chung et al., 1993). There are a number of current theories about how hydrogen 
peroxide stimulates cell proliferation, and the possibility that the hydrogen peroxide 
content of honey may induce these changes. Direct exposure of various cells to low 
concentrations of hydrogen peroxide in vitro has been demonstrated to have various 
effects: it regulates signal transduction pathways, activates transcription factors and 
controls the expression of genes governing growth, differentiation and immune function 
in various cell types (Reth, 2002; Mahadev et al., 2001; Nappi and Vass, 1997; Burdon, 
1995). 
Hydrogen peroxide potentiates the phosphorylation of endogenous cellular proteins which 
are involved in regulation of cell activity. Studies by Golpalakrishna et al. (1986) and 
Kass et al. (1989) have suggested that hydrogen peroxide may temporarily alter the 
kinase-phosphatase balance within cells. Hydrogen peroxide modulates the redox status 
of the cell as a result of changes in cellular levels of oxidised glutathione (GSH) and its 
reduced form (GSSG) (Burdon, 1995). High GSH levels are required for IL-2-dependent 
proliferation, and for cytotoxic T-lymphocyte activity. Proliferating fibroblasts in vitro 
release low levels of superoxide (and its dismutation product, hydrogen peroxide), from 
the action of NADPH oxidase present in the cell membranes (Meister, 1988). The 
cytokines, IL-1 and TNF-a, stimulate further superoxide release in the presence of low 
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levels of hydrogen peroxide (Burdon, 1995). The observations made in these studies 
suggest that cells use hydrogen peroxide to stimulate their growth and division, and that 
hydrogen peroxide functions as an intercellular messenger. Hydrogen peroxide has been 
shown to inactivate the inhibitor of matrix metalloproteinases (MMPs), thereby activating 
the MMPs. MMPs cleave TNF from monocytes and macrophages, which enhance the 
neutrophil response to the injured tissue site and ensure the early inflammation phase 
proceeds at the required rate (Nathan, 2002). 
The insulin-like effects of hydrogen peroxide may mediate growth stimulation of cells, 
and these effects include activation of glucose transport and increased incorporation of 
lipids into glycogen and lipids, along with activation of the receptor tyrosine kinase 
through increased IGF-II binding (Mahadev et al., 2001; Kadota et al., 1986). Hydrogen 
peroxide is known to have a direct effect on the insulin receptor (Koshio et al., 1988). 
Low concentrations of hydrogen peroxide have also been reported to directly stimulate 
angiogenesis (Tur et al., 1995). 
Glycosylated proteins have been demonstrated to have a direct stimulatory effect on 
endothelial cells (Brownlee, 1995; Vlassara et al., 1988; Takata et al., 1988) and it is 
probable that honey would contain these as protein stored in the presence of high levels of 
monosaccharides are likely to react. The proportion of proteins varies according to honey 
type, and the possibility that glycated proteins contained in honey may have immunogenic 
effects has been suggested by Tonks et al. (2001). The terms "glycated" and 
"glycosylated" are here acknowledged to refer to different protein products. Glycated 
proteins are created by the spontaneous reaction of sugars with proteins leading to the 
production of advanced glycation end products (AGEs), occurring without enzyme 
activity (Yim et al., 2001). Glycosylated proteins are created through the enzymatically 
driven N-or 0-linked transfer of sugars to proteins. It is highly likely that honey would 
contain AGEs due to the proteins being in contact with sugars during storage. It is 
possible that glycosylated proteins would be found in honey due to the potential for the 
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non specific transfer of sugars onto proteins by the invertase enzyme. The AGEs will 
stimulate endothelial cells (Price et al., 2004). 
1.4.4 Honey as an anti-inflammatory agent 
Though the process by which honey acts as an anti-inflammatory has yet to be 
demonstrated, the effect has been observed clinically in numerous reports where honey 
applied to wounds reduces the localised swelling, heat and pain associated with 
inflammation (Molan, 1999). Anecdotal evidence from using manuka honey incorporated 
in a gel for topical use has reported suppression of itching and erythema associated with 
mosquito bites and other inflammatory skin reactions due to local anaphylactic reactions 
(P. C. Molan; personal communication). These symptoms are produced by the increased 
liberation of prostaglandins (especially PGE2), which trigger the hypothalmus to increase 
heat production, resulting in development of fever or localised hot areas (Dascombe, 
1985). This m\ay indicate that honey acts to shortcircuit prostaglandin synthesis. Of 
particular note, honey has been observed to reduce inflammation when applied to 
unbroken skin, indicating that the anti-inflammatory activity may be able to diffuse 
through the skin (Molan, 1992a). Indeed, hydrogen peroxide has been demonstrated to 
diffuse through cell membranes and enter the cell nucleus (Reth, 2002) and therefore it is 
plausible that this may occur when honey is applied topically (Molan, 1992a). 
Microscopic examination confirmed that application of honey to inflamed tissues 
significantly reduced the leukocyte count (Postmes et al., 1997). In studies by Postmes et 
al. (1997); Kumar et al. (1993); Oryan et al. (1998); Gupta et al. (1992) and Church 
(1954), reduction of inflammation in wounds where honey was applied in the absence of 
infection was taken as evidence that honey has a direct anti-inflammatory effect. As 
infection was not present, the observed anti-inflammatory effects could not have be 
attributed to any removal of inflammation promoting bacteria. Honey can be used as a 
topical treatment for localised inflammation, and has been used successfully to alleviate 
pain and damage to burned tissues (Subrahmanyam, 1993;1991). 
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1.4.4.1 The possibility that the antioxidant content of honey may account for observed 
anti-inflammatory effects 
It is not known what part of the observed anti-inflammatory effect may be due to the 
presence of antioxidants. The variation in antioxidant content according to honey type has 
been discussed in Section 1.3.1.5. Direct application of antioxidants to bums has been 
demonstrated to reduce inflammation (Burlando, 1978; Subrahmanyam, 1991). There is a 
burgeoning body of evidence which demonstrates that antioxidants have potent effects on 
immune cell function (Bourdon et al., 1999; Grimble, 1994; Am.es et al., 1993) and much 
of the evidence for bioactive agents to have immunosuppressive effects on inflammation 
is based on their antioxidant content (Basova et al., 2002; Meydani and Erickson, 2001; 
Alliangana, 1996; Rao et al., 2003). Antioxidants are known to alleviate tissue damage by 
harmful oxidant species through stabilising ions via covalent bonding of unpaired 
electrons (Grimble, 1994). The observation that topical administration of honey reduced 
post-operative peritoneal adhesions has been speculated to be due to its antioxidant 
content, particularly its content of caffeic acid, benzoic acid, phenolic acid, and flavonoid 
glycones (Aysan et al., 2002). The likely mechanism of observed anti-inflammatory 
action is prevention of the feed-back amplification of inflammation that is due to 
hydrogen peroxide. Clinical studies have confirmed that hydrogen peroxide is directly 
inflammatory to skin and this was why it ceased to be used as an antiseptic on tissues 
(Saissy et al., 1995; Halliwell and Cross, 1994; Salahudeen et al., 1991; Lineaweaver et 
al., 1985). Antioxidants have been demonstrated to block the stimulatory effects of 
hydrogen peroxide and prevent the oxidation of regulatory proteins which occurs when 
free radicals form from it (Grimble, 1994). 
1.5 HOW DOES THE IMMUNE SYSTEM FUNCTION TO PROMOTE 
NORMAL WOUND HEALING? 
Inflammation is the first crucial phase of tissue repair. It arises through the actions of 
immune cells and their production of cytokines, growth factors and oxidant species 
(Enoch and Harding, 2003; Nathan, 2002). When the interplay between these 
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inflammatory cells and their mediator products deviates from the normal sequence, due to 
some breakdown in regulation, clinical disease may develop (Enoch and Harding, 2003; 
Nathan, 2002). The pathogenesis of some key inflammatory diseases is outlined in 
Section 1.6. The process of tissue repair conforms to a series of overlapping but well 
defined phases of inflammation, proliferation and remodelling (Nathan, 2002) as shown 
in Figure 1.1. Where bleeding has occurred in the tissues, a hemostatic phase in which the 
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Figure l. l: Concept map illustrating the overlapping phases of the normal wound repair process. In the 
normal individual, wound healing occurs according to a predictable sequence of phases, in which the 
production of cytokines, growth factors and oxidant species is tightly regulated. Points at which honey may 
be hypothesised to have some activity are indicated by *. (This is a modification of a figure presented by 
Enoch and Harding, 2003). Definitions: ECM extracellular matrix, MMPs matrix metalloproteinases, 
TIMPs tissue inhibitors of metalloproteinases. 
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In order to recognise the steps in the tissue repair process at which honey has been 
hypothesised to intervene, a brief outline of the normal wound healing process is given. 
However, it should be noted that other studies have demonstrated that honey has effects 
on cells during the final remodelling phase of tissue repair (Section 1.4.1 ). 
1.5.1 Events during the inflammatory phase 
The following description of inflammatory cell recruitment mechanisms is a 
comprehensive review of the literature. When tissue damage occurs, soluble mediators 
(histamine from mast cells, kinins from precursor molecules undergoing proteolysis) 
directly cause vascular changes (Nathan, 2002). These include the classic hallmarks of 
inflammation characterised by Celsus some two thousand years ago; tumour, rubor, calor 
and dolor (Benjamini et al., 1996). In simple terms, Celsus was describing local changes 
in vascular permeability and accompanying changes in blood flow. These changes are 
necessary in order for immune cells (leukocytes) to be recruited to the damaged tissues, 
-
so that phagocytes can destroy foreign invaders and clean up the tissues, and for the repair 
process to be initiated (Nathan, 2002; Enoch and Harding, 2003). 
The first phase of repair is dominated by inflammation of the wound and mobilisation of 
the cells in to the injured tissues enabling synthesis of granulation tissue to occur. This 
phase is characterised by infiltration of the polymorphonuclear leukocytes in to damaged 
tissues (Enoch and Harding, 2003; Nathan, 2002). Neutrophils and monocytes migrate to 
damaged tissues in response to chemotactic factors produced by the coagulation cascade 
(Kirsner et al., 1993). Recent studies by Marsland et al., (2005) demonstrate that the 
recruitment of leukocyte subtypes is tightly regulated by chemotactic cytokines, termed 
chemokines. Chemokines are produced and released by a variety of cell types during the 
initial phase of the inflammatory response. To date, there have been 40 chemokine 
proteins identified (Simon and Green, 2005). The chemokines bind to specific seven 
transmembrane spanning G protein-linked receptors on target cells, and this binding 
action causes reconfiguration of adhesion proteins, such as ~ integrins, on the surface of 
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the responding cells. Chemokines stimulate chemotaxis and extravasation of leukocytes 
and can only act on cells carrying the specific chemokine receptor. For example, members 
of the CXC family of chemokines signal through the chemokine receptors CXCRl-5 
(Christopherson and Hromas, 2001). In general chemokines from the CC (~-chemokine) 
family chemoattract monocytes, eosinophils, basophils, and T cells (Sauty et al., 1999). In 
wounded tissue, both macrophage chemoattractant protein-I (MCP-1), macrophage 
inflammatory protein-I (MIP-1), and Rantes are primary chemokines attracting 
macrophages to the injury site, and the time of expression differs for each molecule 
(Jackman et al., 2000). MCP-1 also acts on a subset of T cells and on mast cells bearing 
the CCR3 receptor (Baggiolini, 2001). Conversely, the chemokine Interleukin 8 (Il..-8), a 
member of the CXC family ( a.-chemokine ), results in inflammatory reactions dominated 
by neutrophils (Marshall et al., 2003), and is synthesised by the endothelium. It is now 
well recognised that chemokines such as CCL19 and CCL21do more than simply guide 
migration of immune cells, but through induction of dendritic cell maturation, prime T 
cell responses (Kaiser et al., 2005; Marsland et al., 2005; Yopp et al., 2005). The group 
of CXC chemokines lacking a NH2-terminal ELR sequence are induced through 
interferons (IFN) as a lymphocyte chemoattractant, and include IP-10, Mig, and I-TAC 
(Sauty et al., 1999). In addition to the timing of chemokine release, tight regulation of 
leukocyte migration is effected by their interplay with cytokines and growth factors 
(Werner and Grose, 2003). There is evidence for the existence of immunological synapses 
and that when conjugates form between T cells and antigen-presenting cells (APC), 
chemokine receptors are only sensitive to chemokines released by the APC (Trautmann, 
2005). APC comprise a variety of cells with a common function of processing antigens 
and re-expressing fragments of the antigen on their surface for T cell recognition, 
including dendritic cells, macrophages and B-cells. Therefore, the existence of 
immunological synapses explains why T cells are not distracted by irrelevant, exogenous 
chemokines. It has been understood for some time that while chemokines provide "start" 
signals for T cells to stimulate directional movement, TCR-induced calcium flux 
immobilises the T cell (Trautmann, 2005). Recently, it has been proposed that the 
immunological synapses formed between T cells and APC stabilise the T cell-APC 
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conjugate and act as a costimulatory signal (Trautmann, 2005). Thus, chemokines play a 
key role in both direct and indirect recruitment of leukocytes. 
A mixture of chemokine receptors, integrins and selectins expressed by leukocytes and 
endothelial cells are involved in the recruitment of leukocytes from the blood into the 
tissues. Changes in vascular permeability lower the shear stress so that leukocyte 
movement through the circulatory system is slowed and the immune cells have greater 
contact with postcapillary venules (Nathan, 2002). As the avidity of the integrins 
expressed on the leukocyte membranes toward adhesion molecules on the endothelium 
increases, leukocytes become immobilised (Trautmann, 2005). It is the exposed 
endothelium present in these venules that enables leukocytes to interact with 
endothelium, the primary step in "directing" the immune cells through to the injured 
tissues (Benjamini et al., 1996). The general paradigm governing the adhesion events by 
which immune cells undergo diapedesis (the passage of blood cells through the blood 
vessel walls after the cells have changed shape) are considered in more detail in Section 
7 .1. Briefly, these events include; capture of the leukocytes via interactions with activated 
endothelium (selectins and their carbohydrate ligands), initiating rolling of the leukocytes 
along the endothelium so that integrin molecules on the immune cells bind with counter-
receptors on the endothelial cells (creating firm adhesion) (Enoch and Harding, 2003). 
Following the reconfiguration of adhesion proteins, such as B integrins, in response to 
chemokine binding to surface receptors, leukocytes can then bind to endothelial cells 
lining blood vessel walls (Trautmann, 2005). lntegrins are cell-adhesion receptors which 
enable cell-cell interactions and cell-extracellular matrix communication. The integrins 
are composed of two subunits, one belonging to the a. family, and the other belonging to 
the ~ family (Hynes, 2002). Integrins are one of four types of cell-surface adhesion 
molecules (CAMs), and perform a distinct function from the other three types of CAMs 
(cadherins, Immunoglobulin superfamily, and selectins). lntegrins need to be activated 
before they will bind their ligand (e.g. to VCAMl, MAdCAMl, ICAMs expressed on 
tissues), and clustering of integrins on the cell membrane is necessary for a full biological 
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response (Van Buul and Hordijk, 2004; Worthylake and Burridge, 2001). Re-circulating 
leukocytes also bear adhesion-molecule receptors for the mucin family (GlyCAM-1 and 
CD34) along with the irnrnunoglobulin family (ICAM-1-3, VCAM-1, and MAdCAM-1) 
(Murray et al., 2003). Within seconds of an inflammatory signal being released by 
endothelial cells, P-selectin is expressed on the cell surface, and the leukocyte binds to 
the endothelium via a ligand called the sialyl Lewis-x antigen. After the rolling 
leukocytes slow down through binding with P-selectin (tethering), tight adhesion of the 
leukocyte is effected through activated integrins. The integrin then binds to leukocyte 
integrin ligands, ICAM-1 and ICAM-2, expressed by endothelium (Garbacki et al., 2005). 
Leukocytes do not migrate through epithelium easily without selectin binding, and 
therefore, the combination of integrin binding to integrin ligands, and ligands to 
endothelial E and P-selectin are both necessary. The differential expression of these 
horning receptors provides tight regulation of leukocytes moving into different tissues. 
Once the flattened leukocytes are firmly adhered, diapedesis is facilitated by products of 
the immunoglobulin gene family, enabling the cells to squeeze through the endothelial 
sheet and move toward chemotactic gradients in the target tissues (Benjamini et al., 
1996). Aggregation and shape change of leukocytes undergoing diapedesis are guided by 
various adhesion molecules including CDl lb/ CD18 (Mac-1), CDI la/ CD18 (LFA-1) 
and P-Selectin. Migration through the endothelial wall is guided by various adhesion 
molecules including, ~2 integrins, ICAM-1, VCAM-1 and PECAM-1 (Simon and Green, 
2005; Murray et al., 2003). Chemokines are particularly important in this part of the 
inflammatory response, as they guide leukocytes to the injured or infected site and trigger 
neutrophil phagocytosis. During acute inflammation macrophages derived from 
monocytes destroy microbes, debride wound tissue and release soluble growth factors 
which initiate the second, proliferative, phase of tissue repair. The epithelial tissues 
surrounding the injury site thicken as a result of mitosis and hypertrophy. Ehrlich (1996) 
has stated that optimum thresholds exist for normal wound healing to occur according to 
both time of onset, and duration, of the inflammatory response. Wounds which have late 
onset of inflammation are accompanied by late wound closure and frequently are 
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susceptible to the development of infection. Tissues in which inflammation persists 
beyond the normal time period (such as chronic wounds), or where hypersensitivity 
occurs (increased inflammation intensity) will also be subject to problems associated with 
abnormal healing. 
1.5.2 The proliferation and repair phase 
The development of new blood vessels along the wound margins constitute an integral 
function of the repair phase (Risau, 1997; Slavkin, 2000; Bennett and Schultz, 1993b). It 
is the formation of a blood clot immediately following injury that enables migration of 
cells in to the wound site (Risau, 1997; Slavkin, 2000). Fibrin provides a matrix for 
migration of fibroblasts, keratinocytes and monocytes. Where vasodilation occurs in 
tissue surrounding a bum site, blood flow is restricted in the damaged tissue preventing 
normal cellular migration. As a result of restricted cell movement, thrombus formation 
will frequently occur in arterioles which in tum may lead to local ischemia and tissue 
necrosis (Ehrlich, 1996). Where ischemia and necrosis of the tissues has occurred, it can 
be expected that the wound will take significantly longer for closure to be achieved. The 
appropriate synthesis of growth factors by platelets, such as fibroblast growth factor 
(FGF), TGF-a, TGF-~. and in particular platelet-derived growth factor (PDGF), is 
necessary for migration of fibroblasts (Eswarakumar et al., 2005; Bonner, 2004; Falanga 
et al., 1988). Where growth factor availability is not sufficient for establishment of 
normal mitogenic and chemotactic gradients for fibroblasts, it may be expected that 
delayed development of the collagen matrix will occur (Presta et al., 2005; Ciano et al., 
1986). For these reasons, delayed wound closure is typically correlated with abnormal 
scar formation. 
It is during the proliferative phase of tissue repair that induction of angiogenesis occurs 
and granulation tissue is formed. Collagen and proteoglycan production by the 
granulation tissue leads to an increase in the mechanical strength of the wound. Where the 
wound healing process occurs under optimum conditions, granulation tissue usually 
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appears around 3 days after injury has occurred (Niessen et al., 1998). Granulation tissue 
contains new capillaries, fibroblasts, macrophages and mast cells. The number of 
mononuclear leukocytes present in the damaged tissue continue to increase until they are 
the dominant cell type by the fifth day (Enoch and Harding, 2003). Fibroblasts are 
recruited to the wound site in response to local cytokine production, and divide readily so 
that a very high density of fibroblasts is obtained rapidly (Cook et al., 2000; Mendez et 
al., 1998). Where the inflammatory phase has been prolonged, increased cytokine activity 
may occur and this has been found to correlate with increased keloid formation (Deitch et 
al., 1983). Fibroblast cells continue to increase in number during the proliferative phase, 
and are responsible for the extracellular synthesis of collagen, proteoglycans and 
fibronectin. By the fifth day, granulation tissue fills the entire wound and collagen is 
abundant (Cook et al., 2000). 
Kirsner et al. (1993) describes the migration of epidermal cells as the advancement of an 
epidermal tongue in which the basal cells express selective cell surface markers (such as 
CD44) which are not normally expressed by non-squamous cells. These surface markers 
enable basal cells to move independently of the basement membrane due to loss of 
binding between the cell types. Early studies by Bullough and Mitrani (1978) suggested 
that epithelial cells migrate according to contact inhibition. When loss of contact with 
other cells occurs, individual epithelial cells become motile, and cease migration when 
contact is re-established. 
During angiogenesis, it is thought that factors such as low oxygen tension, lactic acid and 
biogenic amines may stimulate growth regulator production (specifically TGF-~) and 
collagen synthesis (Kirsner and Eaglestein, 1992). Excessive fibrosis, and therefore 
deposition of collagen, may result in abnormal scar development where angiogenesis has 
occurred under hypoxic conditions. The study by Gessin et al. (1988) demonstrated the 
need for vitamin C to be present as a co-factor with detectable oxygen levels for normal 
collagen cross-linking to occur. Where the co-factor was lacking (such as in patients with 
scurvy) or the wound conditions were anoxic, poor wound healing was obtained. 
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1.5.3 Remodelling phase 
The third (remodelling) phase of tissue repair occurs as the open wound is re-
epithelialised and closure of the wound occurs. During re-epithelialisation, the 
granulation tissue matures to form scar tissue. In the normal healing process, fibroblast 
density is reduced via apoptosis as the oxygen levels rise due to neovascularisation 
(Phillips et al., 1998). Interferons produced by T cells inhibit fibroblastic collagen 
synthesis and retard fibroblast proliferation (Kalvakolanu and Borden, 1996). Fibroblast 
translocation of collagen fibrils results in increased packing, giving wound contracture. 
Phenotypic changes to fibroblasts at the margins of the wound to create myofibroblasts 
(containing contractile proteins) enable participation of the cells in wound contracture 
(Ciano et al., 1986). By pulling the surrounding skin in to the scar, contracture increases 
the breaking strength of the healed wound (up to a maximum of 80% of the original 
tensile strength of the uninjured tissue). There is a change in the type of collagen present 
in the wound during the remodelling phase, so that type ill collagen is lysed by 
collagenases produced by a number of cells ( epithelial cells, fibroblasts, macrophages, 
and leukocytes) and be replaced by type I collagen (Enoch and Harding, 2003). Thinning 
of the epithelium occurs around the healed site and the tissue acquires an attachment to 
the underlying dermis as it matures. The change of collagen type in the mature healed 
wound leads to a change in orientation of the scar tissue over the following 6 to 12 
months (Kanzler et al., 1986). Therefore, adequate collagen breakdown by tissue serine 
proteases and proteolytic enzymes is a crucial factor in determining the final appearance 
of a scar. 
1.6 THE PATHOGENESIS OF SOME KEY INFLAMMATORY DISEASES 
Inflammation is a double-edged sword, as the inflammatory process which fights off 
pathogens and enables tissue repair may induce pathological diseases in some 
inflammatory situations (Enoch and Harding, 2003; Coussens and Werb, 2002; Benoist 
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and Mathis, 2002). Honey may provide the therapeutic answer to the immune dichotomy 
(Molan, 1993). 
1.6.1 The compromised immune system prevents normal healing 
When patients have an abnormal leukocyte count, either through primary disorders 
caused by illness (leukemia, AIDS) or through secondary disorders caused by medical 
treatment (chemotherapy) this will have dire consequences for production of the soluble 
mediators which orchestrate inflammation (Dow et al., 1999)(Figure 1.2 illustrates this). 
Where leukocytes are present at abnormally low densities, cytokine production will be 
limited and therefore, suboptimal recruitment of endothelial and epithelial cells to the 
injury site will result (Dow et al., 1999). Phagocytes present at low densities would be 
unable to clear contaminants from the injured tissues, and if bacteria were present they 
could thrive unchecked in the necrotic tissue (Thomson, 2000; Dow et al., 1999; Bucalo 
et al., 1993; Facklam and Washington, 1991). Moreover, if epithelial cells are not 
signalled to close the wound in the final phase of tissue repair, normal healing cannot be 
achieved (Benjamini et al., 1996), and the condition of the wound will deteriorate further 
(Dow et al., 1999). Fibroblasts taken from the edges of chronic venous leg ulcers have 
been found to be less proliferative than normal fibroblasts and it was concluded from 
their altered morphology that these cells had become senescent (Stanley et al., 1997; 
Campisi et al., 1996). If chronic wounds persist for long periods of time it becomes 
increasingly difficult to stimulate healing in the wound environment due to breakdown of 
protease inhibitors such as a2-macroglobulin and al-proteinase inhibitor (Grinnell and 
Zhu, 1996; Rao et al., 1975). When proteases are no longer regulated, the glycoprotein 
fibronectin, which plays an essential role in keratinocyte migration, is constantly 
degraded (Grinnell and Zhu, 1996; Wysocki et al., 1993). Therefore, the development of 
therapeutic agents which can stimulate healing in immune-compromised patients, and 
cause minimal side-effects is of immense value. Based on the observations by Tonks et 
al. (2001) that honey induced cytokine release by resting monocytes, it has been 
hypothesised that honey may boost the immune system and this would be beneficial to 










General introduction and literature review 




Low recruitment of 
phagocytes into wound* 
' 
Wound contaminants not 
removed, bacteria thrive in 
wound debris* 
, I, 
Antigen stimulation of 
leukocytes, low cytokine 
gradients produced due to 
low leukocyte count 
'~ 
I Failure to heal I 
f,c . .............. . 
. ......................... . 
1 Failure to remove 1 
· infection · 
.. .......... A .......... .. 
Figure 1.2: Concept diagram illustrating the development of chronic infection in an immune compromised 
patient. Low leukocyte counts following chemotherapy treatment create suboptimal gradients of 
intercellular messages, and the immune system is slow to respond to infection. Points at which honey is 
hypothesised to have some activity are indicated by *. 
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immune-compromised individuals. Once cytokines have been produced, bystander 
activation leads to the stimulation of neighbouring cells (Figure 1.1). 
1.6.2 Safety issues associated with use of honey as a therapeutic agent 
Where antiseptics are used to clean the wound, their cytotoxic nature damages the healing 
tissues, thus prolonging the healing process. Molan (1998) has noted that no adverse side-
effects from using honey as a wound dressing have been reported in clinical and 
histological observations of humans and experimentally for animals. None were reported 
either in the many papers on the use of honey in opthalmology (Molan, 2001). In a survey 
conducted by K.iistala et al. (1995) allergies to honey were found to be rare. However, 
Helbling et al. (1992) proposed that severe allergies can occur due to the presence of 
pollen and bee proteins in honey. Molan and Allen (1996) demonstrated that the potential 
risk of wound botulism could be avoided by gamma-irradiation of honey to remove 
spores of Clostridium botulinum with no associated loss of antibacterial activity. With 
regard to the possible use of honey as an anti-inflammatory, it is ideal that honey 
produces virtually no side-effects. In the reports reviewed by Molan (1999) only 5 cases 
out of 470 cases treated with honey failed to successfully heal. Only one case in this study 
exhibited side-effects from the honey, in this case painful reactivity to honey as a topical 
treatment. 
1.6.3 Fibrosis as an example of excessive inflammation 
Clinically, keloid scarring is characterised by the presence of excessive dermal collagen 
beyond the confines of the original wound, so that the scar tissue is raised (Figure 1.3). 
Keloid scarring provides a key example of an inflammatory condition which results from 
the unregulated proliferation of fibroblasts during the proliferative phase of tissue repair 
(Figure 1.4). Histologically, keloids consist of the haphazard deposition of collagen fibres 
within the dermis, surrounded by a mucinous extracellular matrix with few macrophages 
and an abundance of eosinophils, mast cells, plasma cells, and lymphocytes (Urioste et 
al., 1999). 
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Figure 1.3: Characteristic appearance of a keloid scar. Note how excess collagen deposition has resulted in 
the characteristically raised and inflamed scar tissue. 
The existence of a keloid scar is the result of persistent inflammation during the 
proliferation phase of wound repair, so that cytokines were produced at excessive levels 
leading to fibrosis (Urioste et al., 1999) as summarised in Figure 1.4. Keloids are 
frequently pruitic, may form strictures and cause much pain for sufferers. Emotional 
suffering as a consequence of cosmetic disfigurement is common to those who exhibit 
keloids. Once developed, keloid scars tend to persist over time as compared to 
hypertrophic scars, which frequently undergo some degree of regression. There are many 
factors which can affect wound healing: the patient's health, nutritional status and 
intervention in the healing process can affect the outcome and affect the incidence of 
excessive scarring. Keloids only occur in humans, and it appears that ethnicity 
predisposes some individuals to keloid development (Ketchum, 1977; Alhady and 
Sivanantharajah, 1969). Though keloids have long been recognised as areas of abnormal 
healed tissue in records dating back as far as the Smith Papyrus around 1,700 BC, the 
exact mechanism by which they are formed and the best course of treatment for and 




, ............ '.'- ............ . 
Continue to 
· : produce ROI and 
: growth factors 
·············.·············· 
············-~·-···········. 









excessive cytokine levels* 
Abnormal cytokine 
gradients generate high 
levels of ROI* 
NF-KB activated, DNA 








Formation of large, 







· ............ ' ........... . 
Figure 1.4: Concept diagram illustrating one mechanism by which a keloid scar may develop as a result of 
excessive inflammation (fibrosis). There are a number of theories about the causal mechanisms for keloid 
development, but ultimately they occur when the normal mechanisms governing fibroblast proliferation are 
lost. One theory is that the excessive production of cytokines and oxidant species by endothelial cells drives 
fibrosis. Possible points at which honey may intervene are indicated by*. Definitions: ROI reactive oxygen 
intermediates, NF-KB nuclear transcription factor KB. 
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Though the actual cause of keloid development remains to be elicited, the best accepted 
theory is that keloids occur when normal control over cell proliferation has been lost. In 
patients exhibiting keloid development, collagen synthesis occurs at a rate 20 times 
greater than for patients with normal skin (Cohen et al., 1971). Oxidant species have been 
reported to alter the DNA of cells and may lead to development of abberant cell types 
such as occur in keloid scars and cancerous lesions (Coussens and Werb, 2002; Finkel 
and Holbrook, 2000; Li and Karin, 1999; Ames et al., 1993). Changes in DNA may lead 
to the loss of tight regulation over inflammatory mediator production (Enoch and 
Harding, 2003), and the ability for cells involved in the wound repair process to function 
according to normal parameters (Coussens and Werb, 2002; Finkel and Holbrook, 2000; 
Li and Karin, 1999; Ames et al., 1993). Antioxidants have been demonstrated to prevent 
damage to DNA caused by oxidant species (Grimble, 1994). 
A long-held theory for keloid development is that abnormal molecular defects produce 
abnormal signals from cytokines and growth factors. Cytokines and growth factors 
transmit signals in to the cytoplasm that start a cascade of growth signal transduction 
reactions. The sensitivity of keloid-derived fibroblasts to growth factors may also be 
significant, as some growth factors induce collagen accumulation (Slavkin, 2000; Overall 
et al., 1989; Ignotz and Massague, 1986). There may be a defect in genes contained in 
keloid-derived fibroblasts that prevents switching off of collagen synthesis. The inability 
of aberrant genes (oncogenes) to regulate cell division has been identified as a main factor 
in tumour development (Weinberg, 1989). Mutations in the genes involved in the cell 
cycle could explain observed increases in proliferation and yet decreased apoptosis as 
described for keloid-derived fibroblasts (Yoshimoto et al., 1999). 
Cohen et al. (1971) demonstrated that a disproportional increase in collagen anabolism 
over catabolism contributed to the uncontrollable collagen synthesis by keloids. The 
collagen contains dense masses of fibroblasts within hyalinized bands of eosinophilic 
nodules (Kischer, 1992). The failure of tissue serine protease and proteolytic enzymes to 
breakdown collagen leads to persistence of collagen in the scar, which appears shiny and 
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bulky (Cook et al., 2000; Urioste et al., 1999; Overall et al., 1989). Hydrogen peroxide 
has been demonstrated to activate serine tissue proteases and proteolytic enzymes, and 
therefore it is hypothesised that honey may act here (Section 1.4.1). Excessive endothelial 
cell proliferation, and subsequent perpetuation of both cytokines and oxidant species, 
results in the development of numerous microvessels encircling the fibroblast-containing 
nodules. Direct application of antioxidants has been shown to reduce excessive cytokine 
production and mediate production of oxidant species (Grimble, 1994), and it is 
hypothesised that the antioxidant content of honey means it might have activity here 
(Section 1.4.1.1). The observation that keloid-derived fibroblasts require very low oxygen 
levels to proliferate (Kischer et al., 1982), raises the possibility that stimulation of 
angiogenesis by hydrogen peroxide (Burdon, 1995; Tur et al., 1995), with the 
accompanying rise in oxygen levels, may inhibit the activity of keloid-derived fibroblasts. 
In an earlier investigation, Diegelmann et al. (1977) reported collagenase inhibitors 
(specifically, cx.1-antitrypsin and cx.i-macroglobulin) were present at much higher levels in 
the keloid. The prevention of collagen breakdown by collagenase is further enhanced by 
the occurrence of chondroitin-sulphate at significantly higher levels in the keloid scar 
(Linares et al., 1993). Chondroitin-sulphate functions to strengthen collagen fibres to 
withstand degradation by collagenase. In normal skin, proteoglycans are responsible for 
mediating fibrosis, and these have been found to occur at subnormal levels in keloids, 
therefore the potential for hydrogen peroxide to stimulate protease activity suggests that it 
may overcome problems with collagen remodelling. 
Other growth factors which occur at elevated levels in keloid scar tissues include; IL-1, 
insulin-like growth factor-1, platelet-derived growth factor, and tumour necrosis factor 
(TNF) (Ghahany et al., 1995; 1993; Lynch et al., 1989). The observation that honey can 
alter cytokine expression (Tonks et al., 2001) leads to the hypothesis that it may 
manipulate at this step in keloid development. 
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1.6.3.1 Existing treatments/or keloid scars 
The existing treatment methods available for prevention and alleviation of keloid scarring 
are briefly reviewed as they illustrate the need which exists for development of a new 
therapy. Furthermore, a comparison of honey to existing treatments highlights the 
potential benefits of its use. 
Existing treatment methods for keloid scars are limited and are used with varying success, 
but many of the more successful methods have undesirable side-effects (Berman and 
Bieley, 1995; Lawrence, 1991; Sherris et al., 1995; Boyadjiev et al., 1995; Darzi et al., 
1992; Tang, 1992; Kiil, 1977). Honey has been reported to be free of side-effects (Section 
1.6.2). Despite poor success, surgical excision has been one of the long-standing 
treatment methods for keloids (Lawrence, 1991; Rockwell et al., 1989). Pressure therapy 
is another keloid treatment method with a long history and a better success rate than 
excision, with recurrence rates of 15-40% (Rockwell et al., 1989; Linares et al., 1993; 
Ward, 1995). Steroidal treatments have been widely used for keloid scars (Berman et al., 
1995; Lawrence, 1991; Sherris et al., 1995; Boyadjiev et al., 1995; Darzi et al., 1992; 
Tang, 1992; Kiil, 1977). Steroids bring some initial relief from the painful aspects of 
keloids, itching and burning, and limited flattening and softening of the scar but have 
been associated with various undesirable side-effects (Murray, 1993). Gastrointestinal 
side-effects are a common consequence of steroid use, and may range from mild bowel 
upsets to ulceration (Nemeth, 1993). hnpaired wound healing often results from steroid 
use (Hunt et al., 1969). Skin hypopigmentation, depigmentation, telangiectasia, and 
necrosis may result (Boyadjiev et al., 1995; Friedman et al., 1988). Though many of these 
side-effects are reversible when the steroid source is removed, complications have been 
recorded where the steroid has entered the surrounding dermis tissue (Murray, 1993). The 
long term use of steroids is not desirable due to development of tolerance in the patient 
and the need for increased dose (Murray, 1993). Radiation therapy continues to give 
moderate success, with a mean recurrence rate of 44% of cases (Berman et al., 1995). 
When combined with surgical excision, mean recurrence rates have been reduced to 24% 
30 
Chapter One General introduction and literature review 
cases (Berman et al., 1995). The other major category of anti-inflammatory drugs are the 
NSAIDS (non-steroidal anti-inflammatory drugs). The mode of action of the NSAIDS in 
tissues is mainly mediated by inhibition of cyclooxygenase activity (Goldstein, 1988). 
Cyclooxygenase is the enzyme responsible for the biosynthesis of prostaglandins, 
released from damaged tissues. NSAIDS include the common drugs, aspirin and 
ibuprofen (administered for rheumatoid athritis), diclofenac (Voltaren), and sulidac. The 
NSAIDS vary widely in their effects on inflammation. Gabriel et al. (1991), identified the 
high incidence with which gastric ulceration accompanies NSAID use. 
1.7 A™S OF THIS STUDY 
The general aim of the current study was to test the effect of honey on a variety of cells 
active at different steps in the inflammatory process, pertinent to wound healing. As 
inflammation is a broad and complex process, and it is not possible to investigate all of 
the cellular interactions involved in a time-limited doctoral study, assays were restricted 
to a small selection of key experiments. The objectives of each experiment are addressed 
in detail at the beginning of each section. 
Prior to this study, few, limited studies had been published which elucidated the 
mechanism by which honey has activity on cells involve in the inflammatory response, in 
vitro. Therefore, a starting point for this thesis was to repeat these limited studies (Tonks 
et al., 2001; Abuharfeil et al., 1999), extending the range of honeys tested and assays 
employed. One of the key objectives of this thesis was to test whether honey has any 
effect on cells active in the early inflammatory phase, and specifically whether honey has 
activity on those cells involved in cytokine production, and therefore cellular recruitment 
(peripheral blood mononuclear cells, focusing on T cells and monocytes). Following a 
series of investigations to determine whether honey has additional activity on T cell 
proliferation beyond that reported by Abuharfeil et al. (1999), receptor staining would be 
used to examine how honey was having this stimulatory effect. Measurement of mRNA 
expression would be used to investigate whether honey had an effect on gene expression 
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for cytokines involved in wound healing. Further, measurement of TNF protein and NO 
would be used to examine whether honey has any effect on production of functional 
protein beyond that which had been reported by Tonlcs et al. (2001). Inclusion of known 
mitogens would be used to provide positive controls against which to compare the 
magnitude of any effects of honey, with a view to assessing whether honey could 
exacerbate inflammation. The inclusion of cells incubated with known mitogens and 
honey would provide a model on which to test for any modulatory effects of honey, and 
therefore, to examine whether honey has any anti-inflammatory effects at this level. 
To investigate whether honey might have any effect on the movement of cells through the 
tissues, the effect of honey on tight junction integrity would be examined. This would 
indicate whether honey might affect the permeability of tissues to leukocytes. The ability 
for honey to modify the uptake of bacteria by neutrophils would be evaluated using a 
commercially available phagocytosis assay, with implications for debridement of wounds. 
To test whether honey plays a role in wound closure, assays would be conducted to 
measure whether honey has activity on fibroblast proliferation. With specific relevance to 
fibrosis, fibroblasts would be cultured with honey and Il..-1 ~. to examine whether honey 
would have any anti-inflammatory effect on the response of fibroblasts to a mitogen 
known to drive fibrotic scar formation. 
Anecdotal reports suggest that honey has both immunostimulatory and anti-inflammatory 
activity, although the mechanism by which this occurs has not yet been established. The 
present study aimed to characterise any activity into fractions of different molecular 
weights, and where activity was found, to discuss the likelihood of the active agent in 
light of published reports. Therefore, a final objective of this thesis was to present a 
comprehensive discussion about the mechanisms by which honey has activity in vitro and 
the feasibility of these observations being realised in vivo. Thus, the objectives of this 
thesis were to screen a broad range of cells for the effect of honey at various steps of the 
inflammatory process, and consider the implications of these observations for wound 
healing. 
Chapter Two: Effects Of Honey On The Proliferation Of T 
Cells 
SUMMARY 
To investigate whether honey could stimulate bovine T cells to proliferate in vitro, both 
MTT and BrDU assays of proliferation and flow cytometry analysis were used. It was 
found that low concentrations of honey stimulated resting T cells to proliferate and 
express the IL-2 receptor in a dose-dependent manner with progressive dilution. This 
suggests that honey contains. lymphomitogenic factors. Manuka honey was stimulatory 
at higher dilutions than pasture honey. Low concentrations of honey induced cell 
division profiles similar to those obtained with Con A-stimulated cells. The stimulatory 
activity of honey was found to be in a high molecular weight fraction. Sugars alone had 
no effect on T cell proliferation, as demonstrated by use of artificial honey (a syrup of 
sugars as in honey). 
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2.1 INTRODUCTION 
Prior to this study several clinical trials had been conducted which demonstrated the 
potential for honey to optimise wound healing. Honey has been observed to promote 
healing of a range of wounds in humans (Molan, 1999; Molan, 1998; Efem, 1988) and 
in experimental animal wound studies (Oryan and Zaker, 1998; Postmes et al., 1997; 
Kumar et al., 1993; Gupta et al., 1992; Bergman et al., 1983, Burlando, 1978). Of 
particular relevance to this chapter it was noted that topical application of honey to a 
variety of wounds led to increased cell recruitment in the wound bed (Subrahmanyam, 
1999; Efem, 1988; Subrahmanyam, 1998) and specifically of lymphocytes (Oryan and 
Zaker, 1998), a key cell type involved in the early stages of repair. Lymphocytes 
constitute a key group of immune cells involved in the inflammation pathway. A study 
by Abuharfeil et al. (1999) demonstrated that low concentrations of honey (0.1 % ) 
induced proliferation of lymphocytes in vitro. As topical application of honey on 
wounds is effective despite the likelihood that the concentration of active component(s) 
diffusing into the tissues is low, this suggested that honey may have activity at 
concentrations below those previously tested. Further, studies on experimental wounds 
in animals reported that orally-administered honey was more effective in treating 
surface wounds than was topically-applied honey (Suguna et al., 1993; Suguna et al., 
1992; El-Banby et al., 1989; Kandi! et al., 1987) so that the effective dose of active 
component would be lower at the wound site. Therefore, the current study aimed to 
investigate the possibility that honey would have activity on lymphocytes at lower 
concentrations than had previously been tested. 
Due to the availability of bovine blood and cell lines from various origins, along with 
the constraints of ethical approval and resources for human studies, assays were 
restricted to the use of these cells. While the activity of cytokines on specific cells is 
known to vary slightly between human and bovine systems (Collins et al., 1999), it is 
assumed that the ability for honey to activate the inflammatory pathway would be 
applicable to both. The use of non-human cell-based inflammation models for human 
application studies is accepted as a viable model in several key wound healing studies 
(Goncalves et al., 2001; Greenwel et al., 2000; Klyubin et al., 1996 and Granstein et 
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al., 1990). These in vitro assays in no way include or contain the complex interactions 
of multiple defense mechanisms that are active in the human body or indeed in vivo in a 
cow. 
Lymphocytes are comprised of two sub-populations, the T cells (including T-helper 
cells) active in cell-mediated immunity, and the B cells which produce antibodies after 
antigenic stimulation (during infection). T cells are the focus of this chapter as they play 
a pivotal role in the inflammation pathway, lysing infected cells and producing 
cytokines which cause subsequent cell recruitment in the inflammation cascade. For 
this reason, the following background has been restricted to a brief overview of T cell 
biology. 
T cells play a central role in host defence and mucosal immunity, and are continuously 
moving through the blood, tissue and lymph (Cunningham, 2002). T cells are mediators 
of immunity and their activation is controlled through interactions with APCs. 
Macrophages play an important role in antigen presentation along with dendritic cells. 
Within the thymus T cells are differentiated from lymphoid cells, and are released as 
mature T cells into the circulation. T cell differentiation in the thymus is accompanied 
by changes in surface markers, with DNA rearrangements generating a diversity of T 
cell receptors (TCRs). Within the thymus there are three selection steps for the 
development of mature T cells. Initially there is positive selection for T cells which 
express both CD4 and CD8 accessory molecules, followed by further selection for cells 
expressing the mature TCR CD4+CD8+ (double positive). The final selection stage is 
the deletion of T cells recognising self antigen, so that the T cells released into the 
circulation will exhibit self-tolerance. Positive selection is unique to T cells which are 
selected for a moderate affinity for self major histocompatability complex MHC-
peptide complexes. MHC are self marker proteins that either link to antigens so they 
can be presented to CD8 cytotoxic T cells (class I), or are found on APC and display 
antigen to CD4 T cells (class II). For the life of each T cell, they will only recognise 
those antigens for which they are specific, and combined in a complex with MHC. T 
cells will enter apotosis if they cannot express their TCR, are not positively selected or 
are removed by negative selection. Those T cells which are removed by negative 
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selection and are not controlled have implications for the development of autoimmune 
diseases. The positively selected mature T cells then lose either their CD4 molecules or 
their CDS molecules and become differentiated as T cell subsets. 
The presence of a complex of transmembrane polypeptides (such as CD3, CD4 and 
CDS) on the cell surface influences antigen binding. The CD3 marker indicates T cells 
as compared with B cells (CD3 negative). Antigen-specific T accessory cell interactions 
occur through the TCR/CD3-MHC/peptide complex (Dewar et al., 2005). Individuals 
possess millions of different T cells, each with a unique TcR for antigen recognition. 
CD4+ T cells exist in two subsets, Th 1 and Th2, producing distinct cytokine profiles, 
with distinct cellular targets. ThO precursor cells make a diverse range of cytokines, and 
are differentiated after activation in the presence of Il...-12 and Il...-18 (released by 
dendritic cells) into Thlcells, or in the presence of Il...-4 (released by B cells) into Th2 
cells (Vos et al., 2000; Murphy, 1998; Sallusto et al., 1998; Abbas et al., 1996). Thl 
cells produce IFN-y, TNF-a, TNF-y, and Il...-2, and regulate classical delayed 
hypersensitivity reactions around macrophage activation and T cell-mediated immunity. 
The Th2 subset on the other hand produce Il...-4, IL-5, Il...-6, Il...-10 and regulate 
immediate hypersensitivity reactions and participate in B-cell antibody-mediated 
immunity (Sauty et al., 1999; Murphy, 1998; Sallusto et al., 1998; Abbas et al., 1996). 
CDS+ T cells respond to viral infections, tumours and also participate in some bacterial 
and protozoan infections. Termed cytotoxic T cells, CDS+ cells kill host cells with 
surface expression of foreign antigens (e.g. harbouring a virus). The recognition of a 
peptide/MHC complex on the surface of an APC by CDS+ T cells is so highly sensitive 
that antigens can be detected at very low densities (Gonzalez et al., 2005). 
On leaving the thymus, T cells recirculate between blood and lymph nodes or mucosa! 
lymphatic tissues. It is in the secondary lymphoid organs that proliferation occurs after 
activation by antigen presented on APC. While naive lymphocytes appear to navigate 
all tissues without bias, memory cells return to tissues in which they first encountered 
antigenic stimulation. Protein antigens are ingested and processed into antigenic 
fragments by activated macrophages or other host APCs (dendritic cells, Langerhan's 
cells). The antigenic fragments are complexed with MHC and presented on the surface 
of the APC to receptors for antigen on helper T cells (CD4+ ). B cells can also process 
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and present antigen to helper T cells. Naive T cells encounter dendritic cells carrying 
antigen in the lymph nodes which stimulates the T cells to proliferate and to express 
activation molecules. Until naive T cells have been stimulated by antigen, they have no 
effector functions, and their sole activity is to recirculate through the peripheral lymph 
organs. In the case of inflammatory skin diseases, the expression of the cutaneous 
lymphocyte-associated antigen (CLA) marker on these previously naive T cells leaving 
the lymph node means that they can home to the site of antigen origin (Cunningham, 
2002). T cells require two signals for full activation to be achieved, the first being 
antigen-specific and delivered through the TCR. A co-stimulatory signal is transmitted 
through the receptor-ligand interaction occurring between surface molecules on APCs, 
B cells and T cells. For example, it is the binding of the CD40 costimulatory molecule 
on the T cells to the CD40L ligand on the dendritic cells which enables antigen 
presentation to be initiated. If adhesion molecule expression can be blocked then it is 
possible to stop T cell proliferation (Dewar et al., 2005). Conversely, overexpression of 
T cell integrins is linked to the development of autoimmunity (Yung et al., 2003). 
The APCs then produce more cytokines (e.g. IL-2) which act to enhance T cell 
proliferation. Indeed, cell-to-cell interactions are critical for T cell proliferation to occur 
(Dewar et al., 2005). The costimulatory signal provided by the APC is received by the 
T cells via CD28/CTLA-4, and this drives the cell to enter the cell cycle and to 
proliferate. T cells themselves clump together in order to initiate proliferation through 
the interaction of LFA-1 and ICAM-1. The interaction of LFA-1 and ICAM-1 is 
therefore of key significance for many cell-cell mediated activities including; T cell 
proliferation, the binding of T cells to endothelium and part of the T cell immunological 
synapse with dendritic cells. 
The antigen signal must be sustained for long enough for the T cells to fully commit to 
mounting an immune response (Gonzalez et al., 2005), and must be withdrawn before 
the T cells become committed to apoptosis. The concept of an immunological synapse 
was introduced in Section 1.5.1. At the immunological synapse, a central cluster of T 
cell receptors are surrounded by a ring of adhesion molecules, and this is where full 
activation of the T cell by the antigen occurs (Trauttman, 2005). 
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Molecules expressed on the endothelium recruit T cells into the tissues. In Section 
1.5 .1, the need for T cell-specific chemokines and cytokines to direct movement of the 
cells toward infected and injured tissues was outlined. As discussed in Section 1.5.1, T 
cells can only receive chemokines and cytokines for which they have the corresponding 
receptors. 
There are a number of pathways by which T cells can be activated. Antigen-
independent interactions are achieved via costimulatory molecules, adhesion molecules 
and cytokines (Dewar et al., 2005). Natural Killer cells exposed to microbial factors 
(e.g. LPS) produce IFN-y and IL-18, in turn stimulating the release of IL-12 froni 
macrophages and dendritic cells. The APCs themselves will be induced to produce IL-
12 by LPS. The IL-12 is received by the IL-12Ra,~ receptor on Thl T cells (Luzzati et 
al., 1997). Changes in Stat-4 induce the Th-1 cell to produce IFN-y, a self perpetuating 
stimulation then occurs as Thl cytokines further Thl responses and indeed 
downregulate Th2 responses. Stat are a family of cytokine receptor signalling 
molecules. Th-1 cells receive RANTES via the CCRl chemokine receptor, Macrophage 
Inflammatory Protein-I (MIP-la,~) via the CCR5 receptor and IP-10 via the CXCR3 
receptor. TGF-~ released by activated Th-0 cells may co-stimulate Th-1 cells along 
with IL-12. Th-2 cells may be co-stimulated by TGF-~ and IL-4. Exogenous IL-4 (e.g. 
released by activated ThO cells in response to dust mite allergens) is received by the IL-
4R receptor on the Th2 cell, and corresponding changes in Stat-6 stimulate the Th2 
cells to release IL-4, creating a self perpetuating stimulation cycle. The chemokines 
Eotaxin (binds to CCR3) and Macrophage derived Chemokine (MDC) which is 
received by the CCR4 receptor further stimulate Th2 cells. The Th2 cytokine profile 
promote the allergy pathway, with IL-2 and IFN-y promoting Ig02, IL-4 promoting 
IgG 1 and lgE, and IL-5 promoting IgA. Once the Th cell response has been polarised 
and full activation has occurred the antigen can be presented directly or indirectly to 
activate different effector cells, macrophages, neutrophils and CD8+ T cells for Thl 
responses, and eosinophils, mast cells and B cells for the Th2 response (Fallon, 2000; 
Hammond et al., 1999; Louis et al., 1998; Murphy, 1998; Sallusto et al., 1998; 
Zelenika et al., 1998; Carter and Swain, 1997; Groux et al., 1997; Abbas et al., 1996; 
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Mosmann and Sad, 1996). Other key cells known to activate T cells include mast cells, 
which can promote T cell activation by means of soluble factors, and enhance T cell 
proliferation and activation (Nakae et al., 2005). 
Once T cells have encountered antigen in the lymph nodes and become fully activated, 
they home to the site of antigen origin. In proximity to the post capillary venule, the T 
cell encounters E-selectin on the endothelial cell surface, and becomes tethered 
(Cunningham, 2002). The leukocyte homing process to target tissues was outlined in 
Section 1.5.1. After becoming tethered to the endothelial cell surface, T cell integrins 
(e.g. LFAl or VLA4) interact with adhesion molecules released by the endothelium 
(e.g. ICAM 1 and VCAM 1), and undergo extravasation to the inflammation site 
(Cunningham, 2002). While the a chemokines are primarily responsible for activation 
of T cells, the ~ chemokines assist chemotaxis of CD4 and CD8 T cells and also 
monocytes (Cunningham, 2002). As mentioned in Section 1.5.1, the efficiency of T cell 
activation depends on a complex interplay between receptor-mediator-antigen kinetics 
and epitope density on the APC. Further evidence that there are a number of signals 
which determine recruitment of leukocytes, comes from the recent discovery that a fat-
like compound, Sphingosine 1-phosphare (SlP), binds to a receptor on T cells and 
assists in the migration of T cells to inflamed or injured tissues (Goetz! and Rosen, 
2005). When excess SlP is produced, T cells infiltrate healthy tissues, leading to the 
development of autoimmune diseases. All of the immunoregulatory lipid molecules 
have effects on cells through G protein-coupled receptors. The lipid molecules have 
diverse effects from proliferation and survival through to migration and signalling. 
However, unlike S lP, which has a generalised effect on T cells (and many other cell 
types), many of the other lipid mediators have effects only on specific subsets of T 
cells. 
The prime function of T cells is to communicate with other cells via soluble cytokine 
mediators and to recognise and kill cells with foreign antigen expressed on their 
surface. During inflammation the ability of T cells to proliferate plays a key role in the 
production of cytokines at adequate levels for subsequent immune cell recruitment to 
the site of tissue injury. When a specific T cell encounters a pathogen it recognises, it 
becomes activated. It must then amplify in order to deal with the infection. The 
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amplification step (T cell proliferation) is dependent on the T cell growth factor, 
lnterleukin-2 (IL-2), which is produced by the Thl subset of CD4+ T cells. T cells must 
first increase expression of receptors for IL-2 before they can respond to this chemical 
signal. Once they can receive IL-2 they proliferate, subsequently boosting the 
lymphocyte population (Los et al., 1995). It is noted that the terms T cell activation and 
T cell proliferation are not necessarily interchangeable. 
However, proliferation of the local T cell population is not sufficient for inflammation 
to proceed at the optimal rate. Homing of circulating lymphocytes to sites of tissue 
injury is the other key process by which recruitment occurs. The process of homing is 
discussed in detail in Chapter 1, and is therefore mentioned briefly here. 
It is evident that there is vast potential for therapeutic agents to intervene at any step in 
T cell function. T cell activation in vivo can be distinguished from that induced in vitro 
by diverse agents such as antigens, plant mitogens, and cytokines (Peacock et al., 1990; 
Kem et al., 1986; Weiss et al., 1986; Meuer et al., 1984). Antibody stimulation may 
also be used to activate T cells in vitro but may have in vivo implications. The two 
parameters which were chosen for investigation in this study were the effect of honey 
on T cell proliferation and the effect of honey on expression of the interleukin-2 
receptor (IL-2 receptor) on the T cell membrane. These aspects were chosen because 
they are easily measured and the techniques used have been well documented in the 
published literature. 
Testing the ability of substances (in this case honey) to induce T cell proliferation is 
easily achieved in an in vitro system. This type of experimental work has been a starting 
point for many investigations aiming to screen various substances for potential 
immunogenic effects (Colic et al., 2002; Wilasrusmee et al., 2002; Wong et al., 1996; 
Yun et al., 1996). Moreover, lymphocytes can be readily used in an in vitro system to 
model inflammation and test the effect of therapeutic agents on inflammation. An 
inflammatory response is easily induced in T cell populations by the mitogenic 
substance Concanavalin A (Con A). Con A is termed a mitogen because it stimulates T 
cells to divide (Kirjavainen et al., 1999). The rationale for using a mitogen to stimulate 
T cell proliferation in these assays was to simulate the inflammatory situation where T 
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cell activation, and subsequent proliferation, occurs along the same pathway. Many 
published studies have used lectins (e.g. Con A) successfully to create a proliferative 
response by lymphocytes in an in vitro culture system (Miller et al., 1991; Young et al., 
1994; Abuharfeil et al., 1999). The binding of Con A to surface glycoproteins initiates a 
series of early activation events including the phosphorylation of intracellular proteins, 
breakdown of phospholipids and a rise in intracellular calcium levels (McCole et al., 
1998). These changes induce nuclear effects and have impacts upon transcription of 
genes in the nucleus. It is these changes that induce the expression of IL-2 receptor and 
the production of IL-2. To investigate whether honey had any stimulatory activity on T 
cell proliferation it was planned to compare the cell response to honey to that induced 
by Con A. 
While it is essential for lymphocytes to undergo proliferation in order to drive the 
inflammatory process, excessive proliferation is harmful to the patient. The importance 
of obtaining cytokine production at levels deemed to be within the normal range to 
create normal wound healing has been discussed at length in Chapter 1. It should be 
emphasised here that cytokine levels falling either side of the normal range may lead to 
impaired wound healing. Low levels of white blood cell activity and, specifically, 
subnormal recruitment of lymphocytes and monocytes will result in inadequate 
production of cytokines needed to stimulate the healing process. Conversely, excessive 
T cell proliferation and subsequent production of cytokines at very high levels can 
contribute to development of various diseases. Where the inflammatory process 
continues for longer than deemed normal, persistent inflammation may result. The role 
of persistent inflammation in keloid development (and auto-immune diseases such as 
arthritis) have been discussed in Chapter 1. However, autoimmune diseases have the 
added complication of populations of aberrant T cells which have escaped positive 
selection in the thymus and are able to respond to antigen on host cells. Effectively this 
means that during autoimmune disease lymphocytes attack the host's own immune 
system, a battle which can only be alleviated by therapeutic intervention or death, and 
produce inappropriate levels of cytokines as a side-effect. Thus in the search for a 
therapeutic agent which enhances T cell activity it is important to remember that 
promotion of excessive mitosis would be a dangerous feature. Taking Con A-stimulated 
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cultures to represent a model of chronic activation, the potency of honey could then be 
compared. 
2.2 MATERIALS AND METHODS 
2.2.1 Reagents 
RPMI complete medium 
All PBMC cultures used RPMI complete medium. A 200 ml volume consisted of 1 X 
RPMI 1640 (GibcoBRL, Grand Island, NY, USA, Cat #11875-093), supplemented with 
L-glutamine (2 mmoVL); 1 % Hepes for buffering in air at 37 ° C (20 mmoVL, BDH 
Laboratory Supplies, Poole, England); sodium bicarbonate (0.396 g, Scientific Supplies 
Ltd, East Tamaki, Auckland); 10% foetal calf serum, NZ origin (GibcoBRL, Cat # 10 
091-148); 10 µl of 2-Mercaptoethanol (0.5 µM, Sigma Chemical Co, St Louis, MO, 
USA); and 1 % Penicillin-Streptomycin (containing 5,000 units/ml penicillin G sodium 
and 5000 µg/ml streptomycin sulfate in 0.85% saline, GibcoBRL, Cat# 15140-122). 
The final volume was achieved by adding RPMI 1640. The pH was adjusted with lN 
NaOH or lN HCl to 7.3 and sterilised by passing small amounts through a sterile 0.2 
µm Sartorius Minisart filter (Sartorius, Gottingen, Germany). The final pH was 
approximately 7.5. 
Ammonium chloride lysis buffer (Nfi4CL) 
A lysis buffer was made by first stirring 2 g of Tris (0.017 moVL, AppliChem, Ottoweg, 
Damstadt) and 7.5 g of Nf4Cl (0.14 mol/L, APS Ajax Finechem, Auburn, Australia) in 
to 900 ml of Milli Q water. The solution was adjusted to pH 7.2 using concentrated 
HCl, and diluted to a final volume of 1 litre. The buffer was sterilised by passing it 
through a sterile 0.2 µm Sartorius Minisart filter, and stored at 4 °C. 
Phosphate-buffered saline (PBS) 
NaCl 8 g (0.138 M) 
KCl 0.2 g (0.0027 M) 
KH2P04 (anhydrous) 0.2 g (0.0014 M) 
Na2HP04 (anhydrous) 1.15 g (0.0032 M) 
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All of the reagents were purchased from BDH Chemicals Ltd., L. R. The phosphate-
buffered saline was made up to 1 litre by adding sterile Milli Q water. The pH 
approximated 7.2 and the phosphate-buffered saline was passed through a sterile 0.2 
µm Sartorius Minisart filter. The phosphate-buffered saline was stored at 4 °C. 
Concanavalin A (Con A) 
In a cytotoxicity cabinet, 5 mg of Con A (Sigma C5275) was weighed in a sterile boat 
and added to 10 ml of sterile RPMI complete medium giving a final concentration of 
500 µg/ml. Aliquots of this solution were stored at -20°C. 
All glassware and metal spatulas were rendered sterile by autoclaving, and plasticware 
was certified endotoxin free and purchased new. All reagents and RPMI complete 
medium was brought to room temperature prior to use (unless otherwise stated). 
2.2.2 Honey solutions 
Both MI09 manuka honey (a batch of manuka honey with non-peroxide activity 
equivalent to 18% w/v phenol as determined by Allen et al., 1991) and a pasture honey 
from the Otago region were tested. These were selected from the samples supplied to 
the University of Waikato Honey Research Unit by various beekeepers for research 
projects. Honey solutions were prepared by diluting raw honey (1.37 g = 1 ml) with 
RPMI complete medium ( 1 ml) to achieve a 50% v/v concentration. The diluted honey 
was warmed in the incubator (37°C), and gently stirred to ensure thorough mixing. 
Further dilution of the 50% honey solutions was performed to obtain the stated final 
concentrations (as presented in all figures throughout the thesis). Addition of an equal 
volume of RPMI medium to the 50% honey solution gave a 25% solution (i.e. a 4-fold 
dilution) and ten-fold dilution steps of this with either cell suspension or medium gave 
honey concentrations of 2.5%, 0.25%, 0.025% e.t.c. Allowance was made for the 
subsequent dilution by other components of the incubation mixture when calculating 
the final concentrations of honey. This meant that an additional dilution step was 
required to compensate for the ratio of honey to other reactants in the assay. For 
example, a serial dilution of 7.5% was required to allow for a 1:3 dilution of honey 
solutions. As honey was diluted by volume the resultant solution was expressed as '% 
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v/v" and has no units being x% honey. The solution was then passed through a 0.25 µm 
filter (Sartorius), and maintained at room temperature, for use within an hour of 
preparation. The honey used in the assays described in this thesis was always 
subsampled from the same batch of honey. Consistency was maintained in preparation 
technique. 
Artificial honey 
Artificial honey was made according to a recipe described by White (1975a), 
formulated from the average composition of at least 400 samples of major commercial 
honey types in the USA. The· following were added (% by weight) to prepare the sugar 
syrup: water 17.2%, fructose 38.4%, glucose 30.3%, sucrose 1.3%, maltose 8.6%, 
maltodextrin 1.4%. The syrup was stored at 4°C and solutions were prepared for use as 
described for natural honey. To make a 50% solution of artificial honey, 1.43 g (taken 
to be 1 ml) of this sugar syrup was diluted with 1 ml of RPMI complete medium. 
2.2.2.1 Preparation of honey fractions 
Manuka honey and Otago pasture honey were fractionated according to four techniques; 
dialysis, ether extraction (manuka honey only), reverse phase chromatography and 
ultrafiltration (as described by Pingoud et al., 2002). 
Dialysis 
Dialysis was performed to separate the high molecular weight (> 10 kDa) and low 
molecular weight (<10 kDa) components of the honey. A 25% (v/v) honey solution was 
made by warming 13.70 g (= 10 ml) of manuka honey with 30 ml of Milli Q water in 
the incubator. It was necessary to dilute the honey solution as a pilot test had shown that 
using concentrated honey would prevent air from escaping from the tubing. Honey (20 
ml) was dialysed in 29 mm diameter lOkDa dialysis tubing (Spectra/Por®) against 10 
x volume Milli Q water at 4°C, in the dark. The water was changed three times over 48 
hand the yellow diffusate was collected and concentrated by freeze-drying (VirTis, NY, 
USA). The diffusate was poured into three round bottomed flasks and shell-frozen by 
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rotating each flask in a slush bath comprised of ethanol and dry ice. Once the flask was 
coated in a fine layer of ice and all of the solution had frozen, the flasks were 
transported to the freeze drier on dry ice. The flasks were attached to the freeze-drier 
and left overnight. Once all of the cool spots and condensation had disappeared, freeze-
drying was complete. At this point the freeze-dried dialysate was reconstituted by 
adding enough Milli Q water to make the volume back up to the original 20 ml volume 
of the honey solution. This again represented a 25% (v/v) honey concentration. Osmotic 
measurement confirmed that the osmolarity of the high molecular weight fraction did 
not exceed that of medium alone. The dialysed honey was frozen at -20°C until 
required. 
Ether extraction 
This procedure was kindly performed by Melanie Snow in the Chemistry Department of 
the University of Waikato, using a liquid/ liquid extraction technique as described by 
Tan et al. (1988). 
Reverse phase chromatography 
Using reverse phase chromatography, the hydrophilic and hydrophobic fractions of 
honey were separated. A 25% (v/v) honey solution was prepared as for dialysis. The 
SepPac cartridge (Waters Corporation, Massachusetts) was prepared by injecting 5 ml 
of ethanol through with a syringe. This was discarded and followed by injection of 10 
ml of water through the cartridge. After the washing step, 15 ml of honey solution was 
injected through the cartridge, followed by air to flush through the honey solution 
which was collected in a sterile bottle then 15 ml of ethanol was injected through the 
cartridge, followed by air and was collected in another sterile bottle. In a final washing 
step, 10 ml of water was injected through the cartridge and discarded, along with 5 ml 
of ethanol which was also stored at -20°C until needed. The 15 ml of honey solution 
collected, which would have contained the hydrophilic components, was at the correct 
concentration for use in the assay. However, the ethanol-eluted hydrophobic 
components and washings were rotary evaporated to remove the ethanol. To perform 
rotary evaporation, the hydrophobic fraction was placed in a round flask, attached to a 
Btichi Rotavapor R rotary evaporator run at 37°C under vacuum. Evaporation was 
complete when a viscous yellow solution was all that remained in the flask. The 
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hydrophobic fraction was reconstituted by adding enough Milli Q water to make the 
volume up to the original volume (15 ml) of the honey solution. 
Ultrafiltration 
Ultrafiltration of honey was performed to separate components of the honey by 
molecular weight. It was achieved by passing a pre-filtered honey solution through a 10 
kDa cut-off membrane (Amicon/ Millipore) using nitrogen gas pressure. A 25% (v/v) 
honey solution was prepared as for dialysis. It was pre-filtered through a series of 
membranes ( 100 µm, 50 µm, Millipore Corporation) to remove the extraneous matter 
(bee tissues, pollen etc) as this will clog the membrane pores. The resulting solution 
was then passed through a glass membrane overlying an 8 µm microporous membrane 
(both from Millipore Corporation). A 10 ml volume was loaded into the ultrafiltration 
chamber, and the ultrafilter left to run in the dark, until all of the solution had moved 
through the membrane. The filtrate was collected and stored at -20°C. The retentate 
components were restored to their original concentration in the honey solution by 
adding 10 ml of Milli Q water and stored at -20°C. 
2.2.2.2 Dilution of the honey solutions to achieve final concentrations for testing 
Final honey concentrations were achieved by conducting serial dilutions of the honey 
solutions with RPMI complete medium. All honey solutions were protected from light 
by wrapping in aluminium foil, to prevent denaturation of the enzymes. Artificial honey 
was used to provide a control for the osmotic effects of the sugars. Solutions of honey 
were prepared immediately prior to use. 
2.2.2.3 Osmolarity of the honey solutions 
The osmolarity of the honey solutions prepared for addition to T cells was measured to 
establish whether: (a) at the concentrations tested, osmolarity caused cell damage; (b) 
osmolarity varied between honey types which might account for any differences in 
Chapter Two : T cell proliferation 
activity. Immediately after preparation of a range of honey solutions diluted in RPMI 
complete medium, the osmolarity of the solutions was determined using a freezing 
point osmometer (303 Osmometer). A plot of osmolarity versus honey concentration 
was constructed and a curve fitted to enable extrapolation to higher honey 
concentrations (see Figure 2.1). 
It can be seen that there were no significant differences in osmolarity between honey 
types at the same concentration. The osmolarity of normal blood is approximately 370 
mOsm (Marieb, 2001). 
2.2.3 T cell extraction procedure 
2.2.3.1 Blood collection 
Blood was collected from the severed jugular vein of a heifer during slaughter at the 
AgResearch Ruakura abbatoir. This blood was collected as a by-product of the routine 
processing of the meat industry and therefore did not require ethics approval. Collection 
of the blood directly in to sterile 50 ml Nunc tubes containing sodium heparin solution 
(1.25 ml of 5000 IU heparin in 5 ml of sodium chloride) minimised contamination. 
Directly prior to blood collection the tubes were coated with the heparin, and carefully 
inverted several times upon addition of the blood to prevent clotting. Immediately 
following blood collection, the T cell isolation procedure was undertaken. 
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Figure 2.1: Plots of osmolarity versus concentration of manuka, Otago pasture and artificial honeys. A). 
concentrations in the range between 0-1 % and B). concentrations in the range between 0-10%. Honey 
dilutions were made in RPMI complete medium and the osmolarity measured using a freezing point 
osmometer. 
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According to standard tissue culture techniques, aseptic conditions were maintained at 
all times and all steps were performed in a laminar flow workstation (Westinghouse Pty 
Ltd). 
2.2.3.2 Isolation of Peripheral Blood Mononuclear Cells 
Lymphocytes were isolated from whole blood according to a method described by 
Carlson and Kaneko (1973) with some modifications. Whole blood was first lysed by 
mixing a 5 ml portion of the heparinised blood with 10 ml of ~Cl lysis buffer and 
spun on a rotor (Chiltern Scientific) for 15 min at room temperature. The lysed blood 
was centrifuged for 10 min at 1 879 x g (Sorval H-400), and the supernatant removed. 
The pellet was resuspended in 5 ml of phosphate-buffered saline, and vortexed (Cenco 
lnstrumenten, Breda, Netherlands) for 30 sec to ensure the pellet was broken up. A 5 ml 
portion of the resuspended leukocyte pellet was carefully layered over 3 ml Ficoll-
Paque (Pharmacia Biotech) according to the manufacturer's instructions, and 
centrifuged at 900 x g (35 min) at room temperature with no brake. The interface layer 
(containing monocytes and lymphocytes) between plasma and Ficoll Paque was washed 
in 10 ml phosphate-buffered saline ( 450 x g, 10 min). The supernatant was discarded 
and the pellet was resuspended in a further 5 ml of lysis buffer solution and incubated 
for 10 min (37°C, 5 % CO2, 95% air). An equal volume of phosphate-buffered saline 
was then added and the tube centrifuged for 10 min (at 450 x g). The supernatant was 
again discarded and the pellet resuspended in 5 .ml of phosphate-buffered saline before 
centrifuging for 8 min (at 250 x g). This step was repeated, to ensure that any platelets 
had been removed. The cells were then suspended in RPMI complete medium and a cell 
count performed by haemocytometer according to standard methods. Lymphocytes were 
not differentiated from monocytes. The cell suspension was then diluted as required 
using RPMI complete medium. This procedure typically produced cell fractions with 
>99 % viability as determined by trypan blue staining. The average harvest for bovine 
lymphocytes within a PBMC fraction prepared in this manner is 88% (12% monocytes). 
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2.2.4 The lymphocyte proliferation assay 
After the cells were obtained from the isolation procedure described in section 2.2.3.2 
they were then referred to as a PBMC cell fraction because the actual proportion of T 
cells was not established. 
2.2.4.1 Assay to measure the stimulatory effect of honey on lymphocyte proliferation 
The standard method for testing the effect of honey on T cell proliferation was to place 
100 µ1 of PBMC suspension (obtained as described in Section 2.2.3.2) in a 96-well flat 
bottom microtitre plate (Maxisorp, Nunc) at a density of 2.5 x 106 cells/ml. In addition 
to the cell suspension, wells received 50 µ1 of honey solutions (diluted in RPMI 
complete medium as described in Section 2.2.2.2). Controls received either 50 µ1 of 
RPMI complete medium or 50 µ1 of RPMI complete medium containing Con A (at a 
final concentration in wells of 5 µg/ml). The final volume was 150 µl. Cells were 
incubated in a humidified atmosphere at 37°C (5% CO2, 95% air) for periods of time as 
stated in each experimental outline (72 h was standard). Where this standard assay 
method was modified for specific experiments this has been stated in the experimental 
outline. 
As the PBMC fractions contained monocytes, and these cells are activated by LPS 
(Beutler and Cerami, 1988), it was necessary to determine whether endotoxin 
contamination had occurred. To verify that stimulatory effects were not due to 
endotoxin contamination, contamination cultures were set up with and without 
polymyxin B (PMB; Pfizer, Karlsruhe, Germany) at 10 µg/ml. PBMC in the 
contamination cultures were exposed to polymyxin B for 30 min at 37°C (5% CO2, 
95% air), prior to adding treatments, to inactivate LPS. No LPS contamination was 
detected. 
For the proliferation assays analysed using flow cytometry, the cells were added in 1 ml 
aliquots to 24-well flat bottom microtitre plates (Nunc), maintaining the same cell 
density (2.5 x 106 cells/ml). This modification was made to facilitate the staining of 
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cells. Honey solutions, RPMI complete medium or RPMI complete medium containing 
Con A (final concentration of 5 µg/ml) were added to the cell suspensions in 50 µl 
aliquots. Cells were incubated at 37°C (5% CO2, 95% air) for periods of time as stated 
in each experimental outline (72 h was standard). The pH of the honey solutions was 
measured prior to adding cells (Radiometer Analytical MeterLab, PHM210), and at the 
concentrations tested, were not found to differ from RPMI complete medium alone. 
2.2.5 Stimulation of lymphocytes with Con A to activate T cells 
Con A is a lectin that binds to glycoproteins on the lymphocyte cell surface and causes 
activation of T cells, stimulating the production of cytokines by T cells (such as IL-2) 
which in tum activate other T cells to proliferate (global T cell stimulation). As 
Abuharfeil et al. (1999) had used 5 µg/ml successfully to stimulate proliferation of 
blood-derived lymphocytes for measurement by MTT assay, this protocol was 
developed in this study as it was directly applicable to the experimental conditions. An 
early pilot study conducted prior to the investigations confirmed that 5 µg/ ml of Con A 
produced good levels of T cell proliferation which enabled clear treatment effects to be 
measured when compared with resting cells (data not shown). 
2.2.6 Measurement of lymphocyte proliferation and activation 
Measurement of lymphocyte proliferation was used to assess the ability of honey to 
activate resting PBMC, via BrDU (bromodeoxyuridine) ELISA and MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay. The MTT assay is one 
of the most commonly used assays for measuring cell proliferation because it is easy to 
use and has been adapted to a microtitre plate-format (Liu et al., 1997). MTT is taken 
into the cells by endocytosis and metabolically reduced into blue insoluble crystals by 
endosomal and lysosomal vesicle enzymes and mitochondrial enzymes (Liu et al., 
1997). The blue crystals are subsequently dissolved in added dimethylformamide and 
the absorbance of the solution measured spectrophotometrically. Prior to use of these 
assays it was necessary to establish a standard curve to ensure that the production of the 
blue formazan product was linear with respect to the number of cells in the PBMC 
culture. Once a linear relationship was established it was possible to estimate the 
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number of viable cells in a sample. Increased MIT response of a PBMC culture with 
honey or a mitogen compared to a control culture indicated that proliferation of these 
cells was increased. 
BrDU ELISA works along the same principles as MIT to indicate cell division status 
of a cell population. BrDU analysis provided an alternative measure of lymphocyte 
proliferation. As no published studies had used the BrDU ELISA method to evaluate 
the effects of honey on lymphocyte proliferation before, it was necessary to adapt the 
methods used from other studies performed with bovine lymphocytes. A study by 
Fisher et al. (1999), using BrDU measurement of lymphocyte proliferation to detect 
stress-induced diseases in cows was selected for this purpose. The BrDU ELISA works 
by incorporation of a labelled bromodeoxyuridine in to the DNA of actively dividing 
cells. In the final step of the BrDU assay, an antibody with a peroxidase enzyme linked 
becomes bound to the BrDU label. It is the binding of the substrate-antibody complex 
which enables development of a blue colour, quantified spectrophotometrically. The 
absorbance obtained is proportional to the number of cell divisions and a standard curve 
enables this information to be interpreted. As with the MIT assay method, the starting 
density of cells, concentration of mitogen used and the amount of time the assay is run 
for are crucial to the sensitivity of the BrDU ELISA. BrDU analysis provides a 
"snapshot" of proliferation so that the results of a BrDU ELISA will reflect how much 
of the labelled base was incorporated into cellular DNA during a 24 hour period. Thus, 
to maximise the sensitivity of the assay it was necessary to pinpoint the time at which 
the lymphocytes in the experimental set up underwent high levels of mitotic activity, 
and then to add the label during this time. 
In order to confirm the results obtained by the BrDU ELISA, flow cytometry was used 
to provide another technique to track cell division. Flow cytometry is an invaluable tool 
for imaging lymphocytes and enables the investigator to confirm that transformation 
has occurred in these cells due to changes in the size and granularity of the cells (Parish, 
1999). These changes are indicated by linear forward scatter and log side scatter 
respectively. Flow cytometry was used in this study to quantify the number of cell 
divisions undertaken by the T cells and to quantify the proportion of cells in each of 
these generations. This was achieved by incubating lymphocytes with CFSE dye at the 
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same time as the test substances. CFSE (5-carboxyfluorescein diacetate succinimidyl 
ester) is a membrane-permanent fluorescent dye which is used to track cell division as 
the fluorescence intensity halves with each cell division. Thus, flow cytometry was used 
to reveal the proportion of cells which fell into various cell divisions based on their 
fluorescent intensity. Detection of the CD3+ T cell receptor using a fluorescent 
antibody specific to this enabled the proportion of cells activated via this receptor to be 
quantified. Flow cytometry was also used to identify the expression of the IL-2 receptor 
on T cells. This was achieved by staining T cells with FITC (fluorescein 
isothiocyanate)-labelled antibodies against the IL-2 receptor. 
2.2.6.1 Trypan blue exclusion 
Cells with an intact membrane exclude trypan blue. Staining of the cells with trypan 
blue distinguishes between those newly committed to apoptosis and those in the later 
stages of cell death as the membrane remains intact in the first stages (Slater, 2001). 
The combination of trypan blue exclusion and proliferation assays together provides a 
useful tool for assessing any cytotoxic effects of honey. Thus, trypan blue exclusion 
was used to establish the osmotic tolerance range of honey prior to commencing assays. 
Trypan blue dye exclusion assays were performed according to standard methods 
(Gorman et al., 1997). In brief, after exposure of lymphocytes to treatment solutions in 
24-well plates, an equal volume of trypan blue solution (0.4% trypan blue in phosphate-
buffered saline) was added to each well containing 100 µI of cell suspension (2.5 x 106 
cells/ml) mixed on a plate shaker and incubated for 1 min (37°C, 5% CO2, 95% air). 
Cell viability was determined using a haemocytometer and bright field microscopy 
(Olympus, 40x) according to the method described by Gorman et al. (1997). 
2.2.6.2 MTT assay 
The 96-well plate MTT assay was a modification of the method of Burres and Clement 
( 1989). The MTT assay performed in this study was purchased as a kit (Roche 
Molecular Biochemicals, Cat. No. 1 465 007). After 2-3 days incubation (37°C, 5% 
CO2, 95% air) of the cell suspension with various treatments in 96-well flat bottom 
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microtitre plates, the MIT assay was performed. To a well containing 150 µl of cell 
suspension, 15 µl of MIT solution was added. The original method was adapted due to 
honey interfering with the MIT assay directly. It was suggested that spontaneous 
conversion of the MIT salts with honey is likely to be a result of the glucose oxidase 
enzyme in the honey interfering with the assay, giving false positives (M. Berridge, 
Malaghan Institute, Wellington: personal communication). The enzyme glucose oxidase 
becomes more active as it is diluted out, and this would explain why the control wells 
with honey in RPMI complete medium without cells had higher absorbance values for 
0.25% manuka honey than 10% manuka honey. The absence of any colour development 
in the control wells containing artificial honey supported this. Microscopic analysis of 
the wells ruled out the presence of a micro-contaminant. 
False positives were avoided by washing the microtitre plates with 100 µ1 phosphate-
buffered saline (room temperature, 320 x g, 15 min) three times to pellet the cells in the 
bottom of the wells, flicking out and res us pending the cells in 100 µl RPMI complete 
medium prior to addition of the MIT reagent. The plate was then returned to the tissue 
culture incubator for 2 h (37°C, 5% CO2, 95% air) to enable the tetrazolium salt to be 
enzymatically reduced by viable cells in the culture. MIT solubiliser (10% sodium 
dodecyl sulfate (SOS), 45% dimethylformamide, adjusted to pH 4.5 with acetic acid) 
was added (0.1 ml/ well) and the plate returned to the incubator overnight (37°C, 5% 
CO2, 95% air), to dissolve the blue formazan precipitate. The absorbances of the 
solutions in the wells were then read at 570 nm wavelength (Bio-Tek instruments). 
Control wells with RPMI complete medium or honey solutions and MIT alone (no 
cells) provided the blank, and the absorbance of the blanks were subtracted from all 
samples. 
2.2.6.3 BrDU ELISA 
The BrDU colormetric cell proliferation ELISA (kit from Boehringer Manheim Cat. 
No. 1 647 229) was performed according to the manufacturer's instructions. Cell 
suspensions were incubated with honey solutions (and control solutions) at 37°C (5% 
CO2, 95% air) for 2-3 days prior to addition of a BrDU label (Section 2.2.4). The study 
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by Fisher et al. (1999) had indicated that adding the BrDU label 72 h after setting up the 
assay gave a good capture of mitotic activity when the starting density of lymphocytes 
was 2.5 x 106 cells per ml. An 18 h incubation time for the cells with the BrDU label 
was chosen because pilot assays performed in the current study had established that this 
enabled sensitive detection of the amount of proliferation which occurred for cells 
exposed to RPMI complete medium alone as compared with cells stimulated with Con 
A. After this time, 15 µ1 of BrDU label was added to each well and the plates were 
incubated (37°C, 5% CO2, 95% air) for a further 24 h. After centrifugation (10 min at 
438 x g, 18°C ) the supernatant was removed and plates dried prior to adding 200 µ1 of 
FixDenat to each of the wells. The plates were incubated at room temperature for 30 
min, and 100 µI of anti-BrDU-POD working solution added to each well. The plates 
were then incubated for 120 min at 37°C (5% CO2, 95% air). Though the manufacturer 
recommended a 45 min incubation time at room temperature, an increased incubation 
time of 120 min at 37°C (5% CO2, 95% air) was found to increase the sensitivity of the 
assay as more binding occurred. The plates were then washed three times with 300 µl of 
washing buffer provided in the kit, and 100 µl of the substrate solution 
(tetramethylbenzidine and peroxide) was added to each well. The plates were incubated 
for a further 10 min at room temperature, and 25 µl of 1 M sulphuric acid added to each 
of the wells to stop the reaction. After 1 min on a plate shaker the absorbance was 
determined at 490 nm with a reference wavelength of 690 nm (BioRad Model 550). 
Control wells with RPMI complete medium or honey solutions and BrDU alone (no 
cells) provided the blank, and the absorbance of the blanks were subtracted from all 
samples. 
2.2.6.4 Flow cytometry analysis 
Flow cytometry was used to confirm the BrDU assay results and to investigate some 
key aspects of T cell response to honey: induction of cell blasting, the number of cell 
division events, identification of the subset of T cell-responders, and induction of the 
IL-2 receptor on the cell membrane. The profile obtained for cells incubated with and 
without honey could thus be compared, and the effects of honey on lymphocytes could 
be determined at a cellular level. 
55 
Chaptl.:r Two : T cell proliferation 
2.2.6.4.1 Staining methods 
To enable cells to be analysed using flow cytometry, they were stained for various cell 
surface markers. The murine anti-CD antibodies are primarily bovine specific. 
Tracking T cell divisions using CFSE-staining 
CFSE (5-and 6-carboxyfluorescein succinimidyl ester diacetate) stain (Molecular 
Probes, Eugene, USA) forms conjugates with proteins within the cell which are retained 
through mitosis and one half of the label is inherited by each daughter cell after 
division. CFSE staining enables independent examination of individual cells within a T 
cell sample. To stain for CFSE analysis, CFSE (10 mM in DMSO) was diluted 1:4 000 
in phosphate-buffered saline to give a 4 µmol/1 working solution and an equal volume 
was added to the cells (2 x 107 cells/ml in phosphate-buffered saline) to achieve a final 
CFSE concentration of 2 µmol/1. The tube contents were mixed several times during 
incubation at room temperature for 10 min. An equal volume of ice-cold foetal calf 
serum was added to the tube and the contents mixed gently. The tube was centrifuged 
for 20 min at 250 x g. The supernatant was decanted, the tube was then filled with 
RPMI complete medium and the cells resuspended gently, then centrifuged for 10 min 
(250 x g). This washing step was repeated three times. The cell density of the 
resuspended cells was then adjusted with RPMI complete medium to achieve a final 
concentration of 2.5 x 106 cells/ ml and 1 ml of suspension was transferred into each 
well of a 24-well microtitre plate (Nunc). Then 50 µl of either honey solutions, Con A 
or RPMI complete medium was added to each well and the cells were incubated for 72 
h (37°C, 5% CO2, 95% air), to enable activation to occur. If the cells were to be double-
stained (using cell surface markers for lymphocyte subsets), the addition of these 
fluorescent-labelled antibodies was done after this incubation period. 
Identification of the actively dividing T cell subset 
As lymphocytes consist of several subset types (Section 2.1) it was decided to 
investigate which type were undergoing cell division in response to honey, and this was 
achieved by staining cells for surface antigens. Figure 2.2 shows that T cell sub-
populations may also be discriminated from each other according to the presence of 
thiols attached to the surface antigens, though these were not identified in the current 
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study. Figure 2.2 shows that T cell populations all express CD3 markers and staining 
for this marker gives assurance that T cells are being analysed. So, for example, if T 
cells from a PBMC fraction were double-stained for CFSE and CD3, the proportion of 
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Figure 2.2: Lymphocyte subsets in freshly isolated PBMCs. PBMCs were stained for surface markers to 
detect monocyte and lymphocyte subsets and gated according to their position in a two-parameter dot 
plot. PBMCs were also stained by Sahaf et al. (2002) for the presence of surface thiols on cell surface 
markers which differ among cell subsets (detected by binding of the fluorescent molecule, ALM (mfi), 
Alexa-maleimide) (figure taken from Sahaf et al. 2002). 
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With reference to Figure 2.2, the T-helper (TH) cells display a specific cell surface 
antigen (CD4) on their membrane. T cytotoxic cells can express either the CD4 or the 
CDS epitope (Meuer et al., 1982). T-suppressor cells display the CDS antigen on their 
surfaces. The T-helper to T-cytotoxic /suppressor cell ratio, also called the CD4+:CD8+ 
T cell ratio is often used as a measure of immune status. According to Rapaport et al. 
(1986) an increase in the CD4+:CD8+ T cell ratio indicates an increased immune 
function with greater responsiveness of lymphocytes to mitogens. 
The expression of the IL-2 receptor on the surface of T cells is a marker of activation 
(Jan, 1994; Los et al., 1995; Cross and Gill, 1999; Carswell and Papoutsakis, 2000; 
Kunitomi et al., 2000). Cells were stained with antibodies binding to the IL-2 receptor, 
using a two-step procedure, with the second antibody being fluorescent and detected by 
the flow cytometer. Antibodies to bovine CD4 markers and bovine CDS markers were 
included to track the expression of the IL-2 receptor by these T cell subsets. 
Cells were stained with a fluorescence-labelled antibody for the various surface markers 
according to a two stage process, adding first the primary antibody (e.g. anti-CD3) and 
then the secondary antibody which binds the first and gives the fluorescence. PBMC 
(106 cells/tube) were placed in 5 ml tubes (Becton-Dickson) after passing through 100 
µm gauze to remove clumps. An equal volume of phosphate-buffered saline containing 
1 % foetal calf serum was added and the tubes centrifuged (322 x g, 5 min, 4°C). The 
supematants were decanted and the cells were resuspended in the drop of supernatant 
remaining. Then, 50 µl aliquots of primary antibody: murine anti-CD3 (MMlA, diluted 
1: 400 in phosphate-buffered saline: Veterinary Medical Research and Development, 
USA) murine anti-CD4 (CC8 diluted 1: 500 in phosphate-buffered saline: gift from N. 
Parlane, AgResearch, Wallaceville), murine anti-CDS (CC63 diluted 1: 500 in 
phosphate-buffered saline: gift from N. Parlane, AgResearch, Wallaceville) or murine 
anti-IL-2R (CACT116A diluted 1: 400 in phosphate-buffered saline: Veterinary 
Medical Research and Development, USA), were added to tubes. Where cells were 
double-stained for both the IL-2 receptor and either the CD4 or CDS surface markers, 
this enabled identification of the T cell subset expressing the IL-2 receptor. 
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Duplicate tubes containing cells stained with same and GC270 IgG2a (Silenus) were 
prepared in the same manner as those stained for specific surf ace markers, to provide a 
control for non-specific binding by the secondary antibody, and to provide baseline data 
for background. When cells were stained for the IL-2 receptor only, the non-specific 
primary antibody murine IgG 1 (Ci4 diluted 1: 400 in phosphate-buffered saline: 
Silenus) was used. 
The tube contents were mixed and incubated in the dark at 4°C for 20 min. After 
incubation, 500 µl of 1 % phosphate-buffered saline was added and the cells were 
centrifuged for 6 min (322 x g, 4°C) the supernatant removed and resuspended in the 
remaining supernatant. The washing step was repeated three times to remove unbound 
antibody. Following the final wash, the secondary antibody was added. If cells were 
stained with CFSE, the secondary antibody was PE-labelled rat anti-murine lgG, 
(Jackson ImmunoResearch Laboratories Inc., PA) used at a dilution of 1: 1 000 in 
phosphate-buffered saline. For single-stained cells (i.e. no CFSE staining) goat anti-
murine-IgG with a FITC label (diluted 1:50 in phosphate-buffered saline: BD 
PharMingen, San Diego, CA) was used as an alternative. This was because the 
fluorescent dye needed to be attached to bound antibody needed to be clearly 
distinguished from the CFSE signal when double staining had been performed. Once 
the antibody was prepared, 50 µI was added to each tube and these were incubated in 
the dark for 30 min at 4°C. After incubation, 500 µ1 of phosphate-buffered saline 
containing 1 % foetal calf serum was added to each tube and the tubes were centrifuged 
at 322 x g (6 min, 4°C) and the supernatant removed. The cells were resuspended in the 
remaining supernatant. The washing step was repeated three times, and the cells were 
finally resuspended in 500 µI of phosphate-buffered saline (containing 1 % foetal calf 
serum). The cells were taken to the flow cytometer for analysis. 
2.2.6.5 T cell identification and marker analysis 
All flow cytometry analysis was performed according to a sequence of gating steps 
(which are summarised in Figure 2.3). 
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Identification of the lymphocyte population 
The first step in flow cytometry analysis was to distinguish lymphocytes from the other 
cell types within the PBMC suspension. Cell size and granularity were determined by 
forward scatter (FSC) and side scatter (SSC) creating a dot plot. The essence of flow 
cytometry is the analysis of the effects produced by the passage of a particle of interest 
through a beam of light, termed an event. In this case the particle is a cell and the beam 
of light was from a blue-green excitation light ( 488 nm argon-ion laser). Light was 
directed at the cells and the deflection of this, or the absorption of light, was measured. 
Clear demarcation in size and granularity exists between polymorphonuclear cells 
(including neutrophils) and PBMCs, with no overlap in the analysis regions between 
these two cell populations (data not shown). In all of these experiments, a minimum of 
10 000 cells were counted in list mode for each event. On the dot plots obtained cells 
were separated into distinct populations of lymphocytes, monocytes and granulocytes 
(including neutrophils), according to their FSC and SSC. A gate was drawn around the 
lymphocyte population (Figure 2.4) by drawing either a rectangle, elipse or free-form 
encirclement around the population of interest and only cells within this gate were 
included in further analysis. 
Identification of actively dividing T cells in a lymphocyte population 
Once the captured data had excluded all of the debris, monocytes and granulocytes, a 
second dot plot was created by using FSC and SSC characteristics of the lymphocytes 
alone. Blasting (large), and therefore actively dividing cells, were selected for analysis 
by gating around the discrete population of cells with greater forward scatter than the 
rest of the population (Figure 2.5). Using the negative controls (cells in RPMI complete 
medium) and positive controls (Con A stimulated cells) the position of the gate was set 
so that all samples were compared with the controls, and positive activation could be 
identified. The position of the gate was subjective, capturing only the cells of interest. 
There was a larger population of blasting cells when lymphocytes were incubated with 
Con A than when incubated with RPMI complete medium alone (Figure 2.5). 
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Figure 2.3: Sequence.of gating steps to identify cell types in flow cytometry 
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Figure 2.4: Dot plot showing different populations of leukocytes according to their specific 
characteristics (source: Anon (a), 2003). The lymphocyte population has been gated by drawing a 
rectangle around the cells exhibiting characteristic FSC and SSC characteristics. 
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Figure 2.5: Dot plots showing characteristic differences between the blasting profiles of T cells 
stimulated with negative and positive controls. T cells (2.5xl06 cells/ml) were incubated with RPMI 
complete medium with or without Con A (5µg/ml) for 72 h prior to flow cytometry analysis. A gate (Rl) 
was placed around the large, blasting cells and the % of cells within this region compared between 
treatments. All subsequent analysis was carried out on cells within the gated region, Rl . When T cells are 
activated they increase in size (known as blasting). This can be assessed by comparing the FSC of cells. 
The effects of incubating T cells with: A, RPMI complete medium (negative control) and B, Con A 
(positive control), indicate that the mitogen is a potent activator of lymphoblasting. 
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The percentage of blasting cells was determined for each treatment and compared to 
non-dividing smaller cells, according to a histogram plot of cell count (number of 
events) versus FSC (forward scatter) (Figure 2.6). All subsequent analysis was carried 
out on cells within the region RI of Figure 2.6. 
Figure 2.6 shows that a single-parameter histogram was created which included all of 
the cells in the gated region, RI (from Figure 2.5). The single-parameter histogram 
(shown in Figure 2.6) has a logarithmic x-axis representing forward scatter and they-
axis representing the number of cells counted in each channel along the x-axis. In 
Figure 2.6, the gate (marker) was set based on the leading edge of the negative control 
(cells in RPMI complete medium). All events to the left of the marker were considered 
to be negative. The number of positive events were then expressed as a percentage of 
total events (cells) in the histogram. The median and mean for each histogram were 
compared between the negative and positive (Con A) controls, along with the 
percentage of cells in the marker region. Ideally, the marker was positioned so that less 
than 1 % of the negative control background fell in the marker region. A geometric 
mean was calculated by the CELLQuest programme. Multiple differing sub-populations 





Figure 2.6: Cell counts of the positive and negative controls in single-parameter FSC histogram plots as 
shown in Figure 2.4 Single-parameter histograms were constructed from the cells contained within Rl 
(from Fig. 2.6). The gate (Gate l) was placed across the population with highest forward scatter, and 
these cells were taken to be activated. The position of the gate was maintained for all samples so that they 
could be compared to each other and to the controls. These are representative examples. 
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Analysis of various cell surface markers 
A two-parameter dot plot was constructed for the cells captured in the gate 1 region of 
the single-parameter histogram (as shown in Figure 2.5). The two-parameter dot plot 
enables measurement of an event with a particular combination of signal intensity for 
two detectors (e.g. FSC and SSC). In order to identify T cells, they were stained for the 
CD3 surface marker and their SSC characteristics examined. The percentage of cells in 
each quadrant of the two-parameter dot plot could be calculated as compared with all 
cells represented in the plot (Figure 2.6). The quadrants are described according to 
location in the plot so that LL (lower left) represents cells negative for both descriptors, 
UR (upper right) represents cells dual positive for both descriptors, UL (upper left) 
represents cells positive for the y-axis descriptor and negative for the x-axis descriptor, 
and LR (lower right) represents cells positive for the x-axis descriptor and negative for 
the y-axis descriptor. The use of double-parameter dot plots enabled the percentage of 
events in each quadrant to be compared among samples. Where T cell had been stained 
for only one surface marker, they were gated according to positive staining for the x-
axis descriptor in relation to their SSC as the y-axis descriptor. For example, T cells 
were gated based on positive staining for the CD3 marker and low SSC characteristics 
(Figure 2.7). The proportion of cells expressing any combination of the surface markers 
could be analysed this way, and the position of double-stained cells in the plot (e.g. 
cells stained for both CD3 and CFSE) could be used to discriminate populations based 
on two parameters. For example, cells positive for both CD3 markers and negative for 
CFSE would be dividing T cells. 
By double-staining cells for the CD3 marker and CFSE, this enabled the division of T 
cells to be tracked using fluorescence channels 1 (FLl) and 2 (FL2). The fluorescence 
channels were used to measure the amount of fluorescent light emitted from each cell 
and this enabled contour plots to be constructed. A contour plot introduces event 
frequency as a third dimension so that the number of events with a particular 
combination of descriptors can be shown. In a dot plot overlapping events obscure one 
another, however in a contour plot a particular combination of colour intensities (or 
shading intensities) are joined between adjacent points with equal density. Contour 
lines sharing the same colour shading represent areas with cells of the same 
fluorescence intensity within. The proximity of contour lines to each other indicate the 
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relative number of cells present in regions of the plot, so that contour lines located close 
together represent a concentrated population of cells. Such representations allow the 
visual discrimination of differing components within the sample, as they will appear as 
disjoint islands of points. By convention, CFSE intensity was represented on the x axis 
(measured using the FLl channel). Fluorescence height is proportional to the maximal 
signal level from cells in the channel (hence FLl-H uses the FLl channel). They axis 
represented the maximal signal level from the other descriptor (i.e. CD3 expression) as 
FL2-H values (shown in the example provided in Figure 2.7). To set the FL2 threshold, 
cells stained with IgG1 non-specific antibodies and PE were used to check for any non-
specific binding by the secondary antibody and to provide baseline data for background. 
After the computer had created the contour plot, a box was placed around the most 
intense cell population (as indicated by an area of closely spaced contour lines) and 
equal-sized regions were gated to the left until all cells were included (Figure 2.7). 
Based on the knowledge that CFSE fluorescence intensity halves with each mitotic 
division, the proportion of cells in each region (and therefore, generation) as indicated 
by the relative colours of the contour lines could be compared between treatments by 
drawing boxes around each. The mean fluorescence of the cells expressing CFSE was 
then obtained as arbitrary fluorescence units (flU) on a logarithmic scale. 
A contour plot was used to identify the double-stained cells expressing the CD3 marker 
and containing CFSE. Using the markers CD3 and CFSE as an example, the FLl 
channel was used to measure the intensity of CFSE-stained cells (represented on the x 
axis). The FL2 channel was used to measure the intensity of the PE-labelled cells 
(represented on they axis). Cells positive for CD3 and CFSE are located at the far end 
of the x axis. Division of the CD3 cells is indicated by a shift in the position of clusters 
toward the y axis (with loss of the CFSE dye and therefore, fluorescence intensity). 
Therefore, reference to the relative position of cells along they axis with respect to the 
x axis identified the CD3+ population (Figure 2.7). The use of relative positioning of 
cells in the contour plot could be used to define T cell sub-populations according to any 
two of the cell markers (IL-2 receptor, CD3, CD4, CDS or CFSE) in combination. 
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Figure 2.7: Use of progressive gating of a contour plot to determine the proportion of cells in each 
generation. T cells were double stained with PE-labelled anti-CD3 and CFSE, and a contour plot 
constructed to identify the populations according to their fluorescent intensity. Contour lines located 
close together indicate concentrated cell populations, and contour lines sharing the same colour represent 
cells sharing the same relative fluorescence intensity. Based on the knowledge that CFSE stained cells 
lose intensity with each mitotic division, the regions, R, were first set by bracketing the intense population 
(far right of X axis), and then adding equal sized boxes to the left. By using the boxes as gates to separate 
out populations according to their fluorescence, the proportion of T cells in each generation could be 
calculated by the CELLQuest programme, and histograms constructed. 
The quantitative data derived from the contour plots could be converted into histograms 
which showed visually the number of times each cell had divided with each generation 
of daughter cells appearing as a distinct peak on the histogram (see Figure 2.8). Data 
were then expressed as the percentage of cells which had divided among total T cells 
counted. 
2.2.7 Preliminary experiment to find the osmotic tolerance of PBMC 
To establish an osmolarity range for PBMC and enable selection of a honey 
concentration which would not cause cell damage, PBMC were incubated for 24 h with 
()(, 
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various concentrations (0.1-10%) of different honeys ( artificial, manuka, Otago 
pasture) or RPMI complete medium alone according to the assay method described in 
Section 2.2.4.1. Cells were cultured for 24 h at 37°C (5% CO2, 95% air) and viability 
was determined using trypan blue exclusion (as described in Section 2.2.6.1). 
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Figure 2.8: A CFSE histogram plot showing the fluorescence intensity, after a 72 h incubation period, of 
unstimulated lymphocytes and stimulated lymphocytes with 0.025% manuka honey. This plot 
demonstrates that most of the cells incubated in RPMI complete medium alone (unstimulated) remain in 
GO, compared to those stimulated with honey which have divided through 1-4 generations (Gl-G4). 
CFSE fluorescence intensity halves with each mitotic division. Frequency refers to the number of cells. 
Two separate experiments were performed. The data presented is a representative example of a single 
experiment. 
The effect of incubating PBMC with a range of concentrations (0.1-10%) of different 
honeys on cell viability are shown in Figure 2.9. 
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Figure 2.9: The effect of honey concentration on PBMC viability. PBMC were incubated for 24 h with 
various concentrations of artificial honey, manuka honey, Otago pasture honey or RPMI complete 
medium alone. Cell viability was assessed using trypan blue exclusion. Data are presented as the mean of 
nine measurements ± SEM (n=9). Differences between the means are indicated by superscript letters, 
where means not sharing common letters within a graph are significantly different (P<0.05). Means did 
not differ significantly between the graphs for corresponding concentrations of honey. 
The results in Figure 2.9 show that honey of all types significantly reduced the viability 
of PBMC at 1 % concentrations but had no significant effect on viability at 
concentrations of 0.5% and less. 
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2.2.8 Statistical analysis 
Unless otherwise stated, all tests were performed in triplicate wells and repeated at least 
twice in time, using blood from two different animals. Each datapoint represents the 
mean ± SEM of OD measurements. The results from trypan blue experiments were not 
derived from OD measurements. As the overall level of BrDU incorporation varies each 
time, data were presented as"% of control". Therefore, to compare treatment data to the 
controls, data was normalised by talcing the mean for triplicate treatment wells as a 
proportion of the mean values obtained for triplicate control wells. SEM for the control 
wells were calculated on raw data and multiplied by the same proportion as used to 
convert the control to 100%. For multiple group comparisons, the data were subjected 
to one way analysis of variance (ANOV A) to determine overall difference between the 
group means. The between group effect was the amount of proliferation (or the 
proportion of cells expressing a fluorescent marker). The levels of the repeated 
measures were at least n=6 for proliferation assays, and at least n=4 for flow cytometry 
analyses. Significant effects were further analysed using Tukey's honestly significant 
difference (HSD) for pairwise differences for within-group comparisons. Systat 
software version 7.0 (SPSS Inc.) was used for all analyses. 
2.3 EXPERIMENTS 
There were two aspects to be examined for the effect of honey on PBMC proliferation. 
The first was whether honey could stimulate cell division in resting PBMC cultures. 
The second was whether honey could modify the response of PBMC to Con A. 
2.3.1 The effect of honey on resting PBMC 
2.3.1.1 The effect of various honeys at concentrations ranging from 0.1-1% on 
proliferation of resting PBMC 
In order to determine whether various honeys had stimulatory activity on resting 
PBMC, bovine cells were incubated with a range of honey concentrations. Proliferation 
was assessed by uptake of BrDU after 72 h incubation (Sections 2.2.4.1 and 2.2.6.3). 
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The effect of incubating PBMC with (0.1-1 % ) concentrations of honey or RPMI 
complete medium alone for 72 h on PBMC proliferation are shown in Figure 2.10. 
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Figure 2.10: Effect of honey concentration on PBMC proliferation. PBMC were incubated with honeys 
(artificial, manuka or Otago pasture) or RPM! complete medium alone. Cells were cultured for 72 hand 
PBMC proliferation over the final 18 h of culture was determined via incorporation of a BrDU label. 
Data represent the mean ± SEM of OD readings for each treatment, expressed as a proportion of the 
control (cells in RPMI complete medium only). Differences between the means are indicated by 
superscript letters, where means not sharing common letters within a graph are significantly different 
(P<0.05). Treatments were conducted in triplicate wells and these means are derived from three 
independent experiments (n = 9). 
The results in Figure 2.10 show that BrDU incorporation by cells varied according to 
concentration for each honey type. Artificial honey did not significantly increase BrDU 
incorporation by cells beyond the control at any concentration. The decrease in cell 
proliferation compared with that of cells with RPMI complete medium alone, recorded 
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for PBMC incubated with 1 % concentrations of all honey types can be attributed to the 
osmotic effects of sugar on the cells, as trypan blue staining had demonstrated this 
effect of sugars on cell viability (Figure 2.9). There was decreased viability for the cells 
exposed to 0.5% artificial honey but this was not significantly less than the control. 
The observation that BrDU incorporation by lymphocytes increased beyond the control 
as the dose of honey decreased (0.5--0.1 % ) indicated that natural honey had a 
significantly greater effect on proliferation at lower concentrations (Figure 2.10). Tests 
for significance in the amount of proliferation induced between honeys at these lower 
concentrations confirmed that the natural honeys were statistically different from 
artificial honey (P<0.05) but only different from each other at the 0.25% concentration 
with manuka honey increasing proliferation more than Otago pasture honey did at this 
concentration (P<0.05). 
2.3.1.2 The effect of various honeys at.final concentrations of 0.0000025-0.025% on 
proliferation of resting lymphocytes 
Based on the initial observation that 0.1 % natural honeys induced the greatest cell 
response, the objective was to determine at what concentration the stimulatory effect 
would be lost. Therefore, the range of honey concentrations tested was extended by 
serial dilution of prediluted 25% honey solutions to obtain final concentrations in 
culture of 0.0000025-0.025%. PBMC were added to a 96-well microtitre plate 
according to the assay method described in Section 2.2.4.1, along with honey solutions 
(manuka, Otago pasture or artificial) or RPMI complete medium alone. Serial dilutions 
of the initial 25% honey solution enabled final concentrations to be obtained, taking 
into account the dilution effects of all well contents. The cells were incubated for 72 h 
(37°C, 5% CO2, 95% air). Proliferation was determined using incorporation of a BrDU 
label (as described in Section 2.2.6.3). 
The effect of incubating PBMC with honey at very low concentrations are shown in 
Figure 2.11. 
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Figure 2.11 : Effect of honey concentration on PBMC proliferation. PBMC were incubated with either 
manuka honey or Otago pasture honey at final concentrations of 0.0000025-0.025% or RPMI complete 
medium alone. Cells were cultured for 72 h (37°C, 5% CO2, 95% air), and PBMC proliferation over the 
final 18 h of culture was determined via incorporation of a BrDU label. Data represent the mean ± SEM 
of OD readings for each treatment, expressed as a proportion of the control (cells in RPMI complete 
medium only). Differences between the means are indicated by superscript letters, where means not 
sharing common letters within graphs are significantly different (P<0.05). Treatments were conducted in 
triplicate and these means are derived from four independent experiments (n = 12). 
The results in Figure 2.11 show that manuka honey at a final concentration of 
0.000025% increased BrDU incorporation by PBMC compared with control cells 
incubated in RPM! complete medium only, but had no effect above the control at a 
lower concentration of 0.0000025%. Manuka honey had a greater stimulatory effect on 
PBMC proliferation when the concentration was reduced tenfold from 0.025-0.0025% 
(Figure 2.11 ). Otago pasture honey increased BrDU incorporation of cells beyond that 
obtained with the control at a concentration of 0.00025%, but not at the lower 
concentration of 0.000025% as seen with manuka honey. Artificial honey had no effect 
on PBMC proliferation at all concentrations compared with the control (data not 
shown). The stimulatory effect on PBMC proliferation of both natural honey types 
increased as honey was serially diluted below a concentration of 0.025%. 
In view of the results obtained in Figure 2.11, the assays were repeated but this time 
using MTT assay to assess the effect of honey concentrations on PBMC proliferation 
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when measured through different mechanisms. The MTT assays gave the same results 
as the BrDU assays (data not shown) and therefore the MTT assay data was not 
presented as it did not differ significantly. However, the MTT assay method 
development was retained in this thesis as a useful reference for future experimental 
design. These two types of assay provided measurement of cell proliferation using 
different biochemical processes: the BrDU assay shows increase in DNA synthesised 
and the MIT assay shows increase in cytoplasmic metabolic activity. 
2.3.1.3 The effect of various honey fractions on proliferation of resting lymphocytes 
In order to characterise the stimulatory agent in honey, manuka honey was fractionated 
as described in Section 2.2.2.1. Bovine PBMC were incubated for 72 h with honey 
fractions according to the method described in Section 2.2.4.1. The fractions were: 
dialysis retentate, dialysis diffusate, high and low molecular weight fractions from 
ultrafiltration, or an ether extract at final concentrations of 0.000025--0.1 %. Dialysis 
fractions of Otago pasture honey were also tested for stimulatory effects at the same 
concentrations as equivalent to natural honey. Proliferation was determined using 
incorporation of a BrDU label (as described in Section 2.2.6.3). 
The ether extract of manuka honey had no effect on PBMC proliferation beyond that 
obtained with RPMI complete medium alone at any of the concentrations tested 
(0.000025--0.1 %) (data not shown). Further, both the low and high molecular weight 
fractions of ultrafiltered honey (using a 10 kDa separation) had no activity beyond that 
obtained for the control (data not shown). 
The effect of exposing PBMC to dialysis retentate fractions at concentrations equivalent 
to 0.000025--0.1 % 1 natural honey are shown in Figure 2.12. 
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Figure 2.12: The effect of dialysis retentate fractions at concentrations equivalent to 0.000025-0. l % 
natural honey on PBMC proliferation. PBMC were incubated with high molecular weight fractions of 
honeys (Otago pasture or manuka) obtained by dialysis, or RPMI complete medium alone. Cells were 
cultured for 72 h (37°C, 5% CO2, 95% air), and PBMC proliferation over the final 18 h of culture was 
determined via incorporation of a BrDU label. Data represent the mean ± SEM of OD readings for each 
treatment, expressed as a proportion of the control (cells in RPMI complete medium only). Differences 
between the means are indicated by superscript letters, where means not sharing common letters within 
graphs are significantly different (P<0.05). Treatments were conducted in triplicate and these means are 
derived from two independent experiments (n = 6). 
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The results in Figure 2.12 show that dialysis retentate fractions at concentrations 
equivalent to 0.025-0.1 % manuka honey induced significant proliferation beyond that 
obtained for the control. At concentrations equivalent to 0.000025-0.025% manuka 
honey, retentate fractions had no activity on lymphocytes beyond that obtained with 
RPMI complete medium alone. Retentate fractions of Otago pasture honey had 
significant stimulatory activity on lymphocytes at concentrations equivalent to 0.025-
0.1 % honey. At concentrations where proliferation was induced there were no 
significant differences in the levels of BrDU incorporation obtained between the 
honeys. These results indicate that the active component in honey is present in the high 
molecular weight fraction (>10 kDa in size) and that it exerts its effects in manuka 
honey diluted 0.025-0.1 %. 
As it was observed that increased concentrations of retentate (of either honey) produced 
an upwards trend for proliferation levels (Figure 2.12) further assays were conducted to 
identify activity at higher concentrations. Bovine PBMC were incubated with retentate 
at concentrations equivalent to 0.1-0.5% manuka honey or RPMI complete medium 
alone as described. Proliferation was determined using incorporation of a BrDU label 
(as described in Section 2.2.6.3). The effect of exposing PBMC to higher doses of 
manuka honey retenate are shown in Figure 2.13. 
The results in Figure 2.13 show that retentate fractions at concentrations equivalent to 
0.1-0.25% manuka honey induced significant PBMC _proliferation compared with the 
control. There was a downwards trend in the amount of cell proliferation as the 
retentate concentration increased. There was no activity beyond that obtained for the 
control when PBMC were exposed to retentate fractions equivalent to 0.5% manuka 
honey. 
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Figure 2.13: The effect of dialysis retentate fractions at concentrations equivalent to 0.1- 0.5% manuka honey 
on PBMC proliferation. Bovine PBMC were incubated with high molecular weight fractions, obtained by 
dialysis, at concentrations equivalent to 0.1-0.5% manuka honey or RPMI complete medium alone. Cells were 
cultured for 72 h (37°C, 5% CO2, 95% air), and PBMC proliferation over the final 18 h of culture was 
determined via incorporation of a BrDU label. Data represent the mean ± SEM of OD readings for each 
treatment, expressed as a proportion of the control (cells in RPMI complete medium only). Differences 
between the means are indicated by superscript letters where means not sharing letters are significantly 
different (P<0.05). Treatments were conducted in triplicate and these means are derived from two independent 
experiments (n = 6). 
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Figure 2.14: The effect of dialysis retentate fractions at a concentration equivalent to 0.1 % manuka honey on 
Bovine PBMC proliferation compared with unfractionated manuka honey (0.1 % ). PBMC were incubated with 
0.1 % concentrations of either unfractionated manuka honey or dialysis retentate fractions at a concentration 
equivalent to 0.1 % manuka honey, or RPMI complete medium alone. Cells were cultured for 72 h (37°C, 5% 
CO2, 95% air), and PBMC proliferation over the final 18 h of culture was determined via incorporation of a 
BrDU label. Data represent the mean ± SEM of OD readings for each treatment, expressed as a proportion of 
the control (cells in RPMI complete medium only). Differences between the means are indicated by superscript 
letters where means not sharing letters are significantly different (P<0.05). Treatments were conducted in 
triplicate and these means are derived from two independent experiments (n = 6). 
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In view of stimulation being less than was seen in Figure 2.10 and Figure 2.11 with 
unfractionated honey, further assays were conducted to compare the magnitude of the 
stimulatory effect induced by the retentate fraction and unfractionated manuka honey. 
Bovine PBMC were cultured with either a retentate fraction (at a concentration 
equivalent to 0.1 % manuka honey) or unfractionated manuka honey (0.1 % ) or RPMI 
complete medium alone. Proliferation was determined using incorporation of a BrDU 
label (as described in Section 2.2.6.3). A 0.1 % concentration was chosen as it had 
been shown to produce optimal PBMC stimulation for both honey treatments. 
The results in Figure 2.14 show that most of the stimulatory activity is lost by 
dialysing manuka honey, as indicated by the reduction in proliferation which occurred 
when PBMC were exposed to retentate fractions compared with that with the 
unfractionated manuka honey. Both honey solutions induced significant PBMC 
proliferation beyond levels obtained for the control. 
2.3.1.4 The effect of exposing PBMC to honey for various times on proliferation 
of resting lymphocytes 
Further assays were conducted to establish the minimum time necessary for PBMC to 
be exposed to 0.1 % manuka honey for significant effects on PBMC proliferation to be 
obtained. Bovine PBMC were incubated with honey as described previously, except 
that the assay method was modified so that addition of the cell suspensions to the 
plate was staggered in time, at 72 h, 48 h, 24 h, 12 h, 8 h, 6 h, 4 h, 2 h, and the last 
series of wells were loaded with cells 30 min prior to conducting a MTI assay (as 
described in Section 2.2.6.2). Cell suspensions were loaded into 96-well plates 
immediately following harvest, and maintained in RPMI complete medium alone until 
transfer to the assay plate and addition of the honey solution occurred. Honey 
solutions were made fresh for each time period. Trypan blue staining had shown that 
PBMC were still viable when maintained in these conditions for 72 h (data not 
shown). All cells were incubated at 37°C (5% CO2, 95% air). The effect of incubating 
PBMC with 0.1 % manuka honey for various lengths of time on PBMC proliferation 
are shown in Figure 2.15. 
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Figure 2.15: The effect on proliferation of PBMC of exposing the resting cells to 0.1 % manuka honey 
for various times. Bovine PBMC were incubated with 0.1 % manuka honey for various times (0.5-72 h) 
prior to MTT assay. Data represent the mean ± SEM of OD readings for each treatment, expressed as a 
proportion of the control (RPMI complete medium only). The absorbance value obtained for each 
timepoint represents the amount of MIT which, in the 2 h period of incubation, has been metabolically 
converted as a proportion of the absorbance values obtained for cells incubated in RPMI complete 
medium alone for the same period. Data represent the mean ± SEM of OD readings for each treatment, 
expressed as a proportion of the control (cells in RPMI complete medium only). Significant differences 
in proliferation between times of exposure to honey are indicated by superscript letters where means not 
sharing letters are significantly different (P<0.05). Significant differences between means for honey and 
RPMI complete medium alone at each time-point are indicated P<0.05). Treatments were conducted in 
triplicate and these means are derived from two independent experiments (n = 6). 
The results in Figure 2.15 show that a minimum period of exposure of 2 his necessary 
for 0.1 % manuka honey to have any stimulatory effects on PBMC proliferation. While 
a 2-12 h exposure time for PBMC to honey significantly increased proliferation 
beyond that obtained for RPM! complete medium alone, an exposure time of 24 h or 
more had the greatest effect on proliferation. There were no significant changes in 
proliferation when cells were incubated with honey beyond 24 h. There was some 
suggestion from the plotted data that proliferation levels had begun to decline after 72 
h of exposure. 
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2.3.1.5 Assessment of the effect of honey on PBMC proliferation using CFSE 
staining 
Aow cytometry was used to provide an independent measure of activation of 
proliferation of T cells, to further verify the results obtained from the BrDU and MTT 
assays. By staining with CD3 antibodies it would be possible to determine the extent 
of T cell proliferation. According to the method described in Section 2.2.6.4, bovine 
PBMC were stained with CFSE prior to incubation with honey (0.0025% ). Cells were 
also incubated with Con A as a positive control. After 72 h the cells were removed 
and stained for CD3 expression. Analysis was undertaken using flow cytometry (as 
described in Section 2.2.6.4). 
With regard to the contour plots in Figure 2.16, relative colour shading indicates the 
relative fluorescence intensity of cells in the plot, so that contour lines sharing the 
same colour represent cells with the same fluorescence intensity. The proximity of the 
contour lines to each other indicates the concentration of cells present in plot regions, 
so that dense populations have lines close to each other. The effect on the cell division 
profile of CD3-labelled cells exposed to honey as compared with Con A or RPMI 
complete medium alone is shown in Figure 2.16. 
Cells cultured for 72 h in the absence of Con A (control, lower left panel in Figure 
2.16) have very little cell division, as shown by the majority of the cells remaining at 
resting stage fluorescence (approximately 2 x 103 FLl). Those cells which have 
divided following incubation with honey (top panels) have also stained negative for 
CD3 (B cells), indicating the honey acts as a T cell stimulus. The quantitative results 
for the cell division profiles for T cells exposed to honey, Con A or RPMI complete 
medium alone (as shown in Figure 2.16) are presented in Figure 2.17. 
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Figure 2.16: A. T cells were identified by gating on CD3+SSC (low) characteristics. B. The effect of 
honey on T cell division as indicated by progressive loss of CFSE stain by CD3 cells. Bovine PBMC 
(2.5 x I06 cells/ml) were costained with primary antibody anti-CD3 and secondary antibody anti-IgG 1 
PE, and CFSE. PBMC were exposed to either: RPMI complete medium, Con A (5 µg/ml) or honey 
(manuka or Otago pasture at final concentrations of 0.0025%), for 72 h prior to tlow cytometry 
analysis. Cells positive for both CD3 and CFSE are located at the far end of the x axis, and division of 
the CD3 cells (with loss of CFSE stain) resulted in a shift of the population toward the y ax is. Cells 
negative for the CD3 marker were located in the lower half of the plot. Two separate experiments were 
performed. The data presented is a representative example of a single experiment. 
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Figure 2.17: The proportion of lymphocytes in each daughter T cell generation according to progressive 
loss of CFSE fluorescence. Lymphocytes (2.5 x 106 cells/ ml) were incubated (37°C, 5% CO2, 95% air), 
with either honeys (Otago pasture or manuka at final concentrations 0.000025-0.025%), Con A (5 µg/ 
ml), or RPMI complete medium alone for 72 h. Differences between the means for the proportion of 
cells within each generation are indicated by superscript letters, where means not sharing letters within 
a division are significantly different (P<0.05). Data in triplicate are shown as the mean ± SEM of a 
single experiment (n = 3). 
The results in Figure 2.17 show that five rounds of cell division were identified for the 
analysis. When T cells were incubated with 0.025% concentrations of either honey, 
the proportion of cells undergoing a fifth round of mitosis was similar to those 
:,; 1 
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incubated with Con A and significantly higher than for the control group. It is possible 
that the cells in the treatment groups had continued to divide beyond five rounds but 
that loss of fluorescent intensity may have prevented resolution from background 
levels at this point. Further, the proportion of cells in the generations 1-5 (Gl-5), were 
significantly higher for cells incubated with Con A or honey (0.025%) than for RPMI 
complete medium alone indicating that honey, like Con A, induced T cell division. 
There was a higher proportion of undivided cells (GO) for cells exposed to RPMI 
complete medium alone than to Con A or honeys. Otago pasture honey had no activity 
on T cell proliferation beyond that obtained for RPMI complete medium alone at the 
lowest concentration, 0.000025%. The stimulatory effect of manuka honey at a 
0.000025% concentration was equal to that of Con A indicating that it has significant 
activity at very low levels as shown earlier with the results obtained from MIT and 
BrDU analysis. 
2.3.1.6 Activation of resting lymphocytes by honey as determined by expression of 
the lnterleukin-2 receptor 
Recently activated T cells express the IL-2 receptor on their cell surface (Pereira et al., 
1999). CFSE stained bovine PBMC that had been cultured with various 
concentrations of honey (Section 2.2.4) were stained for expression of the IL-2 
receptor. Con A was included as a positive control (Section 2.2.4.1). Non CFSE 
stained cells were also cultured and stained for expression of CD4 or CDS and IL-2 
receptor expression. 
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Figure 2.18: The effect of honey on the expression of the IL-2 receptor on lymphocytes. PBMC (2.5 X 
106 cells/ml) were costained with anti-IL-2 monoclonal antibodies and CFSE. PBMC were exposed to 
either: RPMI complete medium, Con A (5 µg/ml) or honey at a 0.0025% concentration (manuka or 
Otago pasture) for 72 h prior to flow cytometry analysis. Cells positive for both the IL-2 receptor and 
CFSE are located in the top right of the plot (within the 102-103 tlU height range as measured by the 
FL2 channel and shown on they axis). With progressive loss of the CFSE stain (indicating cell divison) 
the population expressing the IL-2 receptor shifts toward the y axis. Cells negative for IL-2 receptor 
expression are located in the lower half of the plot. Two separate experiments were performed. The data 
presented is a representative example of a single experiment. 
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As was previously described for Section 2.3.1.5, relative colour shading in the contour 
plots presented in Figure 2.1 S indicates the relative fluorescence intensity of cells in 
the plot, so that contour lines sharing the same colour represent cells with the same 
fluorescence intensity. The proximity of the contour lines to each other indicates the 
concentration of cells present in plot regions, so that dense populations have lines 
close to each other. The effect on the expression of the IL-2 receptor by T cells 
exposed to honey as compared with Con A or RPMI complete medium alone are 
shown in Figure 2.1 S. 
The contour profile exhibited by the cells incubated with honey at a 0.0025% 
concentration, indicates that honey increased their expression of the IL-2 receptor and 
underwent several rounds of cell division. Consequently, by 03 or 04, the expression 
of the IL-2 receptor was lost. The results in Figure 2. lS did not identify which T cell 
subsets were expressing the IL-2 receptor. 
The objective of costaining T cells for the IL-2 receptor and various CD markers was 
to quantify the response of T cell subsets to honey as compared with Con A or RPMI 
complete medium alone. The effect on the expression of the IL-2 receptor by the 
CDS+ T cell subset after exposure to honey, Con A or RPMI complete medium alone 
is shown in Figure 2.19. 
The results in Figure 2.19 show visually the differences in the proportion of CDS+ T 
cells expressing the IL-2 receptor (in gated regions) when T cells had been exposed to 
honey as compared with Con A or RPMI complete medium alone. While the results 
presented in Figure 2.19 give percentages for CDS+ T cells expressing the IL-2 
receptor in each plot, these percentages are obtained from one sample only, and 
therefore the means for the values obtained for two independent experiments are given 
in Figure 2.20. 
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Figure 2.19: The effect on the expression of the IL-2 receptor by CD8+ T cells exposed to honey or 
Con A. After a 72 h exposure to honey (manuka or Otago pasture diluted to final concentrations of 
0.000025-0.025% ), Con A (5 µg/ml) or RPMI complete medium alone, PBMC (2.5 x I 06 cells/ml) 
were double stained with an anti-IL-2 receptor antibody and anti-CD8. FL2 fluorescence is IL-2R, and 
FSC-H is CD8 fluorescence . CD8+ T cells were initially gated using the Con A and control cultures as 
a reference. The presence of cells in the upper right quadrant of a plot indicated they are positive for 
both descriptors. The proportion of cells present in the upper right quadrant was compared among 
treatments (honey or Con A) with the control. Two separate experiments were performed. The data 
presented is a representative example of a single experiment. The percentage values shown in the gated 
areas were assigned by CELLQuest and represent the values obtained for one sample. 
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Figure 2.20: IL-2 receptor expression on bovine CD8+ T cells cultured with honey. After a 72 h 
exposure to honey (manuka or Otago pasture diluted to final concentrations 0.000025-0.025%) Con A 
(5 µg/ml) or RPMI complete medium alone, PBMC (2.5 x 106 cells/ml) were costained with an anti-IL-
2 receptor antibody and anti-CDS. CD8+ T cells were initially gated using the Con A and control 
cultures as a reference. Data represent the mean± SEM proportion of gated CD8+ T cells (as shown in 
Figure 2.19) expressing the IL-2 receptor for each treatment. Differences between the means are 
indicated by superscript letters, where means not sharing common letters within graphs are significantly 
different (P<0.05). Treatments were conducted in duplicate and these means are derived from two 
independent experiments (n = 4). 
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The results presented in Figure 2.19 and Figure 2.20 show that the proportion of 
CDS+ T cells expressing the IL-2 receptor was greater when T cells had been 
incubated with honey (at final concentrations of 0.00025% and 0.025%) or Con A 
compared to cells incubated with RPMI complete medium alone. At both of the higher 
honey concentrations, more than 70% of CDS+ T cells expressed the IL-2 receptor 
compared with more than SO% in the Con A-stimulated group. The proportion of 
CDS+ T cells expressing the IL-2 receptor did not differ among the two natural honey 
types at these higher concentrations. However, at 0.000025% concentrations, only 
manuka honey increased the proportion of cells expressing the IL-2 receptor beyond 
the levels obtained for RPMI complete medium, but to a lesser effect than with the 
higher concentrations. These results indicate that low concentrations of honey induce 
T cells to express a key receptor needed for proliferation to occur. Manuka honey is 
more potent than Otago pasture honey in inducing IL-2 receptor expression. The 
staining for expression of the CD4 surface protein failed to work on the two occasions 
tested and was therefore not continued. 
In addition to performing proliferation assays and measuring cell activation status 
using flow cytometry, cells were checked visually for stimulation by assessing the 
amount of clumping (proliferating cells) using an inverted light microscope. PBMC 
cultures were established as described in Section 2.2.4.1, and the cell cultures exposed 
to manuka honey alone at 0.05% and 0.5% were selected for photographs as they 
provided evidence of the activating effects on T cells of honey at both a low 
concentration, and a concentration at the limit of the osmotic tolerance range. These 
results are shown in Figure 2.21. 
The visual results presented in Figure 2.21 show that very low concentrations of 
manuka honey induce T cells to clump in the same way as a mitogen. At the higher 
concentration (0.5%) of manuka honey, no clumping was evident and the cell cultures 
looked the same as those exposed to RPMI complete medium alone. Further, there is 
no evidence of osmotic stress in the cell cultures exposed to 0.5% manuka honey. This 
evidence suggests that the stimulatory component in manuka honey has been 
suppressed at the higher concentration, and that it is not likely to be due to osmotic 
stress alone. 
RPMI complete medium Con A-stimulated 
0.05 % manuka honey alone 0.5 % manuka honey alone 
Figure 2.21: The visual appearance of bovine PBMC cultures exposed to manuka honey at various 
concentrations as compared with Con A or RPMI complete medium alone. PBMC were incubated with 
manuka honey (at C: 0.05% and D: 0.5% concentrations) B: Con A (5 µg/ml) or A: RPMI complete 
medium alone for 72 h. For each treatment, a representative PBMC culture was photographed after 24 h 
incubation (Olympus 300x). These results are representative of three independent assays. 
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2.4 DISCUSSION 
This study aimed to investigate whether honey had any effect on T cell proliferation. 
The results of the current study provide evidence that low concentrations of honey 
stimulate T cells to proliferate in vitro, but not to the same extent as a classical 
mitogen. 
Cell proliferation encompasses DNA synthesis, mitosis and an increase in cell 
number. The ability of low concentrations of honey to stimulate T cell proliferation in 
vitro are in agreement with observations reported by Abuharfeil et al. (1999), although 
activity in the present study has been identified for lower concentrations than reported 
elsewhere. Physiologically, the concentration of unidentified immunostimulatory 
component of honey reaching the circulation is likely to be in the micromolar 
concentration range. Based on the composition of an average honey type as given by 
White (1975), only 2.4% of the total honey content can be attributed to that other than 
sugars, water and minerals. Taking into account the water content (75%) of an average 
North American adult female (62 kg) being 45 litres, consumption of 10 g of honey 
would deliver a maximum potential dose of 240 mg of the unidentified agent. 
Whether honey is ingested orally or applied topically, the active ingredient will be 
subject to various unknown factors: dilution with wound fluid or digestive juices, pH 
of the interface between honey and wound or honey and gut wall, variable oxygen 
levels, and the presence of enzymes and ions in the body. This means that the 
effective concentration reaching the "target" tissues will be significantly reduced from 
the original dose. However, the most significant point to be taken from these results is 
that T cell proliferation is enhanced by hundred-fold dilutions of honey. If the 
immunostimulatory components of honey are absorbed from the gut and become 
distributed in the total body fluid, then an approximately 0.01 % concentration could 
be expected in the circulation after a teaspoonful of honey has been administered 
orally. A study by Al-Waili (2003) demonstrated that oral ingestion of small quantities 
of honey led to significant changes in the haematological indices of blood. This means 
that honey could be expected to have systemic as well as local immunostimulatory 
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effects. If there is no immune response occurring then honey will stimulate one even 
if only trace quantities of honey are there. It is not currently known how 
biotransformation may affect the active ingredient(s) following consumption. 
Abuharfeil et al. (1999) reported that B cell proliferation increased as honey 
concentrations were diluted from 0.25-0.1 %. A study on the effects of oral ingestion 
of honey on haematological indices in blood showed that it elevated both the 
populations of circulating monocytes and lymphocytes (Al-Waili, 2003). This data 
supports the observations made in the present study. 
Inclusion of the artificial honey control was designed to examine the effect of the 
sugars alone on T cell function. The observations made in this study reveal that sugars 
alone have no effect on T cell proliferation apart from the negative effect of the 
osmotic pressures they exert on cells when osmolarity exceeds 315 mOsm (0.5% 
concentration). In view of the increased stimulatory effect as honey is further diluted, 
it is significant that sugars alone were shown to have no effect on T cell activity. 
Testing of dialysis retentate fractions of honey (with sugars removed) established that 
the osmotic effect cannot be responsible for the suppression of stimulation seen with 
higher concentrations. 
Further, the demonstrated effects on T cell proliferation by dialysis retentate fractions 
confirm that activation cannot be due to supply of glucose to the cells alone. Dialysis 
fractions had a reduced effect on T cell activation suggesting some of the activity had 
been lost during fractionation. That activating effects on T cells are greatest at higher 
honey dilutions means that they are unlikely to be due to a direct nutrient effect on 
cells. These results are in agreement with the other studies which have shown that 
honey stimulates wound healing whereas sugars alone do not (Bose, 1982; Burlando, 
1978; Hutton, 1966). The sugar component of honey has many significant biological 
effects, however these are not relevant to T cells when the availability of glucose in 
the culture medium is not lacking. It is possible that honey could give increased 
metabolic activity to cells without an increase in the number of cells, to give the 
increased activity seen in the MTT assay. However, use of BrDU assays and flow 
cytometry imaging (through CFSE staining) has measured the direct effect of honey 
tJO 
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on cell division. Differences have been observed in the osmotic tolerance of cells by 
authors. While Tonks et al. (2001) reported that 1 % final honey concentrations 
stimulated activity in the MM6 monocytic cell line with no osmotic damage, this was 
not the case in the current study. Cell types will exhibit differences in their osmotic 
tolerance according to many factors, including their biological origin. 
There are a number of plausible mechanisms by which honey may activate T cell 
proliferation and these can be divided into three broad groups based on the likely 
component in honey responsible; proteins, non-protein components of high molecular 
weight, and hydrogen peroxide. 
A number of studies have shown that proteins can activate T cells, and in particular 
proteins with sugars attached (Brownlee, 1995; Vlassara, 1995; Vlassara et al., 1995; 
Takata et al., 1988; Vlassara et al., 1985). Honey is known to contain proteins 
(National Honey Board USA, 2003; Khalil et al., 2001; Molan, 1992b; White, 1975a; 
1963), and it is likely that proteins in honey would be glycated (Tonks et al., 2003), 
due to the propensity for the enzyme invertase (which has glucose transferase activity) 
to transfer glucose on to other groups (e.g. proteins) (White, 1963). Further, long-term 
exposure of the proteins in honey to monosaccharides increases the likelihood that 
sugars will be added onto the proteins via the Maillard reaction (White, 1963). It is 
possible that different honey types have different protein compositions. 
Studies have established that glycated proteins bind to cellular receptors in a similar 
manner to lectins (e.g. Con A) (Jensen et al., 2003; MacCarthy et al., 1994; Takata et 
al., 1988). However, glycated proteins activate T cells through the TcR receptor on 
the cell membranes (Sitkovsky et al., 1984). Full strength honey contains a low 
protein content (Molan, 1992b; White, 1963). That an average honey has an average 
total protein content of 168.6 mg/lOOg honey (National Honey Board USA, 2003), 
and dilution to the very low levels tested in the current study would reduce these 
further, raises doubts about the feasibility of such low concentrations of protein 
having significant stimulatory effects on T cells. Con A loses its effect on T cell 
activation when diluted to 0.01 µg/ml (Beineke et al., 2004). Using the figures 
reported by White (1975a) for the free amino acid content in an average honey, at a 
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0.25% concentration the free amino acid content would be around 1.12 µg/ml. This 
does not take into account the content of any polypeptides. Taking into consideration 
the content of active proteins (such as those derived from royal jelly as reported by 
Simuth et al., 2004) and enzymes, the possible contribution of proteins to the 
observed stimulatory effects cannot be discounted. 
There is extensive evidence indicating that hydrogen peroxide is a cellular activator 
(Reth, 2002; Lee et al., 1999; Li and Karin, 1999; Los et al., 1995; Schreck et al., 
1991, Flohe et al., 1985), specifically for T cells (Reth, 2002; Los et al., 1995). This 
study has shown that honey similarly upregulates expression of the IL-2 receptor and 
induces T cell proliferation. Direct addition of micromolar concentrations of hydrogen 
peroxide to T cells for short periods of time upregulates IL-2 production, and in turn, 
cell proliferation (Los et al., 1995). The results of the current study were in agreement 
with Los et al. (1995), who observed that IL-2 receptor expression was induced by 
exposing Esb-L T lymphoma cells to micromolar concentrations of hydrogen peroxide 
for short periods of time. In addition, it has been shown that honey will induce IL-2 
production by a murine cell line (de Jong, 2003). Further, it has been demonstrated by 
Pani et al. (2000) and Alliangana (1996) that altering the balance between 
exogenously added hydrogen peroxide and antioxidants to a cell culture had a 
profound effect on whether cells proliferated or not. 
Extrapolating from the values for hydrogen peroxide production by honey given by 
Bang et al. (2003), the likely concentration of hydrogen peroxide accumulating in cell 
cultures incubated with 0.25% honey for 30 min would be approximately 0.05 mM. 
This is well below the minimum concentrations of hydrogen peroxide (0.2 mM) 
reported to induce oxidative stress in fibroblasts (Wang et al., 2001). Yet this level is 
well above the minimum levels of oxidant species (0.2-0.1 nmol) observed to 
stimulate fibroblast proliferation (Murrell et al., 1990). A further point to consider is 
that dialysis retentate fractions contained the active, stimulatory component and this 
supports the possibility of hydrogen peroxide being responsible, since glucose oxidase 
would be in the retentate. The glucose in the medium would provide the substrate for 
glucose oxidase to produce hydrogen peroxide. With hindsight, it would have been 
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useful to run the retentate fraction through a separation column to enable purified 
fractions of this to be tested. 
While there is an abundance of evidence for the activating effects of hydrogen 
peroxide on T cells, there are several factors which complicate the likelihood of its 
involvement in the results presented here. The first is the observation that progressive 
dilution of honey below a 30% concentration (120-fold more concentrated solution 
than the 0.25% concentrations found to have activity in the current study) leads to 
significant reduction in the ability of the glucose oxidase enzyme to produce hydrogen 
peroxide (Bang et al., 2003). The second is that manuka honey has a more potent 
stimulatory effect than Otago pasture honey yet has a lower hydrogen peroxide 
content (Molan, 1992b ). 
Hydrogen peroxide has been demonstrated to stimulate cell proliferation when co-
incubated with cells for short periods of time (8 h optimal), and stimulation effects 
were reduced with increased time (Los et al., 1995). However, in the current study it 
was observed that while a 2 h incubation period was sufficient to activate some 
proliferation, maximal effects were obtained after 24 h. It should be noted however, 
that the investigations performed by Los et al. (1995) delivered hydrogen peroxide as 
a bolus to the cells, whereas hydrogen peroxide would have been delivered 
continuously through glucose oxidase activity in the current study. Comparison of the 
amount of time for different honey types to release maximal levels of hydrogen 
peroxide has illustrated that there were large differences according to honey 
composition (Bang et al. 2003). 
While some of the results suggest hydrogen peroxide is the active stimulant, 
practically it is unlikely as manuka honey has a lower hydrogen peroxide content and 
yet a greater stimulatory effect. Manuka honey has a reported hydrogen peroxide 
content which is negligible compared with Otago pasture honey (Molan 1992b; 1998). 
Of particular relevance to the investigations reported here, hydrogen peroxide-driven 
stimulation is enhanced when cells are maintained in the presence of the reducing 
agent 2-mercaptoethanol (2-ME)(Los et al., 1995). Many cell culture mediums 
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include 2-ME, and it was included in all PBMC cultures presented in this thesis. The 
presence of 2-ME may provide some explanation for the greater magnitude of 
proliferation levels obtained for PBMCs incubated with honey in the current study as 
compared with those reported by Abuharfeil et al. (1999) who did not use 2-
mercaptoethanol in their medium. The proliferation levels obtained in the current 
study were up to 2-fold greater for PBMC incubated with the same honey 
concentrations (0.1 % ) than reported for the lymphocytes in the Abuharfeil et al. 
(1999) study. Further evidence for the ability of a reducing environment to maximise 
lymphocyte proliferation comes from a study by Carswell and Papaoutsakis. (2000), 
which demonstrated that low oxygen tension promotes T cell proliferation. Free 
radical scavengers themselves have been reported to activate NF-KB expression, 
strengthening the importance of maintaining a reducing environment to regulate 
normal cell proliferation (Murley et al., 2001). Within the cell, the enzyme-SH groups 
are readily oxidised by hydrogen peroxide (Ahn and Thiele, 2003). 
That honey does not stimulate the same levels of proliferation as a classical mitogen is 
of itself an important observation. The implications of this for the healing wound are 
important, because it is vital for inflammation to proceed at an appropriate level for 
infection to be cleared and for repair to be achieved, and to avoid the problems 
associated with excessive inflammation (e.g. fibrosis or erosion of tissue) or 
inadequate inflammation (failure to heal). 
It was noted that there was often reproducibility problems between assays. This 
problem has also been experienced by de Jong (2003) when conducting proliferation 
assays with T cells obtained from bovine blood and is likely to reflect the 
physiological differences between individual animals. As independent assays 
contained blood from different animals the possibility that an animal exhibited an 
attenuated response to some in vivo event could not be excluded as a source of 
variation in cell activity. A recent study by Baechler et al. (2004) has demonstrated the 
extreme sensitivity of blood cells to ex vivo handling. Of relevance to the current 
study, Baechler et al. (2004) reported that subtle changes which occur in the 
regulation of mRNA expression during handling of blood ex vivo have profound 
implications for activation status of the cells and therefore the outcome of various 
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ELISA measurements. Measurement of pH in various honey solutions and medium 
confirmed that there was no significant variation in pH between treatment cultures. 
The significance to the T cell proliferation response of having accessory cells present 
to variable degrees has not been investigated. Certainly it has been shown by Yancy et 
al. (2001) that the presence of various primary cell populations in vitro assays has a 
profound effect on the activation response. The effect of honey on these other cell 
populations and subsequent effects of chemical messages produced by these cells on T 
cells during the assay have not been evaluated. The use of a non-purified T cell 
fraction creates scope for variation between experiments based on the undetermined 
interactions with other cells in the culture. It is noted that the protocol used in the time 
series experiments may have resulted in the transfer of T cells and monocytes in 
different proportions, and therefore it cannot be determined whether the data in Figure 
2.15 is representative of a mixed population or for T cells only. 
In summary, this study has shown that low concentrations of natural honey induce 
lymphocyte proliferation but not to the same high levels as a classical mitogen. This 
effect suggests that honey might enhance a variety of immune responses, and be of use 
in wound healing situations. Further studies using in vivo models of impaired healing 
or chronic wounds are required before the real nature of its effectiveness can be 
determined. 
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Chapter Three: The Effect Of Honey On Cytokine mRNA 
Expression In Whole Blood 
SUMMARY 
The ability for honey to induce messenger RNA expression for key cytokines involved 
in wound healing was investigated. Conventional reverse transcriptase-PCR was used 
to detect the production of mRNA for honey at 0.25% concentrations for various 
times (0-24 h). The more sensitive molecular technique, quantitative real-time RT-
PCR was then used to quantify the abundance of cytokine mRNA transcripts 
expressed in bovine blood exposed to 0.25% manuka honey as compared with Con A 
or control cultures. Transcriptional activity of ten genes, IL-1, IL-5, IL-12, IL-18, IFN-
y, HSP70, HSP90, i-NOS, TNF-cx., and TGF-~ were studied at the mRNA level during 
a 0-24 h exposure of whole blood to honey. To test for any modulatory effects of 
honey on gene expression in an inflammatory model, whole blood was exposed to 
honey at the same time as LPS and the mRNA expression for the genes was measured. 
The results show that honey up-regulates a wide range of mediators, including TNF-cx., 
IL-1 ~. and TGF-~, and this supports the hypothesis that honey induces cytokine 
release. Honey gave a transient and moderate induction of cytokine mRNA compared 
with a massive and prolonged induction by the mitogens, Con A and LPS. The 
inclusion of honey with LPS led to a reduced expression of mRNA for key 
inflammatory mediators, including iNOS and TGF-~, compared with LPS alone. This 
supports the hypothesis that honey modulates inflammation. 
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3.1 INTRODUCTION 
Cytokines are small messenger molecules secreted by one cell to alter the behaviour of 
itself or another cell (Arai et al., 1990). They are produced by virtually all cells and 
have a wide variety of functions, which are dependent on the tissue they are produced 
in and the type of cytokine (Bocker et al., 2001). However, the principle cytokine 
producing cell populations in blood are the lymphocytes, monocytes/macrophages and 
the neutrophils (Arai et al., 1990). Timing of cytokine expression is crucial for the 
normal wound healing process to occur, and cytokine expression conforms to a 
predictable sequence in a normal tissue repair model (Enoch and Harding, 2003; 
Trengrove et al., 2000; Barone et al., 1998; Moore et al., 1997; Mast and Schultz, 
1996; Harris et al., 1995). The kinetics of gene expression and the production of 
several cytokines following stimulation have been studied (Fraser et al., 1993; Arai et 
al., 1990; Ullman et al., 1990; Crabtree, 1989; Weiss et al., 1986; Kroncke et al., 
1985; Efrat et al., 1982). It is when tight regulation of interactions between various 
growth factors, cytokines and angiogenic mediators breaks down that abnormal 
healing occurs (Section 1.6). 
In inflammation the first cytokines to be produced are IL-1 ~ and TNF-cx, by a range 
of cells involved in the inflammatory response including activated T cells, dendritic 
cells and macrophages (Arai et al., 1990). In addition to being primal danger signals 
(Ullman et al., 1990), these cytokines are proinflammatory and perpetuate activation 
of mononuclear cells through positive feedback amplification (Ullman et al., 1990). 
Of further relevance to wound healing, these cytokines are essential for neutrophil 
recruitment (McClenahan et al., 2000), and in the late inflammatory phase play a key 
role in activation of the fibroblasts and signalling for the formation of the tissue 
matrix (Clarke, 1996). 
Nitric Oxide (NO) plays an important role in tissue repair and the formation of NO by 
cells during inflammation is important for cell signalling to proceed. The enzyme 
inducible nitric oxide synthase (iNOS) is a member of the family of isoenzymes 
responsible for NO production from L-arginine (Liang et al., 2001). Prior to the 
current study, Al-Waili (2003) had reported that oral ingestion of honey led to an 
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increase in NO in saliva. Further, it was reported that honey contains different 
amounts of NO metabolites (Al-Waili, 2003). This suggested honey may have some 
effect upon mRNA expression of the iNOS enzyme. Though NO has a beneficial role 
in tissue repair, the high levels of NO which are produced in a model of excessive 
inflammation, such as that created by incubating blood with LPS, are potentially 
damaging to tissues through the formation of free radicals. 
NO diffuses freely across cell membranes, and is consumed quickly due to the large 
number of molecules with which it interacts. For this reason, NO only has a localised 
effect on cells, behaving in both a paracrine and autocrine manner. NO binds to 
protein receptors in the cell, being either a metal ion in the protein or one of the S 
atoms of the protein. Once bound to the protein, an allosteric change occurs and a 
second messenger forms within the cell (e.g. when NO binds to guanylyl cyclase 
cyclic GMP is generated). NO is involved in blood vessel dilation of endothelial cells, 
with response being effected in seconds. NO also facilitates cell signalling in a 
number of pathways; chiefly through oxidation of kinase signalling, nitrosation of 
protein sulfhydryl groups, and release of metal ions (Dedon and Tannenbaum, 2004; 
Kim and Tannenbaum, 2003). NO enhances the effect of cyclooxygenases and 
stimulates the production of pro-inflammatory eiconosoids. A number of factors 
upregulate iNOS, and these are known to include interleukins, IFN-y, TNF-a and 
LPS. 
Interferon-gamma (IFN-y) plays an important role in activating macrophages and 
stimulating their phagocytic capability by increasing their respiratory rate. IFN-y up-
regulates expression of interleukin (IL)-2 receptor on T-cells (Pighetti and Sordillo, 
1996). IFN-yplays a key role in the second phase of wound healing and the expression 
of constitutive and inducible adhesion molecules necessary for interaction between 
leukocytes and target cells (Bito et al., 2002). Like TNF-a and IL-lp, IFN-ycan act as 
both a primal danger signal and perpetuate activation in mononuclear cells through 
positive feedback amplification (Gallucci and Matzinger, 2001). Of additional note for 
wound healing, IFN-y drives Th1 cytokine production (including the pivotal cytokines 
TNF-a and IL-lp). 
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Interleukins act synergistically during inflammation, mediating many of the effects of 
inflammation including production of nitric oxide synthase. Other Th 1 cytokines, IL-
12 and IL-18 play an important role in inflammation. IL-12, a key molecule in the 
differentiation of Thl CD4+ T cells (Trinchieri, 1995) and augments IFN-y synthesis 
(Alluwaimi et al., 2001) in addition to driving the Th1 cytokine response. IL-18 also 
plays a role in augmentation of IFN-y synthesis in bovine lymphocytes (Shoda et al., 
2004 ). Therefore, it was useful to consider the effects of honey on the mRNA 
expression of each of these key cytokines. 
In comparison, the Th2 cytokines (e.g. IL-5) play a key role at the end of the 
inflammatory process and are involved in the dampening down of the immune 
response. Induction of a mature antibody immune response also involves cytokines of 
the Th2-type. IL-5 is regarded as a representative of this family (Kourilsky and Truffa-
Bachi, 2001) and ultimately leads to activation of the immunoglobulin G pathway 
through promotion of B-lymphocyte activity and differentiation of eosinophils. 
TGF-~, produced by mononuclear cells, plays an important role in activation of 
fibroblast activity and re-epithelialisation (Cobbold and Sherratt, 2000). As described 
in Section 3.1, significant production of TGF-~ and iNOS over a relatively long time 
period are not desirable as they are linked to the development of fibrotic disorders 
(e.g. keloid scarring). TGF-~ is important in the down-modulation of the immune 
response when the antigen has gone. 
TNF-cx., TGF-~ and IFN-y are all examples of cytokines whose actions switch from 
pro-inflammatory to anti-inflammatory according to timing and tissue context. Self-
limited inflammation is normally characterised by decreasing TNF activity, and when 
this fails to occur, mediators such as eicosanoids and nitric oxide will continue to be 
amplified by TNF-cx.. It is noted that other proteins may bind to TNF-cx. mRNA 
transcripts, resulting in either increased stability of the transcript or conversely, its 
breakdown. In arthritis for example, there is a greater proportion of TNF-cx. mRNA 
persisting for longer periods of time (Haringman and Tak, 2004). TGF-~ produced.at 
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high levels over a relatively long time period has been shown to cause gastric 
ulceration through its effects on macrophage and neutrophil infiltration and their 
resultant production of oxidant species (Kulkarni et al., 1993). 
Therapeutic agents which may alter cytokine expression may therefore be of use 
where there is abnormal wound healing. In addition to the wealth of anecdotal reports 
that honey optimises wound healing, limited investigations have indicated that honey 
modifies cytokine production by mononuclear cells in vitro (Tonks et al., 2003; de 
Jong, 2003; Tonks et al., 2001). To investigate the possibility that hydrogen peroxide 
in honey might be responsible for the observed anti-inflammatory effects through 
induction of heat shock proteins (HSP), these were selected for quantification. HSP 
are induced by and confer protective effects against further cellular damage, and 
among these the actions of HSP 70 and HSP 90 in inflammation have been well 
documented (Gallucci and Matzinger, 2001). While HSP 70 stimulates lysosomal 
hydrolysis, HSP 90 binds the tyrosine-specific protein kinase and slows the cell cycle. 
To investigate the role of honey in induction of mRNA for cytokines, the molecular 
techniques, agarose gel electrophoresis and quantitative real-time RT-PCR (real-time 
PCR), were used in the current study to identify whether mRNA coding for key 
inflammatory proteins had been expressed by blood cells. One of the key advantages 
of real-time PCR over gel electrophoresis is that real-time PCR provides a sensitive 
method for detecting expression of mRNA for cytokines and quantifies expression 
even when abundance is very low (Pfaffl, 2003). The advantage of using whole blood 
assays to study inflammatory mediator expression is that they retain all blood 
components and maintain a normal environment for cell-cell interactions, thereby 
mimicking the natural physiological environment (Mayringer et al., 2000). Con A was 
used as a positive control for cellular activation, and on this basis others have used 
Con A to establish an inflammatory model (Mizuhara et al., 1994). 
As honey has been shown to be anti-inflammatory (discussed in Section 1.4.4) an 
additional aim was to test whether honey could modulate the expression of mRNA for 
proinflammatory cytokines (e.g. iNOS) in LPS-treated blood. LPS was used to induce 
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an inflammatory response and provide a model based on published reports (Tse et al., 
2004; Rao, 2001; Hambleton et al., 1996). Primarily a model for infection, LPS is the 
major outer membrane component of gram-negative bacteria. LPS binds with LPS-
binding protein and is then recognised by the CD14 receptor (a GPI-linked protein 
present on the surface of phagocytic leukocytes) (Gretzer and Thomsen, 2000). LPS 
can float around in the supernatant and be accessed by CD14. LPS upregulates CD14 
expression on non-adherent monocytes after 24-72 h incubation periods (Gretzer and 
Thomsen, 2000). After being bound to CD14, LPS acts via the Toll-like receptor 
(TLR)4 coreceptor (1), and ligation of these receptor complexes activates a signal 
transduction cascade (Belge et al., 2002). On any one cell there are a number of TLRs, 
which bind to proteins being produced. After mobilisation of transcription factors (e.g. 
NF-KB), cytokines (e.g. TNF-cx) are expressed. 
3.2 MATERIALS AND METHODS 
3.2.1 Reagents 
Alsevers 
A 1 L solution of Alsevers was made consisting of; D-Glucose 20.5 g, TriNa Citrate 
8g; citric acid 0.55 g, distilled water 1000 ml, and NaCl 4.2 g. These reagents were all 
purchased from BDH Laboratory Supplies, Poole, England. 
Sodium acetate 
A 2 M solution was prepared by dissolving 27 .22 g of sodium acetate powder (Sigma-
Aldrich, cat no# A-8219) in 1 litre of Milli Q water. The pH was adjusted to 4 using 
2M acetic acid. 
PCR buffer 
10 mM Tris-HCl, 50 mM KCl, pH 8.3 
Reverse Transcriptase buffer 
Purchased in Superscript First Strand Kit (GibcoBRL, Grand Island, NY) containing 
200 mM Tris-HCl (pH 8.4) 500 mM KCI. 
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dNTP mix (10 mM) 
Purchased in Superscript First Strand Kit (GibcoBRL, Grand Island, NY) containing 
10 mM each dATP, dCTP, dGTP, dTTP. 
Concanavalin A (Con A) 
Con A stock solutions were prepared as described in Section 2.2.1 to a final 
concentration of lmg/ml (Sigma C5275). 
Honey solutions 
M109 manuka honey, Otago pasture honey and artificial honey were prepared as 
described in Section 2.2.2. 
LPS solutions 
A 1 mg/ml stock solution (E. coli serotype 0111: B4; Sigma-Aldrich UK; cat no# 
L4516) was purchased. The LPS was diluted with medium to final concentrations in 
wells of 10 µg/ml (unless otherwise stated). 
3.2.2 Preparation of whole blood 
Blood was collected from a Holstein-Friesian steer by tail venipuncture, containing 
K3EDT A. The cattle were well-fed, free of diseases and held in quarantine conditions. 
In the laboratory, 10 ml of blood was mixed gently with 2 ml of RPMI 1640 base 
medium (GibcoBRL) and 3 ml of Alsevers solution. The blood was transferred to 
three 50 ml tissue culture flasks (Greiner) in 5 ml aliquots. 
3.2.3 Assay design 
3.2.3.1 Assay to measure stimulatory effects 
Bovine blood was incubated with honey or the mitogen Con A (to provide a positive 
control) for 24 h prior to RNA extraction. To investigate the effect of honey on 
mRNA expression of immune-related genes, blood was cultured for 24 h with honey. 
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The blood was subjected to three treatments, honey, Con A or no stimulation. Con A 
was added to give a final concentration of 5 µg/ml. 
The treatments (honey solutions, Con A or RPMI-1640 basal medium) were added to 
separate flasks each containing 5 ml of the diluted blood. All treatments were added to 
flasks in 25 µl aliquots. Control blood suspensions received 100 µl of RPMI-1640 
base medium only. The blood was incubated for 24 h (37°C, 5% CO2, 95% air in a 
humidified atmosphere) and 1 ml of suspension removed for RNA extraction from 
each flask at Oh, 6 h, 12 h, 24 h after addition of the treatments. The cytokines, IL-IP, 
IL-5, IL-12, IL-18, TNF-cx, IFN-y, TGF-p, iNOS, HSP70, HSP90 were selected for 
study. 
3.2.3.2 Assay to measure modulatory effects 
To investigate the effect on cytokine expression when blood was exposed to honey at 
the same time as LPS, the experiment was set up as described above, with the addition 
of LPS (final concentration 10 µg/ml). The control flasks were set up. One with no 
addition and the second with LPS alone (final concentration 10 µg/ml). The 
experiment continued as described in Section 3.2.3.1. All PCR reactions were 
performed in duplicate and repeated in time at least twice, according to standard 
protocols. 
3.2.4 Lysis of cells and RNA extraction 
The 1 ml aliquot of blood was immediately placed in a 15 ml Sarsted tube containing 
4 ml of 5 M Guanidium Thiocyanate (GdnSCN, Roche). The tubes were left at room 
temperature until the final sub-sample had been collected at 24 h. At this point the 
tubes were inverted several times and 0.5 ml of 2 M sodium acetate (pH 4) and 2 ml 
of 100% ethanol were added to each tube to precipitate the nucleic acids, particularly 
the tRNA. The tube was incubated on ice for 10 min prior to centrifugation for 15 min 
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(18 547 x g, 4°C, Beckman) to pellet the nucleic acids. The supernatant was then 
removed. 
The RNA pellets were resuspended in 1 ml of Trizol reagent (ProGenz) to prevent 
degradation of mRNA and the suspension transferred to a 1.5 ml Eppendorf tube, and 
thoroughly mixed by vortexing. Following 5 min incubation at room temperature, 200 
µl of chloroform was added and mixed by vortexing for 20 sec, and the tubes 
incubated on ice for 10 min. The tubes were centrifuged for 15 min (Eppendorf, 572 x 
g, 4°C) and the clear layer at the top of the supernatant was transferred into a new 1.5 
ml Eppendorf tube. An equal volume of isopropanol was added to the clear 
supernatant, and the contents mixed by gentle inversion of the tube prior to incubation 
for 20 min at -20°C. The tube was then centrifuged for 10 min (Eppendorf, 572 x g, 
4°C) to pellet the RNA and the supernatant removed. To further precipitate the RNA, 
1 ml of 70% ethanol was added to the RNA pellet and mixed by vortex for 10 sec to 
resuspend. The tube was centrifuged for 5 min (Eppendorf, 572 x g, 4 °C) and all of 
the ethanol removed using a pipette, leaving the RNA pellet to air dry. The RNA 
pellet was dissolved in 20 µl of 10 mM Tris (pH 7 .8) 0.66 M MnC}z and mixed by 
vortex for 10 sec prior to addition of 1 µl of DNAse (Promega) to remove any residual 
DNA. The tube was incubated for 30 min in a thermomixer (37°C). DNAse was 
inactivated by adding 1 µl of EGTA (Promega DNAse Stop Solution) and the tube 
incubated for 10 min at 65 °C. To check the quality of the extracted RNA, 2.5 µl of 
RNA from each tube was run in a 2% agarose gel (Section 3.2.4.1) in TAE buffer. The 
samples electrophoretically separated at 55 volts for 45 min, and the intensity of the 
bands compared using a Bio-Rad GS-690 hnaging Densitometer. RNA integrity was 
indicated by the presence of sharp, clear 28S and 18S rRNA bands, preferably with 
the 28S band twice as intense as the 18S rRNA band. Partially degraded RNA would 
appear as a low molecular weight smear (not seen in the current study). RNA purity 
was checked by measuring the absorbance of samples at 260 nm (A260) using a 
UVNis Spectrophotometer (Model U-2001, Hitachi Instruments Inc). Values of 1.9-
2.1 were considered acceptable. It was observed that relatively small quantities of 
RNA were recovered from the bovine blood preparations in comparison with the 
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volumes recovered from human blood samples (R. T. M. C. Cursons; personal 
communication). 
3.2.4.1 Preparation of a 2% agarose gel 
Agarose (2 g) was added to 100 ml TAE buffer (0.04 M Tris, 5 mM sodium acetate, 1 
mM EDTA, pH 7.8) and microwaved on high for 2 min. The agarose was cooled to 
approximately 65°C by swirling the flask in a cool water bath, and 2 µl of ethidium 
bromide (10 mg/ml stock solution) was added. Approximately 30 ml was poured into 
a gel caster (Horizon® 11.14, GibcoBRL), an 8 lane comb was added, and the gel was 
left to set. 
3.2.5 Primers 
Specific cytokines that play a key role in the immune response during wound healing 
were chosen for investigation. Primer pairs were selected based on previous 
publications (Shoda et al., 2004; Amills et al., 2004; Hunter-Lavin et al., 2004; 
Schmitz et al., 2004; Eicher et al., 2003; Konnai et al., 2003; Alluwaimi and Cullar, 
2001; Leutenegger et al., 2000; Mertens et al., 1996). Care was taken to ensure that 
the RT-PCR primers spanned intron sequences so that any possible DNA product 
could be excluded. All primers were purchased from Sigma-Aldrich and are listed in 
Table 3.1. For each cytokine, primer solutions were prepared by adding 80 µl of TE 
buffer to 10 µl of forward primer stock and 10 µl of reverse primer stock in an 
Eppendorf tube, and stored at 4 °C . 
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3.2.6 Conventional RT-PCR Analysis 
This technique was chosen to detect whether rnRNA for specific proteins of interest 
had been expressed, as PCR is absolute in terms of whether a template is present. This 
enabled a number of proteins to be screened for further quantification with real-time 
PCR. 
All steps were carried out in a PCR cabinet. After extraction of purified RNA (given 
in Section 3.2.4), cDNA was prepared for conventional RT-PCR according to a 
method adapted from Jobin et al. (1998) and Bierhaus et al. (1997). 
3.2.6.1 First-strand cDNA synthesis 
Complementary DNA (cDNA) was synthesised with a Superscript™ First-Strand 
Synthesis Reverse Transcriptase kit (GibcoBRL, Grand Island, NY, Cat no# 11904-
018) following the manufacturer's instructions. Briefly, for each blood sample, 5 µI of 
RNA (1 µg/ml) was placed in a 1.5 ml Eppendorf tube along with 1 µI Oligo dT 
(GibcoBRL) and 1 µl 10 mM dNTP (GibcoBRL) mix and the contents mixed by 
inversion. The tubes were incubated for 5 min at 65°C to separate secondary 
structures from the RNA. The tubes were then put on ice for 10 min to enable the 
oligo dT primers to anneal to single-stranded RNA. 
In a separate 1.5 ml Eppendorf tube 2 µI 10 x Reverse Transcriptase buffer 
(GibcoBRL, described in Section 3.2.1) was placed with 5 µI 25 M MgCh, 2 µ1 of 0.1 
M DTT, and 1 µ1 of RNaseOUT Recombinant RNase inhibitor (GibcoBRL). The 
contents of this tube were added to the tube containing the RNA (with oligo dT 
primers attached) and incubated at 42°C for 2 min prior to addition of 1 µ1 of 
SUPERSCRIPT II™ reverse transcriptase (GibcoBRL). The contents of the tube were 
mixed by inversion and then incubated for 50 min at 42°C. 
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Table 3.1: List of the forward and reverse primers for the amplification of the interleukin (IL)-1, IL-5, IL-12, IL-18, interferon (IFN)-'Y, inducible-nitric oxide synthase (i-NOS), tumour 
necrosis factor (TNF)-a, and transforming growth factor (TGF-~). 
Length Optimal conditions Accession 
Gene Primer sequence8 (forward and reverse, 5' - number 
3') Primer (bpt Product (bp) MgCI/ Anneal temperature Acquisitiond Product", Cow (locus) 
(mM) (OC) temperature (°C) Tm (°C) 
IL-I~ CAA GGA GAG GAA AGA GAC A 19 
TGA GAA GTG CTG ATG TAC CA 20 
236 4 53 83 85.4 M372l l 
IL-5 TGG CAG AGA CCT TGA CAC TG 20 
TTT TCA CAG CAT CCC CTI GT 20 
405 3 53 83 64.3 NM_l73922 
IL-l2p40 AACCTGCAACTGAGACCATT 20 
ATC CTI GTG GCA TGT GAC TT 20 
186 4 55 85 87.3 Ul 1815 
IL-18 TTG CAT CAG CTI TGT GGA AA 20 
TGG GGT GCA TIA TCT GAA CA 20 
754 4 60 75 63.9 NM_l7409l 
IFN-y ATA ACC AGG TCA TIC AAA GG 20 
ATT CTG ACT TCT CTI CCG CT 20 
218 4 52 82 84.6 M29867 
TGF-~ 1 AGA GAG GAA ATA GAG GGC TT 20 
ATG AA T CCA CTI CCA GCC CA 20 
262 l.2 60 76 66.6 NM17462l 
TNF-a TAA CAA GCC GGT AGC CCA CG 20 
GCA AGG GCT CTI GAT GGC AGA 21 
277 3 62 79.5 69.0 AFOI1926 
HSP70 TGC TGA TCC AGG TGT ACG AG 20 
CGT TGG TGA TGG TGA TCT TG 20 
184 4 58 72 92 V0947G06 
HSP90 TGA CGA GGA TGA CCC CAC TG 20 
TGG AGG GAA TGG AGA CAG AGC 20 
335 4 55 72 92 NM005346 
iNOS ACC TAC CAG CTG ACG GGA GAT 21 
TGG CAG GGT CCC CTC TGA TG 20 
316 4 62 88 66.0 Ul4640 
107 
Chapter Three rnl<.NA cxprcs~ion in whole hlood 
The reaction was terminated by first incubating the tubes at 70°C for 15 min, and then 
placing the tubes on ice. To remove the RNA, 1µ1 of RNase H (GibcoBRL) was added 
to the tube and the contents gently mixed by inversion prior to incubation of the tube at 
37°C for 20 min. The cDNA was stored at 80°C. 
3.2.6.2 PCR with HotStar® Taq 
The PCR process involves multiple cycles of template denaturation, primer annealing, 
and primer elongation to amplify DNA sequences. HotStar® Taq DNA Polymerase 
(Qiagen, Valencia, NV) was used for PCR amplifications. An antibody complexed to 
Taq polymerase acts to block polymerase activity until after the first 94°C denaturation 
step during PCR cycling. Using a Superscript First-Strand Synthesis System for RT-
PCR kit (GibcoBRL), amplifications were performed according to the manufacturer's 
instructions. PCR reactions (20 µl) contained 0.2 mmol/1 dNTPs, 200 nmol/1 forward 
primer, 200 nmol/1 reverse primer, 0.4 U HotStar ® Taq DNA Polymerase, PCR buffer 
(1 x), 1.5 mmol/1 magnesium chloride and 0.8 µl cDNA from the reverse transcriptase 
reaction (Section 3.2.6.1). A PTC-100 Thermocycler (MJ Research, Reno, NV) was 
used for PCR thermo-cycling. After pre-incubation for 2 min at 94°C, the target DNA 
was amplified with 40 cycles, each cycle consisting of a denaturation step at 94°C (20 
sec melting), annealing for 20 sec at 55°C ( optimised for the specific genes, as 
presented in Table 3.1), and extension at 68°C for 35 sec. 
3.2.6.3 Electrophoresis of DNA 
To check whether the cDNA had been successfully synthesised, a 2% agarose gel was 
run containing 5 µl of 100 bp DNA ladder (lnvitrogen, 100 bp DNA) and 10 µl of 
amplified cDNA for each sample. Agarose gels were prepared as described in Section 
3.2.4.1, and DNA samples were premixed with 2 µl of DNA loading dye (40% sucrose, 
0.25% bromophenol blue, 0.25% xylene cyanol). A 100 bp DNA ladder (lnvitrogen) 
was loaded on each gel to enable the base pair size of the DNA products to be 
determined. Electrophoresis was carried out in Horizon tanks (lnvitrogen) containing 
TAE (1 x) buffer, at 100 v until separation was achieved. DNA was illuminated using 
UV, and photographed using the Gel-Doc system (Bio-Rad). 
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3.2.6.4 Quantitative Real-Time RT-PCR 
Real-time PCR was used to provide a quantitative measure of the transcription of 
mRNA for specific proteins of interest. A fluorescent marker is hybridised to the cDNA 
between two PCR primers for a single gene of interest. As PCR proceeds, the 5' 
nuclease activity of the Taq polymerase cleaves the probe, releasing the tag such that 
the fluorescence is proportional to the amount of cDNA present. SYBR Green® (Roche) 
was used as a fluorescent marker allowing any double-stranded DNA generated during 
PCR to be detected (Wilhelm and Pingoud, 2003). Specificity of the PCR products was 
confirmed by dissociation curve analysis and electrophoresis on a 2% agarose gel. 
After extraction of purified RNA (Section 3.2.4) it was prepared for real-time PCR 
according to a method adapted by Dr Ray Cursons and Gina Chu (University of 
Waikato) from that described by Konnai et al. (2003). All steps were carried out in a 
PCR cabinet. 
Real-time (quantitative) PCR was performed using a LightCycler instrument (Roche) to 
perform the PCR reaction, including fluorescent emission and detection of the signals. 
Real-time PCR reactions were carried out in a total volume of 25 µl. A reaction master 
mix was prepared consisting of 15 µ1 HotStar Taq DNA polymerase (Qiagen), 480 µ1 of 
5 x Qiagen PCR buffer supplemented with MgCh to 2.5 mM, 1800 µl of Milli Q water, 
0.2 mM dNTPs (Roche), 48 µl Rox reference dye (lnvitrogen), 24 µl SYBR Green® 
dye and 36 µl Triton X-100 (stops dye from binding to the plastic tube). The real-time 
PCR reaction mixture (10 µl) contained 80 nM forward primer, 80 nM reverse primer, 
2 µl Lightcycler FastStart DNA Maste?Ius SYBR Green® (Roche), and 5 ng reverse-
transcribed RNA. To exclude genomic DNA contamination, a negative control was 
done for every reaction set by performing the RT-PCR reaction with sterile water 
instead of cDNA. 
There were ten genes of interest in total. The samples were analysed for both the target 
genes and an endogenous control gene, ~2-microglobulin (~2M). The expression levels 
of the target genes were reported relative to the expression levels of ~2M. It is 
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recognised that housekeeping genes are differentially expressed under various 
experimental conditions (Rogler et al., 2004). 
The LightCycler protocol consisted of pre-incubation for 15 min at 94°C followed by 
amplification of target cDNA with 40 cycles, each cycle consisting of a denaturation 
step at 94°C for 20 sec, annealing for 10 sec at 55°C, extension at 68°C for 30 sec, and 
determination of fluorescence at 80°C for 15 sec. The LightCycler detects the point at 
which the fluorescent signal generated by the PCR reaction is visible above the 
background fluorescence of the sample. 
In addition, melting curve analysis was performed which resulted in single product 
specific melting temperatures above 80°C for each primer pair, confirming specificity 
of each primer pair. All real-time amplifications were performed using an ABI PRISM 
7700 Sequence Detection System (Applied Biosystems, Foster City, CA). Data capture 
included the values obtained for PCR stage 2, extension step 4. The data for IL-5 and 
IL-18 was obtained from the extension step 3 as those reactions were found to have a 
lower melting point (68°C). All primers were selected to span intron sequences, so that 
genomic DNA amplification was not possible. 
After analysis of the real-time PCR results, an end-product sample of DNA from the 
reaction for each gene was analysed by gel electrophoresis (Section 3.2.6.3). This 
enabled the presence of any DNA contamination to be verified and the size of the 
products to be determined by comparison with a SYBR Green ® ladder. The agarose 
gel was prepared as described in Section 3.2.4.1 omitting the ethidium bromide due to 
the presence of the SYBR Green® dye. 
A Sequence Detector v. 1. 7 of the ABI system in a Mackintosh computer was used to 
analyse each RT-PCR plate, and the clipped file was exported to Microsoft Excel as 
fluorescence level per cycle number. Using the LinReg PCR programme, a linear 
regression line was calculated to fit the log-linear phase of the data points for each 
sample. A minimum of 4 data points were included in the data analysis for each sample, 
and the slope was chosen for each data set by taking in combination, the slope closest to 
the maximum along with the highest possible r2 value. Only samples with PCR 
efficiencies above 1.5 were selected. The starting concentration (No) of the cDNA 
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template of each sample was calculated from the intercept extrapolated from the 
straight line that fitted best to the included data points which was expressed in terms of 
fluorescence intensity. 
All data values were expressed as the expression relative to the control sample (time 0) 
and corrected for P2M gene expression (endogenous control gene). To normalise the 
level of fluorescence of each gene of interest the following equation was used: 
relative expression at time O = concentration N° value for gene of interest at time 0 
concentration N° for P2M at time 0 
For each time point the relative expression of the gene of interest was calculated by 
normalising levels of fluorescence to that obtained for P2M at the same time point: 
relative expression at time x = concentration N° value for gene at time x 
concentration N° value for P2M at time x 
Final step 
The relative expression of the gene of interest at time x (i.e. 6 h) was then normalised 
for the relative expression of the same gene at time 0, by dividing the answer from step 
2 by the answer from step 1. 
111 
Chaptcr Thn.:c mRNA expression in whole blood 
3.2.7 Statistical analysis 
Data was gathered using the LinRegPCR programme (Ramakers et al. , 2003), 
quantifying the PCR product in the log-linear phase of the PCR reaction using linear 
regression analysis. The starting concentration of mRNA and the individual PCR 
efficiencies were calculated for each sample. The kinetics of cytokine mRNA 
expression was determined for blood exposed to the various treatments. Results were 
expressed as relative abundance of target gene mRNA normalised against ~2M mRNA. 
After setting the threshold Ct value, the clipped files showing the fluorescence intensity 
of each reaction at each cycle were exported in the spreadsheet format of Microsoft 
Excel (version 97 SR-2 and XP). Real-time PCR reactions were performed in duplicate 
and were repeated in time at least twice. However, the data presented in this thesis was 
obtained for duplicate samples, as only samples with the same C1 values could be 
compared for significance. This is because data was analysed for overall effects of 
treatment and time by ANOV A (P<0.05). A two-way ANOV A was used to analyse 
data, with timepoint and treatment as the parameters. The two-tailed Students' t-test 
was applied for statistical comparisons between individual groups. Unless otherwise 
stated, data presented are expressed as means± SEM (calculated from the LinRegPCR 
programme). 
3.3 RESULTS 
In Section 3.2.4 it was noted that prior to PCR, total RNA was electrophoretically 
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Figure 3.1: 28s and 18s RNA bands of total RNA isolated from blood samples. This is a representative 
example. 
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It can be seen from Figure 3.1 that the RNA samples had clear 28s and 18s bands, and 
that there was no DNA contamination. 
As described in Section 3.2.7.3, when using the relative quantification strategy, the 
increase or decrease of cellular cytok.ine mRNA levels has to be calculated in relation to 
a constantly expressed housekeeping gene (~2M). This quantification compensates for 
minimal changes in the quantity and quality of different cDNA preparations. The 
amplification of the ~2M gene is shown in Figure 3.2. 
1 2 
3 4 5 6 7 8 9 10 11 12 N L 
Figure 3.2: Ethidium bromide-stained agarose gel. Amplification of the housekeeping gene B2M in whole 
blood exposed to honey (lanes 1-4), Con A (lanes 5-8) or maintained in medium alone (lanes 9-12). N= 
the negative control/water. L=lOO bp ladder (B2M product =280 bp). This gel was representative of the 
results from all of the RT-PCR amplifications (n=8). The data are from replicate experiments. 
The results in Figure 3.2 confirm that all of the samples contained cDNA of good 
quality and that no amplification of ~2M had occurred in the absence of cDNA. It is 
noted that the samples in lanes 6 and 9 had less DNA than others. 
3.3.1 The direct effects of honey on the expression of mRNA in bovine blood 
As described in Section 3.2.7.3, real-time PCR was used to compare the abundance of 
amplicon between samples. At various times (ranging from O to 24 h), cells were 
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collected and the RNA purified and reverse transcribed. By normalising the abundance 
of PCR product to the housekeeping gene product, the total mRNA content was 
corrected for, so that abundance of the amplicon could be compared among samples. By 
presenting the results for each cytokine, at each time-point, as a proportion of that 
expressed on the mRNA from the same initial blood sample at time 0, change in 
relative cytokine mRNA expression could be shown (Figure 3.3). Each bar on the graph 
represents up- or down-regulation of a target gene in relation to the endogenous control, 
P2M. A logarithmic scale was used, and time O values are shown by the baseline (y = 
1). The effect of blood stimulation on cytokine mRNA expression is shown in Figure 
3.3. 
The profile and kinetics of mRNA production for cytokines were quantitatively and 
qualitatively different for blood exposed to honey as compared to Con A or toRPMI 
medium alone (the control). The mRNA expression obtained for control blood cultures 
(Figure 3.3) shows that whole blood constitutively synthesised readily detectable levels 
of mRNA for each of the cytokines studied. Further, all of the studied cytokines, except 
IFN-y, were down regulated compared with time O basal production levels. At the 24 h 
measurement, mRNA expression in control cultures for IFN-y had returned to the same 
levels as obtained for time 0. 
For most of the cytokines, their mRNA expression increased by the 6 h timepoint for 
honey-treated and Con A-activated cultures (Figure 3.3). By contrast, HSP90 was 
down-regulated at 6 h of honey or Con A stimulation. In the honey-treated cultures, 
iNOS was also down-regulated at the 6 h timepoint. Considering the range of cytokines 
as a complete picture, honey-stimulated cultures have a different kinetics profile to that 
obtained for Con A-activated cells. 
Following Con A stimulation of blood cultures, peak mRNA expression for most 
cytokines occurred by 6 h post-stimulation. For the Con A-stimulated cultures, peak 
expression of TGF-P, TNF-a, and HSP 70 occurred between 6-12 h post-stimulation. 
With the exception of HSP90, which peaked by 24 h post-stimulation, there was a 
decrease in mRNA expression for Con A-activated cells over the final 12 h in culture. 
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Figure 3.3: Cytokine mRNA expression in blood induced by honey or Con A. Bovine blood was treated 
with 0.25% manuka honey or Con A (5 µg/ml), as compared with RPMI 1640 alone. RNA was extracted 
from these blood cells at 0, 6, 12 or 24 h, and analysed by quantitative real-time RT-PCR . The results 
shown are ratios obtained by dividing concentrations of the PCR products from the cytokine genes by 
those from the ~rmicroglobulin gene and related to time O data. Values are representative of single 
results. 
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In general, the peak mRNA expression for cytokines in the honey-activated blood 
occurred by 6 h post-stimulation. However, IL-5 was down-regulated at 6 h and peaked 
at 12 h post-stimulation. On the basis of two independent PCR analyses, the results for 
IL-5 and IL-12p40 were found to be real. Also, peak IFN-y mRNA expression occurred 
at 24 h post-stimulation for the honey-treated cultures. Another significant difference 
was that iNOS was down-regulated over the culture period for honey-treated cells. 
Further, mRNA expression for IL-18 and TNF-cx was strongly down-regulated in 
honey-treated blood after 6 h in culture. With the exception of IL-12p40, IFN-y and 
HSP90, expression of mRNA for the cytokines in honey-treated blood decreased over 
the last 12 h in culture. The expression of mRNA for HSP70 by 6 h after honey 
stimulation was profound compared with Con A-activated cultures. 
In the following figures, a few key cytokine mRNA amplicons on which honey had a 
significant effect (from Figure 3.3), were selected for further statistical analysis. The 
following figures show the relative mRNA abundance (incorporating data from Figure 
3.3 and a second PCR reaction) expressed as a percentage of time O values from RNA 
abundance (normalised to ~2M mRNA). The effect of exposing whole blood to honey 
or Con A compared with medium alone on expression of mRNA for IL-1 ~. TNF-cx or 
TGF-~ (from Figure 3.3) is shown in Figure 3.4. 
The stimulation effect of 0.25% manuka honey on mRNA for IL-1 ~. TNF-cx, and TGF-
~ was profound. Maximal relative mRNA abundance for each of the cytokines in 
Figure 3.4 was detected after 6 h of stimulation with honey or Con A. Induction of 
mRNA for IL-1~ was 1.3-fold greater, and for TNF-cx was 1.2-fold greater in honey-
treated cultures than for Con A-activated blood. In contrast, mRNA expression for 
TGF-~ was 1.5-fold greater for Con A-activated cultures than for honey-treated blood. 
While the expression of mRNA for TNF-cx and TGF-~ had decreased to basal levels for 
honey-stimulated cultures by 24 h post-stimulation, there remained significant 
expression of mRNA for these cytokines at the 12 h timepoint. 
The effect of exposing whole blood to honey or Con A on expression of mRNA for 
iNOS and HSP70 is shown in Figure 3.5. There were potent differences in the amount 
of iNOS mRNA expressed for cultures according to stimulation treatment. 
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Figure 3.4: IL-1~, TNF-a and TGF-~ rnRNA expression induced by honey or Con A. Blood was treated 
with 0.25% manuka honey or Con A (5 µg/ml), compared with RPMI 1640, and rnRNA product for 0-24 
h, measured by quantitative real-time RT-PCR. The results were expressed as rnRNA abundance 
calculated relative to non-stimulated cells at time 0, after normalisation against the housekeeping gene, 
B2M. Error bars represent the SEM of two independent experiments. Superscript letters indicate 
significant differences within a timepoint for individual cytokines, and means not sharing letters are 
significantly different (P<0.05). 
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While Con A-activated cultures had I-fold higher expression of mRNA for iNOS at 6 h 
post-stimulation, expression levels had increased 6-fold by 12 h post-stimulation. 
HSP70 was up-regulated by 6 h at levels 1.6-fold greater in cultures stimulated with 
honey than Con A. However, by the 12 h timepoint expression of mRNA for HSP70 
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Figure 3.5: HSP70 or iNOS mRNA expression induced by honey or Con A. Blood was cultured in RPMI 
1640 (control) or stimulated with 0.25% manuka honey or Con A (5 µg/ml), and mRNA product for 0-24 
h, measured by quantitative real-time RT-PCR. The results were expressed as mRNA abundance 
calculated relative to non-stimulated cells at time 0, after normalisation against B2M. Error bars represent 
the SEM for two independent experiments. Superscript letters indicate significant differences within a 
timepoint for individual cytokines, and means not sharing letters are significantly different (P<0.05). 
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3.3.1.1 Electrophoresis results 
Use of conventional RT-PCR showed in absolute terms whether a transcript was 
present (by a band on the gel) or not (no band). In Figure 3.6 three representative gels 
obtained by conventional RT-PCR are shown. 
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Figure 3.6: The effect of honey on cytokine mRNA expression in whole blood was measured using 
conventional RT-PCR. (L) 100 bp ladder; (l) no treatment (control); (2) 0.25% artificial honey; (3) 
0.25% manuka honey; (4) 0.25% Otago pasture honey; (5) 5µg/ml Con A. Results are representative of 
three experiments. 
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As shown in Figure 3.6, there were no detectable bands for any of the cytokines for 
control blood cultures indicating that any mRNA expression for these cytokines were 
too low to be detected by conventional RT-PCR. These results confirmed that artificial 
honey had no effect on rnRNA expression beyond the control. These results were 
consistent with the expression profiles obtained using quantitative real-time RT-PCR. 
Differences in honey composition were shown to have an effect on induction of mRNA 
for IFN-y. At a 0.25% concentration, manuka honey but not Otago pasture honey 
induced expression of mRNA for IFN-y. Gel electrophoresis could not detect any 
differences in the levels of mRNA expressed for the ten cytokines (listed in Table 3.1) 
for blood stimulated with Con A alone or at the same time as honey (data therefore not 
shown). An alternative rnitogen, LPS, which acts on monocytes through the CD14/ Toll 
receptor 4 complex and B cells, was also examined for its effect on cytokine expression 
by whole blood cultures (Figure 3.7). 
The addition of 0.25% manuka honey to LPS-stimulated blood cultures led to a 
decrease in mRNA expression for some cytokines (Figure 3.7). There was a potent 
decrease in rnRNA expression for IL-12p40 and TNF-a when blood was exposed to 
honey at the same time as LPS, compared with LPS alone. There is suggestion from the 
kinetics profile in Figure 3.7 that levels of mRNA expression for iNOS and TGF-~ are 
decreased when blood is co-stimulated with honey and LPS compared with LPS alone. 
LPS stimulated a rapid increase in mRNA expression as shown by increa~ed expression 
at 6 h. In four of the seven cytokines tested, expression remained at this level for a 
further 6 h. 
In contrast to cultures stimulated with LPS alone, cultures co-stimulated with honey and 
LPS had 50-fold higher levels of mRNA expression for HSP70 at 6 h. Further, mRNA 
for HSP 90 was only expressed in the cultures exposed to both LPS and honey. Of the 
cytokine mRNA arnplicons regulated by honey in combination with LPS (from Figure 
3.7), three were selected for further statistical analysis. The following figure shows the 
relative mRNA abundance (incorporating data from Figure 3.7 and a second PCR 
reaction), expressed as a percentage of time O values for mRNA abundance (normalised 
to ~2M mRNA). 
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Figure 3.7: Cytokine mRNA expression in blood induced with LPS alone or LPS and honey. Bovine 
blood was treated with LPS (10 µg/ml) alone or at the same time as 0.25% manuka honey as compared 
with RPMI 1640. RNA was extracted from these blood cells at 0, 6, 12 or 24 h, and analysed by 
quantitative real-time RT-PCR . The results shown are ratios obtained by dividing concentrations of the 
PCR products from the cytokine genes by those from the ~rmicroglobulin gene and related to time 0 
data. Values are representative of single results. 
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Figure 3.8: TGF-~, iNOS or HSP70 mRNA expression induced by LPS or LPS and honey. Bovine 
blood was cultured in RPMI 1640 in the presence of LPS (10 µg/ml) alone or with the addition of 
0.25% manuka honey, and mRNA product for 0-24 h, measured by quantitative real-time RT-PCR. . 
The results were expressed as mRNA abundance calculated relative to non-stimulated cells at time 0, 
after normalisation against B2M. Error bars represent the SEM for two independent experiments. 
Superscript letters indicate significant differences within a timepoint for individual cytokines, and 
means not sharing letters are significantly different (P<0.05). 
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It can be seen in Figure 3.8 that the addition of honey when blood was stimulated with 
LPS altered the mRNA expression for several cytokines. There were significantly 
higher levels of mRNA expression for TGF-~ and iNOS in LPS-stimulated cultures, 
indicating that honey had decreased induction of mRNA for these cytokines. Relative 
expression of mRNA for HSP70 was strongly increased for cultures stimulated with 
both honey and LPS, with a peak at 6 h post-stimulation. In contrast, for LPS-
stimulated cultures there was a transient increase in mRNA for HSP70 at 6 h post-
stimulation. 
3.4 DISCUSSION 
The findings in the current study show that honey directly induces mRNA expression 
for a range of cytokines in whole blood cultures. The expression of cytokine mRNA 
does not guarantee the production of functional protein. A number of events need to 
occur before mRNA transcripts are translated into functional proteins. Therefore, it is 
premature to speculate about how the mRNA profiles observed in the current study 
translate to functional proteins. However, it is expected that changes in mRNA 
expression and levels of mature protein would follow a similar trend (Dokter et al., 
1993; Entrican et al., 1992; Nordmann et al., 1989). 
The observation that low level constitutive expression of mRNA for certain cytokines 
could be detected in freshly isolated, non-stimulated bovine blood may reflect 
induction of mRNA during the collection process (Donnelly et al., 1991; Fuhlbrigge 
et al., 1987). It is likely that an in vivo attenuation event may influence the 
immunological responsiveness of the blood. Leukocytes are sensitive to ex vivo 
handling (Baechler et al., 2004), and this may influence gene expression. Post-
transcriptional regulation is also known to interfere with the stability of a mRNA 
transcript (Tovey et al., 1988) and this may influence the amount of time a message 
can persist in culture before it degrades and the likelihood of it being detected. When 
the transcription of a gene is increased, a higher concentration of the corresponding 
mRNA results. It follows from this that the concentration of mRNA in supernatants at 
any time will be affected by the stability or half-life of a particular mRNA. Factors 
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that increase mRNA stability can be expected to raise the concentration of that mRNA 
molecule, and it is not known how honey affects mRNA stability. A further unknown 
is how honey might influence the rate of translation of mRNA into functional 
proteins, and this needs to be investigated. 
Worthy of note here is the observation by Tonks et al. (2003) that TNF-a. protein 
peaked around 6 h after monocytes were treated with honey, consistent with the peak 
in mRNA expression for TNF-a. by 6 h observed in the current study. TNF-a. mRNA 
has a short half-life (Smart, 1995) and hence, is rapidly translated into TNF protein 
appearing as early as 30 min after LPS stimulation (Belge et al., 2002). Both mitogens 
induced a rapid induction of mRNA for pro-inflammatory mediators, and this is 
followed by a prolonged period of mRNA expression. Honey also induces a rapid 
expression of key pro-inflammatory genes, but the response is generally transient 
compared with the mitogens. 
Others have reported that production of inflammatory cytokines by LPS-stimulated 
blood monocytes and dendritic cells peaks after 6 h in culture (Bueno et al., 2001). 
Due to its nature as an endotoxin, it is expected that LPS would act on different cell 
types and via different receptors to honey. Feezor et al. (2003) have reported that LPS 
up-regulates genes involved in pro-inflammatory signalling, such as those encoding 
IFN-regulatory factors, IFN-stimulated proteins, and signal transduction genes (i.e. 
NF-KB). The kinetics profile for LPS-stimulated blood is likely to reflect the blood 
monocytes being the primary target of LPS (Hambleton et al., 1996). Con A, a T cell 
mitogen (Miller et al., 1991), is likely to have induced a cytokine mRNA profile 
which reflects T cell activation. Therefore, the differences which exist for the mRNA 
profiles in honey-treated cultures and mitogen-stimulated cultures must reflect the cell 
types which are being activated (Boldrick et al., 2002). The results from Section 2.4 
demonstrate that honey has activity on T cells. That honey-treated blood cultures 
induce a different mRNA profile than Con A-stimulated blood is clear indication that 
honey also has activity on cells other than T cells. Further, that honey induces a 
different kinetics profile for mRNA to that obtained for Con A-activated cultures 
suggests that honey works through a different mechanism to the lectin. 
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The results presented in the current study demonstrate that honey has potent effects on 
the Th1-type cytokine (IL-1~, IL-12 p40, TNF-a and TGF-~). mRNA profile. Further 
evidence that honey may activate macrophages comes from its ability to upregulate 
mRNA transcripts for IL-12 p40, produced mainly by macrophages and Natural Killer 
cells (Collins et al., 1999). Macrophages are also known to produce high levels of 
TNF-a and IL-1~ (Havsteen, 2002). That honey induces expression of mRNA for 
these proinflammatory signals in the first 6 h is consistent with what is observed 
clinically for the rapid effect of honey in stimulating wound healing (Tonks et al., 
2003; Phuapradit and Saropala, 1992; Efem, 1988). The decrease in mRNA 
expression levels which occurred for most cytokines in the last 12 h in culture is likely 
to reflect increased apoptosis and loss of viability due to the in vitro environment 
(Baechler et al., 2004 ). Decreased expression of mRNA transcripts by honey-
stimulated cells may indicate that honey activated an apoptotic mechanism. 
The unexpected profile for IL-5 mRNA expression obtained for honey-treated blood 
may reflect what is known about the susceptibility of mRNA transcripts to individual 
variations in genetics, environment and handling (Baechler et al., 2004; Radich et al., 
2004; Myrianthefs et al., 2003; Whitney et al., 2003). In particular, the expression of 
IFN-responsive genes are known to vary between individuals (Whitney et al., 2003), 
and over a time course (Baechler et al., 2004). Radich et al. (2004) have 
demonstrated that some individuals have constitutive expression of IFN-regulated 
genes and this influences their response to various stimuli such as LPS. To increase 
the reliability with which a comparison of the amount of target gene expressed can be 
made with the reference gene, given that differential expression of housekeeping 
genes may occur (Rogler et al., 2002), a second reference gene could have been 
included. These variable experimental conditions may include disease state, 
therapeutic regimens, or tissue source (Mackay, 2004). It has been reported that B2M 
is not an appropriate reference gene for detecting gene expression in systems induced 
with TNF-a or IFN-y as both of these genes have their responsive elements in the 
promotor of ~2M (Ullmannova and Haskovec, 2003). However, this was not of 
concern here. 
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That manuka honey induced transcription of mRNA for the heat shock proteins is an 
important observation. That there was no detectable expression of heat shock protein 
expression in control cultures confirms that this result was unlikely to be an artefact of 
blood processing prior to RNA extraction. The component in honey most likely to be 
responsible for heat shock protein induction is hydrogen peroxide, though the 
likelihood of this agent exerting these effects in the presence of antioxidants is 
dubious. The ability for glycated proteins or antigenic complexes formed from a 
combination of polyphenols and proteins to induce heat shock proteins cannot be 
ruled out. 
The cytokine mRNA profile obtained with honey gives strong support to speculation 
that hydrogen peroxide may provide the mechanism for cellular activation. Hydrogen 
peroxide is reported to induce rapid cellular activation (Reth, 2002). To investigate 
this hypothesis further, it would be useful to track the expression of mRNA for 
nuclear factor 1CB (NF-lCB), a transcription factor known to be activated by hydrogen 
peroxide (Reth, 2002). Of potential relevance here, it has been reported that low 
concentrations of hydrogen peroxide stimulate both IL-1 p and TNF-a transcription 
(Haddad, 2002) and hydrogen peroxide is produced by glucose oxidase in honey 
(Bang et al., 2003). Transcription of TGF-P is also known to be induced by the 
presence of oxidant species (such as hydrogen peroxide) and is crucial for recruitment 
of monocytes to the wound site (Junn et al., 2000). As discussed in Section 3.1, TGF-
p plays an important role in fibroblast activation in the later stages of inflammation. A 
key regulator of cytokine induction is NF 1CB and hydrogen peroxide has been 
implicated in the phosphorylation and subsequent removal of the NF 1CB inhibitor, 
I1CB, thereby activating transcription (Adcock et al., 1994). In light of a report by Xie 
et al. (1994) it is known that activation of NF-lCB is necessary for induction of iNOS 
gene expression by macrophages, further justifying the need to investigate whether 
honey may have an effect on NF-lCB. 
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The possible role of glycated proteins and anti-oxidants in the immunological 
response induced by honey cannot be ruled out by the results reported here. Havsteen 
(2002) has proposed that flavonoids found in honey may play a significant role in the 
activation of the immune system. Havsteen (2002) proposed that flavonoids modulate 
inflammation through their effects on P-kinase cascades, most likely at the ATP-
binding site. Protein P-kinase cascades play a pivotal role in the production of 
cytokines. There is evidence that flavonoids stimulate the release of IFN-y protein by 
macrophages and this has been attributed to effects on protein phosphokinases 
(Mitrocotsa et al., 1999; Sen and Lengyel, 1992). In particular, it has been reported 
that flavonoids stimulate macrophages to produce IL-1 (Havsteen, 2002) a monokine 
which stimulates T cell activity. In view of the observed potency with which honey 
stimulates mRNA transcription for IL-1 p in whole blood, and IL-1 protein by 
monocytes (Tonks et al., 2003), this raises the likelihood that flavonoids may play a 
role. It is surmised that flavonoids can act as antigens since antibodies to them have 
been found in the human blood (Havsteen, 2002). 
Others have demonstrated that antioxidants reduce the mRNA expression of iNOS 
proteins (Bito et al., 2002; Tsai et al., 1999), and of particular relevance to the current 
study, tannins have been shown to inhibit iNOS mRNA and iNOS activity (Yokozawa 
et al., 2002). TGF-P is known to inhibit iNOS expression by decreasing iNOS mRNA 
stability (Chen et al., 1998). Of further relevance to the current study, Yokozawa et al. 
(2002) reported that low concentrations of tannins modulated cell response to LPS. 
While others have demonstrated · that sugars alone can stimulate transcriptional 
activity of IL-18 in a variety of epithelial-like cell lines (by Takeuchi et al., 1999) and 
of IL-IP in PBMC cultures (Shapiro and Dinarello, 1997), sugars alone (artificial 
honey), at the concentrations tested in the current study, had no effect on mRNA 
expression. 
Evidence from the current study which does not support the hypothesis that hydrogen 
peroxide is the active component, comes from the observation from gel 
electrophoresis that manuka honey and not Otago pasture honey at 0.25% 
concentrations induced the transcription of IFN- y mRNA. This observation must be 
127 
Chapter Tim.:.: mRNA ..:xpn.:ssion in whole hlood 
due to the differences in composition between the two honeys and manuka honey has 
a lower hydrogen peroxide content than the Otago pasture type. It remains to be 
demonstrated how the levels of IFN-y mRNA expression correspond to those of 
functional IFN-y protein. However, it is noted that the superior antibacterial activity of 
manuka honey in vivo (Molan, 1992b) would be consistent with up-regulated levels of 
IFN-y. This is based on the known ability for IFN-y to increase phagocytosis and also 
antigen presentation by class II MHC proteins (Hu et al., 2001). Further, the 
observation that upregulation of bovine IFN-y in tum up regulates bovine IL-2 
receptors (Pighetti and Sordillo, 1996) provides a possible mechanism by which honey 
was observed to stimulate expression of lymphocyte IL-2 receptors (Section 2.3.1.6). 
Thus, the effect of honey on expression of IFN-y protein would be a key area for 
future investigation. 
This increases the probability that an antigenic protein or polyphenol complex, likely 
to occur at higher concentrations in manuka honey (Section 1.3.1.5), may be the active 
component. Of further relevance here, Simuth et al. (2004) have reported that the 
presence of royal jelly proteins in various honeys directly stimulate murine 
macrophages to produce TNF-cx.. 
The antioxidant content of honey was discussed in Sections 1.3.1.4 and 1.4.4.1. 
Flavonoids in particular have been proposed to have an anti-inflammatory effect on 
iNOS proteins (Tsai et al., 1999). Like honey itself, there is abundant evidence that 
flavonoids can have both a stimulatory and modulatory role, and the answer to this 
apparent dichotomy lies in their ability to interfere with cellular signalling. In Section 
1.4.4.1 of the current study, the ability for flavonoids to ameliorate in the 
inflammatory pathway through effects on free radicals was discussed. Of further note, 
it has been reported that flavonoids inhibit the activity of IL-5 (Park et al., 1999). 
That honey induced a transient response for mRNA transcription, compared with the 
persistent induction obtained with the mitogens is likely to be beneficial for wound 
healing. The massive and prolonged expression of pro-inflammatory cytokine mRNA 
and corresponding proteins obtained with Con A or LPS-stimulation of cultures in 
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vitro, would likely contribute to the pathogenesis of inflammatory disease and tissue 
damage, and yet carefully regulated production of these cytokines results in tissue 
healing (Zhang and Morrison, 1993; McCartney-Francis et al., 1993). 
In the current study, LPS-stimulated blood provided a model of excessive 
inflammation. The implications of the observed modulatory effect of honey on 
cytokine mRNA amplicons in LPS-stimulated cells in vitro, for ameliorating 
inflammatory conditions in vivo are unknown. It is noted that in the current study the 
cytokine mRNA expression of blood cultures was only measured over a 24 h period, 
and wound healing takes place over a far longer period of time. 
Considering the effect of honey on induction of cytokine mRNA, it is hypothesised 
that initially honey induces some of the pro-inflammatory responses during blood 
incubation in vitro, but later it acts to counter-regulate the hyperinflammatory state by 
up-regulating anti-inflammatory mediators. It is also possible that honey has dual 
effects to be able to induce both pro- and anti-inflammatory states at the same time 
and that this is what contributes to observed accelerated healing with minimal 
scarring. Therefore, honey may potentially modulate inflammatory states· without 
excessive suppression of the host defence system. The effects on cytokines raise the 
question of how and in what form and concentrations the "stimulating components" 
from honey have to the blood in vivo. 
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Chapter Four: Stimulation By Honey Of TNF-cx Production By 
Monocytes 
SUMMARY 
To investigate whether honey could induce THP-1 monocytes to release TNF-a., 
bioassays using WEHI cells were carried out to measure TNF-a. production after the 
monocytes were exposed to honey. Honey was found to stimulate release of TNF-a. by 
the monocytes when at a range of concentrations between 0.000025-0.1 %, with no 
differences between the levels produced at the various concentrations of honey. At 
concentrations from 0.25-1 % the TNF-a. production decreased as the concentration of 
honey increased. This may indicate an anti-inflammatory action overrides the stimulatory 
effect at concentrations greater than 0.25%. Sugar content had no effect upon TNF-a. 
release, as demonstrated by the artificial honey control. There were no differences 
between honey types (manuka honey and pasture honey) in induction of TNF-a. release. 
Time-course analysis confirmed that a 4-6 h incubation period of cells with 0.25% honey 
gave maximal TNF-a. production. A 2 h minimum exposure period of cells to honey was 
critical for TNF-a. production. Incubation of LPS-stimulated monocytes with honey had 
no effect on their subsequent TNF-a. production. A good correlation was found between 
the TNF measurements detected by ELISA and the WEHI Bioassay. 
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4.1 INTRODUCTION 
Monocyte production of cytokines and chemokines is crucial in determining whether the 
outcome of wound healing will be normal. There are a number of pathways which could 
potentially be modified by exposure of monocytes to honey. The production of TNF-a is 
of particular relevance to wound healing as it stimulates the inflammatory cascade which 
is necessary for tissue repair to occur (Beige et al., 2002). However, in high 
concentrations TNF-a is one of the most harmful endogenous pro-inflammatory 
cytokines (Tracey and Cerami, 1993) and may lead to tissue destruction (Sommer et al., 
1994). In Section 3.4 it was established that honey stimulates blood cells to express 
cytokine mRNA for TNF-a. However, it was not established which of the cell types 
cultured expressed the TNF-a mRNA and the objective of the investigations described in 
this chapter was to measure the production of biologically active TNF-a (or TNF protein) 
by a monocyte cell line and determine whether TNF production was influenced by honey. 
Research conducted by Tonks et al. (2001) established that 1 % concentrations of manuka 
and pasture honeys induced low levels of TNF-a (200-500 pg/ml) release by a 
macrophage-like cell line. The investigations described in this chapter were designed to 
repeat the assays described by Tonks et al. (2001) and confirm their findings using a 
different cell line. A further aim for the investigations described in the current study was 
to extend the range of honey concentrations tested to identify where the TNF-inducing 
activity stopped. The production of TNF-a by monocytes has been studied using a variety 
of assay types, the most common of which include ELISA (Dewar et al., 2005) and 
WEHI Bioassays (Carter et al., 1999; Joyce et al., 1997; Khabar et al., 1995; Kurzman et 
al., 1993; Espevik and Nissen-Meyer, 1986) to detect protein, and RT-PCR (Amills et al., 
2004) to detect mRNA expression. 
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4.1.1 A brief introduction to monocyte biology 
In order to understand the function of monocytes in the immune system and to 
comprehend how changes to this function may be brought about by incubation of the cells 
with honey, it is necessary to begin with a brief summary of the functional biology of 
monocytes. Monocytes represent the circulating macrophage population, and use integrin 
molecules (e.g. ~2 integrins) to adhere to ICAM-1 on the endothelial cells. As described 
in Section 1.5.1, the adhesion molecules utilised by monocytes are now well established. 
lntegrin binding induces activation of multiple transcription factors, the expression of key 
cytokines (e.g. IL-1~) and accumulation of cytokine mRNA (Bocker et al., 2001). Both 
LPS-binding and integrin-binding to the endothelium are required for translation of 
cytokine mRNA into functional protein (Bocker et al., 2001). In particular, the production 
of functional IL-1 ~ is critically interrelated with changes in cytoskeletal structure of the 
monocyte to enable spreading and extravasation (Bocker et al., 2001). The ability for 
monocytes to adhere to the endothelium, undergo diapedesis, and migrate out to the 
tissues is critical for their differentiation into macrophages (Arai et al., 1998; Benjamini 
et al., 1996). Chemotactic factors (including bacterial breakdown products, complement 
components, and leukotriene B4) act on the cell membrane and result in cell movement 
toward injured tissues (Arai et al., 1998). Unlike the lymphocytes, monocytes do not 
proliferate, but undergo differentiation to become macrophages, potent producers of 
reactive oxygen intermediates (Martin and Edwards, 1993). Monocytes are created in the 
bone marrow and only spend a brief time in the blood system, constituting 2-8% of the 
total leukocytes found in the blood as compared with lymphocytes constituting 20-30%. It 
is in the tissues that the monocytes change their phenology and become specialised 
macrophages, for example the Kupffer cells in the liver (Ziegler-Heitbrock, 1989). The 
monocyte-differentiated macrophages enter the site to replace neutrophils which 
dominate during the first 24-48 h after tissue injury, removing cellular debris and foreign 
material through phagocytosis. Monocytes bear Fe and C3b receptors on their surfaces (as 
do neutrophils) which enable recognition of opsonized materials for phagocytosis 
(Barbuddhe et al., 1998; Benjamini et al., 1996). They play an important role in host 
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resistance to pathogens by virtue of their phagocytic and antibacterial activities 
(Higgenbotham and Pruett, 1994). 
Mononuclear macrophages produce hydrogen peroxide and, via a reaction of the 
phagosome, generate a hydrogen peroxide-myeloperoxidase-halide system, producing 
reactive oxygen intermediates which kill bacteria (Tonks et al., 2001). The hallmark of 
chronic inflammation is infiltration of the tissues with mononuclear inflammatory cells 
(monocytes being among these) resulting in tissue damage from reactive oxygen 
intermediates produced from leaked hydrogen peroxide. 
Endotoxin-stimulated macrophages are the most important source of TNF (Beutler and 
Cerami, 1988) and the monocyte/macrophage lineage respond to the presence of Gram-
negative or mixed Gram-negative/positive lipopolysaccharide (LPS) antigen with a 
massive production of TNF-a (Kurzman et al., 1993). As described in Section 3.1, LPS 
binds to CD14, and acts via the Toll-like receptor (TLR)4 coreceptor (1) (Beige et al., 
2002). After ligation of these receptor complexes, a signal transduction cascade is 
activated which mobilises transcription factors (e.g. NF-1d3) leading to production of 
cytokines (e.g. TNF-a). Given that LPS stimulates TNF-a production by monocytes, it is 
crucial to determine whether any possible endotoxin contamination in vitro culture could 
contribute to levels of this cytokine. The activity of TNF-a in the innate immune system 
is only part of its role in wound healing. TNF-a has a broader range of effects on host 
immune responsiveness, enhancing interactions with other blood cells. TNF-a is 
considered to be pro-inflammatory because it recruits other cells to fight bacterial 
infection during inflammation. 
TNF-a primes and activates phagocytes (Jiang et al., 1992) and initiate their anti-bacterial 
and tumoricidal activity, as well as to increase expression of adhesion molecules on the 
surfaces of endothelial cells (Lefkowitz and Lefkowitz, 2001). Of particular relevance to 
this study, TNF-cx has been reported to stimulate T-cell proliferation, upregulate MHC, 
and initiate the production of other cytokines by T cells (among them IL-2) (Chaudhri and 
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Clark, 1989). In many cases TNF-a. exerts its cellular effects through IL-1 in a paracrine 
manner, (Mantovani et al., 1998). Monocytes also produce growth factors along with 
hydrolases, collagenase, and elastase. It has also been shown to increase phagocytosis by 
neutrophils (Utreras et al., 2000), and has a role in inducing production of reactive 
oxygen intermediates by fibroblasts and stimulating their proliferation via bystander 
activation (O'Toole et al., 2001; Meier et al., 1990). Furthermore, it has been 
demonstrated to increase permeability of tight junctions (Singh et al., 2001). Monocytes 
produce the vasoactive amines histamine and serotonin, the classic mediators of vascular 
permeability. The TNF family includes 19 members of proteins which signal through 29 
receptors, and either induce cellular proliferation, survival, differentiation or apoptosis 
(Aggarwal, 2003). Clearly, the release of TNF-a. by monocytes is a key determinant of 
immune function and plays an important role in lymphocyte activation and immune 
regulation. 
TNF-a. has been implicated in a number of inflammatory diseases caused by an abnormal 
immune response, including rheumatoid athritis (Leflcowitz and Leflcowitz, 2001), 
Crohn's disease and multiple sclerosis (Sharief and Thompson, 1992). In rheumatoid 
athritis, TNF-cx. is essential for the perpetuation of inflammation (Leflcowitz and 
Leflcowitz, 2001) and this is primarily due to its activating effect on both immune and 
non-immune cells, such as endothelial cells and osteoblasts, thus amplifying cytokine 
concentrations (Carter et al., 1999). TNF-a. binds with its receptor, triggering the 
phosphorylation and subsequent destruction of IKB, liberating NF-KB. Once in the 
nucleus, NF-KB acts as a transcription factor, binding to enhancers and promoters of 
genes. Indeed, glucocorticoids exert their anti-inflammatory and immunosuppressive 
effects through enhancing the production of IKB (Gortz et al., 2005; Leflcowitz and 
Leflcowitz, 2001). NF-KB turns on the genes encoding IL-1 and other key cytokines which 
induce inflammation, along with the genes needed for cell proliferation, cell adhesion and 
angiogenesis. 
13-1-
Chapter Four TNF-a Pro<luetion bv monoi.:yte~ 
Therefore, the search for therapeutic agents which have activity on TNF-a production 
specifically are of prime importance to drug discovery. There are now well established 
anti-TNF biologicals, used in treating inflammatory conditions such as rheumatoid 
arthritis and Crohn's disease e.g. entanercept and infliximab (Singh and Suruchi, 2004). 
These therapies apply monoclonal antibodies to TNF-a, the IL-6 receptor, and the 
recombinant soluble TNF-a receptor (Wakarnatsu et al., 2005). Monoclonal antibodies to 
TNF-a block binding of this cytokine with its receptor, and therefore the intracellular 
pathways activated by TNF-a (e.g. mitogen-activated protein kinases such as 
p38MAPKa and extracellular signal-regulated kinase such as ERK in the synovial 
membrane) are blocked or inhibited (Gortz et al., 2005). 
The THP-1 cell line was selected for studying the effect of honey on TNF-a production as 
it has been extensively characterised (Wang et al., 2001; Kremlev et al., 1997; Kremlev 
and Phelps, 1997; Schwende et al., 1996; Auwerx, 1991) and in particular its ability to 
produce TNF-a in response to LPS (Janie et al., 2003) and retain its ability to synthesise 
and secrete cytokines (Grandics, 2002) make it a good experimental model. 
4.2 MATERIALS AND METHODS 
4.2.1 Culture media 
RPMI Complete medium 
RPMI 1640 with 10% foetal calf serum (as described for T cells in Section 2.2.1). 
Bioassay medium 
RPMI 1640 with 3% foetal calf serum (as described for T cells in Section 2.2.1). As 10% 
foetal calf serum was known to interfere with the WEHI Bioassay it was necessary to 
reduce the serum content. Monocytes require serum in the medium to maintain normal 
metabolic function. Although 3% serum content is not optimal for monocyte culture, it 
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has been used successfully by others where assays were sensitive to serum levels (Jiang et 
al., 1992). Preliminary assays conducted in this study indicated that THP-1 incubated in 
3% foetal calf serum produced TNF-a at levels that enabled treatment effects to be 
detected by the WEHI Bioassay (data not shown). 
Trypsin solutions 
PBS containing 0.25% trypsin and 5 mM EDT A. 
Honey Solutions 
Solutions of manuka M109, Otago pasture honey and artificial honey in bioassay medium 
were prepared as described for Section 2.2.2. 
LPS solutions 
As described in Section 3.2, 1 mg/ml stock solution (E. coli serotype 0111: B4; Sigma-
Aldrich UK; cat no# L4516) was purchased. The LPS was diluted to final concentrations 
in wells of 10 µg/ml (unless otherwise stated). This single concentration was chosen 
based on pilot studies, as the higher dose was found to induce higher TNF-a production 
levels. 
All glassware was autoclaved and plasticware was purchased new. 
4.2.2 Cell lines and subculturing 
WEHI 164 var 13 
The mouse fibrosarcoma cell line WEHI 164 clone 13 was purchased from American 
Type Culture Collection (ATCC, VA USA). The cultures were grown in an atmosphere 
of 5% CO2, 95% air (37°C), and maintained twice-weekly by seeding a new flask with 
cells at a density of 1 x 106/ml based on the methods described by Khabar et al. (1995). 
The WEHI cells are a mixture of floating and adherent cells. Non-adherent cells were 
removed from culture flasks and the adherent cells were washed twice with 5 ml of PBS. 
1:36 
C haptt:r Fuur TNF-a production bv monucvtc, 
Adherent cells were dislodged by incubation with 5 ml of the trypsin stock solution 
(Section 4.2.1) for 5 min, followed by gentle scraping. The cell suspension was 
centrifuged (223 x g, 5 min) after which time the supernatant was discarded and the cell 
pellet re-suspended in RPMI complete medium. The same method was used to split the 
cell cultures 1: 10 (with complete medium) 2 days prior to use in assays (as described by 
Khabar et al., 1995). 
THP-1 
The human monocyte line, THP-1, was obtained as a gift from J. Fraser, Auckland 
University, and were used between passages 5 and 40. Cells were cultured in suspension 
and passaged once a week, to maintain densities between 5 x 105 and 1 x 106 cells/ml 
(according to ATCC guidelines). They were grown in RPMI complete medium containing 
0.5 µM mercaptoethanol (P-ME) and 10% foetal calf serum (5% CO2, 95% air, 37°C). 
PBMC 
Peripheral blood mononuclear cells (PBMC) were isolated from bovine blood using the 
Ficoll procedure as described in Section 2.~.3.2. 
4.2.3 Preliminary Investigations 
4.2.3.1 Establishing an osmoti.c tolerance range of honeys for THP-1 monocytes 
Prior to conducting TNF-cx assays, it was necessary to establish an osmotic tolerance 
range for the THP-1 monocytes. THP-1 cells were loaded into wells of a 96-well 
microtitre plate, at a final density of 2 x 106 cells/ml and incubated with various honey 
concentrations (0.1-3% v/v) for 48 h (37°C, 5% CO2, 95% air). Honey was diluted with 
bioassay medium to obtain the final honey concentrations, and treatments were conducted 
in triplicate. Bioassay medium alone was included as a control. As the sole objective of 
this assay was to examine the viability of the THP-1 cells, trypan blue staining was used 
to count the proportion of viable cells (Section 2.2.6.1). Briefly, 100 µl of cell suspension 
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from a single well was mixed with an equivalent volume of trypan blue, and after 1 min 
incubation (37°C, 5% CO2, 95% air), a haemocytometer count was performed. 
4.2.3.2 Setting up of depletion cultures to determine whether monocytes in bovine 
blood were responsible/or TNF-aproduction 
In Section 3.4 it was reported that honey induced expression of mRNA for TNF-a. in 
whole bovine blood. In order to test whether monocytes might be responsible for the 
observed TNF-a. production in the presence of honey, depletion cultures were established. 
Briefly, heparinised bovine blood was centrifuged on a Ficoll Paque (Pharmacia Biotech) 
gradient (as described in Section 2.2.3.2) and cells from the interphase were collected. To 
isolate the monocytes from the PBMC fraction, the PBMC were incubated on a plastic 
Petri dish (Nunc) for 18 hat 37°C (5% CO2, 95% air). Subsequently, the supernatant was 
removed and the adherent cells were detached by means of a 0.02% EDTA solution and 
suspended in RPMI complete medium (10% foetal calf serum). The cells were then 
recentrifuged on Ficoll gradient (900 x g) for 1 h at 4°C. A highly purified fraction of 
monocytes of more than 98% viability, determined by 0.5% trypan blue exclusion, was 
used in a WEHI Bioassay. 
The experimental design reported in Section 2.2.4.1 was modified slightly so that the 
purified monocytes were distributed among wells of a 96-well microtitre plate at a density 
of 2.5 x 106 cells/ml in 100 µl of bioassay medium (3% foetal calf serum). Either manuka 
honey (to obtain the required final concentration), LPS (10 µg/ml) or bioassay medium 
alone was added in 50 µl aliquots to triplicate wells and incubated for 6 h (37°C, 5% 
CO2, 95% air). The supematants were collected via centrifugation and stored at -80°C for 
use in a WEHI Bioassay. 
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4.2.3.3 Establishing whether honey had any osmotic or other direct effects on WEHI 
cells 
Prior to commencing the Bioassay it was necessary to establish whether honey had any 
osmotic or other direct effects on the WEHI cells. To enable any effects on cell 
metabolism and viability to be assessed, MTI assays were used (Section 2.2.6.2). WEHI 
cells were seeded in 100 µl aliquots into wells of a 96-well microtitre plate, at a final 
density of 2 x 104 cells/well in RPMI complete medium. Control wells were set up 
containing RPMI complete medium only. The plates were incubated for 48 h before the 
supernatants were removed and either bioassay medium or honey was added. Various 
honey concentrations were incorporated into bioassay medium. All treatments were 
conducted in triplicate. The plates were incubated at 37°C (5% CO2, 95% air) for 48 h, 
after which time the honey solutions were replaced with 100 µl of bioassay medium, and 
10 µl of MTI (50 µg/ml, Roche Molecular Biochemicals, Cat. No. 1 465 007) added to 
each well before returning the plate to the incubator. After 4 h (37°C, 5% CO2, 95% air) 
100 µl of 10% SOS (in 0.01 M HCL, Roche Molecular Biochemicals) was added to each 
of the wells. The plates were left to incubate at 37°C (5% CO2, 95% air) overnight, to 
allow all of the tetrazolium crystals to be solubilized. The optical density was determined 
at 570 nm (Bio-Tek instruments, as in Section 2.2.6.1). 
4.2.4 WEHI Bioassay 
TNF-a has a cytotoxic effect on the murine fibrosarcoma cell line WEHI 164 (clone 13). 
The detection limits for this Bioassay have been reported as 0.029 ng/ml (Carter et al., 
1999) and less than 0.1 ng/ml (Joyce et al., 1997). WEHI were seeded in 96-well plates at 
2 x 104 cells/well, in RPMI complete medium. Cell control wells received only RPMI 
complete medium. The plates were left for 48 h before the supernatants were replaced 
with those obtained from honey-treated monocytes or the assay standards. Each well of 
the WEHI-containing microtitre plate was loaded with 50 µl of the supernatant and 50 µl 
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of bioassay medium containing 1 µg/ml actinomycin-D (Sigma) as described in the 
methods of Carter et al. (1999) and Khabar et al. (1995). 
For control of LPS contamination, contamination cultures were set up with and without 
polymyxin B (PMB; Pfizer, Karlsruhe, Germany) at 10 µg/ml. Monocytes in the 
contamination cultures were exposed to polymyxin B for 30 min at 37°C (5% CO2, 95% 
air), prior to adding treatments, to inactivate LPS. All glassware and metal spatulas were 
autoclaved. Only sterile and endotoxin-free culture flasks, microtitre plates, and pipette 
tips were used. No LPS contamination was detected. 
4.2.4.1 Quantification ofTNF-a release 
After a further 48 h incubation (37°C, 5% CO2, 95% air), the test fluid in the wells was 
removed by flicking, in one careful movement. The adherent WEHI cells were washed 3 
times using phosphate-buffered saline (room temperature), to ensure all traces of the test 
supernatants were removed. One hundred microlitres of bioassay medium was added to 
each well followed separately by 10 µ1 of MTI. The microtitre plate was incubated for 4 
h (37°C, 5% CO2, 95% air) to enable reduction of the tetrazolium salts by WEHI cells. To 
stop the reaction, 100 µl of SOS was added, and the plate returned to the incubator 
overnight (37°C, 5% CO2, 95% air). The plate was then agitated on a plate shaker (30 
min) to ensure homogeneity of the purple dye through the solution. Optical density at 570 
nm was measured using a Bio-TEK plate reader. A standard curve was generated using 
the recombinant TNF standard by plotting optical density against concentration 
(Appendix 1). WEHI cells cultured in bioassay medium alone were taken to represent 
100% viability. The optical density readings from the blank wells were subtracted from 
the other readings to allow for any colour from MTI not arising from metabolism. 
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4.2.4.2 Standards 
To allow quantification of TNF-a. production, four standards were used with final TNF-a. 
concentrations of lng/ml, 0.5 ng/ml, 0.1 ng/ml and 0.05 ng/ml. To make the standards, a 
2 ng TNF-a. stock solution (2 µ1 of 10 µg TNF-a. stock in 10 ml of bioassay medium) was 
diluted with bioassay medium containing actinomycin-D (5 µ1 of actinomycin-0, Sigma, 
St Louis, MO, at a concentration of 1 mg in 1 ml DMSO, added to 9.905 ml of bioassay 
medium) giving a final concentration in all wells of 0.5 µg/ml actinomycin-0. The 
standards were added in triplicate (100 µ1) to wells containing the WEHI cells. The 
standard curves showed a linear relationship existed between the OD readings obtained 
for WEHI cells and the TNF-a. concentration of the standards (Appendix la). The upper 
detection limit of the WEHI Bioassay is 1 ng/ml (1000 pg/ml) of TNF, as survival of the 
WEHI is 100% at these levels. As Tonks et al. (2003; 2001) had reported that honey 
induced small levels of TNF production (less than 500 pg/ml) this was not deemed to be a 
problem. Results are expressed as nanograms (ng) of TNF-a. per millilitre of supernatant 
fluid. 
4.2.S TNF-a ELISA 
To confirm the results obtained using the WEHI Bioassay, a commercial enzyme-linked 
immunosorbent assay (ELISA) was used to measure the TNF-a. content of supernatant 
fluids which had been stored at -80°C (human TNF-a. ELISA Cat # BMS223HS, Bender 
MedSystems, Austria) with a detection limit of 0.13 pg/ml. All of the reagents and 
antibodies were provided in the kit, and the manufacturers instructions were adhered to. 
Briefly, the basic principle of the ELISA was the quantitative solid-phase sandwich 
enzyme immunoassay technique in which a monoclonal antibody specific for human 
TNF-a. was used to coat microtitre plates (Nunc). All reagents, antibodies and 
supematants were added 100 µI/well, and all washing steps were performed 4 times with 
PBS (1 % Tween 20). The supematants were diluted 1 :4 with diluent prior to the assay as 
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determined by preliminary testing. After incubation (2 h, room temperature) the 
microwells were washed, blotted, and the test supematants (and controls) were added in 
triplicate to wells of the plate, enabling the protein to bind to the antibodies adsorbed to 
the microwells. After a further 2 h incubation (room temperature) a biotin conjugated 
antibody (anti-TNF-a polyclonal rabbit) was added to the wells and bound to the TNF-a 
protein captured by the monoclonal (first) antibody. Following 2 h incubation (room 
temperature) the wells were washed and streptavidin-HRP added and bound to the 
polyclonal antibody. After a 20 min incubation (room temperature) the wells were 
washed and loaded with tetramethyl-benzidine (with 0.02% hydrogen peroxide). After 
incubation (30 min, room temperature) 50 µl of lM phosphoric acid was added to each 
well to stop the reaction. The optical density was measured immediately at 450 nm 
against a reference wavelength of 540nm (Bio-Tek). 
The average absorbance values for each set of duplicate standards and samples were 
calculated, and a standard curve was produced (Appendix lb). The standards were 
supplied in the ELISA kit. A standard curve was prepared for each plate assayed. Results 
are expressed as nanograms (ng) of TNF-a per millilitre of supernatant fluid. 
4.2.6 Experiments 
4.2.6.1 Measuring the effect of honey on TNF-a release by resting monocytes 
After 3 to 4 days of growth, THP-1 cells were harvested, and distributed among wells of a 
96-well microtitre plate at a density of 2.5 x 106 cells/ml in 100 µl of bioassay medium. 
Honey was serially diluted from an original 25% stock solution and added in 50 µl 
aliquots to triplicate wells to obtain final concentrations of 0.000025-0.1 %. As indicated 
in Section 2.2.2, the dilution steps were adjusted to allow for the volume of other 
reactants in the assay mixture. 
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After the monocytes had been incubated for 4 h (37°C, 5% CO2, 95% air) with the honey, 
the plates were centrifuged (Sorval 503 x g, 15 min) and the supernatant removed. All 
treatments and controls were conducted in triplicate wells and the experiment was 
replicated three times. Supernatant fluids were stored at -80°C for later assays. 
4.2.6.2 Characterising the active fraction of honey responsible for inducing TNF-a 
release 
M109 manuka honey was fractionated by dialysis into high and low molecular weight 
fractions using a membrane with a 10 kDa cut-off (as described in Section 2.2.2.1). The 
dialysed honey fractions were serially diluted so that final concentrations of 0.000025-
0.1 % were obtained (as described in Section 4.2.7.1) and incubated with THP-1 cells for 
4 h (37°C, 5% CO2, 95% air) prior to centrifugation (Sorval 503 x g, 15 min). After 
collection of the supernatants, they were stored at -80°C. Artificial honey and bioassay 
medium alone were included in addition to blanks (as previously described in Section 
4.2.7). All treatments and controls were conducted in triplicate wells and the experiment 
was run three times. The supernatants were then assayed for presence of 1NF using the 
Bioassay described. 
4.2.6.3 Time-series analysis of effect of honey on TNF-a production of THP-1 cells 
The levels of TNF-a have been observed to rise and peak within 90 min after LPS has 
been added to monocytes, and fall to basal levels around 4-6 h later (Tracey and Cerami, 
1993). In the present study it had already been established that a 2 h minimum incubation 
period was required for honey to have activity on T cells (Section 2.3). Investigations by 
Tonks et al. (2003) demonstrated that a 2 h incubation period was sufficient for honey to 
have effects upon MM6 cells but that a 4-6 h period gave maximal TNF-a production. In 
order to find the incubation time needed for honey to induce maximal TNF-a production 
by THP-1 cells, a range of pre-incubation times were chosen between 0-24 h. THP-1 
cultures (2.5 x 106 cells/ml in a 96-well microtitre plate) were incubated with 0.25% 
honey (artificial, M109 or Otago pasture) at 37°C (5% CO2, 95% air) for 0, 2, 4, 6, 8, 12 
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or 24 h prior to collection of the solutions. Cells incubated with bioassay medium alone 
for these time periods were included as a control. All treatments and controls were 
conducted in triplicate wells and the experiment was replicated three times. As has been 
previously described (Section 4.2.7), the plates were centrifuged (Sorval 503 x g, 15 min) 
to obtain the supematants. The supematants were then assayed for TNF using WEHI cells 
(2 x 104 cells/well). A single plate was used for each time point and the supematants were 
stored at -80°C until the Bioassay. 
4.2.6.4 Investigation to determine whether honey can modulate TNF-a release by 
LPS-stimulated monocytes 
LPS stimulates TNF-a production by monocytes, achieving maximal levels when used at 
a minimum of 10 to 100 ng/ml and up to a maximum of 20 µg/ml (Sipe et al., 1992). The 
modulatory effect of honey solutions on lymphocyte response to Con A was demonstrated 
in Section 2.3.2, and based on those results, an assay was conducted to measure whether 
honey could interfere with TNF production of LPS-stimulated monocytes. Briefly, 
monocytes were delivered to a 96-well microtitre plate at a density of 2.5 x 106 cells/ml in 
100 µl of bioassay medium. Samples were treated with LPS (10 µg/ml) or left untreated. 
After 24 h incubation (37°C, 5 % CO2, 95% air) serial dilutions of honey were added in 
50 µI aliquots to triplicate wells to obtain final concentrations of 0.000025-0.1 %. After a 
further 24 h incubation (37°C, 5 % CO2, 95% air), the supematants were obtained after 
centrifugation and stored at -80°C. The experiment was repeated twice. 
4.2.6.5 Comparison of the measurements obtained for TNF in supernatants from the 
WEHI Bioassay with those obtained using a commercially available EUSA 
Briefly, THP-1 cultures were stimulated with either LPS (10 µg/ml), manuka honey 
(0.025-1 %) or bioassay medium alone for 4 h (37°C, 5 % CO2, 95% air) and the 
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supematants harvested by centrifugation and stored at -80°C. TNF-a. content in the 
supematants was then determined for duplicate samples and standards by both the WEHI 
Bioassay and a TNF-a. ELISA. 
4.2.6.6 Statistical analysis 
Values were expressed as the mean of triplicates ± SEM, and each experiment was 
replicated at least twice (n=6). For multiple group comparisons, the data were subjected 
to one-way analysis of variance (ANOV A) to determine overall difference between the 
group means. The amount of TNF-a. produced was the between group effect. Significant 
effects were further analysed using Tukey's honestly significant difference for pair-wise 
differences for within group comparisons. Significance was accepted if P<0.05. For the 
comparison between ELISA and WEHI Bioassay determinations, a one-way ANOV A 
was used to analyse significance in results obtained. Significance was determined using 
Tukey's honestly significant difference and was accepted if P<0.05. Systat (version 7) 
was used for all analyses. 
4.3 RESULTS 
4.3.1 THP-1 viability 
To establish a range of honey concentrations which could be tested for TNF-activating 
effects on THP-1 cells, it was first necessary to assess the osmotic tolerance range of the 
cells. The effect on THP-1 viability following incubation with honey is shown in Figure 
4.1. This experiment determined that natural honeys had no effect on viability at 1 % 
concentrations, but that equivalent concentrations of artificial honey reduced viability of 
the THP-1 cells. Beyond 1 %, viability of the monocytes was reduced, indicating that the 
maximum honey concentration to be included for use in the TNF assays was 1 %. Further, 
these viability assays indicate that while sugars alone at 1 % reduced viability, when the 
equivalent concentration of sugars were present in honey, there was no detectable effects 
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on monocyte viability. That the osmolarity of the natural honey solutions did not differ 
significantly from artificial honey (sugars alone) was established in Section 2.2.2.3. 
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Figure 4.1: The direct effect of honey on THP-1 cell viability. Cells were incubated with various honeys 
(manuka, Otago pasture, or artificial) for 48 h and compared with THP-1 cultured in bioassay medium 
alone (I 00% viable). Data are presented as the mean of triplicates ± SEM (n=9). Differences between the 
means are indicated by superscript letters, where means not sharing corrunon letters within a graph are 
significantly different (P<0.05) . 
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4.3.2 Depletion cultures to identify the contribution of monocytes in a whole blood 
fraction to TNF production 
Prior to conducting TNF-a measurements in a monocytic cell line, it was important to 
test the assumption that the TNF-a detected in the blood cultures (Section 3.3.1) came 
from the monocytes. Purified monocytes from bovine blood were incubated with either 
0.25% manuka honey, LPS (10 µg/ml) or bioassay medium for 6 hand the TNF content 
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Treatment 
LPS 
Figure 4.2: TNF-a production by monocytes derived from bovine blood after incubation with LPS or 
manuka honey. Bovine monocytes were incubated for 6 h with LPS (10 µg/ml), manuka honey at 0.25%, or 
bioassay medium alone. Supernatants were measured in a WEHI Bioassay. Differences between the means 
are indicated by *, where means not sharing * are significantly different (P<0.05). Treatments were 
conducted in triplicate and these means are derived from two independent experiments (n=6). 
As shown in Figure 4.2, monocytes derived from bovine blood released significant 
amounts of TNF-a after incubation for 6 h with 0.25% manuka honey compared with the 
control group (medium alone). Monocytes treated with LPS produced twice as much 
TNF-a as the honey-treated cells during the same period. These results justified further 
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investigation to determine how honey activates monocytes and more specifically, 
production of cytokines involved in tissue repair. 
4.3.3 Direct effects of honey on WEHI cells 
To ensure that honey had no deleterious effects on WEHI cell survival following 
incubation with honey, MTT assays were performed as shown in Figure 4.1. Honey alone 
had no direct effect on WEHI cell viability (and metabolism) at concentrations tested in 
these assays (0-1 % v/v) as determined by optical density. This experiment confirmed that 
honey would not cause direct effects upon WEHI cells (a fibrosarcoma cell line) and 
interfere with their use in a Bioassay. 
WEHI Bioassays were conducted to measure the amount of TNF-a produced by THP-1 
monocytes exposed to various honey concentrations. The THP-1 monocytes were 
incubated with. a range of honey concentrations which were shown to stimulate PBMC 
activity (Section 2.3.1). The amount of TNF-a produced by the monocytes was 
determined with the WEHI Bioassay. The effect on TNF-a production of exposing 
monocytes to various honey concentrations is shown in Figure 4.4. 
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Figure 4.3: The direct effect of honey on WEHI metabolism and viability. WEHI fibrosarcoma cells were 
incubated with various honeys (manuka, Otago pasture, or artificial) for 48 h and compared with WEHI 
cultured in bioassay medium alone (100% viable), using an MTT assay. Data are presented as the mean of 
triplicates± SEM (n=9). Differences between the means within graphs are indicated by * (P<0.05). 
150 
Chapin Fuur TNF-c,( production I" munuc\ tc, 
1.1 

















u'.. z 0.2 f--
0.1 a 
0 
0 IO LO IO IO LO IO ..... 
(\J C\I C\I C\I ci ~ ci 0 0 0 0 








Q) 0.6 (J 
C: 








0 IO IO IO IO LO IO 
C\I C\I C\I C\I ci C\I ci 0 0 0 C! 0 0 0 0 
0 0 ci 0 C! ci 
0 
Otago pasture honey concentration(%) 
Figure 4.4: Levels of TNF-a produced by THP-1 monocytes exposed to various honey concentrations. 
THP-1 were incubated for 4 h with various honeys (manuka or Otago pasture) or bioassay medium alone. 
Supematants were measured in a WEHI Bioassay. Differences between the means are indicated by 
superscript letters, where means not sharing corrunon letters within a graph are significantly different 
(P<0.05). Treatments were conducted in triplicate and these means are derived from two independent 
experiments (n=6). 
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4.3.4 Effect of honey on TNF-a production by resting monocytes 
The THP-1 cell line was selected for use in the assays. Both natural honey types elicited 
TNF-a. production by the monocyte cell line beyond that of the bioassay medium alone. 
In contrast artificial honey had minimal stimulation activity on the monocytes, with levels 
less than 0.5 ng/ml at all concentrations tested, 0.000025-0.1 %. 
Maximal TNF-a. production was obtained for monocytes incubated with 0.25% manuka 
honey. Concentrations greater than 0.25 % had decreased TNF-a. production. The effects 
of honey at lower concentrations (0.000025-0.0025% 1) varied between experiments so 
that there was no statistical difference between the TNF levels stimulated by this range of 
honey concentrations. Investigation of the osmotic tolerance range for THP-1 monocytes 
had detected slight reduction in cell viability when incubated with 1 % honey, but not to 
the same extent as with PBMCs (Section 2.2.7.1). However it was observed that cells still 
produced significant TNF-a. levels despite the slight osmotic problem although less than 
at0.25%. 
Figure 4.4 shows that Otago pasture honey induced TNF-a. production by monocytes at 
all of the concentrations tested, but that the amounts of TNF-a. produced were not 
significantly different from each other. The size of the error bars indicates that there were 
reproducibility problems for the amounts of TNF-a. produced by monocytes exposed to 
Otago pasture honey between assays replicated in time. Therefore it was impossible to 
distinguish any effects between honey concentrations, and yet activity was still exerted 
beyond medium alone. 
The optimal stimulatory dose was determined to be 0.25% honey. A direct comparison of 
manuka, Otago and artificial at 0.25% concentrations is shown in Figure 4.5. 
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Figure 4.5 : Levels of TNF-cx produced by THP-1 monocytes exposed to 0.25% honeys. THP-1 were 
incubated for 4 h with 0.25% concentrations of various honeys (manuka, Otago pasture or artificial) or 
bioassay medium only. Supematants were collected and assayed in WEHI Bioassay. Differences between 
the means are indicated by *, where means not sharing * are significantly different (P<0.05). Treatments 
were conducted in triplicate and these means are derived from three independent experiments (n=9). 
Monocytes incubated with 0.25% concentrations of manuka honey or Otago pasture 
honey were activated to produce TNF-a beyond those levels obtained for bioassay 
medium. Artificial honey had no activating effect. No significant differences were 
detected between manuka honey and Otago pasture honey for their stimulation of TNF-a 
production at 0.25%. 
In order to identify the fraction of honey responsible for this stimulatory effect, honey was 
fractionated by dialysis. The effect on TNF-a production of exposing monocytes to 
fractions from dialysis of manuka honey are shown in Figure 4.6. 
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Figure 4.6: Levels of TNF-a produced by THP-1 monocytes exposed to dialysis fractions of manuka honey 
equivalent to 0.5% honey. THP-1 were incubated for 4 h with fractions of low molecular weight (<10 kDa) 
or high molecular weight (>10 kDa) manuka honey, artificial honey or b1oassay medium only. Supematants 
were collected and measured in a WEHI Bioassay. Differences between the means are indicated by*, where 
means not sharing * are significantly different (P<0.05). Treatments were conducted in triplicate and these 
means are derived from three independent experiments (n=9). 
While 0.25% concentrations of whole honey were optimal for induction of TNF-a. 
release, 0.25% honey fractions had no activity beyond the bioassay medium alone. 
Therefore, the range of concentrations of the honey fractions were extended. Incubation 
of monocytes with the high molecular weight fraction of manuka honey (0.5%) had 
stimulatory activity, whereas no activity was detected for the equivalent low molecular 
weight fraction. Artificial honey had no activity. No activity was detected for equivalent 
fractions of Otago pasture honey beyond medium alone. The concentration of TNF-a. was 
less than 0.1 ng/ml in the control cultures. 
As the samples were dialysed and the sugars were removed from the high molecular 
weight fractions, higher concentrations did not create osmotic problems. The range of 
concentrations tested were therefore extended for the high molecular weight fractions. 
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The effect on TNF-a production of exposing monocytes to higher concentrations of 
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Figure 4 .7: Levels ofTNF-a produced by THP-1 monocytes exposed to fractions of dialysed manuka honey 
equivalent to 0.5% and 1 % honey. THP-1 were incubated for 4 h with fractions of high molecular weight 
(>10 kDa) manuka honey, artificial honey or bioassay medium only. Supematants were collected and 
measured in a WEHI Bioassay. Differences between the means are indicated by*, where means not sharing 
* are significantly different (P<0.05). Treatments were conducted in triplicate and these means are derived 
from three independent experiments (n=9). 
Both 0.5% and 1 % high molecular weight fractions of manuka honey had a stimulatory 
effect on TNF-a production by monocytes beyond bioassay medium alone. Artificial 
honey had no activating effect at either concentration tested. 
Contrary to the results obtained for whole honey, increased concentration of the fraction 
led to increased TNF-a production. There were significant differences detected between 
the 0.5% and 1 % high molecular weight fractions, with the 1 % fraction exhibiting the 
greatest stimulatory activity. No activating effect was detected for the low molecular 
weight fractions of manuka honey at either concentration tested beyond the bioassay 
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medium alone (0.5% < 10 kDa 0.022 ng/ml ± 0.012, 1% <10 kDa 0.01 ng/ml ± 0.026, 
bioassay medium alone 0.01 ng/ml ± 0.018). 
To study the time-dependent effects of different honeys on TNF-a production, monocytes 
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Figure 4.8: Effect of different incubation periods of 0.25% (v/v) honeys with THP-1 monocytes on TNF-a 
production. THP-1 were incubated with 0.25% honey (artificial, manuka or Otago pasture types) or 
bioassay medium alone for various periods. Supematants were collected and measured in a WEHI 
Bioassay. Each point represents the mean for each treatment (conducted in triplicate). Error bars show SEM 
(n=9). Significant differences between the results at each time point and at the starting time(*) and between 
types of honey at each time point (indicated by superscript letters where means not sharing significant 
letters are significantly different) are shown (P<0.001 analysed by ANOVA and Tukey's pair-wise 
comparisons). 
Incubation of monocytes with either manuka or Otago pasture honeys (at 0.25% 
concentrations) for times between 2-8 h, significantly increased their TNF-a production 
beyond bioassay medium alone. After 12 h exposure to 0.25% honeys, the levels of TNF-
a detected in the supernatants had returned to baseline levels. TNF-a production peaked 
when the monocytes had been incubated with the honeys for 4-6 h. Sugars alone had no 
activating effect on TNF-a production at any time. The activity of manuka honey and 
Otago pasture honey was not significantly different from each other at any time-point. 
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4.3.5 Effect of honey on TNF-a production by LPS-stimulated monocytes 
To examine whether honey can modulate TNF-a production by monocytes after LPS-
stimulation, cultures were exposed to various manuka honey concentrations for 4 h 
following 24 h incubation with LPS (Figure 4.9). TNF activity in LPS-stimulated 
monocyte cultures exceeded immunoassayable TNF-a in the WEHI Bioassay (> 1 ng/ml). 
This meant that treatment effects of honey on LPS-stimulated monocytes could not be 
determined using the WEHI Bioassay, and therefore a commercially available TNF 
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Figure 4.9: Effect of exposing LPS-stimulated THP-1 monocytes to various manuka honey concentrations 
on TNF-a production. THP-1 were incubated with LPS ( 10 µg/ml) for 24 h prior to various manuka honey 
concentrations or bioassay medium alone and the cells incubated for a further 4 h. Supematants were 
collected and measured in a TNF-a ELISA. Each point represents the mean for each treatment (conducted 
in triplicate). There were no significant differences between the means (P<0.05). These means are derived 
from two independent experiments (n=6). 
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The results in Figure 4.9 show honey had no measurable effect on the amount of TNF-a. 
produced by monocytes after they had been pre-exposed to LPS for 24 h. Assays were 
then conducted to investigate whether manuka honey (0.25% and 0.5%) could interfere 
with the TNF production by LPS-stimulated monocytes when cell exposure time to LPS 
was reduced (2-24 h). There was no significant difference in the effect of honey on the 
TNF response by LPS-stimulated monocytes when exposure time with LPS was reduced 
(data not shown). Honey could not modulate the production of TNF protein after the cells 
were pre-exposed to LPS for a minimum of 2 h. The effect of increasing the amount of 
time LPS-stimulated monocytes were exposed to manuka honey (0.25% and 0.5%) from 
2-6 h had no effect on TNF-a. production. Of further note, a comparison of Figure 4.4 
and Figure 4.5 with Figure 4.9, demonstrates that LPS stimulated TNF-a. production more 
strongly than honey had done. 
4.3.6 Validation of TNF-a. determinations from the WEHI Bioassay by ELISA 
The purpose of these assays was to compare the determinations from the WEHI Bioassay 
with those obtained using a commercially available ELISA. Briefly, THP-1 cultures were 
stimulated with either LPS (10 µg/ml), manuka honey (0.025-1 %) or bioassay medium 
alone for 4 h and the TNF protein content in the supematants was then determined for 
duplicate samples and standards by both the WEHI Bioassay and a TNF-a. ELISA (Table 
4.1). 
The data presented in Table 4.1 demonstrate that a good correlation was found between 
the ELISA and WEHI Bioassay when TNF-a. was measured in supematants. This 
confirms the observations which have been reported in the current study. 
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Table 4.1: Comparison of total TNF (ng/ml) detected in supematants from monocytes exposed to various 
treatments using a commercial TNF ELISA and a WEHI Bioassay. THP-1 cultures were stimulated with 
either LPS ( 10 µg/ml), manuka honey (0.025-1 % ) or bioassay medium alone for 4 h and the TNF protein 
content in the supematants was then detennined using both assay methods. Treatments were conducted in 
duplicate and the data represent the mean (± SEM) of two separate assays. (> I means the levels were 
beyond the detection limits of the Bioassay). 
Treatment ELISA (ng/ml) WEHI BIOASSA Y (ng/ml) 
LPS 0.97 ± 0.08 >1 ± 0.04 
1% manuka 0.32 ± 0.001 0.38 ± 0.07 
0.5% manuka 0.54± 0.02 0.57 ± 0.004 
0.25% manuka 0.48 ± 0.001 0.51 ± 0.08 
0.025% manuka 0.65 ±0.09 0.67 ± 0.05 
0.025% manuka + 0.59 ± 0.02 0.53 ± 0.003 
polymyxin B 
Bioassay medium 0.16 ±0.003 0.21 ± 0.004 
4.4 DISCUSSION 
The physiological relevance of the investigations described here were twofold; to see 
whether honey could stimulate release of TNF-a. in resting monocytes, a key cytokine 
involved in the early phase of tissue repair (Belge et al., 2002). Further, to investigate 
whether honey could modulate the production of TNF-a. by LPS-stimulated monocytes 
with view to its potential use as a mediator of excessive TNF production as occurs in the 
pathogenesis of some inflammatory diseases (Lefkowitz and Lefkowitz, 2001 ). 
The observation that 1 % honey elicits low levels of TNF-a. release by monocytes (0.2-0.5 
ng/ml) corroborated the earlier findings by Tonks et al. (2003; 2001). However, the 
current study is the first to demonstrate that very low concentrations of honey can induce 
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TNF-a release by resting monocytes (2.5 x 10-5-1 x 10-1). These results have important 
consequences for the potential use of honey. 
Of further note, the results presented in the current study show that the 1 % honey 
concentration tested by Tonks et al. (2003; 2001) was not optimal for TNF induction 
which was obtained at a 0.25% concentration. It is possible that removal of 
cytotoxic/osmotic effects would have occurred with progressive dilution of honey below 
1 %. Reduction in glucose content due to dilution of honey would contribute to removal of 
osmotic effects. The observation that natural honeys did not cause osmotic damage to 
THP-1 monocytes at 1 %, unlike an equivalent concentration of artificial honey (sugars 
alone), despite having the same osmolarity, may indicate the presence of protective agents 
in honey. The existence of both an anti-inflammatory and a stimulatory component in 
honey and each exerting their effects at opposite ends of the dilution range (0-1 % ) cannot 
be ruled out at this stage. Further fractionation of honey to isolate the stimulatory agent 
needs to be undertaken so that this can be resolved. 
Timing of measurement for TNF content in the supematants is known to be critically 
linked to the amount of cytokine which will be free in the suspension. After monocytes 
had been cultured with honey for 6 h the levels of TNF protein detected in the 
supematants decreased. It is likely that the TNF is either taken up by TNF receptors on 
the monocyte cells or broken down by proteases. Further, TNF is a fragile cytokine with a 
short half-life, breaking down quickly after production and cannot be detected in culture 
after a fairly short time (up to 80 min) (Smart, 1995). Various factors such as temperature 
at which the medium is maintained will have further impacts on the half-life of this 
cytokine (Smart, 1995). If monocytes continually respond to the honey stimulus a 
equilibrium level of TNF-a will be reached where the rate of breakdown becomes the 
same as the rate of synthesis, and this may explain the peak in TNF-a production 
observed after 4-6 h incubation. Of further note here, in Section 3.3 it was observed that 
transcription of mRNA for TNF-a was significantly down regulated after blood had been 
exposed to honey for 12 h. In Section 3.3, the implications for blood handling ex vivo 
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prior to performing any assay were discussed. A study by Baechler et al. (2004) reported 
that TNF-related genes and TNF itself is critically sensitive to ex vivo handling of cells 
and specifically, incubation time. 
The time-dependent effects of honey reported in the current study confirm those observed 
by Tonks et al. (2003) and indicate that a 4-6 h incubation period of monocytes with 
honey gives maximal TNF-a. levels. This optimal stimulation period may relate to cell-
cytokine mechanisms only, and have no bearing on the nature of the stimulatory agent in 
honey. Saitoh et al. (2003) have reported that the induction of TNF-a. is rapid due to its 
preformed existence in mast cells and its release by T cells and monocytes, early arrivals 
to the site of tissue damage, but that its induction is only transient. It has been reported 
that delivery of hydrogen peroxide by honey decreases over time and the rate of this 
decline is dependent on the rate at which catalase breaks down hydrogen peroxide (Bang 
et al., 2003). However, it is not yet understood what the implications of these 
observations made in higher concentrations of honey ( optimal at 50%) are for the very 
low concentrations shown to have immunological activity in the current study. Maximum 
levels of hydrogen peroxide are produced after 30 min when samples are incubated at 
35°C, and production is reported to decrease steadily after this time (Kerkvliet, 1996). 
Even when ideal conditions are maintained, the activity of the glucose oxidase enzyme 
declines to a low, basal rate after 24 h (Buntting, 2001). Further, White and Subers (1964) 
have reported that the glucose oxidase enzyme operates most efficiently within a narrow 
range of pH (with an optimum pH of 6), and this is likely to be altered through changes in 
medium composition over time, though monitoring pH during the current study did not 
detect any pH fluctuations. White blood cells themselves produce catalase, with levels 
produced ranging from high amounts by neutrophils to very little by monocytes (Sagone 
et al., 1984). The consequences of this activity are unclear, but may have implications for 
the research described here if hydrogen peroxide was indeed shown to play an important 
role in monocyte function. 
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The absence of LPS in contamination cultures as demonstrated by culturing cells in the 
presence of polymyxin B confirms that observed stimulation of TNF release from 
monocytes by honey cannot be due to endotoxin content. The role of sugars alone 
(represented by artificial honey) on stimulation of TNF-<X production was also excluded 
in the current study. 
The levels of TNF which are required for tissue healing to be initiated in vivo are not 
readily transferable to in vitro culture. The role of TNF-<X in tissue repair has been 
demonstrated in vivo and is known to accelerate wound epithelialization and 
neovascularization (Frank et al., 2003). The mechanisms by which TNF promotes tissue 
repair include; mitogenic effects on fibroblasts, stimulation of collagen synthesis and 
capillary formation possibly through synergistic actions with platelet-derived growth 
factor (Fu et al., 1996). Further, a single dose of exogenous TNF to an experimental 
wound was found to increase both the RNA and DNA content of regenerative tissue (Fu 
et al., 1996). That low concentrations of honey induce monocytes to produce TNF-a 
increases the likelihood that honey may optimise the damaging and killing activity of 
activated macrophages in damaged tissues. 
The observation that the in vitro effect of exposure to honey on monocyte TNF 
production was clearly distinct in its magnitude from that observed after exposure to 
LPS, an agent involved in endotoxic shock. The observation that honey has no additive 
effect on LPS-stimulated TNF-<X production is important for its potential use as a therapy, 
as TNF-<X contributes to the pathogenesis of a range of inflammatory diseases when 
produced at high levels (Joyce et al., 1997). That honey stimulates the release of modest, 
though statistically significant amounts of TNF-<X compared with LPS, means that it is 
unlikely to contribute to production of the cytokine at levels which lead to pathogenesis. 
Yet, the significant levels of TNF-a released by honey-stimulated monocytes may be of 
considerable significance if sufficient to induce tissue repair processes. 
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Although the active agent has not been identified, it is characterised by its presence in a 
high molecular weight fraction exceeding 10 kDa. The observation that fractionated 
honey did not produce activity in the same manner as whole honey has implications for 
the identity of the active agent. In the high molecular weight fraction, sugars have been 
removed and it is likely the cells will respond differently to these fractions compared with 
whole honey. It may be a consequence of interrupting some synergy existing within 
whole honey. The observation that there was much less activity in the fractions of 0.25 % 
honey than in the original 0.000025% honey concentration raises several possibilities for 
the nature of the active component in the honey. The >10 kDa fraction would have 
contained the glucose oxidase enzyme (which breaks down glucose to produce hydrogen 
peroxide) but not the glucose substrate. However, the bioassay medium, containing 
RPMI-1640, had a glucose content of 2000 mg/I meaning that some of its substrate would 
have been available when the > 10 kDa fraction was diluted with medium in the wells. 
However, the availability of the glucose substrate would be greater for the enzyme 
contained within whole honey due to its glucose content. A further possibility may be that 
the FAD cofactor for glucose oxidase (needed for the enzyme to function) had been 
dialysed out. It is not currently known how the FAD cofactor is bound to the glucose 
oxidase enzyme contained in honey, and therefore the ease with which it may be removed 
during fractionation processes (P. C. Molan; personal communication). 
Catalase is present in foetal calf serum and acts to metabolise hydrogen peroxide, with the 
potential to negate the tissue-stimulatory effects produced by the presence of hydrogen 
peroxide in honey. Hydrogen peroxide has been demonstrated to modify the redox status 
of various cells and cause corresponding changes in the activation of the transcription 
factor NF-KB, leading to changes in cellular activity and function (Los et al., 1995). 
Therefore, it is very likely that hydrogen peroxide could activate monocytes. That natural 
honey promotes TNF-a. release by unprimed monocytes fits well with what is observed 
clinically, the optimisation of wound healing when honey is used. 
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It was noted in Section 2.4 that various cells, including monocytes, possess receptors for 
glycated proteins. Binding of glycated proteins has been reported to trigger the release of 
cytokines by monocytes (Brownlee, 1995; Wolff et al., 1991) and it is likely that honey 
contains these. As the dialysis retentate fraction had a potent stimulatory effect on 
monocytes, it would therefore be useful to examine the possible contribution of protein 
content to induction of TNF. Of further note, the equivalent retentate fraction of pasture 
honey did induce TNF release, and this is likely to reflect the difference in composition of 
the two honeys, (such as manuka honey having more protein). 
The results of the study undertaken here have highlighted a multitude of investigations 
which need to be performed in order to fully understand the implications of these results. 
The extent to which the in vitro model used here differs from the in vivo situation means 
that the results of this study are not readily transferable in the absence of further testing. 
However, there is no evidence that these in vitro results could not be realised in vivo. 
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SUMMARY 
To test whether honey could modulate LPS-stimulated NO production by THP-1 
monocytes and bovine peripheral blood mononuclear cells, Greiss assays were performed. 
Both manuka and Otago pasture honey at 0.5% and 1 % concentrations suppressed LPS-
induced nitrite release in a dose-wise manner, indicating modulation of nitric oxide 
production. Manuka honey had a more potent modulating effect on LPS-driven nitrite 
production than pasture honey, and maintained activity at 0.25%. Sugars alone had no 
effect. High molecular weight dialysis fractions of either honey contained the activity, but 
some of the activity was lost by fractionation. An ether extract of manuka honey led to the 
greatest modulation of nitrite production by LPS-stimulated monocytes. 
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5.1 INTRODUCTION 
It has been established by the current stu~y that honey downregulates mRNA expression 
for the inducible nitric oxide synthase enzyme (iNOS) by LPS-stimulated blood cells 
(chapter 3), and the investigations described here were undertaken to determine whether 
this also correlated with decreased production of nitric oxide (NO) protein. The critical 
role played by NO in the pathogenesis of inflammatory diseases (e.g. colitis) is well 
established (Childress and Stechmiller, 2005; Rizk et al., 2004; Bansal and Ochoa, 2003; 
Bilsel et al., 2000; Chen et al., 1998; Grimble, 1994; Ochoa et al., 1991; Marietta, 1988), 
and therapeutic agents which can ameliorate NO production are of immense value. 
NO has a diverse range of activites, both anti and pro-inflammatory depending on the 
context in which it operates and the interactions undertaken with other mediators. NO is 
known to impair wound healing and lead to tissue damage by increasing vascular 
permeability (ligand mediated and flow dependent), thereby enabling infiltration of 
tissues by leukocytes (Rizk et al., 2004; Schwentker and Billiar, 2003). NO inhibits 
leukocyte adhesion to vascular endothelium, inhibits platelet adhesion to vascular 
endothelium (anti-thrombotic), and anti-proliferative 
Once present in tissues, hydrogen peroxide released by leukocytes during their host 
defense response gives rise to the superoxide radical, which in tum may combine with 
NO to form peroxynitrite (Zhu et al., 1992). Peroxynitrite is a highly unstable free radical 
which is reported to cause loss of normal cell function due to damaging effects on DNA 
(Rizk et al., 2004; Patel et al., 1999; Inoue et al., 1993). 
In Section 3.1, the involvement of NO in cell signalling was outlined. The substrate for 
NO is L-arginine, and after being transported into the cell it is acted upon by nitric oxide 
synthase (NOS), forming NO and citrulline (Rizk et al., 2004). NO is continuously 
produced by constitutive NO synthase (cNOS), and the activity of cNOS is modulated by 
calcium. Substances such as bradykinin, histamine, insulin and substance P stimulate 
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release of calcium when ligands are bound to their receptors, and therefore, stimulate NO 
production by this mechanism. Shear forces acting on the luminal surface of vascular 
endothelium also stimulate calcium release and therefore, increased cNOS activity. The 
inducible form of NO (iNOS) is not calcium-dependent, but is stimulated by cytokine 
activity (e.g. IFN-y, TNF, interleukins such as IL-1), is controlled by transcription factors 
such as NF-lCB, IFN-regulatory factor-I, and bacterial endotoxins (e.g. LPS) (Rizk et al., 
2004; Bansal and Ochoa, 2003; Chen et al., 1998). Induction of iNOS occurs over several 
hours and produced 1,000-fold more NO than by cNOS. However, cytokines such as 
TGF-P, IL-4 and IL-11 have been found to suppress stimulated iNOS expression in 
macrophages (Rizk et al., 2004; Chen et al., 1998). After diffusion across cell 
membranes, NO is rapidly consumed due to its high reactivity with a diverse range of 
molecules. NO binds to protein receptors in the cell, being either a metal ion in the 
protein or one of its S atoms, and this triggers an allosteric change in the protein and the 
formation of a second messenger (e.g. cyclic GMP, cGMP) (Rizk et al., 2004; Bansal and 
Ochoa, 2003; Chen et al., 1998). The cGMP then acts to initiate cytokine release. 
As noted in Chapter 3, cytokines do not operate in isolation and when production of a 
single cytokine changes, this will have profound effects on cellular activation and the 
inflammatory response of an individual ((Rizk et al., 2004; Bansal and Ochoa, 2003; 
Chen et al., 1998; Lamas et al., 1991; Ferrante et al., 1988). For this reason, when NO is 
produced at high levels it is associated with the onset of chronic inflammation (Cobbold 
and Sherratt, 2000). It should be noted however, that NO is necessary for wound healing 
to occur, playing a vital role in host defense (Wink and Mitchell, 1998), and in tissue 
repair (Witte and Barbul, 2002). NO is needed for collagen deposition, cell proliferation 
and wound contraction (Witte and Barbul, 2002). Total inhibition of NO would have dire 
consequences for immune function (Patel et al., 1999) and tissue repair (Witte and 
Barbul, 2002). 
There is some evidence that honey can modulate NO production. A study by Bilsel et al. 
(2002) tested the anti-inflammatory effect of 50% honey on experimentally induced 
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colitis in rats. Applied as an enema, the honey had an effect on colitis through prevention 
of free radical release and a decrease in NO production. In addition to anecdotal 
observations that honey reduces inflammation (Molan, 2004), Tonks et al. (2001) 
reported that levels of reactive oxygen intermediates were reduced by addition of honey 
to mitogen-stimulated monocytes. This would suggest that honey could decrease the 
formation of peroxynitrite, and that this might account for anecdotal observations that 
honey alleviates tissue damage. Therefore, the following investigations were designed to 
test the hypothesis that the ability for honey to modulate NO production is key to the 
mechanism by which honey has anti-inflammatory effects. Many different cell types 
produce NO, and among these the macrophages constitute a key group (Wallace et al., 
2000). To investigate whether honey could modulate NO production, LPS-stimulated 
THP-1 monocytes were used to provide an established inflammatory model in vitro of 
tissue macrophages (Jagannath et al.,1998; Chen et al., 1996; Mautino et al., 1994). To 
determine whether honey may have any effect on NO production by immune cells it was 
necessary to consider both; (a) how much NO was being produced and (b) how much NO 
was actually being removed by various agents in an in vitro system, by using Greiss 
assays. 
5.2 MATERIALS AND METHODS 
Nitrite and nitrate are both formed from the reaction of NO with oxygen and water, so 
that quantification of nitrite levels by the Greiss reagent provides a reliable measure for 
NO (Martin and Edwards, 1993). Therefore, use of the Greiss reagent to measure nitrite 
(a stable metabolite of NO) enabled the effect of honey on NO levels in PBMC culture to 
be investigated. Prior to adopting the Greiss method, the more sensitive method described 
by Turner (2001), enabling quantification of the conversion of N03 to N02, was utilised. 
Unfortunately several attempts to follow this method established that honey distorts the 
modified Greiss assay, and this was abandoned for the less sensitive Greiss method. For 
the purposes of this thesis however, a simple demonstration of the effects of honey on 
nitrite levels in PBMC cultures and THP-1 monocytes was deemed adequate. 
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The method used was adapted from Martin and Edwards (1993). NO production was 
determined as the amount of stable end product (nitrite) in the PBMCs or THP-1 culture 
medium. This is because NO is very labile, with a half-life of only seconds (Marietta et 
al., 1988). 
5.2.1 Cell cultures 
Preparation of the PBMC cultures was performed as described in Section 2.2.3.2. The 
THP-1 monocytes were maintained according to the procedures described in Section 
4.2.2. 
In separate experiments PBMCs or THP-1 monocytes were placed in 96-well plates at a 
density of 1 x 106/ml. The cell densities were adopted from the methods described by 
Tonks et al. (2003) and Jungi et al. (1996). The cell suspension contained complete 




As described in Section 3 .2.1, a 1 mg/ml stock solution (E. coli serotype 0111: B4; 
Sigma-Aldrich UK; cat no# L4516) was purchased. The LPS was diluted to final 
concentrations in wells of 10 µg/ml (unless otherwise stated). 
Concanavalin A (Con A) 
As described in Section 2.2.1, a 500 µg/ml stock solution was prepared. Unless otherwise 
stated, the Con A stock solution was further diluted to final concentrations of 5 µg/ml in 
wells. 
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Sodium nitrite (NaN02) 
A 100 mM stock was prepared by dissolving 6.9 mg of NaN02 in 1 ml of RPM! medium. 
Greiss reagent 
The reagent was freshly prepared by mixing equal parts of 0.2% N-
[naphthyl]ethylenediamine dihydrochloride in H20 and 2% sulphanilamide in 5% 
phosphoric acid (H3P04) (Wako Fine Chemicals). 
5.2.3 Honey solutions 
It had been established in Section 4.3.1 that THP-1 monocytes had a different osmotic 
tolerance from PBMCs (Section 2.2.7). At the 0.5% (v/v) honey concentration, the sugars 
contained in honey begin to have negative effects on PBMCs, and at 1 % (v/v) the osmotic 
effects on the cell population is significant. Visual inspection of the cell populations 
revealed that a high proportion of lymphocytes, monocytes and macrophages had osmotic 
damage. Although some signs of osmotic stress were observed for lymphocytes at the 
0.5% concentration, only slight cell damage was noted for monocytes and macrophages at 
this honey concentration. However, THP-1 cells tolerate the higher 1 % (v/v) honey 
concentration. With this in mind the honey concentrations tested in the Greiss assays 
described were restricted to a maximum of 0.25% (v/v) for PBMC and 1 % (v/v) for THP-
1 monocytes. Solutions of M109 manuka honey, Otago pasture honey, and artificial 
honey in RPMI complete medium were prepared as in Section 2.2.2. Dialysed fractions of 
honey were prepared in RPMI complete medium as in Section 2.2.2.1. An ether extract of 
manuka honey (containing the ether-soluble components of the honey) was made as 
described in Section 2.2.2.1. The pH of the honey solutions was measured using a pH 
meter (Mettler Toledo) and did not differ significantly from medium alone. 
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5.2.4 Measurement of NO levels 
5.2.4.1 Preparation of Greiss calibration curve 
To enable the quantification of nitrite in suspension, a calibration curve was prepared for 
each assay by diluting the NaN02 standard within the range 0-100 µmol/L. The RPMI 
complete medium alone provided the blank (0 ng/ml NaN02). For each standard, 75 µl 
was loaded in duplicate to wells of a 96-well flat bottom plate, and 25 µl of the Greiss 
reagent added. The plate was incubated for 10 min at room temperature, protected from 
light, and the absorbance read spectrophotometrically at 550 nm (BioTek) within 30 min. 
The average absorbances were calculated for each of the standards, and the average 
absorbance from the blank wells subtracted. The mean absorbance values for each 
standard dilution were then plotted against the standard concentration of NaN02 (as given 
in Appendix 2). The nitrite concentration of each sample could then be determined by 
interpolation from the standard curve. The assay had a lower limit of detection of 1.56 
µM. 
5.2.4.2 Determination of NO content in cell suspensions 
After incubation of the cells, the plates were centrifuged (Sorvall, 503 x g, 15 min) to 
pellet the cells and 75 µl of each supernatant was transferred to a separate well of a sterile 
96-well flat bottom plate. All samples were loaded in triplicate. Samples were diluted 
with diluent so that detectable nitrite fell within the sensitivity range of the assay. The 
Greiss reagent was added in 25 µl volumes to the supernatant and the plate was incubated 
for 10 min at room temperature. Optical density was measured at 550 nm (BioTek) and 
the control values subtracted from treatment wells. The total nitrite produced following 
treatment was then determined from a standard curve. 
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5.2.5 Statistical Analyses\ 
Values were expressed as the mean of triplicate wells ± SEM. All data presented have 
been adjusted for background absorbance. Each experiment was replicated in time at least 
twice (n=6). For multiple group comparisons, the data were subjected to one-way analysis 
of variance (ANOV A) to determine overall differences between the group means. The 
group effect was the amount of NO produced. Significance was further analysed using 
Tukey's honestly significant difference for pair-wise differences for within group 
comparsions. Results were accepted as statistically significant when P<0.05. Systat 
(version 7) was used for all analyses. 
5.2.6 Preliminary experiments 
Comparison of THP-1 and PBMCs for NO production 
To establish whether the THP-1 monocytic cell line would provide a more sensitive 
model for NO measurement than bovine blood-derived PBMCs, the Greiss assay was 
performed for both cell types. This had the additional benefit of assessing whether the 
results obtained from using a cell line had physiological relevance, by comparing them 
with results obtained from primary cells (PBMCs). Preliminary assays showed that 
adding LPS alone to PBMCs did not trigger a sufficient response for sensitive detection 
of nitrite by the Greiss method. Addition of Con A stimulates T-cell proliferation by 
initiating cytokine production and subsequently, bystander activation (Miller et al., 1991; 
Young et al., 1994). Prior stimulation of the THP-1 monocytes with Con A before 
addition of the treatments was not required. 
To induce production of NO, the cells were incubated with Con A, LPS or both. 
Suspensions of PBMCs or THP-1 monocytes were loaded in 980 µl aliquots into wells of 
a 24-well plate at final densities of 1 x 106/ml. Triplicate wells of PBMCs received 10 µl 
of Con A solution (500 µg/ml) and incubated for 24 h (37°C, 5% CO2, 95% air), prior to 
10 µl of a LPS solution (10 µg/ml). THP-1 monocytes only received 10 µl of LPS 
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solution (10 µg/ml). All cells were incubated for 24 h (37°C, 5% CO2, 95% air) with 
LPS. Control wells for both cell types received 10 µl of RPMI complete medium only. 
The OD values obtained for control wells after a Greiss assay was performed were 
subtracted from OD values obtained for treatment wells. 
The effect on NO production of incubating PBMCs and THP-1 cells with LPS are shown 
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Treatment 
Figure 5.1: Nitrite concentration of supematants from stimulated PBMCs and THP-1 cell suspensions. 
PBMCs were each incubated with Con A (5 µg/ml) for 24 h prior to addition of LPS (10 µg/ml) and the 
cells incubated for 18 h (37°C, 5% CO2, 95% air). THP-1 monocytes were incubated with LPS (10 µg/ml) 
alone for 18 h (37°C, 5% CO2, 95% air). Each point represents the mean for each treatment (conducted in 
triplicate). Differences between the means are indicated by superscript letters, where means not sharing 
common letters are significantly different (P<0.05). These means are derived from three independent 
experiments (n=9). 
LPS-stimulated THP-1 monocytes produced significantly higher levels of nitrite than any 
of the stimulated PBMC cultures. Exposure of the PBMCs to LPS alone led to production 
of nitrite beyond levels obtained when cells were incubated with RPMI complete medium 
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alone. However these levels were significantly lower than those obtained for LPS-
stimulated THP-1 cells. Exposure of the PBMCs to Con A for 24 h prior to LPS-
stimulation increased nitrite production beyond that obtained for PBMCs incubated with 
LPS alone, but at significantly lower levels than for THP-1 cells with LPS alone. There 
were no detectable levels of nitrite in the supematants from PBMCs incubated with Con 
A alone, which confirmed that Con A was not inducing nitrite production. As THP-1 
monocytes produced higher levels of NO and did not require pre-incubation with Con A, 
all future nitrite measurements were performed using these cells. However, key assays 
were repeated using PBMC to verify that results obtained were not restricted to the THP-
1 cell line. 
5.2.7 Experimental design 
5.2.7.1 Measuring the direct effect of honey on NO production by mononuclear cells 
To measure the direct effect of honey on NO production by PBMC and THP-1 
monocytes, cells were incubated with various honey concentrations for 24 h prior to 
conducting a Greiss assay. Suspensions of PBMCs or THP-1 cells in RPMI complete 
medium were loaded in 950 µl aliquots into wells of a 24-well flat bottom plate at final 
densities of 1 x 106/ml. Cells were incubated with honey (artificial, manuka, Otago 
pasture) at 0.25% (v/v) for PBMCs and 1 % concentrations (THP-1). The honey 
concentrations were added to triplicate wells of the 24-well plates in 50 µl aliquots and 
the cells incubated for 24 h (37°C, 5% CO2, 95% air). Controls of cells incubated with 
RPMI complete medium only were included as a basis for comparison, and the OD values 
obtained for the controls were subtracted from OD values obtained for treatment wells. 
Background absorbance was determined by the inclusion of wells containing the range of 
honey concentrations and no cells. 
To determine whether components of honey react with nitrite and thus remove it or 
whether the protein in honey would interfere with the assay, the Greiss reaction was run 
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with the range of nitrite standards with and without 1 % manuka honey present. Honey 
was found to have no effect on the concentration of nitrite standards, indicating that any 
effects observed for treatment wells were not due to honey removing nitrite from solution 
directly and were due to an effect on the cells. 
5.2.7.2 Measuring the effect of honey on NO production by LPS-stimulated 
monocytes 
To measure the effect of honey on NO production by LPS-stimulated THP-1 monocytes, 
cells (1 x 106/ml) were added to a 96-well flat bottom plate in 940 µl volumes. To each 
well either 50 µl of honey solution (artificial, manuka or Otago pasture, serially diluted to 
obtain final concentrations of 0.1-1 %), or RPMI complete medium, was added along 
with 10 µl of LPS solution (10 µg/ml). Cells were the incubated for 18 h (37°C, 5% CO2, 
95% air) prior to performing a Greiss assay. 
5.2. 7.3 Characterising the fraction of honey which modulates NO production by LPS-
stimulated monocytes 
Assays were repeated as described in Section 5.2.7.2, to test the effect of honey fractions 
on NO production by LPS-stimulated monocytes. Testing of honey fractions was 
undertaken to characterise the active component in honey. Based on the optimised dose 
range established by the assays performed in Section 5.2.7 .2, dialysis fractions of either 
honey type (manuka or Otago pasture) and an ether extract of manuka honey were tested 
at a concentration equivalent to 1 % honey. As before, honey was added at the same time 
as LPS. Cells were then incubated for 18 h (37°C, 5% CO2, 95% air) prior to performing 
a Greiss assay. 
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5.3 RESULTS 
To determine whether honey stimulated cells directly to produce NO, THP-1 cultures 
were incubated with honey at various concentrations. No nitrite could be detected in any 
of the supematants, indicating that NO levels were below the detection threshold (less 
than 1.56 µM, data not shown). 
To examine the immunomodulatory activity of honey on the NO production of LPS-
stimulated monocytes, honey was added to cells at the same time as LPS. Both natural 
honey types at higher concentrations (0.5-1 % v/v), significantly reduced nitrite levels 
below those obtained for cells stimulated with LPS alone. There was a dose-wise 
inhibitory effect on NO production with increasing honey concentration (0.5-1 % ), but 
this was only just significant (P<0.05). Incubating LPS-stimulated monocytes with 1 % 
concentrations of either natural honey type led to the greatest inhibitory effect on NO 
production. Only manuka honey had a significant effect on NO levels at a 0.25% 
concentration, but no effect at 0.1 % concentrations. An inverse relationship existed, with 
NO production by LPS-stimulated monocytes decreasing with increasing honey 
concentration (Figure 5.2). 
To compare a monocytic cell line with a complex population of cells, PBMC were then 
incubated with the same range of honey concentrations (Figure 5.3). 
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Figure 5.2: Effect of treating LPS-stimulated THP-1 monocytes with concentrations of various honeys. 
Monocytes were incubated with honey (artificial, manuka or Otago pasture) at concentrations 0.1-1%, or 
RPMI complete medium, and LPS (10 µg/ml). The cultures were incubated for 18 h (37°C, 5% CO2, 95% 
air) and nitrite detennined using the Greiss reagent. Each point represents the mean for each treatment 
(conducted in triplicate). Differences between the means are indicated by superscript letters, where means 
not sharing common letters within graphs are significantly different (P<0.05). These means are derived 
from two independent experiments (n=6). 
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The results in Figure 5.3 show that incubation of LPS-stimulated PBMCs with honeys at 
0.5% concentrations, suppressed nitrite production indicating that 0.5% honey modulated 
NO production as compared to positive controls (cells with LPS alone). Visual inspection 
of the cultures indicated that some cell damage had occurred in the cultures incubated 
with 0.5% concentrations of honey and the sugar syrup (cell viability at this concentration 
with artificial honey was 85.1 % ± 3.2, manuka honey 88.3% ± 2.6, and Otago pasture 
honey 91.4% ± 4.6). Artificial honey had no effect on NO production by LPS-stimulated 
PBMC. This indicated that the effect of the 0.5% natural honeys on nitrite levels could 
not be attributed to sugars alone. Only manuka honey had a modulatory effect on NO 
production at a 0.25% concentration. At 1 % concentrations, both honeys and the sugar 
syrup lead to less NO production by LPS-stimulated PBMC than the positive control (as 
indicated by measurable nitrite), but also a decreased cell viability (artificial honey 55.1 % 
± 8.4, manuka honey 63.6% ± 7.1, and Otago pasture honey 67.3% ± 9.6). After the 
effects of sugars alone on NO production were removed, the effect of 1 % natural honeys 
on NO production were indistinguishable from 0.5% concentrations. Therefore, both 
manuka honey and Otago pasture honey had a modulatory effect on NO production by 
LPS-stimulated PBMC at 0.5% and 1 % concentrations but not in the dose-wise manner as 
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Figure 5.3: Nitrite concentration of supernatants from PBMC suspensions incubated with various honeys 
and LPS. PBMCs were exposed to Con A (5 µg/ml) for 24 h, and then incubated with LPS (10 µg/ml) and 
various honeys (artificial, manuka or Otago pasture) at 0.1-1 % concentrations or RPM! complete medium 
alone. Cells were then incubated for 18 h (37°C, 5% CO2, 95% air) prior to conducting a Greiss assay. Each 
point represents the mean for each treatment (conducted in triplicate). Differences between the means are 
indicated by superscript letters, where means not sharing common letters within graphs are significantly 
different (P<0.05). These means are derived from two independent experiments (n=6) . 
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The effect on nitrite production of incubating LPS-stimulated monocytes with dialysis 
fractions at a concentration equivalent to 1 % honey are shown in Figure 5.4. 
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Figure 5.4: The effect of dialysed honey fractions on nitrite production by LPS-stimulated THP-
1 monocytes. THP-1 ( I x 106 cells/ml), were incubated with LPS (IO µg/ml) and dialysis fractions at a 
concentration equivalent to I% Otago pasture honey or manuka honey. The cells were incubated for 18 h 
(37°C, 5% CO2, 95% air), prior to determination of the suspension nitrite levels using the Greiss reagent. 
Data is presented as a proportion of that from cells incubated with LPS alone (4.32 rnicromoles ± 0.71). 
Each point represents the mean for each treatment (conducted in triplicate). Differences between the means 
are indicated by superscript letters, where means within graphs not sharing common letters are significantly 
different (P<0.05). These means are derived from three independent experiments (n=9). 
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Retentate fractions (> 10 kDa) of both honeys obtained from dialysis, at a concentration 
equivalent to 1 %, decreased nitrite production. The diffusate fractions ( <10 kDa) 
obtained from dialysis of either honey had no effect on NO production. 
To compare the activity present in dialysed retentate fractions of honey with the original 
unfractionated stock, LPS-stimulated monocytes were incubated with 1 % honeys 
(manuka or Otago pasture) or retentate fractions of these honeys (at concentrations 
equivalent to 1 % honey). The effect of honey fractions compared with original stock 
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Figure 5.5: The effect on nitrite production by LPS-stimulated THP-1 monocytes, of high molecular weight 
fractions of honey compared with unfractionated honey stocks. THP-1 (l x 106 cells/ml), were incubated 
with LPS (10 µg/ml) and 1% honeys (manuka or Otago pasture) or retentate fractions of these honeys 
obtained from dialysis (at concentrations equivalent to l % honey). The cells were incubated for 18 h (37°C, 
5% CO2, 95% air), prior to detennination of the suspension nitrite levels using the Greiss reagent. Data is 
presented as a proportion of that from cells incubated with LPS alone (5.27 micromoles ± 0.23). Each point 
represents the mean for each treatment (conducted in triplicate). Differences between the means are 
indicated by superscript letters, where means not sharing common letters are significantly different 
(P<0.05). These means are derived from three independent experiments (n=9). 
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Fractionation of honey by dialysis leads to a loss of some of the modulatory activity 
found in natural honey. While the retentate fractions inhibited NO production compared 
to the control (cells stimulated with LPS alone), less inhibition was obtained than with the 
original honey stock. There were no significant differences between the honey types in 
modulatory effects on NO production by LPS-stimulated monocytes. 
The effect on nitrite production of incubating LPS-stimulated monocytes with either 1 % 
whole manuka honey, or fractions of this obtained from dialysis or an ether extract (at 
concentrations equivalent to 1 % honey) are shown in Figure 5.6. 
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Figure 5.6: The effect on nitrite production by LPS-stimulated THP- l monocytes, of an ether extract of 
manuka honey, compared with a high molecular weight fraction or the unfractionated stock. THP-l (I x 106 
cells/ml), were incubated with LPS (IO µg/ml) and either 1 % manuka honey, or fractions of this honey stock 
(retentate fractions of this honey obtained from dialysis or an ether extract) both at concentrations 
equivalent to I% honey. The cells were incubated for 18 h (37°C, 5% CO2, 95% air), prior to determination 
of the suspension nitrite levels using the Greiss reagent. Data is presented as a proportion of that from cells 
incubated with LPS alone (4.87 micromoles ± 0.36). Each point represents the mean for each treatment 
(conducted in triplicate). Differences between the means are indicated by superscript letters, where means 
not sharing common letters are significantly different (P<0.05). These means are derived from three 
independent experiments (n=9). 
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The modulatory activity present in the manuka honey stock solution was retained in the 
ether extract with similar levels of inhibition obtained with an ether extract at a 
concentration equivalent to 1 % natural honey as the honey source at 1 %. 
5.4 DISCUSSION 
The current study presents evidence that honey modulates, but does not completely 
inhibit, the production of NO by LPS-stimulated monocytes. LPS-stimulated monocytes 
were used to provide an inflammatory model in vitro of tissue macrophages. In Section 
5.1, it was noted that NO plays a crucial role in host defense but is cytotoxic and pro-
inflammatory at high concentrations. A tightly regulated cellular redox state is necessary 
for proper cell functioning. A number of in vivo studies have shown that iNOS inhibitors 
exacerbate infectious diseases (Evans et al., 1993; Chan et al., 1995), indicating that NO 
plays a crucial role in host defense. One of the key problems with glucocorticoid use is 
that they totally inhibit NO production, preventing the physiologically important actions 
of NO from being effected (Yokozawa et al., 2002) which in itself contributes to 
undesirable side-effects. Indeed, NO has an important role as an intercellular signal 
molecule, perpetuating inflammation through interactions with cytokines and growth 
factors, and therefore plays a key role in the tissue repair process (Wink and Mitchell, 
1998). Release of NO is an important part of the macrophage anti-bacterial repertoire, and 
has also been shown to be cytotoxic to both tumour cells and parasites, thus benefiting the 
host (Patel et al., 1999). Therefore, it is important that honey does not inhibit production 
of NO. 
There are two aspects of the effect of honey on NO production which need to be 
considered here. The first is the direct effect of honey on NO production by resting cells. 
In Chapter 3, incubation of whole blood with 0.25% manuka honey was shown to induce 
upregulation of iNOS mRNA beyond medium alone, but not to the same levels obtained 
with a mitogen. However, in the current study, incubation of THP-1 monocytes or PBMC 
with honey alone did not produce detectable levels of NO compared with medidm alone. 
This result is likely to be due to the lack of sensitivity of the Greiss assay with a lower 
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detection limit of 1.56 µM. Others have reported that honey directly activates the nitric 
oxide system resulting in low levels of NO production (Al-Waili, 2003; Al-Waili and 
Boni, 2003; Ali, 1997). Of further note, Al-Waili (2003) has reported that honey ingestion 
only had a slight inducing effect on NO levels in saliva. In addition, Al-Waili (2003) 
proposed that different honeys contain various concentrations of nitric oxide metabolites 
and that this may influence the capacity of honey types to activate tissue healing. The 
direct effect of honey on NO production by resting cells was not the focus of this chapter, 
however, this could be investigated further using western blotting and antibodies against 
iNOS protein. Further, it has been demonstrated that NF-1d3 is a transcription factor 
essential in regulation of iNOS expression after LPS-stimulation (Xie et al., 1994). 
Therefore, it would be useful to examine the expression of NF-1d3 in relation to iNOS 
expression and production of NO protein. 
The second point for consideration here is the base level of NO necessary to enable 
normal inflammatory processes to occur, and whether honey might reduce these to sub-
optimal levels. Clearly this is not what is observed anecdotally, where honey is 
consistently associated with enhanced tissue repair along with alleviation of inflammation 
(Molan, 1999; 1998). Critical levels of NO are required for angiogenesis, inflammation, 
cell proliferation, matrix deposition and remodelling, and specifically for the functioning 
of collagen and collagenase (Witte and Barbul, 2002). Diabetic wound healing 
impairment is one of the best-known chronic wound situations and is the result of sub-
optimal NO levels (Luo and Chen, 2005). Murrell (1997) reported that NO levels needed 
to increase 5-fold from base levels over the 7-day period following injury for a tendon to 
heal. Though not readily transferred to the inflammatory model in vitro, this would 
indicate that NO would need to be increased above base levels for the necessary 
inflammatory response to occur, and this is what is seen with honey. It has been 
established in the current study that LPS-stimulated monocytes exposed to honey still 
produce more NO than resting cultures in medium alone. 
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In view of the observed ability for honey to stimulate cytokine production (Chapters 3 
and 4) and the knowledge that cytokines interact with NO to stimulate immune function 
(Childress and Stechmiller, 2005; Rizk et al., 2004; Bansal and Ochoa, 2003; Bilsel et al., 
2000; Chen et al., 1998; Grimble, 1994; Ochoa et al., 1991; Marietta, 1988) the 
observation that honey alone has only a slight stimulatory effect on NO production 
compared with a mitogen at an optimal concentration is important. As honey has been 
shown to modulate the cytokine profile of immune cells, and therefore modulates activity 
within the inflammatory cascade, it could be speculated that honey might interfere with 
the induction of NO by immune cells. NO is induced primarily by activated immune cells, 
and the amount of NO produced is directly controlled by the activity of the NOS 
isoenzymes, their activity in tum controlled by the production of inflammatory cytokines 
(Liang et al., 2001; Jiang et al., 1998). 
Of particular relevance to wound healing, NO has been implicated in keloid scarring. 
Macrophages produce NO (Schaffer et al., 1997b) and NO stimulates fibroblasts to 
produce collagen (Schaffer et al., 1997a). Fibroblasts themselves produce NO leading to a 
self-amplification loop for collagen synthesis (Schaffer et al., 1997a). While NO is 
essential for neovascularisation (Lisids et al., 1997) and re-epithelialisation (Schaffer et 
al., 1997b), when produced at high levels it is thought to stimulate excessive collagen 
production by fibroblasts and result in keloid and hypertrophic scarring (Cobbold and 
Sherratt, 2000). The proven ability for honey to downregulate iNOS expression in an 
inflammatory model (Section 3.3) and to modulate NO production in an inflammatory 
model provides a mechanism by which honey reduces scarring in bum patients (as 
observed by Subrahmanyam, 1991). 
The total levels of NO obtained for the THP-1 monocyte cultures in the current study are 
low compared with other published investigations using murine macrophages (Mautino et 
al., 1994). This is likely to be a feature of the THP-1 cell line (Jagannath et al., 1998; 
Nathan and Hibbs, 1991). NO production by primary monocytes is known to vary widely 
among individuals (Mautino et al., 1994). Therefore, it is difficult to assign concentration 
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thresholds for NO production, but rather it is the change in kinetics that appears to be 
important. 
That subtle differences have been observed for osmotic tolerance and production of nitrite 
between the PBMCs and THP-1 cultures is reflective of their different population 
structures and origins. Unlike the THP-1 monocytic cell line which was of human origin 
and immortal, PBMCs were derived from bovine blood ex vivo, and contained a range of 
cell populations. It has been established that macrophages are key producers of NO (Jungi 
et al., 1996), and therefore the proportion of macrophages in culture will have significant 
effects on NO levels and thus, measurable nitrite. It is encouraging that honey modulated 
NO production by both LPS-stimulated PBMC and LPS-stimulated THP-1, indicating 
that the activity could potentially be realised in vivo. The investigations presented in the 
current study now need to be extended to in vivo models. 
The lack of substantial differences between the effects of the two honeys despite likely 
variation in the content of antioxidants, hydrogen peroxide and protein of each (Molan 
1992b) makes it difficult to speculate about the active component. Artificial honey was 
found to have no activity beyond medium alone, indicating that sugars alone could not 
account for modulatory effects. Trypan blue exclusion confirmed that cell death was not a 
major cause of the decrease in NO production. This suggests that LPS stimulation of the 
THP-1 cells does not affect cell sensitivity to the cytotoxic effects of honey. 
The neutralising effect of medium on the acidity of honey, and the resulting lack of 
differences in pH between the different honey solutions and medium alone, indicates that 
pH cannot be responsible for the observed differences. The current study has 
characterised the modulatory agent as being primarily of a high molecular weight, noting 
that some of the activity was lost during fractionation by dialysis. Further, it was 
demonstrated that the active component was present in an ether extract of manuka honey. 
In addition, it was observed that manuka honey still had significant modulatory effects on 
NO production by LPS-stimulated monocytes at a lower concentration than Otago 
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pasture honey (0.25% ). Drawing these observations together, it is clear that the 
modulatory component is present at a higher concentration in manuka honey. 
With reference to what is currently known about the composition of manuka honey 
(Section 1.3.1.5) it is likely that a higher content of proteins and/or antioxidants in 
manuka honey may account for having activity at lower concentrations. The nature of the 
active compound must therefore be both ether soluble and of high molecular weight. 
Honey is known to contain polyphenols bound to proteins (Gheldof et al., 2002). Phenols 
are characterised as anti-oxidant compounds due to their ability to scavenge peroxyl 
radicals and their ability to reduce and chelate ferric ion which catalyse lipid peroxidation 
(Yao et al., 2004; Gheldof et al., 2002). The possibility that tannins may bind iron and 
prevent formation of radicals and therefore modulate activation of NF-KB was introduced 
in Section 2.4.2.1. 
Ether extract has been characterised as a concentrated source of polyphenols and 
flavonoids (both antioxidants) and would also contain the aromatic groups present in 
honey (Arts et al., 2002). This knowledge raises the likelihood of antioxidant 
participation in the observed modulatory effects of honey on nitrite content. The ability of 
antioxidants to sequester metals and to trap radicals by their propensity for electron 
sharing is well understood (Grimble, 1994). The significance of this is that the presence 
of antioxidant species (such as the aromatic structures contained in honey) form electron 
bonds with peroxynitrite and this prevents the formation of free radicals. Chelation of 
ferric ion prevents the reaction of NO with transition metals to form damaging metal-NO 
adducts. Honey has been demonstrated to scavenge free radicals (Frankel et al., 1998). 
Confirmation that honey had no effect on nitrite standards indicates that honey must 
interfere with NO production by the cells rather than remove nitrite from the suspension 
medium. A number of studies have investigated the mechanisms by which various 
antioxidant drugs interfere with NO production by immune cells in vitro. There is 
overwhelming evidence that flavonoids inhibit the induction and activity of the NOS 
isoenzymes responsible for NO production from L-arginine (lelpo et al., 2000; Liang et 
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al., 2001; Heller et al., 1999; Jiang et al., 1998). In Section 3.3 it was shown that 
exposure of whole blood to honey prior to LPS leads to downregulation in iNOS mRNA 
expression, and this is evidence that honey interferes with enzymic production of NO. 
It is not currently known how antioxidants interact directly with NO, however in addition 
to their effect on NO production, antioxidants have been shown to stop the production of 
peroxynitrite by inhibiting superoxide generation through electron sharing with free 
radicals (Keaney et al., 1999). As described in Section 3.4.2, Yokozawa et al. (2002) 
reported that tannins inhibited iNOS mRNA and iNOS activity. Of particular relevance to 
the current study, Yokozawa et al. (2002), reported that very low concentrations of 
tannins were sufficient to suppress iNOS production. 
Uric acid is an endogenous antioxidant and has been shown to inhibit peroxynitrite-
related chemical reactions (Spitsin et al., 2002). Of relevance to the current study, Al-
Waili (2003) reported that honey increases the uric acid level in blood serum indicating 
that honey augments the antioxidant status of the body. 
Evidence from the current study that honey reduces NO production by LPS-stimulated 
monocytes is in accordance with anecdotal evidence that honey reduces inflammation and 
the production of free radical species (Tonks et al., 2001), on the basis that NO 
participates in the formation of peroxynitrite. There is evidence that NO contributes to the 
development of pathological conditions including the onset of insulin-dependent diabetes 
mellitus through generation of peroxynitrite, reported to induce apoptosis and DNA 
damage in a variety of cells (Patel et al., 1999; Inoue et al., 1993). The serious side-
effects associated with free radical tissue damage during the inflammatory phase of 
wound repair highlight the need for therapies which can modulate the content of oxidant 
products in the cellular environment (Grimble, 1994). This may be achieved by mopping 
up radicals and their intermediates in suspension through metal sequestration or trapping, 
or by regulating their release from cells via feedback inhibition (Bourdon et al., 1999; 
Grimble, 1994; Thomas, 1992; Zawadzki et al., 1991). Furthermore, the observation that 
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honey decreases NO production but does not totally stop its production means that it may 
reduce inflammation but will not prevent tissue repair. This raises the possibility that 
honey might modulate NO production in vivo. 
The results presented in the current study demonstrate a clear effect of honey on NO 
production by LPS-stimulated monocytes, thus providing a valuable contribution to an 
understanding of the mechanism by which honey is anti-inflammatory. The results of the 
investigations performed here suggest the possible therapeutic use of honey to alleviate 
tissue damage caused by persistent inflammation. It is premature to speculate about the 
targeted use of honey to reduce NO levels during inflammatory disease in the absence of 
in vivo testing. Considering the bigger picture, these results demonstrate that the role of 
antioxidants in honey justify further attention. 
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SUMMARY 
To investigate whether honey has an effect on phagocytosis, whole blood was 
incubated with honey and the ability of neutrophils to take up fluorescent-labelled 
bacteria was measured using the Phagotest® assay. The artificial honey control 
provided clear evidence that low concentrations of honey ( optimal at 0.25%) induce 
phagocytosis by neutrophils due to the supply of sugars. Manuka honey had an 
additional opsonizing effect on bacteria, which enhances the phagocytic response 
beyond that seen with sugars alone. 
Chapter Six Neutrophils 
6.1 INTRODUCTION 
Phagocytic leukocytes play a key role in the immune response to tissue damage 
functioning to remove foreign matter and damaged host tissue from the wound site. A 
common therapeutic use of honey is application to wounds (Molan, 2004), thereby 
creating a physiological environment where phagocytes are in contact with honey at 
the local wound site. With this interaction in mind, there is potential for honey to have 
an effect on phagocyte efficacy. The investigations described here measured the 
effects of honey on phagocytosis, when honey was applied in an in vitro model 
analogous to a fresh wound. 
The potential for honey to modify neutrophil behaviour has been investigated by 
Abuharfeil et al. (1999) who demonstrated that low concentrations of Jordanian 
wildflower honey led to a slight increase in phagocytosis of heat-killed bacteria. This 
published account, taken in conjunction with anecdotal reports that honey promotes 
both elimination of infectious agents from wounds and reduces the need for artificial 
debridement, presented strong justification to investigate the direct effect of honey on 
phagocytes. Phagocytes include polymorphonuclear cells and macrophages, with 
neutrophils constituting up to 70% of the total leukocyte population in blood 
(Benjamini et al., 1986). Therefore, due to their high density in blood, any impact on 
neutrophils could be expected to have profound effects on wound healing, and these 
specific phagocytes were selected for study. 
The inflammatory response increases vascular permeability, resulting in migration of 
neutrophils and monocytes into the surrounding tissue. Neutrophils are produced in 
the bone marrow and are released into the circulation in a terminally differentiated 
state (Benjamini et al., 1996). Once present in the blood, the neutrophils are ready to 
respond to any immune challenges. The neutrophils engulf debris and micro-
organisms, providing the first line of defense against infection. Neutrophil migration 
ceases after the first few days post-injury if the wound is not contaminated. If this 
acute inflammatory phase persists, due to wound hypoxia, infection, nutritional 
deficiencies (Brosche and Platt, 1995), medication use, or other factors related to the 
patient's immune response, it can interfere with the late inflammatory phase. 
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Neutrophils have a repertoire of mechanisms to effect host defence and clean up 
injured tissue sites, and the current study focuses on the role of neutrophils in wound 
healing. In order for wound healing to occur, neutrophils need to perform an essential 
tissue debridement role, removing dead and dying cells, and digesting both the fibrin 
mesh and clot (Lorena et al., 2002; Dierich et al., 1987). To enable tissue debridement 
to occur, fibrinolytic enzymes and lysosomal enzymes are produced by the neutrophils 
(Dierich et al., 1987; Benjamini et al., 1996). Neutrophils release cytokines, growth 
factors, and nitric oxide, and induce nearby keratinocytes to migrate across the 
wounded epithelium. In addition, neutrophils produce lymphokines which are 
chemotactic for lymphocytes (Benjamini et al., 1996). Further, the lactic acid 
produced as an end product of phagocytosis stimulates proliferation of fibroblasts in 
the proliferation phase of tissue repair which follows initial inflammation (Section 
1.5). 
There are several stages of phagocytosis, and these have been well characterised 
(Benjamini et al., 1996). Receptors on neutrophil cell membranes enable them to 
respond to gradients of chemicals released by various cells (chemotaxis), and this 
directs movement to sites of tissue injury. Once at the origin of the chemotactic factor, 
Fe receptors on the neutrophil enable them to adhere to micro-organisms via antibody 
interactions. Cellular debris and micro-organisms are taken into the cell by 
pseudopodia, enabling the lysosomal contents (a combination of chemicals including 
myeloperoxidase, hydrogen peroxide and chloride) to fuse with the phagosome and 
digest the contents (Benjamini et al., 1996). Macrophages are drawn to the site of 
tissue injury in response to myleoperoxidase released by neutrophils (Lefkowitz and 
Lefkowitz, 2001), themselves removing cellular debris including apoptotic neutrophils 
(Cox et al., 1995). 
In order to function efficiently neutrophils require an adequate supply of nutrients and 
oxygen (Taylor et al., 1992). Phagocytes consume oxygen during a respiratory burst 
and this is converted to hydrogen peroxide (Dierich et al., 1987). The possibility that 
topical application of honey to wounds may improve the supply of these substances to 
tissues has been suggested (Gupta et al., 1992). Importantly, disease states associated 
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with impaired or excessive wound healing can be attributed to defects in these 
responses. Two key examples of impaired wound healing where neutrophil 
populations are themselves known to be impaired occur in patients with diabetes 
mellitus (Pierce, 2001) and undergoing chemotherapy (Stark et al., 2005). The 
majority of the neutrophil population is stored within the bone marrow where a 
reservoir is maintained as a buffer against neutrophil depletion. The toxic action of the 
chemotherapeutic agents appears mainly in the myeloid lineage (neutrophils), leading 
to severe and sustained neutropenia (Stark et al., 2005). Diabetes has been shown to 
interfere with chemotaxis so that neutrophils cannot migrate into damaged tissues in 
adequate numbers (Pierce, 2001 ). Bums patients also exhibit poor wound healing, and 
it has been established that neutrophils present in the burned wound site do not ingest 
tissue debris and micro-organisms efficiently, interfering with tissue debridement 
(Kaufman et al., 1990; Crogan, 1976). 
Phagocyte activity is also known to be affected by the nutritional status of the host 
(Brosche and Platt, 1995; Taylor et al., 1992). One example for which overwhelming 
evidence exists, is that zinc deficiency can alter the chemotactic response of 
neutrophils, leading to reduced phagocytosis and an inability to debride the wound site 
(Taylor et al., 1992). These observations raise the possibility that including nutrient-
dense substances in the diet (e.g. honey) may have significant implications for 
phagocyte efficacy. 
To enable comparison with known potentiators of the phagocytic response, a range of 
substances were used to provide positive controls, and these are considered briefly 
here. Before they can engulf pathogens, neutrophils must first bind th~m. A range of 
priming agents such as TNF-a. and LPS are known to dramatically increase the 
phagocytic performance of leukocytes (Condliffe et al., 1998). TNF-a. has particular 
physiological relevance as an early activating signal, as it is released by mast cells 
upon damage to blood vessels (Wu et al., 1999), and regulates cellular adhesion 
molecules on a number of leukocytes including neutrophils (Lefkowitz and Lefkowitz, 
2001). Further, TNF-a. is released constitutively by mast cells upon injury, thus does 
not provide a model only relevant to an infected wound. The classical stimulating 
agents LPS and tMLP, derived from bacteria, were included on the basis of their 
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established ability to promote phagocytosis. LPS has been reported to induce 
significant levels of phagocytosis when neutrophils have been cultured in vitro (Zhao 
et al., 2003), and specifically for bovine neutrophils (Ducusin et al., 2001). The mode 
of action by which LPS activates neutrophils to take up particles is well understood. 
Diez-Fraile et al. (2002) have reported that the presence of LPS leads to upregulation 
of neutrophil surface receptors, specifically CD18 and CD1 lb, and it is the expression 
of these that enables the cells to bind to the particles. 
Formyl-methionyl-leucyl-phenylalanine (tMLP) is a low level physiological agonist, 
known to induce neutrophil accumulation in skin (Colditz and Movat, 1984). N-
Formyl peptides are derived from proteolytic breakdown of bacterial and 
mitochondrial proteins, and is associated with inflammation in the gut region (Nguyen 
and Pei, 2005). 
Finally, phorbol-12-mystritate-13,-acetate (PMA), a direct activator of protein kinase 
C was used to provide a high level stimulus for the intracellular signalling pathway 
(Benjamini et al., 1996). 
As blood flow slows near the infection site, neutrophil membrane sialic acid-
containing carbohydrate called sialyl Lewisx tether the neutrophils to the endothelium 
via the P- or E- selectins expressed on the endothelial surface. Neutrophils roll along 
the endothelial surface until chemokines (e.g. IL-8), complement C5a, and platelet-
activating factor (PAF) bind receptors on the neutrophil, and signal the neutrophil to 
express integrins (Simon and Green, 2005). Integrin activation and upregulation are 
separate processes and can be independently induced by separate stimuli. 
Upregulation does not necessarily imply an active adhesion molecule. To enter the 
inflamed/ injured tissues, neutrophils adhere to the vascular endothelial cell walls via 
their surface integrin receptors (Simon and Green, 2005). Neutrophil recruitment is 
directed by transendothelial gradients of IL-8, synthesised by the endothelium in 
response to exogeneous TNF-a. and IL-1 p, or from cells resident in the inflamed 
tissues and diffusing through the endothelium (Marshall et al., 2003). It has been 
shown that binding of IL-8, released by endothelial cells, is essential for neutrophil 
transendothelial migration as it binds the neutrophils to the endothelium (Marshall et 
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al., 2003). Further, plasminogen activator inhibitor-1 (PAI-1) released by platelets and 
endothelial cells stabilises IL-8 gradients to facilitate neutrophil recruitment (Marshall 
et al., 2003) and make the neutrophils more toxic. IL-8 exerts its chemoattractant 
function via binding with its cognate receptor CXCR2 (Zhou et al., 2005). VEGF 
(Vascular Endothelial Growth Factor) also plays an important role in the recruitment 
of neutrophils into tissues, being chemotactic and stimulates a rapid Mac-l(an 
inducible P2 integrin) expression as well as a LFA-1 expression so that the neutrophils 
bind with activated vascular endothelial cells (Garbacki et al., 2005). LFA-1 and Mac-
1 both enable neutrophils to interact with ICAM-land ICAM-2 expressed on 
endothelium, along with neutrophil expression of PECAM (Simon and Green, 2005). 
The integrins facilitate diapedesis through more tight bonding. Neutrophils then 
secrete proteolytic enzymes to penetrate the basement membrane. 
Recent evidence challenges the notion that neutrophils are terminally differentiated, 
short lived phagocytes, and infact perform diverse tasks including, phagocytosis, 
antigen presentation and immunoregulation (Zhou et al., 2005). This study aimed to 
extend the limited observations by Abuharfeil et al. (1999) that honey stimulates 
phagocytosis, by examining the effects of a range of honey concentrations and types 
on phagocyte activity. Further, this study aimed to characterise the active component 
in honey, and to use several different assay techniques to investigate the mechanism 
by which honey has been reported to induce phagocytosis. 
6.2 MATERIALS AND METHODS 
Reagents 
The Phagotest® diagnostic kit was purchased from Orpegen Pharma (Heidelberg, 
Germany). Phorbol myristate acetate (PMA), recombinant TNF-a and n-formyl-
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methionyl-leucyl-phenylalanine (fMLP) were purchased from Sigma Chemical Co., 
(St. Louis, MO). Giemsa stain and LPS were obtained from Sigma-Aldrich (UK). 
Honey solutions 
M109 manuka honey, Otago pasture honey and artificial honey were freshly prepared 
as described in Section 2.2.2. Unless otherwise stated, honey stocks were diluted in 
RPMI 1640 basal medium (GibcoBRL) to create v/v solutions. Dialysis fractions at 
concentrations equivalent to that found in manuka honey (0.25%) were prepared as 
described in Section 2.2.2.1, and diluted in RPMI 1640 basal medium. 
6.2.1 Blood collection 
Bovine blood was collected into 50 ml Nunc tubes containing heparin solution (5 
IU/ml) from the jugular vein of a freshly slaughtered heifer at the AgResearch 
abbatoir. Whole blood was used for the Phagotest® assays. 
6.2.2 Measurement of phagocytosis 
A commercial Phagotest® kit was purchased to measure phagocytosis. The proportion 
of neutrophils which had ingested bacteria was obtained, and 2hagocyte efficiency 
was calculated based on the number of bacteria ingested per cell (as described by 
Wimmer et al., 2004; Gastaldello et al., 2000; Carulli et al., 1998). The Phagotest® 
assays were performed according to the manufacturer's instructions (Orpegen 
Pharma). 
Heparinised whole blood was transferred in 100 µl volumes to 12 x 75 mm tubes. All 
assays were performed within an hour of receiving the blood. After the blood had 
been incubated (37°C, 5% CO2, 95% air) with 10 µl of either; various treatments 
(honey, artificial honey, LPS) or RPMI basal medium, all tubes were placed on ice for 
10 min to cool them down. Each tube then received 20 µl of pre-cooled Fluorescein 
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isothiocyanate labelled (ATC)-£. coli at a concentration of 109 cells/ml (ratio of 
bacteria:leukocytes was 25: 1). The tubes were vortexed at low speed for 3 secs, and 
then the samples were placed in a shaking waterbath (Julabo, Labortechnik GMBH, 
Germany) for 10 min at 37°C, and agitated constantly at 120 rpm to allow 
phagocytosis. Duplicate baseline control tubes were prepared for each treatment, with 
identical preparation to the corresponding treatment samples, but were placed on ice 
(0°C) just prior to addition of bacteria, and were maintained on ice during the assay 
period. All treatments were conducted in triplicate. At the end of the incubation 
period, samples were placed on ice to stop phagocytosis. To each tube (samples and 
controls), 100 µ1 of ice-cold quenching solution was added, and each tube gently 
vortexed. The tube contents were each washed twice with 3 ml of washing solution 
(centrifuged at 250 x g for 5 min at 4°C). To each tube, 2 ml of lysing solution was 
added (pre-warmed to room temperature), and the tube contents vortexed. After a 20 
min incubation at room temperature, the tubes were centrifuged (250 x g for 5 min at 
4 °C). Finally the samples were washed twice (3 ml washing solution followed by 
centrifugation at 250 x g for 5 min at 4 °C), and 100 µI of propidium iodide was added 
for 10 min at 0°C to stain the DNA. 
6.2.2.1 Preparation of counting slides and counting procedure 
To analyse phagocytosis, 100 µl of stained blood was transferred from individual 
tubes to a haemocytometer. For each· haemocytometer count, the total number of 
neutrophils present in 5 squares from the centre set of 25 squares was obtained 
according to standard methods. The counts were performed within an hour after the 
staining procedure, protecting the blood from light at all times. 
Using the same 5 squares, 3-6 visual fields were scanned under 400 x magnification, 
and 100 neutrophils randomly chosen for examination (Leica TCS-NT 
Epifluorescence with a blue filter block; BA 520; excitation of 465-495 nm). The 
number of neutrophils with engulfed bacteria and/or adherent bacteria were expressed 
as a proportion of total neutrophils. Phase-contrast in bright field was used where 
necessary to clarify visual counts. 
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The quenching solution enabled the discrimination of attached and internalised 
bacteria, by suppressing the fluorescent green colour of the adherent bacteria and not 
the colour of internalised bacteria. The propidium iodide stain enabled discrimination 
of leukocyte nuclei from bacterial aggregates, and from each other based on the 
morphology of the nuclei . Where bacteria were both attached to the cell surface and 
engulfed, the cell was placed in the 'engulfed' category. Cells with bacteria attached 
to the surface or engulfed bacteria were both defined as phagocytosing neutrophils. 
Figure 6.1: Position of fluorescent beads in a bovine blood-derived neutrophil (from preliminary 
assays). Use of quenching solution, and phase-contrast under bright field microscopy (400 x), enabled 
discrimination between attachment and internalisation of bacteria. 
6.2.3 Statistical analysis 
All tests were performed using triplicate samples and repeated at least twice (n=6 
independent observations). The mean % values obtained for the duplicate baseline 
control tubes (maintained on ice throughout the assay period), were subtracted from 
the corresponding treatment means. A two-way analysis of variance (ANOV A) was 
used to test the significance of the phagocytosis curve, with the parameters, timepoint 
and activating agent. Significant effects were further analysed using Tukey's honestly 
significant difference for pair-wise differences for within group comparisons. The 
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paired student's t-test was used to compare the effects of different activating 
substances on phagocytosis with the effects of RPMI basal medium alone. For 
multiple group comparisons, the data were subjected to one-way analysis of variance 
(ANOV A) to determine overall difference between the group means. Significance was 
accepted for P<0.05. Systat software version 7.0 (SPSS Inc.) was used for all 
analyses. 
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6.3 EXPERIMENTAL DESIGN 
6.3.1 Preliminary experiments 
Preliminary experiments were conducted to optimise conditions. Initially neutrophils 
were isolated from bovine blood, and flow cytometry was used to measure the uptake 
of ATC-labelled beads. However, the difficulties associated with preparation of the 
purified neutrophil suspensions, requirement for optimised serum content and 
opsonization of beads, and lack of physiological relevance of the purified cell 
suspensions to the wound in vivo meant that the earlier assays were abandoned. 
The decision to use a microscope and count neutrophils in a blood smear necessitated 
time spent optimising counting procedures. Initially the precision with which 
neutrophils could be recognised using the Phagotest® assay was determined from 
counts obtained by haemocytometry (propidium iodide-stained cells) and from 
standard slides (Giemsa-stained cells). 
6.3.1.1 Calculation of average neutrophil numbers in a bovine blood smear and 
precision of counting 
According to the Phagotest® assay protocol, only leukocytes were present in the 
counting slides (as red blood cells were lysed and removed). To prepare Giemsa-
stained slides, after lysing the blood cells (Section 6.2.2), the cell pellet was 
resuspended in 200 µl of PBS, and 10 µl of the suspension smeared across a standard 
microscope slide. The remaining suspension was stained with propidium iodide, for 
haemocytometer counts. Standard procedures were then followed for preparation of 
methanol-fixed Giemsa stained slides. Briefly, the smear was fixed in absolute methyl 
alcohol for 5 min, and coloured with Giemsa stain (20 min) according to the 
manufacturer's instructions (Sigma-Aldrich). The number of neutrophils was counted 
among a total of 100 cells on each slide (Nikon Eclipse TS 100) using 3 visual fields 
under 400 x magnification. These counts were compared with those obtained from 
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haemocytometry (Section 6.2.2.1 ). The morphology of leukocyte nuclei was checked 
against a reference guide (Wheater et al., 1987). 
For the counting precision tests, slides were prepared from five different tubes of 
bovine blood (all obtained from the same animal). Each tube of blood was subsampled 
for haemocytometry and the Giemsa-stained slide counts. The average number of 
neutrophils per 100 cells was 59 ± 4. In addition, these results indicated that a 
minimum of 3 visual fields would need to be viewed to obtain 100 neutrophils for 
counting. In order to ensure that all counts were representative of treatment 
differences, two slides were prepared from each tube of blood, and the average of the 
two readings used in the statistical analysis. The number of neutrophils obtained from 
each count were found to be comparable. This indicated that staining nuclei with 
propidium iodide could be used reliably to discriminate between leukocytes, based on 
the morphology of their nuclei. 
6.3.1.2 Optimising the positive controls 
Positive controls were included to provide a baseline for differences in the activity of 
resting cells compared with primed cells. Positive controls were chosen according to 
published reports, and included LPS, fMLP, PMA, or recombinant TNF-a. (Table 6.1). 
To optimise the response of phagocytes to activation by the positive controls, a series 
of assays were conducted based on the conditions described by published reports 
(Zhao et al., 2003; Rivas et al., 2002; Ducusin et al., 2001; Crowley and Raffin, 
1991 ), and are not shown here. 
Incubation period with positive controls 
One hundred microlitres of heparinised blood was loaded into 12 x 75 mm tubes, and 
either fMLP, LPS, PMA or TNF-a. at the stated final concentrations, were added as 
summarised in Table 6.1. To triplicate blood samples, a 10 µl volume of a single 
activating agent or RPMI basal medium alone was added to each tube, and two further 
tubes also prepared to act as baseline controls. After the blood had been incubated 
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(37°C, 5% CO2, 95% air) for the indicated times (0--30 min), bacteria were added 
according to the Phagotest® assay protocol, first placing the baseline control tubes on 
ice. The baseline controls were maintained on ice throughout the assay period, and the 
mean values obtained from these controls were subtracted from the corresponding 
treatment samples. The proportion of neutrophils which had taken up bacteria by 
phagocytosis (out of total neutrophils) were calculated (described in Section 6.2.2) 
and means for each time-period (conducted in triplicate) were compared (Figure 6.2). 
Table 6.1: Priming regimes for positive controls 
Primary Cone. Incubation Secondary Incubation Reference 
stimulant time (min) stimulant time (min) 
TNF-a. 10 ng/ml 0--30 NIL 0 O'Flaherty et al., 1991 
TNF-a. 10 ng/ml 0--15 fMLP 15 Heine et al., 2000; 
(0.01 Crowley and Raffin, 1991 
mmol) 
LPS 10 ng/ml 0--30 NIL 0 Ducusin et al., 2001 
LPS 10 ng/ml 0-15 fMLP 15 De Leo et al., 1998 
(0.01 
mmol) 
fl.MP 100 ng/ 0--30 NIL 0 Zhao et al., 2003 
ml 
PMA 10 ng/ml 0-30 NIL 0 Zhao et al., 2003; 
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Figure 6.2: Effects of different priming agents on the phagocytosis of fluorescent-labelled bacteria by 
bovine neutrophils. A. Effect of length of incubation with either; fMLP (100 ng/ml), TNF-a (10 ng/ml) , 
LPS (10 ng/ml), on the % neutrophils taking up bacteria compared with the effects of RPMI basal 
medium alone. * P<0.05, for each timepoint, means not sharing * are significantly different from each 
other. Data are expressed as the mean ± SEM of 2 independent experiments, conducted in triplicate; 
n=6). B. Effect of different activating agents; LPS alone (lO ng/ml), LPS (10 ng/ml) for 15 min prior to 
addition of fMLP (100 ng/ml) for 15 min, TNF-a alone (lO ng/ml), or TNF-a (10 ng/ml) for 15 min 
prior to addition of fMLP (100 ng/ml) on % neutrophils taking up bacteria. * P<0.05, means not sharing 
* are not significantly different from each other. Data are expressed as the mean ± SEM of 2 
independent experiments, conducted in triplicate; n=6) . 
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Priming blood with either LPS alone, LPS for 15 min followed by 15 min incubation 
with tMLP, PMA, or TNF-cx. prior to tMLP, induced a maximal phagocytic response. 
TNF-cx. alone, induced a lower uptake of beads than the other priming agents over the 
assay period. These results indicated that priming blood for 30 min was sufficient to 
produce significant differences in the proportion of phagocytising neutrophils between 
resting and treated blood cultures. In addition, these results confirmed that while TNF-
cx. alone induced significant neutrophil activity compared with the control, the 
presence of bacterial peptides potentiated a stronger response. 
6.3.1.3 Viability of leukocytes following incubation with honey 
To ensure that the honey solutions did not have detrimental effects on neutrophil 
viability, blood was incubated with various concentrations of honey for 30 min prior 
to trypan blue staining. Briefly, 100 µI of heparinised bovine blood was loaded into a 
12 x 75 mm tube along with 10 µI of a serially diluted honey solution (manuka, Otago 
pasture or artificial, to obtain final concentrations 0.1-1% v/v) and incubated (37°C, 
5% CO2, 95% air), for 30 min. Blood with 10 µI RPMI basal medium was included as 
a control. According to the methods described by Gorman et al. ( 1997), an equal 
volume of typan blue was added to each tube and the contents incubated for 1 min at 
37°C. Using haemocytometry under bright field (Olympus, 40 X), the proportion of 
viable leukocytes was established by observing 100 leukocytes in 3-6 fields of view. 
The effect on cell viability of exposing leukocytes lo honey concentrations are 
presented in Figure 6.3. 
Honey at concentrations between 0.1--0.5% (v/v), of all three types, had no effect on 
leukocyte viability. Earlier assays had established that neutrophils constituted an 
average of 59 ± 4% of total leukocytes in a typical bovine blood sample. At the 1 % 
concentration there was a significant decrease in cell viability with all honeys 
indicating that sugars were causing osmotic stress. Based on these results, assays were 
restricted to testing honey concentrations within the established osmotic tolerance 









GI 50 ·; 





0 0.1 0.25 0.5 
Honey concentration (%) 
a control 
•manuka 
D Otago pasture 
• artif ic ial 
Neutrophils 
Figure 6.3: The effect of honey concentration on leukocyte viability. Bovine blood was incubated with 
and without honeys (manuka, Otago pasture or artificial) at various final concentrations (0.1-1 % ) for . 
30 min and assessed for viability using trypan blue staining. Data points represent the mean of triplicate 
counts± SEM and the assay was replicated twice (n=6). Each mean% was compared with the mean of 
the blood control (RPMI basal medium alone). * P<0.05 , where means not sharing * are significantly 
different from each other. 
6.3.2 Evaluation of the direct etTect of honey on neutrophils 
To detennine whether honey has a direct effect on phagocytosis by neutrophils, blood 
was incubated with honey concentrations prior to addition of bacteria. 
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6.3.2.1 Identification of honey concentrations with an activating effect on uptake of 
bacteria by neutrophils 
Blood was dispensed into triplicate tubes, following the protocol described in Section 
6.2.2. Honeys (artificial, manuka or Otago pasture) were added in a 10 µl volume to 
give final concentrations of 0.025-0.5% (v/v). Blood incubated with 10 µl of RPMI 
basal medium was included as a control. The proportion of neutrophils which had 
taken up bacteria (out of total neutrophils) was calculated (Section 6.2.2). 
6.3.2.2 Comparison of the activating effect of manuka honey stock and dialysed 
fractions at concentrations equivalent to 0.25% on uptake of bacteria by neutrophils 
To characterise the stimulatory component in honey, blood was incubated with 0.25% 
concentrations of honeys (Section 6.3.2.1), in addition to dialysed manuka honey 
retentate (with sugars removed, at a concentration equivalent to 0.25%). The 
proportion of neutrophils which had taken up bacteria (out of total neutrophils) was 
calculated (Section 6.2.2). 
To exclude the possibility that endotoxin contamination could account for the 
additional stimulation seen with honey (beyond sugars alone), a contamination assay 
was run. Both honey solutions and LPS solutions (10 ng/ml) were incubated with 
polymyxin B (PMB; Sigma), at a concentration of 10 µg/ml (37°C, 5% CO2, 95% air) 
for 60 min prior to adding to blood. As before, blood was loaded in triplicate tubes 
and incubated with 10 µ1 volumes of either; PMB treated honey, untreated honey, or 
PMB treated LPS for 30 min prior to conducting the assay (as described in Section 
6.2.2.). Blood incubated with either RPMI basal medium, or untreated honey, was 
maintained under the same conditions and were included as controls. 
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6.3.2.3 Investigation to determine whether priming blood with both honey and TNF-
a would augment phagocytosis 
The aim of the current study was to determine whether honey would have effects on 
aspects of cell function pertinent to tissue repair. When honey is applied to a fresh 
wound, it will be present at the same time as TNF-a, released initially by mast cells 
(Wu et al., 1999). This assay was performed to determine whether honey would 
augment the activating effect of TNF-a on phagocytes. The possibility that honey 
might augment phagocytosis was based on the observations by Condliffe et al. (1998), 
that neutrophils show an enhanced response when several agents act in concert. 
Recombinant TNF-a (10 ng/ml) and diluted manuka honey (to obtain a final 
concentration of 0.25%) were added to blood in triplicate tubes, according to two 
regimes; TNF-cx. alone for 15 min followed by honey, or honey and TNF-a added at 
the same time. By adding the TNF-cx. prior to the honey, this was simulating the 
release of TNF-a by mast cells at the site of a fresh wound. The protocol was then 
followed as described in Section 6.2.2. 
6.3.3 Evaluating the effect of honey on opsonization of bacteria 
These assays were designed to measure the indirect effect of honey solutions on 
neutrophil activity. Opsonizing beads and bacteria by pre-coating them with various 
agents has been demonstrated to have significant effects on their uptake by phagocytes 
(de la Fuente et al., 1998; Volle et al., 2000; Ducusin et al., 2003). By priming the 
bacteria with honey prior to adding the bacteria to blood, the effect of honey on the 
opsonization of bacteria could be measured. Nonopsonized bacteria (with FITC-label) 
were used instead of opsonized bacteria (at the same ratio as described in Section 
6.2.2). Bacteria opsonized with 1 % BSA were included as a positive control (as 
described by Ducusin et al. 2003). 
6.3.3.l Measuring the effect of honey on the opsonization of bacteria with BSA 
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Opsonization of the bacteria was adapted from the methods described by Nagata et al. 
2003 and Volle et al. 2000. The E. coli bacteria were added to either: 1 ml of 
phosphate-buffered saline (containing 1 % BSA), 1 ml of phosphate-buffered saline 
alone (providing the non-opsonized control), or 1 ml of honey (artificial or manuka at 
0.25% ), giving a final concentration of 1 x 109 bacteria/ml (according to the 
manufacturer's instructions; Phagotest, Orpegen Pharma), and incubated at 37°C for 
60 min prior to assay use. The blood received no treatments prior to the opsonized 
bacteria, and the phagocytosis assay was performed according to the protocol 
described in Section 6.2.2. 
Though phagocytes would have been exposed to honey when the bacterial suspension 
was added to the tubes, the resulting hundred-fold dilution meant that the honey was 
at concentrations shown previously to have no effect (0.025%; Figure 6.3). 
6.4 RESULTS 
The proportion of neutrophils in blood, which had taken up bacteria by phagocytosis 
after priming with honeys (manuka, Otago pasture or artificial) at various final 
concentrations (0.025-0.5%) were examined. The results are presented in Figure 6. 4, 
and show the proportion of phagocytosing neutrophils as a proportion of total 
neutrophils. 
All the honeys tested stimulated significantly more phagocytosis by neutrophils at 
final concentrations between 0.1-0.5% than obtained with RPMI basal medium alone. 
There were no differences between the effect of Otago pasture honey and artificial 
honey on the cells, indicating that the observed effects were due to sugars alone. At a 
0.25% concentration, however, manuka honey had an optimum effect on 
phagocytosis, not seen with the other honeys. This cannot be accounted for by sugars 
alone. At a 0.5% concentration, manuka honey had no activity beyond artificial honey 
at the same concentration. 
Since 0.25% honey showed a stimulatory effect on phagocytosis, a contamination 
control experiment was undertaken adding PMB, which prevents LPS binding to its 
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receptor. While the stimulating effect of LPS on phagocytosis was completely 
inhibited by the addition of PMB, there was no effect on the amount of phagocytosis 
induced by honey. This indicates that the stimulatory effect of honeys on neutrophils 
cannot be attributed to endotoxin content (Figure 6.5). 
To determine how the levels of phagocytosis stimulated by the honeys compared with 
known priming agents (using TNF-a-fMLP as a model for an infected wound, and 
TNF-a alone to simulate inflammatory signals from injured tissues), the number of 
neutrophils taking up bacteria were calculated as a proportion of total neutrophils for 
each treatment. Blood was either primed with TNF-a (10 ng/ml; 15 min) followed by 
fMLP (100 ng/ml; 15 min), TNF-a (10 ng/ml; 30 min) or an optimal concentration of 
each honey (diluted to a final concentration of 0.25%; 30 min) and compared with 
resting blood (Figure 6.6). 
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Figure 6.4: Effects of different honey concentrations on the phagocytosis of fluorescent bacteria by 
bovine neutrophils. Blood was incubated with and without honeys (manuka, Otago pasture or artificial) 
at various final concentrations (0.025-0.5%), prior to addition of bacteria. A Phagocytosis assay was 
conducted and the proportion of neutrophils taking up bacteria calculated. At each concentration, the 
paired student's t-test was used to compare the mean % neutrophils taking up bacteria in blood 
exposed to honey compared with the control (RPMI basal medium) (* P<0.05 , data are expressed as the 
mean ± SEM of 2 independent experiments, conducted in triplicate; n=6). 
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Figure 6.5: Control experiments to investigate the role of endotoxin in the honey-stimulated 
phagocytosis of fluorescent bacteria by bovine neutrophils. Both manuka honey (giving a final 
concentration of 0.25%) and LPS (10 ng/rnl) were incubated with polymyxin B (10 µg/rnl , 37°C, 5% 
CO2, 95% air) for 60 min prior to adding to blood, and the samples incubated for 30 min (37°C, 5% 
CO2, 95% air) prior to addition of bacteria. Blood incubated with RPMI basal medium prior to addition 
of bacteria was included as a control. A Phagocytosis assay was conducted and the proportion of 
neutrophils taking up bacteria calculated. At each concentration, the paired student's t-test was used to 
compare the mean % neutrophils taking up bacteria in blood exposed to honey compared with the 
control (RPMI basal medium) (* P<0.05, data are expressed as the mean ± SEM of 2 independent 
experiments, conducted in triplicate; n=6). 
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Figure 6.6: Effects of honey compared with TNF-a on the phagocytosis of fluorescent bacteria by 
bovine neutrophils. Blood was incubated with and without either: TNF-a (10 ng/rnl; 15 min) followed 
by fMLP (100 ng/ml), TNF-a (10 ng/ml; 30 min), or honey diluted to obtain an optimal final 
concentration (artificial, manuka or Otago pasture 0.25%; 30 min), prior to addition of bacteria. Each 
mean was compared with the control (blood with RPMI basal medium). * P<0.05, data are expressed as 
the mean ± SEM of 2 independent experiments, conducted in triplicate; n=6. 
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Priming blood with TNF-cx.-fMLP had a maximal effect on the proportion of 
neutrophils undergoing phagocytosis (96.3% ± 3.1 % ). TNF-cx. alone had a similar 
stimulatory effect on the proportion of neutrophils taking up bacteria to manuka honey 
at a final concentration of 0.25%. Both artificial honey and Otago pasture honey (at 
final concentrations of 0.25%) induced a higher proportion of neutrophils to take up 
bacteria than seen when RPMI medium was added to blood, but this activating effect 
was lower than that obtained with manuka honey at the same concentration. 
To characterise the active component in manuka honey (at the optimal concentration, 
0.25% ), which could not be accounted for by sugar content alone, blood was primed 
with fractions of manuka honey obtained from dialysis. Dialysis removed sugars from 
the high molecular weight fraction of honey. Blood was primed with manuka honey 
stock, dialysed fractions of the same manuka honey (at final concentrations equivalent 
to 0.25% honey), and compared with artificial honey as a control for sugar content 
alone. As before, the number of neutrophils taking up bacteria was calculated as a 
proportion of total neutrophils for each treatment (Figure 6.7). 
Both manuka honey stock, and both fractions of this stock, had stimulatory activity on 
phagocytosis beyond that obtained when RPMI medium was added to blood. There 
was no significant difference in the uptake of bacteria when blood was primed with 
fractions of manuka honey or artificial honey. Only manuka honey stock had a 
significant stimulatory effect beyond that seen with an equivalent concentration of 
artificial honey. As the retentate fraction had sugars removed by dialysis, these results 
must indicate that some high molecular weight compound in honey has an activating 
effect on neutrophils (Figure 6.7). When present together, the high molecular weight 
compound augments the stimulation induced by the sugars. The high molecular 
weight fraction of Otago pasture honey at an equivalent final concentration (0.25%), 
had no stimulatory effect on phagocytosis beyond RPMI basal medium. This indicates 
that the non-sugar stimulatory component, is likely to be unique to manuka honey. 
The possibility that honey was merely sticky, and that bacteria were non specifically 
binding to the cell surface but not being taken up, was addressed by examining 
location of the bacteria. TNF-cx. alone was included as a positive control for 
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comparison with honey as it had previously been shown to induce a similar level of 
activation. Blood was primed with and without TNF-a., manuka honey or artificial 
honey (both at 0.25% final concentrations), and the proportion of neutrophils with 
adherent or engulfed bacteria calculated (Figure 6.8). 
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Figure 6. 7: Effects of sugar content on the phagocytosis of fluorescent bacteria by bovine neutrophils. 
Blood was primed with or without either: manuka honey (stock and dialysed fractions of the stock at 
final concentrations equivalent to 0.25% honey), a high molecular weight fraction of Otago pasture 
honey (0.25%), or artificial honey (0.25%) prior to addition of bacteria. A Phagocytosis assay was 
conducted and the proportion of neutrophils taking up bacteria calculated. Each mean was compared 
with that obtained for artificial honey and for RPMI basal medium. * P<0.05, data are expressed as the 
mean ± SEM of 2 independent experiments, conducted in triplicate; n=6. 
Despite the likelihood that these agents have different stimulatory mechanisms, the 
proportion of adherent and engulfed bacteria were similar when blood was primed 
with either TNF-a., manuka honey or artificial honey. There were significantly more 
engulfed bacteria when blood was exposed to the priming treatments than to RPMI 
basal medium alone, and the control had more bacteria adhered to the neutrophil 
surface than bacteria actually engulfed. 
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Figure 6.8: Effects of honeys compared with TNF-a. on the proportion of adherent versus engulfed 
bacteria in neutrophils from bovine blood cultures. Blood was incubated with and without TNF-a. (10 
ng/ml; 30 min) or honey diluted to obtain optimal final concentrations (artificial or manuka; 0.25%; 30 
min), prior to addition of bacteria. A phagocytosis assay was conducted and the number of neutrophils 
with adherent bacteria compared with engulfed bacteria were calculated as a proportion of total 
neutrophils taking up bacteria. Means for each treatment were compared with that obtained for the 
control (blood with RPMI basal medium), separately for adherent versus engulfed means. * P<0.05, 
data are expressed as the mean± SEM of 2 independent experiments, conducted in triplicate; n=6. 
To test the possibility that honey might augment the stimulatory effect of TNF-a on 
phagocytosis, blood was primed with either TNF-a for 15 min followed by addition of 
honey for 15 min (as a model for application of honey to a wound after TNF-a 
signalling by local cells had begun), or with TNF-a and honey added at the same time 
(as a model for honey added immediately following surgery). The activating effect 
was compared with TNF-a alone. The number of neutrophils taking up bacteria was 
calculated as a proportion of total neutrophils for each treatment. Honey did not 
augment the TNF-a stimulus when added at the same time as TNF-a, or following 
prior incubation of the blood with TNF-a (null result, data not shown). These results 
indicate that when TNF-a is present in blood cultures in vitro, it has a maximal effect 
on neutrophil activity which honey cannot modulate. However, of prime importance 
here, honey did not exacerbate the stimulatory effect of exogenous TNF-a on 
neutrophils in vitro. 
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A further possibility to be tested was that honey may opsonize bacteria, and that this 
could account for the additional stimulation observed for blood primed with manuka 
honey (at a final concentration of 0.25%). Nonopsonized bacteria were primed with 
and without 1 % BSA or 0.25% honeys (artificial or manuka), and the number of 
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Figure 6.9: Effects of opsonizing bacteria with honey compared with I% BSA on the phagocytosis of 
bacteria by bovine neutrophils. Bacteria were incubated with phosphate-buffered saline +/- I% BSA or 
0.25% concentrations of artificial or manuka honeys for 60 min (37°C, 5% CO2, 95% air) prior to 
addition to blood cultures. A phagocytosis assay was conducted, and the number of neutrophils taking 
up beads were calculated as a proportion of total neutrophils. Each mean was compared with that 
obtained for the control (blood with non-opsonized beads). * P<0.05, data are expressed as the mean± 
SEM of 2 independent experiments, conducted in triplicate; n=6. 
The proportion of neutrophils taking up bacteria was significantly higher when 
bacteria were incubated with either: manuka honey, a high molecular weight fraction 
of manuka honey (both at 0.25% ), or phosphate-buffered saline containing 1 % BSA, 
prior to conducting a Phagocytosis assay than with phosphate-buffered saline alone. 
Incubation of bacteria with artificial honey had no effect on phagocytosis beyond 
phosphate-buffered saline alone. This result indicates that sugars alone cannot account 
for the opsonizing effect observed for bacteria incubated with manuka honey. That 
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bacteria opsonized with a high molecular weight fraction of manuka honey (with 
sugars removed), induced similar levels of bacteria uptake to the manuka stock, 
indicates the component acting as an "opsonin" must be of a high molecular weight. It 
was observed that background levels of phagocytosis were lowered when non-
opsonized bacteria were used in a Phagocytosis assay (compared with Figures 6.2, 
6.4-6.8). Though stimulating uptake of bacteria beyond the control, opsonizing 
bacteria with manuka honey did not induce the same levels of phagocytosis as had 
been seen when neutrophils were exposed to equivalent concentrations of manuka 
honey prior to conducting an assay with BSA-opsonized bacteria (Figures 6.4-6.8). 
Further, these results suggest that the additional stimulation of phagocytosis observed 
for manuka honey-primed blood (Figures 6.4-6.9), may be due to some opsonization 
effect on bacteria. 
6.5 DISCUSSION 
The prime objective of the current study was to model in vitro, the physiological 
environment which is created when honey is applied to a fresh wound site, and to 
investigate whether honey has an effect on phagocytosis. While limited studies had 
demonstrated that 0.1 % honey could stimulate low levels of phagocytosis (Abuharfeil 
et al., 1999), this was the first to investigate the mechanisms by which honey has this 
stimulatory effect. 
The current study provides clear evidence that low concentrations of honey (optimal at 
0.25%) induce phagocytosis by neutrophils due to the supply of sugars. The increased 
availability of sugars to the phagocytes gained by adding low concentrations of honey 
to cell suspensions increases cell activity. These conclusions fit well with the 
observations by others (Abuharfeil et al., 1999; Efem, 1988). While there is 
substantial evidence that low levels of sugars activate the respiratory burst of 
macrophages (Gelderman et al., 1998; Lefkowitz et al., 1997 and Lincoln et al., 1997) 
and neutrophils (Cohn and Morse, 1960), it has been established that neutrophil 
functions are rapidly downregulated once an optimal dose of sugars is exceeded 
(Candlish, 1993). It was noted that the stimulatory effects of sugars in the current 
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study were minimal compared with the positive controls. The assays described in the 
current study were conducted under ideal culture conditions, and sugars were unlikely 
to be lacking. This may mean that there is potential scope for greater stimulatory 
effects to be obtained when the cellular environment is suboptimal (i.e. during 
illness). 
It was noted, as has been reported by others (Ducusin et al., 2001), that there is a high 
background level of phagocytosis in blood when no priming agent is present (Figures 
6.2, 6.4-6.9). A key observation in this study was that when blood is primed with 
some potentiating agent, the proportion of engulfed bacteria increases in relation to 
the proportion of bacteria merely adhered to the cell surface. This must indicate that 
the priming agent is stimulating the neutrophils to actively ingest bacteria, and 
therefore induces phagocytosis at levels beyond the background activity, which fits 
with numerous reports by others (Ducusin et al., 2001; Cohen et al., 2001; Heller et 
al., 2001; Benjamini et al., 1996). The observation that similar proportions of bacteria 
adhered to the neutrophil surface as were ingested by neutrophils, regardless of the 
priming stimulus, suggests that once initiated phagocytosis is an all-or-nothing 
response. In this study, the potential for honey to play a role in the chemotactic 
response of neutrophils to bacteria was not investigated, as it was assumed that the 
high ratio of bacteria:cells adopted (according to the Phagotest® protocol) was such 
that neutrophils would not need to seek out bacteria. Based on the demonstrated 
ability for honey to activate phagocytosis in vitro, it is suggested that a series of 
investigations could be designed to test whether honey affects chemotaxis, though this 
was beyond the scope of the objectives stated in this study. 
At an optimal concentration (0.25% ), manuka honey induces a similar level of 
phagocytosis as exogeneously applied TNF-a, an artificial model for one of the first 
mediators released at the site of tissue injury. In thermal injury, TNF-a release is 
often compromised by damaged tissues (Kaufman et al., 1990; Crogan, 1976), and 
this directly contributes to the low numbers of neutrophils present in burnt tissues. 
Inadequate numbers of phagocytes lead to impaired debridement and defense 
functions (Kaufman et al., 1990; Crogan, 1976), and consequently, tissue repair. 
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These results suggest a mechanism by which honey may have a place in treatment of 
burns, and help to explain what is observed anecdotally (Subrahmanyam, 1991). 
The observation that manuka honey at an optimal concentration (0.25%) had no 
additional activating effect on neutrophils beyond TNF-a is itself a useful 
observation. While induction of phagocytosis by a stimulus is a necessary response, 
high levels of neutrophil activity have been associated with tissue damage due to the 
production of free radical species (Flohe et al., 1985). In the current study, maximal 
concentrations of LPS and fMLP were demonstrated to induce a potent phagocytic 
response (96.3% ± 3% ), which was 35% higher than phagocytic activity elicited by 
manuka honey. It is likely that the small stimulatory effect induced by manuka honey 
would be sufficient to initiate phagocyte activity in a non-infected wound, as it 
potentiated the same levels of activity as TNF-a. It is noted that the complexities of 
the non-infected wound in vivo are different from the simple in vitro model adopted 
here, and it would be useful to extend these observations to an animal model. 
Interactions between receptors on the neutrophil cell surface and chemical signals 
produced by the target are essential for phagocytosis to occur (Benjamini et al., 1996; 
Brown, 1995). Evidence that supports the likelihood that the additional stimulation 
obtained with manuka honey may be due to protein content, comes from reports that 
glucose-modified proteins act as attractants for neutrophils (Cohen et al., 2001). 
Glucose-modified proteins have been demonstrated to modulate neutrophil 
chemotaxis, glucose uptake and consequently, phagocytosis (Cohen et al., 2001; 
Cohen et al., 2000). Much of the evidence that elevated levels of glycated proteins 
inhibit the respiratory burst of neutrophils comes from diabetes modelling (Candlish, 
1993). A number of reports have established that glycated proteins are created when 
D-glucose reacts with serum albumin (Wu et al., 1996) and that the resultant glycated 
proteins may have profound effects on various cells (Jensen et al., 2003; MacCarthy et 
al., 1994 and Takata et al., 1988) and especially the phagocytes (Cohen et al., 2001; 
Cohen et al., 2000; Thornalley, 1999; Makita et al., 1994; Makita et al., 1991; 
Kirstein et al., 1990; Seow et al., 1987; Johnson et al., 1983). 
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Only manuka honey (0.25%) acted as an opsonin for bacteria. It has been established 
that manuka honey has a higher protein content than pasture honey types and this may 
help to explain these observations (Weston, 2000). It is reasonable to assume that the 
ability of manuka honey to act as an opsonin indicates that the active compound must 
manipulate the recognition by neutrophils of ligands on the phagocytosed beads. 
Phagocytosis may only be achieved when specific receptors on neutrophils recognise 
ligands on their target (Brown, 1995). Opsonizing beads with Bovine Serum Albumin 
acts through an indirect binding mechanism as serum contains complement (Volle et 
al., 2000). The interaction of complement and AGE has been identified as an 
important factor in increased macrophage-activation by glycated proteins (Vlassara et 
al., 1985). Perhaps the most convincing evidence in support of this study comes from 
the observation that macrophages have receptors for AGE and uptake beads coated 
with AGE-linked to Bovine Serum Albumin (Takata et al., 1988). Of relevance here, 
Wu et al. (1996) reported that incubation of serum albumin with D-glucose creates 
glucose-modified proteins which have profound effects on various cells, including the 
phagocytes. 
Protein glycation and AGE are associated with increased free radical activity (Ahmed, 
2005). AGE acting through receptors such as the receptor for advance glycation end 
products (RAGE, along with AGE-RI, AGE-R2, AGE-R3, sRAGE, macrophages 
scavenger receptor) induce NF-lCB activation and cytokine production (Ahmed, 2005; 
Pullerits et al., 2005; Hein and Franke, 2002). In addition to effects on intracellular 
signalling, gene expression, and release of pro-inflammatory molecules, the AGE-
RAGE association leads to the production of free radicals (Ahmed, 2005). AGE 
receptors are found in a range of immune cells, and the stimulation of NF-KB through 
AGE-RAGE interaction leads to a more prolonged activation than NF-KB stimulation 
through cytokines (Hein and Franke, 2002). Sustained receptor expression of RAGE 
has been demonstrated to create a positive feedback loop (Pullerits et al., 2005). There 
is evidence that a soluble RAGE receptor (sRAGE) can block the ligand-RAGE 
interaction through direct binding with leukocyte ~2-integrin Mac-1 (Pullerits et al., 
2005). The implication for the sRAGE being a competitive receptor with RAGE is 
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that upregulation of sRAGE will reduce infiltration of neutrophils into tissues. Cell-
bound RAGE function as a counter-receptor for leukocytes, resulting in an 
amplification of the inflammatory response (Pullerits et al., 2005 
However, the total concentration of proteins in manuka honey is low (National Honey 
Board USA, 2003; Molan, 1992b), and this casts doubts on the feasibility of their 
likely potency. Evidence that supports the possibility that the antioxidant content of 
manuka honey may account for its additional stimulatory activity comes from reports 
that phagocytosis is augmented when phagocytes are exposed to antioxidants (Heller 
et al., 2001; Linden et al., 1988). The high molecular weight fractions of dialysed 
manuka honey would contain large polyphenols (Molan, 1992b ). 
A direct nutritive effect of honey on cells cannot be ruled out. A number of reports 
have proposed that the availability of trace levels of zinc and copper influences 
phagocyte activity (Lentsch et al., 2001; Chandra and Chandra, 1986) and that 
marginal deficiencies in copper cause markedly impaired functions of both neutrophils 
and lymphocytes. This is due to the requirement of key enzymes for copper to act as a 
cofactor. Honey contains copper, and a study by Al-Waili (2003) reported that oral 
ingestion of small amounts of honey was sufficient to markedly increase serum copper 
concentrations. Honey was also found to give a slight increase in serum zinc levels 
(Al-Waili, 2003). Therefore, it is possible that elevation of copper and zinc levels in 
phagocyte cultures obtained by addition of honey may have enhanced neutrophil 
activity. The feasibility of such low concentrations of honey having this effect in the 
current study are unknown (though the demonstrated ability for oral ingestion of small 
amounts of honey to have significant effects on serum content reported by Al-Waili, 
2003, make it likely). 
While observations from the phagocytosis assays offer insight into the mec~anisms by 
which honey has been observed to promote tissue repair in a variety of wound types 
(Molan, 2004; Wood et al., 1997; Harris, 1994; Efem, 1988), no anti-inflammatory 
activity was identified. Due to the limitations of an in vitro system, the use of an 
animal model will be necessary to shed light on the effects on neutrophil functions in 
vivo. 
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Integrity 
SUMMARY 
The effects of honey on tight junction (TJ) resistance were assessed for MOCK cell 
monolayers subjected to an EGTA challenge. It was found that manuka honey and 
pasture honey have protective effects on TJ following the challenge, and enhance post-
challenge recovery of transepithelial resistance. Manuka honey had greater modulatory 
activity on TJ with increased concentration from 0.1-1 %, and 1 % concentrations of both 
honeys gave the greatest protective effects. Manuka honey appeared to have greater 
protective effects than pasture honey. Application of manuka honey (at 1 % final 
concentrations) to both the apical and basolateral sides of the MOCK cell monolayer 
significantly enhanced TJ tightness beyond the control. Dialysis of the honey confirmed 
that the high molecular weight fraction contained the active component. Diffusate 
fractions from either honey type had no effect on TJ. Artificial honey had no effect. 
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7.1 INTRODUCTION 
While this thesis had identified a number of points at which honey had been shown to 
stimulate activity in a range of cell types, limited evidence for the anti-inflammatory 
activity of honey had been found. Yet, there is abundant evidence from both clinical 
trials and from experimental animal models, that honey has anti-inflammatory activity in 
a range of therapeutic applications including: tissue repair after bum injury (Postmes et 
al., 1997; Burlando, 1978) and disruption of the gastric mucosa (Bilsel et al., 2002; 
Gharzouli et al., 2001; Ali et al., 1997). Inflammation can only proceed if activated 
leukocytes can leave the circulation and undergo a number of cellular adhesion 
interactions, enabling them to pass through permeable tight junctions, and reach the 
tissues (Mowery et al., 2004). The main focus of the investigations described here was to 
test whether honey effected any changes in tight junction (TJ) permeability. 
In order for leukocytes to pass through the cell layers between the vascular system and the 
target tissues, diapedesis must occur, whereby leukocytes must adhere first to the vascular 
endothelium, and then squeeze through tight junctions. This series of events is initiated 
by a sequence of interactions between selectins on leukocytes, and activated endothelial 
cells and connective tissues (Ebnet and Vestweber, 1999). 
After adhesion of leukocytes to the endothelium has occurred, diapedesis and 
transmigration is regulated by the permeability of TJ in the endothelium and surrounding 
tissues. The TJ (zonula occludens), is part of the plasma membrane surrounding 
endothelial or epithelial cells near their apical domain, and has two key functions; acting 
·as a barrier by regulating the paracellular transport of molecules and ions across cell 
sheets, and as a fence, separating the apical and basolateral domains of the plasma 
membrane (Schneeberger and Lynch, 1992). By uncoupling the barrier and fence 
functions, Singer et al. ( 1994) demonstrated that the two functions are distinct from each 
other. Therefore, TJ provide a barrier function, regulating movement of cells between the 
tissues (Singer et al., 1994; Schneeberger and Lynch, 1992). 
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The structural integrity of the TJ is dependent on the localization of key TJ proteins, 
occludin, claudin-I, zonula occludens-I (ZO-I), junction adhesion molecule-I (JAM-I, 
A, B, C) and molecules such as VE-cadherin (Wittchen et al., 2003; Hopkins et al., 
2003). VE-cadherin is a calcium reliant adhesion molecule, and therefore removal of 
calcium will prevent integrins from functioning. If calcium is removed, monocytes will 
not adhere to plastic surfaces due to the inability of MAC- I to function. Where the 
assembly of proteins in the TJ is disrupted, the barrier function breaks down. When the 
barrier function is breached, such as occurs during the inflammatory response, the TJ 
become permeable to leukocytes, enabling them to accumulate in tissues and creating 
inflammation as a result. As this study used a pulmonary epithelial cell line to study the 
effect of honey on tight junctions it is appropriate to consider what is currently known 
about the role of tight junctions in immune exclusion of bacteria and viruses. Enteric 
pathogens either alter cytoskeletal structure or specific tight junction proteins (Berkes et 
al., 2005). There is divergence in the mechanisms and resultant signalling pathways by 
which different microorganisms disrupt the epithelium. Clostridium perfringens, an 
anaerobic bacterium causing food borne gastrointestinal illness, has an endotoxin ( C 
perfringens endotoxin, CPE), which binds to the epithelial cell surface and increases 
permeability (Berkes et al., 2005). The 200 kDa CPE complex contain the TJ protein 
occludin, and induce TJ fibrils and remove claudin-4 from TJ, disrupting the TJ structure 
(Berkes et al., 2005). Other TJ proteins known to function as receptors for micro-
organisms include junctional adhesion molecules, to which reovirus bind, along with both 
the coxsackievirus and the adenovirus receptor (Berkes et al., 2005). A further example 
of how micro-organisms disrupt TJ integrity comes from a documented study on 
Escherichia coli cytotoxic necrotizing factor-I (CNF-I) (Hopkins et al., 2003). CNF-I 
changes the polarization of key TJ proteins, occludin, ZO-I, and JAM-I and displacement 
of the proteins leads to profound reductions in TJ gate function (Hopkins et al., 2003). 
Epithelial mechanisms to protect against penetration by micro-organisms include the 
expression of cytokines, adhesion molecules, and MHC class II molecules Berkes et al., 
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2005) after bacterial adherence or invasion. Secretion of IL-8 by basement membrane in 
response to transendothelial migration regulates the migration of neutrophils (Marshall et 
al., 2003). Both invasive and non-invasive enteric pathogens trigger activation of NF-KB 
(Berkes et al., 2005), and this transcription factor controls the expression of most of the 
proinflammatory cytokines, chemokines, immune receptors and cell surface adhesion 
molecules. Several cytokines involved in IBO and Crohn's disease act through activation 
of the STAT family (Musso et al., 2005). Leukocytes are recruited into intestinal tissues 
by chemotactic substances and adhesion molecules (e.g. ICAM-1, vascular cell adhesion 
molecule 1 (VCAM-1), mucosal addressin cell adhesion molecule 1 (MAdCAM-1) and 
E-selectin) on the surface of endothelial cells lining blood vessels (Miller et al., 2005). 
Leukocytes bind with the endothelial cell adhesion molecules according to the expression 
of their respective integrin counter-receptors. ROS have been shown to upregulate the 
expression of cell adhesion molecules on endothelium (Segui et al., 2004). The oral 
ingestion of honey will bring it into contact with the gut mucosa, and may have 
implications for inflammatory gut conditions. 
After inflammation has been initiated it proceeds according to two key phases, cellular 
adhesion followed by diapedesis (Figure 7 .6). Briefly, cellular adhesion is the phase 
incorporating capture of the leukocytes via interactions with activated endothelium. 
Selectins and their carbohydrate ligands initiate rolling of the leukocytes along the 
endothelium so that integrin molecules on the immune cells bind with counter-receptors 
on the endothelial cells (creating firm adhesion) (Kruidenier et al., 2003). Once the 
flattened leukocytes are firmly adhered, diapedesis is facilitated by some members of the 
immunoglobulin gene family (e.g. ICAM, VCAM), enabling the cells to squeeze through 
the endothelial sheet and move toward chemotactic gradients in the target tissues. At the 
target tissues, leukocytes may have to migrate through another epithelial layer. It is this 
second key phase of inflammation that is the focus of the investigations described in this 
chapter. Cell emigration from the circulation and into the target tissues depends on 
permeability of TJ. Consequently, if TJ are too tight the cells will not cross the barrier, 
and inflammation will not proceed. Movement is not just a consequence of TJ integrity, 
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but also a combination of factors including the expression of appropriate adhesion 
molecules and counter-receptors for the integrins. As well a re-distribution of molecules 
such as VE-cadherin, the junctional adhesion molecules (JAM-A, -B, and -C), PECAM 
and CD99 in endothelium. 
The investigations described in this chapter were based on studies performed by 
Stelwagen and Ormrod (1999; 1998), which focused on the development of a cell-based 
assay for TJ integrity to evaluate and characterise the anti-inflammatory activity of 
hyperimmune milk. Likewise, the in vitro model described herein was designed to mimic 
the barrier function of TJ as occurs in both the gut and the skin. 
In persistent inflammation, TJ remain leaky thereby maintaining swelling and associated 
white blood activity in the affected site, resulting in tissue damage from excessive free 
radical production (Lichtenberger, 2001). It follows from an anti-inflammatory 
perspective that it is desirable to restore TJ integrity quickly after an inflammatory 
challenge, to prevent persistent inflammation from causing further tissue damage. TJ 
leakiness has also been associated with administration of various anti-inflammatories, 
such as steroids and NSAIDs, which cause loss of the intestinal barrier function and result 
in the abnormal passage of blood components into the gut (Lichtenberger, 2001). 
However, the observed increase in gut permeability accompanying administration of 
NSAIDs (such as lndomethacin) result from cell damage and resulting reduction in cell 
cover rather than changes to TJ themselves (Hollander, 1999). 
Across polarised cell layers a small potential difference exists but only when TJ are intact 
(Stelwagen et al., 1994). In vitro it is possible to measure electrical resistance across a 
cell monolayer, which changes according to the permeability of the TJ, decreasing when 
they become leaky and increasing as the integrity is restored (Stelwagen et al., 1999). The 
electrical resistance can be measured directly, and changes in resistance can be mapped 
through time, in the presence or absence of bioactive substances, following an 
inflammatory challenge. It was this technique that enabled Stelwagen et al. (1999) to 
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investigate the effects of hormones on the molecular structure of TJ in mouse mammary 
cells (Stelwagen et al., 1999) and the anti-inflammatory activity of HIMF (Stelwagen and 
Ormrod, 1998). 
In order to understand how honey may have an impact on restoration of TJ integrity, it is 
necessary to consider how the composition of the TJ is affected by known damaging 
agents, (such as EGTA), and protective agents, (such as HIMF). TJ are dynamic 
structures. There are many known agents which increase permeability across the TJ, these 
include: endocrine factors, cytokines, bacterial products, and specific toxins such as 
Vibrio cholerae (called Zonula Occludens Toxin) (Hollander, 1999; Nguyen and Neville, 
1998). 
The primary objective of this chapter was to investigate if honey acts at this level. While 
evaluation of the effects of honey on white blood cell function provides an indication of 
bioactivity at the earliest stages of inflammation, measuring the impact of honey on TJ 
integrity enables examination of a downstream effect. The observation that topical 
application of honey led to a reduction in the total neutrophil count at the site of 
inflammation (Postmes et al., 1997), may reflect some modulatory effect on adhesion and 
diapedesis. There are a number of reports which demonstrate that honey conveys a 
protective effect to the gastric mucosa (Bilsel et al., 2002; Gharzouli et al., 2001; Ali et 
al., 1997) but these have not measured any effects on TJ. Addition of honey to the apical 
side of the cell lawn in the TJ assay is analogous to both topical application of honey to 
skin or oral ingestion of honey. Application of honey to the basal side of the cell 
monolayer in the TJ assay is analogous to honey present in the circulating bloodstream. 
It was therefore useful to extend the scope of this study to investigate whether honey has 
a significant effect on inflammation at this stage of the process, by measuring its effect on 
TJ integrity when cells were exposed to an inflammatory challenge. Addition of EGTA to 
MOCK cells results in chelation of calcium ions and the subsequent disruption of the 
paracellular barrier both in vitro and in vivo ( Stelwagen et al., 1995; Pitella et al., 1993; 
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Neville and Peaker, 1981). Both in vivo and in vitro experiments have clearly 
demonstrated the requirement of TJ for adequate extracellular calcium levels (Stelwagen 
et al., 1995; Pitellea et al., 1993). These extracellular calcium levels are necessary to 
ensure sufficient intracellular calcium, in tum required for TJ assembly and maintenance 
(Cerijido et al., 1993). EGTA was used in this study to challenge TJ in the presence or 
absence of honey. If any activity was identified, a further objective was to perform a 
simple fractionation of honey by dialysis and attempt to characterise the molecular weight 
of the bioactive component. 
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7.2 MATERIALS AND METHODS 
7.2.1 Reagents 
DMEM culture medium 
Culture medium for MOCK was comprised of: Oulbecco's modified Eagle's medium 
(OMEM; containing 1.5 g/L sodium bicarbonate and 4.5 g/L glucose,GibcoBRL, Cat# 12 
100-046); 10% Foetal Calf Serum (GibcoBRL, Cat # 10 091-148); 1 % Penicillin-
Streptomycin (GibcoBRL, Cat# 15140-122). 
Phosphate-buffered saline 
Dulbecco A; Oxoid BR14; 1 tablet in 100 ml of distilled water. 
Trypsin-EDT A 
To a trypsin stock solution (25 g/1 trypsin, GibcoBRL) was added 20% EDT A. 
Honey solutions 
Honey solutions were prepared as described in Section 2.2.2. Two honey types were 
selected for testing, M109 manuka honey and Otago Pasture honey, along with dialysis 
fractions of each (prepared as described in Section 2.2.2.1). Artificial honey was used to 
control for the osmotic effects of sugar. 
7.2.2 Cells and culture 
Madin-Darby canine kidney cells (MOCK, strain m were supplied by AgResearch 
(Ruakura). They are an epithelial cell line that forms an adherent cell monolayer. Cells 
were used between passage numbers 82 and 93. Cells were passaged every 2 days, at 
which time cells could be removed for experimental use. 
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Maintenance 
MOCK cells were passaged every two days, seeded (1 x 106 cells/ml) in Nunc culture 
flasks (160 ml, Life Technologies), and incubated at 37°C (5% CO2, 95% air). To split 
the cells, the growth medium was poured off, the cell lawn washed once with 4 ml of 
phosphate-buffered saline and 4 ml of trypsin-EOTA (Gibco) added. The flask was 
placed in an incubator (37°C, 5% CO2, 95% air) for 10 min after which time the flask was 
tapped to loosen any cells which remained adhered to the base. The trypsin-EOTA was 
inactivated by adding 5 ml of OMEM medium across the cell lawn and any loose cells 
washed off the flask wall and collected at the bottom of the flask. If a significant number 
of cells remained adhered to the wall of the flask, a cell scraper was used to remove these. 
The cell suspension was then transferred to a 15 ml centrifuge tube (Nunc). The cells 
were centrifuged (Mistral) at 223 x g for 3 mins, and the supernatant discarded. The cell 
pellet was re-suspended in 2 ml of OMEM medium, and 1 ml containing cells split for 
passage in a sterile flask with the other cells set aside for experimentation. 
7.2.3 Setting up a TJ assay 
To prepare sheets of MOCK cells for testing the effects of anti-inflammatory activity on 
TJ, a series of chambers were seeded with cells and the change in transepithelial 
resistance (TER) monitored following the addition of various treatments. 
7.2.3.1 Seeding the inserts 
To prepare the cell monolayers, one insert (Nunc Anapore inserts,10 mm, 0.02 µrn pore 
size; Life Technologies) was placed in to each well of a 12-well culture plate (Nunc). Into 
each of 11 inserts 500 µl of cell suspension (at a density of 3 x 106 cells per insert) was 
added. 
A haemocytometer was used to establish viable cell density, counting nuclei stained with 
crystal violet (16 mg crystal violet, 4 ml 1 M citric acid, 36 ml Milli Q, Sigma-Aldrich). 
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Staining of the cells was achieved by placing 100 µI of the cell suspension (the cell pellet 
re-suspended in 5 ml of DMEM medium), in an Eppendorf tube, vortexed for 10 secs 
with 900 µl of crystal violet. 
The 121h well was reserved as a background well and received only 500 µl of DMEM 
medium (no cells). Once the inserts were loaded, 300 µl of extra DMEM medium was 
loaded into each well (so that wells contained a final volume of 800 µI). The plate was 
incubated overnight (37°C, 5% CO2, 95% air). After 24 h, formation of TJ was assessed 
by TER measurement across cell monolayers using a Millicell-ERS voltohmmeter 
(Millipore, Bedford, MA, USA). Each of the inserts was removed from the culture plate 
and placed in an Endohm-12 chamber (World Precision Instruments, Sarasota, FL, USA). 
TER values were recorded as n.cm2• Readings were taken when values remained 
unchanged on the voltohmmeter for at least 5 sec. The TER of the background well (with 
DMEM medium and no cells) was subtracted from TER measurements. TER were 
deemed to have formed when TER readings were > 700 n.cm2• The cell preparations were 
then ready for addition of the honey solutions. 
7.2.3.2 Exposure of the cell monolayers to honey solutions 
To deliver the honey solutions, it was first necessary to remove the DMEM medium. A 
standard sequence was adopted for removal of the medium, first aspirating the medium 
from the plate wells and then from the inserts, taking care not to touch the membrane. 
The medium was refreshed every 24 h. This sequence for aspirating medium ensured 
minimum disruption to the apical side containing the cell monolayer. The inserts were 
each loaded with 500 µl of honey solutions (diluted in DMEM medium to final volumes). 
Controls received 500 µl of DMEM medium only. The preparation of honey stock 
solutions was according to the method described in Section 2.2.2. For each treatment, 
there were five replicates (five seeded inserts) per assay run. The plate was left to 
incubate for a further 24 h to enable the cells to adjust to their culture conditions before 
being subjected to an EGT A challenge. Further, exposure of the cell monolayers to honey 
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solutions prior to the EGT A challenge enabled any protective effects on TJ conferred by 
the treatments to be detected. The inclusion of background wells containing 800 µl of 
honey solution (at the same final concentration as used in treatments) and no cells 
provided a baseline TER measure to compare the conductivities of the different solutions. 
7.2.3.3 The EGTA challenge 
Preparation of the honey solutions containing EGT A 
To measure the protective effect of honey against damage by EGTA, the cells were 
subjected to an EGTA challenge. Before commencing the EGTA challenge the TER of 
the cells was measured again exactly 24 h after the previous measurement. EGTA was 
added at a final concentration of 3 mM. 
Administering the EGTA challenge 
Immediately prior to the EGTA challenge, TER measurements were taken (time O data). 
The background readings were always taken first, followed by the control and the honey 
' 
solutions beginning with the lowest concentration. To enable the EGTA-containing honey 
solutions (and control solution) to be loaded, the medium was aspirated from the inside of 
inserts and replaced by treatment solutions. No EGTA was loaded into the background 
insert. The plate was incubated for 60 min, after which TER of each insert was measured. 
The plate was placed in the incubator for a further 60 min and a second reading 
conducted 60 min after the first had been performed (time 2 data). Once the final reading 
had been performed, the contents of the wells and inserts were changed to honey 
containing medium without EGTA. The plate was returned to the incubator for a further 
24 h (i.e. post-challenge recovery period). 
During the recovery period, TER measurements were recorded to determine the effect of 
honey solutions on the ability of TJ to regain their original TER at time O (prior to the 
EGTA challenge). TER readings were repeated 24 hand 48 h after the EGTA had been 
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replaced with honey solutions (or DMEM medium only). No further solution changes 
occurred during this period. 
7.2.4 Preliminary Experiments 
Establishing whether honey could interfere with TER measurements across the insert 
membrane 
To investigate the possibility that honey might be adhering to the well insert, thereby 
creating an artificial barrier, honey solutions (artificial, manuka and Otago pasture 
honeys, at 0.1, 0.5, 1, and 3%) or DMEM medium alone were loaded into unseeded 
inserts, and incubated in the absence of cells. The TER measurements were tracked daily 
over a three day period. There were no significant differences in TER for inserts 
containing honey solutions beyond DMEM medium alone (all were in the range of 35-
440.cm2 corrected for 0.6 cm2 area which is similar to normal background readings) and 
this established that the presence of honey would not have any direct effects on TER 
measurements. 
Establishing a tolerance range for MOCK cell osmolarity 
To identify honey concentrations which damage MOCK cells, 500 µl of suspension 
containing 3.6 x 106 cells per ml was loaded in to wells of a 24-well microtitre plate 
(Nunc). After 24 h the DMEM medium was removed by aspiration and replaced with 500 
µl of various dilutions of honey to obtain final concentrations (0.1, 0.5, 1 and 3% 
artificial honey, manuka honey and Otago pasture honey) each in triplicate. The plates 
were incubated at 37°C (5% CO2, 95% air) for 24 h. Prior to removal of the honey 
solutions, the appearance of the cell membranes was noted (shrivelled membranes 
indicate osmotically stressed cells). After incubation, honey solutions were removed and 
replaced with 100 µl of trypsin (2%) before returning the microtitre plate to the incubator 
for 10 mins to dislodge the cells from the plate. After addition of 100 µl of DMEM 
medium (to neutralise the trypsin) the cell suspensions were removed and an equal 
volume of phosphate-buffered saline added. After centrifugation (223 x g 3 min), the 
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cells were re-suspended in I ml of phosphate-buffered saline and viability assessed using 
trypan blue staining. 
The effect on cell viability of exposing MOCK monolayers to honey concentrations are 
shown in Figure 7. I. The results in Figure 7. I show that direct incubation of MOCK cells 
with I% final concentrations of artificial honey (sugars alone) caused significant osmotic 
damage. At 3% concentrations, all honey types caused significant osmotic damage. 
A further osmotic tolerance assay was conducted to examine whether osmotic effects of 
honey on cells would be different when a freeflow of sugars exists (as is the case in the 
TJ assay). Using the TJ assay, inserts were seeded with MOCK cells at a density of 3 x 
106 cells per insert (as described in Section 7.2.3.1) and after 24 h inserts were loaded 
with honey solutions (manuka honey, Otago pasture honey or artificial honey at final 
concentrations ranging from 0.1-3%) or OMEM medium alone as described in Section 
7.2.3.2. After 24 h incubation the honey solutions were aspirated from the inserts, leaving 
the cell monolayer intact. To each insert, 200 µl of trypsin-EOTA was added, and the 
plate returned to the incubator for IO min (37°C, 5% CO2). After incubation, 200 µl of 
OMEM medium was added to each insert and the cell suspensions retrieved and a 
viability count performed using trypan blue stain (as before). The objective of this 
experiment was to test whether higher concentrations of honey would pose osmotic 
problems when used in a system enabling freeflow of sugars. 
There was no osmotic damage to MOCK cells incubated with the honey solutions at any 
of the concentrations tested when the cells were exposed to honey in the TJ assay set-up. 
However, it was noted that the volume of solution in the insert had increased 
significantly, indicating that the OMEM medium in the well chamber had been drawn up 
through the insert membrane. The volume contained in the insert was near the top of the 
walls after 24 h (pilot assays testing the osmotic effects of higher concentrations of honey 
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Figure 7 .1: The direct effect of honey concentration on MOCK cell viability. Cells were incubated for 24 h 
with various concentrations of honeys (Otago pasture, manuka honey or artificial) or DMEM medium alone. 
Cell viability was assessed using trypan blue exclusion. Data points represent the mean of five wells ± SEM 
and the assay was replicated twice (n=lO). Differences between the means are indicated by superscript 
letters, where means not sharing common letters within graphs are significantly different (P<0.05). 
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>3% had shown that after 24 h the contents of the insert were spilling over the insert 
walls back into the plate well, therefore altering the experimental conditions). These 
results demonstrate that when the cell monolayers were exposed to honey-free medium on 
one side and honey on the other side, that osmotic flow through the cells would prevent 
osmotic damage from occurring (analogous to honey on an open wound). However, the 
problems created by drawing of the medium into the insert meant that testing would be 
restricted to honey concentrations below 3% in this assay system. Although 3% honey 
had posed osmotic problems in a closed system (Figure 7 .1 ), these problems did not occur 
in the freeflow environment of the TJ assay, and was therefore included as the upper 
concentration tested. 
7.2.S Experimental Design 
7.2.5.1 Establishing the direct effect of honey on T J resistance 
Inserts were seeded with MOCK cells at a density of 3 x 106 cells per insert (as described 
in Section 7.2.3.1) and after 24 h inserts were loaded with honey solutions (manuka 
honey or artificial honey at 0.1 and 1 % final concentrations) or OMEM medium alone as 
described in Section 7 .2.3.2. TER measurements were recorded at 24 h intervals over a 72 
h period. No EGTA challenge was undertaken. Manuka honey was used as a 
representative example of natural honey. 
7.2.5.2 Establishing whether honey has activity on T J resistance during and following 
an EGTA challenge 
Inserts were seeded with MOCK cells at a density of 3 x 106 cells per insert (as described 
in Section 7 .2.3.1) and after 24 h, inserts were loaded with honey solutions (manuka, 
Otago pasture, or artificial honey at final concentrations ranging from 0.1-3%) or OMEM 
medium alone as described in Section 7 .2.3.2. The MOCK cells were then exposed to an 
Chapter Seven Ti!!ht Junctions 
EGTA challenge (as described in Section 7.2.3.3) and recovery of TI integrity monitored 
by taking TER measurements 1 h, _24 h and 48 h after the challenge. 
This assay was repeated using dialysis fractions of manuka honey and Otago pasture 
honey at final concentrations equivalent to 1 % honeys. 
7.2.5.3 Establishing whether honey has different effects on T J resistance when added 
to the basal side of the insert compared with the apical side 
MOCK cell monolayers were prepared as described for Section 7.2.3.1. As described for 
Section 7 .2.3.2, manuka honey, Otago pasture honey or artificial honey (at 1 % final 
concentrations) was added to the insert and was present on the apical side of the 
monolayer, being analogous to contact of honey with either the gut mucosa or the skin. 
To other inserts, manuka honey, Otago pasture honey or artificial honey (at 1 % final 
concentrations) was added to the plate well instead of DMEM medium. This created a 
basal application which was analogous with circulation of honey in the bloodstream. The 
control contained DMEM medium on both sides of the monolayer. 
7.2.6 Statistical Analysis 
Consistency in measurement was maintained throughout the assays. The insert was 
centred on the electrode in the chamber, and each time the probe was introduced to the 
insert it was ensured that the probe was immersed in liquid. The conductivity of the 
electrical charge is optimised by total surface contact with fluid. 
Data were analysed with the GLM procedure of SAS (SAS System for Windows, Release 
6.11, 1996; SAS Institute Inc., Cary, NC, USA), and differences between means were 
considered significant at p<0.05. Standard error bars represent SEM. The data were 
expressed as mean TER values taken as a proportion of those obtained for each 
corresponding treatment prior to the EGTA challenge (after 24 h incubation with honey 
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solutions). TER values of insert membrane and medium (i.e. no cells, medium alone), and 
membrane surface area (i.e. 0.6 cm2) of the insert were used to correct TER 
measurements, and TER is expressed as n.cm2• The model used the pre-experiment TER 
measurement as a covariate to adjust for the starting cell density of the inserts. 
Differences between treatments were analysed by ANOV A. Replicates were blocked to 
correct for replication effects. Means for each treatment represent TER values obtained 
for five replicates, and the assays were repeated twice (n=lO). 
7.3 RESULTS 
The effect on TER measurements of exposing MOCK cells to honey solutions compared 
with those obtained with DMEM medium alone are shown in Figure 7 .2. The results in 
Figure 7.2 show that after 24 h incubation with 1 % manuka honey, TER values were 
significantly higher than obtained for cells incubated with either concentration of artificial 
honey or medium alone. An increase in TER values was coupled to an increase in TJ 
tightness. These results indicate that after 24 h, 1 % manuka honey increased the 
resistance of the MOCK cell TJ. The lower concentration of manuka honey (0.1 % ) had 
no effect on TJ resistance beyond OMEM medium alone. After a further 24 h (at the 48 h 
time-point) there were no significant differences between the TER measurements 
obtained for any of the honey treatments. 
The effect on TJ resistance during and following an EGTA challenge of incubating 
MOCK cells with various honeys (manuka, Otago pasture or artificial) or OMEM 
medium alone at concentrations in the range from 0.1-3% are shown in Figure 7.3. 
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Figure 7.2: The direct effect of honey on TJ resistance in kidney cells (MDCK). Cells were maintained for 
72 h in either medium or honey solutions (manuka or artificial at 0.1 or 1 % final concentrations). Honey 
was added at O h and TER was measured at this time-point and again at 24 h intervals. The data are 
expressed as the mean of five replicates ± SEM and the assay was repeated twice (n=lO). Differences 
between the means are indicated by superscript letters, where means not sharing common letters within a 
timepoint are significantly different (P<0.05). 
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Figure 7.3: Effect of an EGTA challenge on loss of transepithelial resistance (TER) in honey-treated kidney cells 
(MOCK). Cells were maintained for 24 h with or without honeys (manuka, Otago pasture or artificial at 0.1, 0.5, 
I or 3% final concentrations) prior to a 2 h challenge with 3mM EGT A (in honey solutions). Data points 
represent the mean of five replicates ± SEM and the assay was repeated twice (n= 10). The data are expressed as 
mean TER values, taken as a proportion of those obtained for each corresponding treatment prior to the EGT A 
challenge. Differences between the means are indicated by superscript letters, where means not sharing common 
letters within a timepoint are significantly different (P<0.05). 
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The results in Figure 7.3 show that both manuka and Otago pasture honey exerted 
protective effects on TJ after challenging the cells for 2 h with EGTA, as TER values did 
not drop as low as occurred with DMEM medium alone. Artificial honey did not show 
this protective effect, indicating that sugars alone cannot be responsible. Manuka honey 
appeared to convey a greater protective effect to TJ integrity during the EGTA challenge 
than Otago pasture honey. 
Both manuka honey and Otago pasture honey significantly enhanced restoration of TER 
24 h after addition of EGT A. At this timepoint, TER values were highest for cells 
incubated with 1 % manuka honey. Therefore, manuka honey at 1 % enhanced the ability 
of TJ to recover their TER as a proportion of the values recorded prior to the 
inflammatory challenge. Artificial honey had no effect on TJ recovery above that 
obtained for DMEM medium alone (Figure 7.3). The effect on TJ resistance during and 
following an EGTA challenge of incubating MOCK cell monolayers with dialysis 
fractions of manuka honey and Otago pasture honey (both at concentrations equivalent to 
1 % honeys) or DMEM medium alone are shown in Figure 7.4. 
The results in Figure 7.4 show that retentate fractions ( equivalent to 1 % concentrations as 
found in manuka honey or Otago pasture honey) showed protective effects on TJ as 
indicated by the TER values, which did not drop as low as with DMEM medium alone 
during the EGTA challenge. The diffusate fractions had no significant effect. After 24 h 
recovery, the cells exposed to the retentate fractions had significantly higher TER values 
than those obtained with DMEM medium alone. By the 48 h recovery time-point, there 
were no significant differences in TJ resistance for cells incubated with retentate fractions 
and DMEM medium alone. 
The effect on TJ resistance during and following an EGTA challenge of incubating 
MOCK cell monolayers with manuka honey at 1 % or DMEM medium alone applied to 
the basal side of the monolayer compared with the apical side are shown in Figure 7.5. 
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Figure 7.4: Effect of an EGTA challenge on loss of transepithelial resistance (TER) in dialysed honey-
treated kidney cells (MOCK). Cells were maintained for 24 h with or without honey (retentate or diffusate 
fractions of manuka or Otago pasture honeys at final concentrations equivalent to 1 % ) prior to a 2 h 
challenge with 3mM EGT A (in honey solutions). Data points represent the mean of five replicates ± SEM 
and the assay was repeated twice (n=lO). The data are expressed as mean TER values, taken as a proportion 
of those obtained for each corresponding treatment prior to the EGT A challenge. Differences between the 
means are indicated by superscript letters, where means not sharing common letters within a timepoint are 
significantly different (P<0.05) . 
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The results in Figure 7.5 show that manuka honey (1%), conveyed a protective effect to 
TJ independently of the side of the cell monolayer to which it was applied. Though 
manuka honey significantly increased TJ resistance during the 24 h recovery period 
compared with DMEM medium, the effects were lost by the 48 h timepoint. 
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Figure 7 .5: Effect of an EGT A challenge on loss of transepithelial resistance (TER) in honey-treated kidney 
cells (MOCK), when honey was applied apically versus basally to cell monolayers. Cells were maintained 
for 24 h with or without honey (manuka or artificial honeys at 1 % final concentrations) applied to either the 
apical or basal side of the cell monolayers, prior to a 2 h challenge with 3mM EGT A (in honey solutions). 
Data points represent the mean of five replicates ± SEM and the assay was repeated twice (n= IO). The data 
are expressed as mean TER values, taken as a proportion of those obtained for each corresponding 
treatment prior to the EGT A challenge. Differences between the means are indicated by superscript letters, 
where means not sharing common letters within a timepoint are significantly different (P<0.05). 
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7.4 DISCUSSION 
TJ provide a crucial protective barrier in tissues such as the intestine, which can be 
altered by a variety of physiological, pathological and pharmacological stimuli. An EGTA 
challenge was adopted in the current study to provide a model to challenge TJ integrity by 
chelating extracellular calcium. It is noted that EGTA has a different mode of action to in 
vivo factors such as cytokines, growth factors, bacterial products and specific toxins, all 
of which open up TJ to enable infiltration of the leukocytes into damaged tissues (Lee et 
al., 1991; Hochman and Artursson, 1994), as these do not chelate calcium. These agents 
act through a diverse range of pathways but the outcome is that they all act to open up the 
TJs. In the current study honey has been demonstrated to ameliorate some EGTA-induced 
TJ disruption (compared with the control) and to increase recovery of TJ tightness during 
the 24 h recovery period following an EGTA challenge. 
The choice of EGTA to create a model for tight junction disruption is questioned due to 
its mode of action as a calcium chelator. In Section 7 .1, the necessity for integrins to have 
calcium in order to function was discussed. EGTA will disrupt a range of adhesion 
molecules. An additional key function for calcium is to influence cell signalling through 
binding to various proteins. With hindsight, LPS may have been a more appropriate 
model for tight junction disruption as applied to the gastric mucosa. 
Although most of the evidence that honey is anti-inflammatory comes from studies on 
wounds in the skin (Gupta et al., 1992; Kumar et al., 1993; Oryan and Zaker, 1998) and 
especially from clinical use on bums (Postmes et al., 1997; Burlando, 1978) the anti-
inflammatory effect of honey on the gastric mucosa has also been reported (Bilsel et al., 
2002; Gharzouli et al., 2001; Ali et al., 1997; Haffejee and Moosa, 1985; Salem, 1981). 
While the effects of honey on TJ integrity in an inflammatory model have been 
considered in isolation in the current chapter, the TJ functions within a complex 
signalling pathway, and the proven ability for honey to have effects at other points in this 
pathway will have profound implications for TJ functioning in vivo. Briefly, studies on 
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the loss of the barrier function of the intestinal mucosa in Irritable Bowel Disease (IBO) 
have established that over-expression of NO plays a key role in peroxynitrite-mediated 
protein nitration, leading in tum to abnormally high neutrophil infiltration and excessive 
inflammation (Kruidenier et al., 2003). In some cases an altered epithelial barrier is the 
proximate cause of the disease, while in other cases, loss of barrier function is a 
secondary consequence of the disease process (Bjamason and Peters, 1996). 
Although epithelial tight junctions provide a tighter barrier than those found between 
endothelial cells, they both share the same function role. As specific tight junction 
proteins vary among tissues along with factors regulating tight junction permeability (Goo 
et al., 2005), the effects of honey should be investigated for various tissues and caution 
needs to be employed regarding statements about general effects. 
There are a number of points in the inflammatory cascade at which honey might modulate 
the first stage of inflammation (Figure 7.6), indirectly or directly. It is possible that honey 
may enhance tissue health due to optimisation of nutrient supply (Al-Waili, 2003; 
Subrahmanyam, 1996). While it is noted that sugars alone had no activity on TJ, honey 
contains many nutrients in addition to sugars and manuka honey differs in specific 
content of these from Otago pasture honey (White, 1975a). The observation that manuka 
honey may increase the tightness of TJ when cells were not exposed to EGT A lends 
support to honeys ability to support tissue health (and therefore functioning). Further, it 
should be noted that Gharzouli et al. (2001) observed that both natural honey and a 
complex sugar mixture conveyed protective effects against ethanol-induced gastric 
mucosal damage in rats. The ability for honey to increase the uric acid content of serum 
has been suggested as a possible mechanism by which antioxidants may reduce 
inflammation in the gastric mucosa (Al-Waili, 2003), and should be mentioned here. 
Though the molecular basis for the effect is not known, there are several possibilities for 
the mechanisms by which honey may have an anti-inflammatory effect on TJ disruption 
during exposure of the cells to EGTA, and in the subsequent recovery period. The 
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possibility that a high molecular weight component in honey interferes with the chelation 
of calcium induced by EGTA cannot be ruled out. Calcium mobilisation is a widely used 
signalling mechanism and influences NF-KB activation (Watson et al., 2001) so if honey 
manipulates calcium mobilisation in some way then this will have implications for the 
inflammatory response. When calcium is removed by chelation, E-cadherin (an adhesion 
molecule which enables TJ to form) is re-distributed along with TJ proteins (e.g. claudin 
and occludin) causing TJ to open up and cells to separate from each other (Clarke et al., 
2000; Citi, 1994). 
The possibility that honey acts on adhesion molecules, or on the mobilisation of the TJ 
proteins needs to be investigated further. A further possibility which needs to be explored 
is the possible role of honey on stabilising actin filaments. Actin filaments are necessary 
for the opening and closing of TJ, and stabilisation of the actin filaments restricts the 
actions of calcium chelators (Phillips et al., 1989). If proteins can chop actin this may 
destabilise TJ. 
The observation that honey increases the resistance of TJ (and therefore TJ intactness) 
during the 24-h recovery period beyond that obtained by the control suggests that a high 
molecular weight component in honey has interfered with EGTA-induced disruption of 
the TJ. If TJ were not completely disrupted, the resistance across the mono layer could be 
restored in a relatively shorter time than for cells in medium alone which had no buffer 
against disruption. When the EGTA solutions were removed, TER was re-established 
after 24 h for MOCK cells maintained in medium alone compared with a significant 
increase in resistance beyond the original TER values (prior to addition of EGTA) after 
24 h for cells exposed to 1 % honey solutions. The possibility that honey increases the 
health of the cells may also apply here. Ali et al. ( 1997) have proposed that honey may 
contain a 'sucralfate-like' substance which reduces the vascular permeability of the 
gastric mucosa. In future experiments it would be useful to conduct calcium-EGTA 
titration assays to ensure that the influence of any calcium in honey is eliminated. 
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The role of components of honey in cell signalling may be of importance to the ability for 
honey to act as a TJ modulator. Hydrogen peroxide has been shown to have direct action 
on NF-ld3 (as discussed in Section 2.4) through oxidation involving free radicals formed 
by the Fenton reaction (Cross et al., 1987). Components in honey bind up iron to stop it 
catalysing the Fenton reaction (Buntting; 2001). Tannins, likely to be present in honey, 
bind iron, and complex with proteins and thus would be present in the retentate fractions 
obtained by dialysis. A number of studies have shown that agents which activate protein 
kinase C cause TJ disruption (Mullin et al., 1992; Ellis et al., 1992; Balda et al., 1991) 
and it is possible that an antioxidant in honey may interfere with this activation. The 
observation that the high molecular weight fractions of honey contain the active 
component confirm that the size of the agent must exceed 10 kDa. The observations that 
1 % concentrations of manuka honey directly increases the tightness of MOCK cell TJ 
(independent of an EGTA challenge) after a 24 h incubation period, and that manuka 
honey has a greater effect than Otago pasture honey suggest that the active compo~ent 
occurs at higher concentrations in manuka honey. The demonstrated effects of 
antioxidants to remove intercellular oxidant species and exert anti-inflammatory actvity 
through this mechanism has been discussed (Section 1.4.4.1). Differences in antioxidant 
content of the honey types may explain observed differences in potency, being 
significantly higher for the manuka honey. However, it should be noted that the high 
molecular weight fraction does not contain a complete anti-oxidant profile, as some of the 
antioxidant compounds would likely have been removed in the diffusate (P. C. Molan; 
personal communication). Along with tannins, polyphenols would be bound to proteins in 
the retentate fractions. Various chemical classes of antioxidants have been demonstrated 
to regulate cell adhesion through modulation of specific signal transduction pathways 
(Sen and Roy, 2001). 
The lack of an established antioxidant profile for the dialysis fractions makes it difficult 
to draw any conclusions about the role of antioxidants in the observed effects of honey on 
TER. The fact that Otago pasture honey contains such low levels of antioxidants and yet 
has activity on TER levels beyond the control means it is unlikely these compounds could 
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be responsible for all of the observed effects. Further, the likelihood that the diffusate 
fraction contains antioxidants and yet has no effect on TER beyond the control also casts 
doubt on the possible contribution of these compounds to the observed effects. 
Two factors make it unlikely that hydrogen peroxide plays a significant role in the 
observed anti-inflammatory effects: the first is that manuka honey has a more potent 
effect than the pasture type of honey and yet a far lower hydrogen peroxide content; the 
second is that the activity was present in the high molecular weight fraction so that the 
glucose oxidase should have been deprived of its substrate, removed in the diffusate. It 
has been pointed out however, that the glucose content of the medium would have acted 
as a substrate source (Section 2.4). The optimum concentration of glucose for honey 
glucose oxidase activity is known to be high, but the level in the medium was probably 
quite low. That there were no significant differences in the effect of retentate fractions 
and stock solutions on TJ suggests that glucose oxidase activity was not involved (and 
therefore hydrogen peroxide itself was not responsible for the observed activity). 
The concept of the inducible heat shock proteins as molecular chaperones to protect 
against cellular injury (e.g. calcium chelators such as EGTA) was introduced in Section 
2.4.2.1. It is possible that exposure of the MOCK monolayers to honey solutions may 
have induced low level oxidative stress due to the presence of hydrogen peroxide, and 
that heat shock proteins may have been synthesised which conveyed a protective effect 
during the inflammatory challenge. Of relevance to the current study, Bailey et al. (2004) 
reported that the heat shock proteins (HSP 27 and 70) were induced in retinal pigment 
epithelial cells to protect from the disruption of the TJ barrier function. MOCK cells have 
been demonstrated to express mRNA for HSP 70 (Cowley et al., 1995). The induction of 
heat shock proteins after exposure to sub-lethal doses of hydrogen peroxide has been 
observed for a number of cells which form TJs. In particular, Shivers et al. (1988) 
identified the synthesis of a recovery protein in endothelial cells from the brain capillaries 
which they proposed to speed up reassembly of TJ s and the recovery period after an 
inflammatory challenge. Further evidence comes from reports by Rokutan (2000) and 
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Rokutan et al. (1998) which demonstrated the key role that heat shock proteins (such as 
HSP70) play in gastric mucosa! defence, interfering with apoptosis through suppression 
of JNK activation (a transcription factor) and through protection of mitochondria. Of 
additional interest here, with regard to the function of TJ in the intestinal mucosa, it has 
been reported that trefoil factors are expressed by epithelial cell monolayers which 
convey both protective effects to the monolayers during an inflammatory challenge and 
promotes rapid re-establishment of mucosa! integrity after injury (Kindon et al., 1995; 
Mashimo et al., 1996). This raises the possibility that honey may have an effect on trefoil 
expression. 
In Chapters 3 and 4, the ability of honey to induce both mRNA expression for cytokines, 
release of TNF-a. protein by resting monocytes, and to reduce NO availability in rnitogen-
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Figure 7.6: Conceptual diagram to explain the movement of leukocytes from the blood to injured tissues. 
Generation of oxidant species along with cytokines by platelets and phagocytes activate blood leukocytes to 
migrate to blood/tissue borders. The expression of CAMs (cell adhesion molecules) on leukocytes and 
selectin by the endothelium enable the blood cells to plug the capillaries, and cytokines increase the 
penneability of tight junctions (Hollander, 1999), enabling the cells to enter the tissues via diapedesis. 
Points at which honey has been hypothesised to act on this first stage of inflammation are indicated by *. 
The effects of honey on selectin production are not yet known, and are denoted *?, to indicate the validity in 
investigating these in future experiments. 
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recruitment step of inflammation. The results discussed here suggest that honey has 
additional activity at the TJ permeability step. This may be further evidence of honey 
manipulating cytokine production, which has been demonstrated to determine TJ 
permeability (Hollander, 1999). This is discussed in further detail in Chapter 9. Although 
the effect of honey on the leukocyte-endothelium binding step has not been investigated 
in this study, the results obtained here indicate that this would be a worthwhile area for 
future research. These results also raise questions about whether epithelial cell growth 
may have occurred and potentially masked the effect of tight junction recovery, or vice 
versa. In Section 1.4.1 the proven ability for honey to act as a cell growth stimulant was 
discussed. Of further interest, it would be useful to examine whether honey was having 
effects on tight junction protein expression (e.g. occludin) at the molecular level. 
The observation that manuka honey has both protective and restorative effects on TJ 
when applied to either the apical side or the basolateral side of the MOCK monolayer 
suggests that the anti-inflammatory activity can be delivered through both oral (through 
the gut wall), and topical applications as well as through the systemic circulation. 
The implications of honey having activity as a TJ modulator to the overall inflammatory 
response are that recovery from inflammatory events may be quicker. Evidence that 
replacement of standard electrolyte solutions with honey solutions during oral rehydration 
after bacterial diarrhoea shortened the period of gut disturbance (Haffejee and Moosa, 
1985) may be due, at least in part, to restoration of TJ integrity and therefore, normal 
barrier function to the gut wall. The demonstrated ability for honey to alleviate redness 
and swelling (inflammation) from bums (Burlando, 1978) may also be attributed to the 
recovery of the TJ barrier function and the cessation of leukocyte infiltration to the 
tissues. A potential danger for use of an agent which prevented TJ from opening up 
would be that leukocytes could not reach damaged tissues and the necessary inflammatory 
response could not proceed. However, while honey was demonstrated to ameliorate some 
of the disruption caused by EGT A, the actions of the chelator were not prevented and this 
is analogous with expected activity in vivo when a bacterial infection occurs. Further, the 
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results of the current chapter raise the possibility that oral delivery of honey along with 
classical steroids may help to alleviate some of the disruption caused by gut permeability 
(through effects on TJ). 
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Chapter Eight: The Effect Of Honey On Fibroblast 
Proliferation 
SUMMARY 
The effect of various honey concentrations on the proliferation of the 3T3-Ll fibroblast 
cell-line in vitro was investigated using MIT proliferation assays. Both manuka honey 
and pasture honey (0.25%) increased fibroblast proliferation. Artificial honey had no 
effect on fibroblast proliferation, indicating sugars have no role in mitogenic activity. 
This suggests that honey contains factors which directly promote cell division in 
fibroblasts. 
An in vitro model was used to test whether honey-induced factors produced by peripheral 
blood mononuclear cells (PBMC) could activate fibroblast proliferation. These assays 
were performed to examine whether honey could have an indirect stimulatory effect on 
fibroblasts. Incubating fibroblasts with supematants derived from honey-stimulated 
PBMCs (at 0.025% concentrations of honey) led to significant fibroblast proliferation. 
Low concentrations of honey (less than 0.1 % ) do not directly stimulate fibroblast 
proliferation, therefore factors produced by honey-stimulated PBMCs must promote 
fibroblast proliferation. A high molecular weight fraction of manuka honey obtained from 
dialysis contained the active component. The diffusate obtained by dialysis (containing 
sugars) had no activity. 
To investigate whether honey could modulate the response of fibroblasts to an 
inflammatory agent, fibroblasts were exposed to honey for various times prior to and at 
the same time as IL-1 p. Honey did not augment fibroblast proliferation when added at the 
same time as IL-IP. Prior incubation of fibroblasts with honey (0.25-1%) for 2 h before 




The link which is forged between the inflammatory process and the repair of tissue itself 
by fibroblasts was introduced in Chapter 1 and is the focus of this chapter. Anecdotal 
evidence and experimental animal models attest to the ability of honey to optimise wound 
healing and reduce scar formation (Rozaini et al., 2004; Al-jady et al., 2000; Suguna et 
al., 1993; Suguna et al., 1992; Molan, 1991), as a consequence of effects on fibroblast 
activity (Rozaini et al., 2004; Lusby et al., 2002; Al-jady et al., 2000; Suguna et al., 
1992). In numerous reports on the clinical useage of honey it has been noted that honey 
promotes the formation of granulation tissue (Dunford et al., 2000; Taks, 2000; Farouk et 
al., 1998; Dumronglert, 1993; Efem, 1993; Subrahmanyam, 1991; Subrahmanyam, 1998; 
Efem, 1988; Wadi et al., 1997; Braniki, 1981; Armon, 1980; Cavanagh et al., 1970; 
Hutton, 1966), granules of fibroblasts growing where new capillary beds form by budding 
out from blood vessels. It is these fibroblasts that produce the scar tissue that fills in the 
damaged area and over which epithelial cells glide to provide new skin cover. In 
experimental wounds in animals honey has been shown to stimulate the synthesis of 
collagen (Suguna et al., 1992), and other connective tissue components (Suguna et al., 
1993). The objective of the investigations described here was to establish whether honey 
has any effect on fibroblasts in vitro, with a view to possible effects on wound healing. 
As described in Chapter 1, a key first step for the mechanism by which fibroblasts knit a 
wound closed is for them to proliferate. They perform this function in response to 
chemical messages (cytokines) produced by cells involved in the inflammatory phase of 
wound repair (Witte et al., 1998). Scar formation is a necessary step in tissue repair but 
excessive scarring results from persistent inflammation. This is thought to be caused by 
abnormal cytokine gradients (particularly of IL-1~) produced by overactive leukocyte 
activity, leading to subsequent fibroblast overactivity and formation of raised scars 
(Ghahany et al., 1995; Lynch et al., 1989). Conversely, abnormally low cytokine 
signalling by leukocytes (such as occurs in an immune-compromised patient) leads to 
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insufficient fibroblast multiplication and ultimately, tissues fail to be repaired (Dow et al., 
1999). 
In view of the observation that honey is associated with optimal wound healing and that 
fibroblast proliferation is a crucial step in this process, investigations were performed to 
test the effect of honey on proliferation of fibroblasts in vitro. A pre-adipocyte cell line, 
3T3-Ll, was selected for use in proliferation assays as they are accepted to provide a 
model on which to measure inflammatory responses (Edward Wood, University of Leeds, 
personal communication), and they respond to IL-1 ~ (Kimball et al., 1988). However, it 
was noted that there are distinct differences between the Swiss 3T3-Ll fibroblasts used in 
this study and primary skin fibroblasts, in collagen synthesis, growth rate, and response to 
growth factors (Oda et al., 1990; Vande Berg et al., 1989; Buckley-Sturrock et al., 1989). 
However, the positive results from this study justify further studies being carried out 
using wound-derived fibroblasts. Stimulation of the fibroblasts with IL-1~ was used to 
provide a positive control for activation of fibroblast cultures, and provide a model of 
excessive inflammation on which to test the effect of honey on. This model had particular 
physiological relevance to inflammation in vivo as IL-1~ produced by mononuclear cells 
is an important switch in the induction of fibroblast activity, and particularly in excessive 
scar formation (Wahl, 1988). The ability for honey to stimulate fibroblast directly was 
also tested. 
8.2 MATERIALS AND METHODS 
8.2.1 Reagents 
DMEM complete medium 
Complete medium was made up to 100 ml containing: DMEM, Dulbecco's modified 
Eagle's medium (containing 1.5 g/L sodium bicarbonate and 4.5 g/L glucose,GibcoBRL, 
Cat # 12 100-046); 10% foetal calf serum (GibcoBRL, Cat # 10 091-148), and 1 % 
Penicillin-Streptomycin (GibcoBRL, Cat# 15140-122). 
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Where the serum content was reduced in individual medium preparations, this has been 
indicated in the experimental design sections. 
Trypsin 
2.5% trypsin stock solution (25 g/1 trypsin, GibcoBRL), containing 1 % EDTA and 
phosphate-buffered saline (17.6 ml). 
Phosphate-buffered saline 
Dulbecco A tablets (Oxoid BR14; 1 tablet in 100 ml distilled water) 
Honey solutions 
Solutions of manuka honey (M109) and Otago pasture honey were prepared as described 
in Section 2.2.2. Dilutions of stock solutions were made to allow for the 1 :20 dilution 
factor of honey by reactants in the assay to obtain stated final concentrations. Artificial 
honey was made as described in Section 2.2.2. Complete medium (containing 0.05% 
foetal calf serum) was used to dilute the honey stock solutions. The pH of final cultures 
containing honey was checked and not found to differ significantly from cultures 
containing DMEM medium alone. 
8.2.2 Cell Sub-culturing 
The Swiss Albino 3T3-Ll fibroblast cell line (AgResearch, Ruakura) were maintained in 
DMEM complete medium. To prevent differentiation into adipocytes from occurring in 
the culture flasks it was necessary to split the cultures when the cells were just confluent 
(every 3 days). Experiments were carried out with cells at passage numbers between 5 
and 15, as some authors have noted that cells lose their responsiveness with successive 
passages (Wahl, 1988). As fibroblasts are adherent cells, trypsin was used to detach the 
cells from the flask by adding 4 ml trypsin solution after the medium had been removed 
and the cell surface washed with 20 ml of phosphate-buffered saline. The trypsin was left 
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in the flask for 2 min (37°C, 5% CO2, 95% air) after which time an equal volume of 
DMEM complete medium was added, and the supernatant removed by centrifugation 
(Sorval, 223 x g, 3 min). The pellet was re-suspended in 5 ml of DMEM complete 
medium, and 1ml of suspension added to 29 ml of DMEM complete medium in a new 
culture flask. The flasks were incubated at 37°C (5% CO2, 95% air). Cells were grown in 
DMEM complete medium and seeded in to 96-well flat-bottom plates at 2.5 x 104 
cells/ml for 48h (37°C, 5% CO2, 95% air). During this period, the mouse derived 
fibroblasts adhered to the bottom of the wells. It was important to ensure that the 
fibroblasts were not overconfluent in the wells, as contact inhibition reduces sensitivity of 
the cells to stimulation by mitogens (Wahl, 1988). After 48 h, the medium was removed 
from the wells by flicking, and the cells washed with phosphate-buffered saline before the 
medium was replaced with 100 µl of treatment solution. 
8.2.2.1 Establishing a non-con.fluent fibroblast monolayer 
To establish non-confluent monolayers in a 96-well microtitre plate, 500 µl of fibroblast 
cell suspension (2.5 x 104 cells/ml diluted in DMEM complete medium) was loaded into 
each well and the cells incubated for 24 h (37°C, 5% CO2, 95% air). After 24 h the 
supernatant was removed by gently flicking the plate, and the cells washed twice to 
remove any serum by adding 100 µl of phosphate-buffered saline to each well and 
centrifuging the plate (223 x g, 3 min). 
8.2.3 Analysis of cell activity using MTT assay 
Proliferation levels obtained for each treatment regime were determined using the MTT 
assay described in Section 2.2.6.2. A standard curve was constructed to determine the 
relationship between absorbance reading (OD) at 570 nm, and cell density (Appendix 3). 
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8.2.3.1 Statistical analysis 
Unless otherwise stated, analyses of difference in fibroblast proliferation between 
treatments and experiments was done by one-way ANOV A using Systat software version 
7 (SPSS Inc.). The between group effect was the amount of proliferation. Significance 
was further analysed using Tukey' s honestly significant difference (HSD) for pair-wise 
differences for within group comparisons. All tests were performed in triplicate wells and 
repeated at least twice (n=6 measurements), and each datapoint represents the mean ± 
SEM of optical density (OD) measurements for two experiments. As the overall 
conversion of tetrazolium salts varies each time, data were normalised by taking the mean 
for triplicate treatment wells as a proportion of the mean values obtained for triplicate 
control wells. SEM for the control wells were calculated on raw data and multiplied by 
the same proportion as used to convert the control to 100%. Systat was used for all 
analyses. Results were accepted as statistically significant when P<0.05. 
8.2.4 Experimental Design 
In order to find the maximum concentration of honey which could be added to fibroblast 
monolayers without reducing cell viability, initial assay were performed to establish an 
osmotic tolerance range. In order to measure the direct effect of honey on fibroblasts, 
monolayers were exposed to honey concentrations. As well as having direct effects on 
fibroblasts at the wound site, honey would have indirect effects on fibroblasts through its 
activity on PBMCs and their production of cytokines which drive fibroblast activity 
(Wahl, 1988). It had already been established that honey directly induces rnRNA 
expression for cytokines in whole blood (Chapter 3), and production of TNF protein by 
THP-1 monocytes (Chapter 4), suggesting that honey might have indirect effects on 
fibroblasts. Therefore, assays were undertaken to test if honey has activity on fibroblasts 
partly or wholly via stimulation of cytokine production in leukocytes. To increase 
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physiological relevance to the real wound healing situation, supematants derived from 
honey-stimulated PBMCs were incubated with fibroblast monolayers to measure any 
indirect effects of honey on fibroblast proliferation. 
In the inflammatory situation, fibroblasts proliferate in response to growth factors and 
cytokines produced by immune cells. IL-1~ is a known mitogen which has been shown to 
direct fibroblast cells into the S phase of the cell cycle, and has been used by various 
authors to model the effect of inflammation on fibroblast activity (Wahl, 1988). 
Modelling experiments by Kimball et al. (1988) have determined that 3T3 fibroblasts 
proliferate in a dose-dependent fashion in response to interleukin- I (IL-1 ). As anecdotal 
reports have suggested that honey minimises scar development, and associated recovery 
from tissue damage, it was useful to examine whether honey had any effect on the 
response of fibroblasts to a mitogen. To test whether honey could modulate fibroblast 
proliferation in response to a mitogen, monolayers were exposed to honey prior to and at 
the same time as IL-1~. To identify the active component in honey, assays were repeated 
to test for stimulatory activity and modulatory activity in honey fractions 
Establishing the osmotic tolerance range of fibroblasts 
To identify honey concentrations which damage fibroblast cells, 500 µl of suspension 
containing 2.5 x 104 cells/ml (in DMEM complete medium) was loaded in to wells of a 
24-well microtitre plate. After-24 h the medium was removed via aspiration and replaced 
with 500 µl of honey diluted to obtain final concentrations (0.1, 0.5, 1 and 3% in DMEM 
complete medium containing 0.05% foetal calf serum) added to triplicate wells. The 
plates were incubated at 37°C(5% CO2, 95% air) for 24 h. Prior to removal of the honey 
solutions, appearance of the cell membranes was noted to identify osmotically stressed 
cells. Honey solutions were then removed and replaced with 100 µI of trypsin before 
returning the microtitre plate to the incubator for 2 min to dislodge the cells from the 
plate. The trypsinised cell suspensions were removed via autopipette, drawing the 
solution up and down to ensure the cells were retrieved. The contents from each triplicate 
series of wells were placed in a separate 15 ml centrifuge tube and diluted with an equal 
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volume of phosphate-buffered saline. The tubes were centrifuged (223 x g, 3 min) and the 
pellet resuspended in 1 ml of phosphate-buffered saline. Into an Eppendorf tube was 
placed 100 µl of cell suspension and 100 µl of trypan blue and mixed by vortexing the 
tube contents. Then a haemocytometer count was performed to determine the total 
number of cells for each treatment along with the proportion of viable cells. 
8.2.4.1 Testing whether honey has a direct stimulatory effect on fibroblast 
proliferation 
To treatment wells, 100 µl of honey solution (at final concentrations of 0.1, 0.25, 0.5, or 
1 % v/v, diluted in DMEM complete medium containing 0.05% foetal calf serum) was 
added. All treatments and controls were conducted in triplicate. Control wells received 
100 µl of DMEM complete medium containing 0.05% foetal calf serum added to the cell 
monolayer. Background wells containing only honey solutions were included to allow for 
any background absorbance from the honey, and the mean OD value for these was 
subtracted from treatments and controls. The plates were incubated for 72 h (37°C, 5% 
CO2, 95% air) after which time cell density was assessed using the MIT assay (as 
described in Section 2.2.6.2). 
8.2.4.2 Testing whether honey may have indirect stimulatory effects on fibroblasts 
through factors produced by honey-stimulated PBMCs 
To measure the indirect effects of honey on fibroblasts, PBMCs were exposed to 0.025% 
final honey concentrations, then the supematants from these were incubated with 
fibroblast monolayers to test the effects on proliferation. The 0.025% concentrations of 
honey had been shown to both, stimulate lymphocyte proliferation and not affect viability 
in Section 2.3. This experiment was based on the method described by Wahl (1988) 
which clearly demonstrated that lymphocyte- and monocyte-derived fibroblast growth 
factors can be harvested from PBMCs and will drive proliferation when added to 
fibroblasts (Agren et al., 1999; Mendez et al., 1998; Phillips et al., 1998). 
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PBMCs were isolated from bovine blood as described for the T-cell assays in Section 
2.2.3. Into each well of a 24-well microtitre plate, 950 µl of cell suspension (2.5 x 106 
cells/ml) was loaded along with 50 µl of honey solutions (serial dilutions of manuka, 
Otago pasture or artificial honey 50% stock solutions) or DMEM complete medium 
alone. The cells were incubated for 24 h (37°C, 5% CO2, 95% air). Supematants were 
collected by centrifugation of the plates (503 x g, 15 min, Sorval) and the supematants 
were passed through a 0.2 µm filter (Supor® Membrane Acrodisc®, Pall Corporation) to 
remove any residual cells. 
As serum interferes with fibroblast proliferation assays, it was necessary to reduce the 
serum content of the suspensions and this was achieved by diluting each treatment 1 :4 
with serum-free DMEM medium (Wahl, 1988). This reduced the amount of serum to 
which fibroblasts were exposed, to ensure that the sensitivity of the assay was maintained. 
The limitations of diluting the PBMCs-derived supematants were that any factors 
produced by the cells would be diluted. The objective of this assay was to establish 
whether honey could stimulate PBMCs to produce factors which would have activity on 
fibroblast proliferation. As it was confirmed that honey had no effect on fibroblast 
proliferation at concentrations below 0.25% (Figure 8.2) the honey at 1/5 of 0.025% 
would not have a direct effect on fibroblasts. Non-confluent fibroblast monolayers (2.5 x 
104 cells/ml) were established, and washed as described in Section 8.2.3.1. To triplicate 
wells containing the washed fibroblasts 100 µl of the diluted supematants from the 
PBMCs were added. Blanks were included to account for the absorbance due to honey 
solutions alone and the mean OD value obtained for these were subtracted from all 
values. The plates were incubated (37°C, 5% CO2, 95% air) for 48 h before the cell 
density was measured by the MTT assay (as described in Section 2.2.6.2). 
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8.2.4.3 Testing whether honey augments IL-1/3-stimulation of fibroblast proliferation 
To test whether honey would augment IL-1 ~ effects if added to cultures at the same time, 
honey was delivered to monolayers at the same time as IL-1~ (100 ng/ml). Briefly, non-
confluent fibroblast monolayers (2.5 x 104 cells/ml) were established, washed (Section 
8.2.3.1), and each well received 100 µl of either honey (0.25-1 %final concentrations) 
containing IL-1 ~. or DMEM complete medium containing IL-1 ~ and the cells incubated 
for 48 h (37°C, 5% CO2, 95% air). Blanks were included to account for the absorbance 
due to honey and the mean OD values obtained for these were subtracted from all values. 
After 48 h, the cell density was determined by means of the MTT assay (as described in 
Section 2.2.6.2). 
8.2.4.4 Testing whether exposure of.fibroblasts to honey before IL-1/3-stimulation has 
any effect on proliferation 
There are two cases where fibroblasts could potentially be exposed to honey prior to an 
activating stimulus, in people who consume honey as a preventative, and when honey is 
applied to a fresh wound. Therefore, testing whether prior exposure of fibroblasts to 
honey does have physiological application. After establishing non-confluent fibroblast 
monolayers (2.5 x 104 cells/ml), they were washed (Section 8.2.3.1), and each well 
received 100 µ1 of either honey (0.1-1 %) or DMEM complete medium. Preliminary data 
had established that a 2 h exposure of fibroblasts to honey prior to IL-1 ~ was the 
minimum time necessary to obtain any effects on proliferation, and extending the pre-
incubation period gave no further effects. After 2 h incubation (37°C, 5% CO2, 95% air), 
the honey solutions were removed, the cells washed with 100 µ1 of phosphate-buffered 
saline, and the plate centrifuged (223 x g, 3 min). To each well was added either, 100 µl 
of a honey solution, or DMEM complete medium (with 0.05% foetal calf serum) 
containing IL-1~ (at a final concentration of 100 ng/ml), and the cells incubated for 48 h 
(37°C, 5% CO2, 95% air). Blanks were included to account for the absorbance due to 
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honey and the mean OD values obtained for these were subtracted from all values. After 
48 h, the cell density was determined by means of the MIT assay (as described in Section 
2.2.6.2). 
8.2.4.5 Characterising the components in honey with activity on fibroblasts 
The aim of these assays was to characterise the components of honey responsible for 
stimulatory and modulatory effects on fibroblast proliferation. Manuka honey and Otago 
pasture honey were dialysed using a 10 kDa membrane (as described in Section 2.2.2.1). 
As mentioned in Section 2.2.2.1, according to the size of the components in honey, 
glycosylated proteins and anti-oxidants were collected in the high molecular weight 
fraction (>10 kDa retentate) and sugars in the low molecular weight fraction (<10 kDa 
diffusate). It was possible that some sugars were retained in the retentate fraction due to 
the larger size of the long chained oligosaccharides. While the polyphenols bound to 
proteins would have been retained in the retentate due to their size, the smaller 
antioxidants would have been in the diffusate fraction (P.C. Molan; personal 
communication). As the sugars had been removed from the high molecular weight honey 
fractions, the concentration range was extended to include 3%, as this would potentially 
increase the dose of any active component present. 
Non-confluent fibroblast monolayers (2.5 x 104 cells/ml) were established and washed as 
described in Section 8.2.3.1. To these were added 100 µl of the honey fractions (in 
DMEM complete medium containing 0.05% foetal calf serum). The cells were incubated 
for 48 h prior to MIT assay. After exposing the fibroblasts to the honey fractions for 2 h 
the supernatants were replaced with of 100 µl of fresh honey solutions containing IL-1~ 
(at a final concentration of 100 ng/ml). Blanks were included to account for the 
absorbance due to honey solutions alone, and the mean OD values obtained for these 
were subtracted from all values. The cells were incubated for 48 h with the honey 




To assess the effect of honey solutions on fibroblast viability, trypan blue staining was 
used to examine the proportion of live cells after a 24 h exposure to various 
concentrations of honey. Both artificial honey (containing sugars alone) and natural 
honeys significantly reduced cell viability above 1 % final concentrations (Figure 8.1). 
Therefore, concentrations used to test the effects of crude honey on fibroblast activity 
were restricted within the range 0-1 %. 
To test the direct effects of honey on fibroblast proliferation, cell monolayers were 
incubated with honey for 72 h prior to an MTT assay. Manuka honey and Otago pasture 
honey increased fibroblast proliferation at a single concentration, 0.25%, and the effects 
were lost either side of this optimal concentration (Figure 8.2). Artificial honey had no 
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Figure 8.1: The effect of honey concentration on fibroblast cell viability. Cells were incubated with honey 
(manuka, Otago pasture or artificial) at final concentrations ranging 0.1-3% or DMEM complete medium 
(containing 0.05% foetal calf serum) alone for 24 h. Viability was then assessed by trypan blue exclusion. 
Data points represent the mean of triplicate wells ± SEM and are derived from two independent assays 
(n=6). Differences between the means are indicated by superscript letters, where means not sharing corrunon 
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Figure 8.2: Direct effect of honey at various concentrations on fibroblast proliferation. 3T3-Ll fibroblasts 
were exposed for 72 h to honey (manuka, Otago pasture or artificial) at various final concentrations in the 
range from 0.1-1 % or DMEM complete medium (containing 0.05% foetal calf serum) alone. After 72 h, 
cell density was detennined by the MTT assay. Data are expressed in proportion to the control (fibroblasts 
exposed to complete medium containing 0.05% foetal calf serum). Data points represent the mean of 
triplicate wells± SEM and are derived from three independent assays (n=9). Differences between the means 
are indicated by superscript letters, where means not sharing common letters within graphs are significantly 
different (P<0.05). 
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Figure 8.3: The effect on fibroblast proliferation of supernatants obtained from PBMCs exposed to honeys. 
Fibroblasts were incubated for 48 h with five-fold diluted supematants obtained from PBMCs exposed to 
0.025% final concentrations of honey (manuka, Otago pasture or artificial) or DMEM complete medium 
alone. Cell density was detennined by the MTT assay. Data are expressed in proportion to the control 
(supernatants from PBMCs exposed to medium alone). Data points represent the mean of triplicate wells ± 
SEM and are derived from three independent assays (n=9). Differences between the means are indicated by 
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Figure 8.4: The effect on proliferation of exposing fibroblasts to honeys for various times prior to 
stimulation with IL- Ip. 3T3-Ll fibroblasts were exposed to honey at 0.25% final concentrations (manuka, 
Otago pasture or artificial) for various times (0-24 h) prior to addition of IL- IP ( 100 ng/ml). After 48 h cell 
density was detennined by the MTT assay. Data are expressed in proportion to the control (fibroblasts 
stimulated with IL-1 p alone for 24 h). Data points represent the mean of triplicate wells ± SEM and are 
derived from three independent assays (n=9). Differences between the means are indicated by superscript 
letters, where means not sharing common letters within graphs are significantly different (P<0.05). 
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To investigate the possibility that honey could have indirect effects on fibroblast 
proliferation, supematants were obtained from honey-stimulated PBMCs and added to 
fibroblast monolayers. Supematants obtained from artificial honey-stimulated PBMC had 
no activating effect on fibroblasts (Figure 8.3). This indicated that sugars alone at a 
0.025% concentration do not induce PBMC to produce fibroblast-activating factors. 
However, both natural honeys had an indirect stimulatory effect on fibroblast 
proliferation, indicating that at 0.025% concentrations, both natural. honeys tested must 
induce the release of fibroblast-activating factors by PBMC. 
To test whether honey could potentially exacerbate fibrosis, honey was added to 
fibroblasts at the same time as IL-1 ~ and proliferation measured. Honey had no effect on 
resultant fibroblast proliferation, indicating that at all concentrations of natural honey 
tested (0.25-1 %) honey did not augment IL-1~-stimulation. This also indicated that 
when added at the same time as a high dose of IL-1 ~ ( 100 ng/ml), honey did not modulate 
fibroblast proliferation at the concentrations tested (0.25-1 %). The positive effect of IL-
1~ (100 ng/ml) was demonstrated by a mean absorbance reading of 0.358±0.0114 
compared with cells maintained in medium alone (0.1793±0.0099). As there was no 
effect, data is not shown, although observations for 0.25% honey concentrations were 
included in Figure 8.4. 
To establish whether pre-exposure of fibroblasts to honey could modulate their 
subsequent response to IL-1 ~. fibroblasts were exposed to honey for various times prior 
to addition of IL-1~ (Figure 8.4). The 0.25% concentration was selected as it had been 
shown to be optimal for inducing cellular effects in earlier assays. Artificial honey (and 
therefore, sugars alone) had no effect on resultant proliferation, indicating sugars cannot 
modulate cytokine-stimulated proliferation. After a minimum 2 h pre-exposure period, 
both natural honeys had a modulatory effect on IL-1 ~-stimulated proliferation. Increasing 
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Figure 8.5: The effect on proliferation of exposing fibroblasts to various honey concentrations prior to 
stimulation with IL- I~- 3T3-LI fibroblasts were incubated with final concentrations (0.1-1 % ) of honey 
(manuka, Otago pasture or artificial) or DMEM complete medium for 2 h prior to addition of IL- I~ (I 00 
ng/ml) . After 48 h, cell density was determined by the MTT assay. Data are expressed in proportion to the 
control (fibroblasts stimulated with IL- I~ alone). Data points represent the mean of triplicate wells ± SEM 
and are derived from three independent assays (n=9). Differences between the means are indicated by 
superscript letters, where means not sharing common letters within graphs are significantly different 
(P<0.05) . 
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To establish whether pre-incubating cells with a different dose of honey might have a 
more potent modulatory effect on IL-IP-driven proliferation, monolayers were exposed to 
a range of honey at final concentrations (0.1-1 %) prior to addition of IL-lp. While 
natural honeys had no effect on IL-IP-driven proliferation at concentrations below 0.25%, 
they suppressed proliferation at concentrations between 0.25-1%. However, the slight 
modulatory effect did not differ significantly between these doses (Figure 8.5). Visual 
assessment of the cell cultures indicated that this result could not be due to osmotic stress. 
Although only a 0.25% concentration of honey had been demonstrated to have a 
stimulatory effect on fibroblasts, there were no indications to why the single dose alone 
had activity. In an attempt to characterise the active component, honey was fractionated 
using dialysis, and tested at a 0.25% concentration. The retentate fractions obtained from 
dialysis (>10 k.Da, at a final concentration equivalent to 0.25%), of both honeys, 
significantly increased fibroblast proliferation beyond medium alone. Comparison of the 
levels of proliferation obtained for fibroblasts exposed to retentate fractions, compared 
with unfractionated honey, indicates that the active component is totally in the retentate 
fractions. The diffusate fractions (<10 k.Da) of both honeys had no significant effect on 
fibroblast activity beyond medium alone (Figure 8.6). 
To characterise the modulatory component, honey was fractionated using dialysis, and 
tested at a 1 % final concentration. Upon removing the sugars from the high molecular 
weight fraction, the possibility that this may have removed any masking effect of the 
modulatory component needed to be explored, and therefore a 1 % concentration was 
tested. At 1 % concentrations, retentate fractions of both honeys modulated the effect of 
IL-1 P-driven fibroblast proliferation, and indicated that all of the activity is in the 
retentate (Figure 8.7). As before, diffusate fractions (<10 k.Da) of both honeys had no 
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Figure 8.6: The effect of dialysed honey fractions on fibroblast proliferation. 3T3-Ll fibroblasts were 
incubated with dialysis fractions of manuka honey or Otago pasture honey at a final concentration 
equivalent to 0.25% honey and compared with cells incubated with DMEM complete medium alone or 
0.25% unfractionated honey. After 48 h, cell density was detennined by the MTT assay. Data are expressed 
in proportion to the control (fibroblasts exposed to DMEM complete medium containing 0.05% foetal calf 
serum). Data points represent the mean of triplicate wells ± SEM and are derived from three independent 
assays (n=9). Differences between the means are indicated by superscript letters, where means not sharing 
common letters within graphs are significantly different (P<0.05). 
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Figure 8.7: The effect on proliferation levels of exposing fibroblasts to dialysis fractions of honey prior to 
stimulation with IL-1 p. 3T3-Ll fibroblasts were incubated with dialysis fractions of honey at a final 
concentration equivalent to I% manuka honey, Otago pasture honey or I% unfractionated honey for 2 h 
prior to addition of IL-IP (100 ng/ml). After 48 h, cell density was determined by the MIT assay. OD 
values as a proportion of those cells exposed to IL- IP alone. Data are expressed as the proportion of the 
control. Data points represent the mean of triplicate wells ± SEM and are derived from three independent 
assays (n=9). Differences between the means are indicated by superscript letters, where means not sharing 
common letters within graphs are significantly different (P<0.05). 
8.4 DISCUSSION 
The current study provides evidence that honey has a direct stimulatory effect on 
fibroblast activity but not at the same levels as obtained for stimulation with the pro-
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inflammatory cytokine, IL-1 p. Further, proliferation was obtained after exposure of 
fibroblasts to honey-treated PBMC suspensions, indicating that honey has an indirect 
effect on fibroblasts through activation of cytokine and growth factor production. 
Conversely, where fibroblasts had been exposed to honey for a minimum of 2 h prior to 
stimulation with IL-1 P at high levels, as would likely be the case when honey is 
consumed as a preventative, IL-IP-driven proliferation was modulated. The serious 
health consequences for wound healing in patients when fibroblast activity is aberrant 
highlight the need for therapies which can optimise tissue repair processes. Further, it was 
shown in the current study that honey does not augment IL-IP-driven proliferation. The 
observations made in the current study are in agreement with clinical evidence which 
suggests that honey modifies fibroblast activity (Rozaini et al., 2004; Lusby et al., 2002; 
Al-jady et al., 2000; Suguna et al., 1992). 
Incubation of fibroblasts with low concentrations of either type of natural honey at 0.25% 
concentrations stimulated proliferation. This indicates that honey must contain factors 
which directly promote cell division in fibroblasts. Viability testing confirmed that the 
decrease in stimulatory activity which occurred as the honey concentration exceeded 
0.25% was not due to any osmotic stress created by sugars. Therefore, some other 
component in honey must have been exerting inhibitory activity on the stimulatory agent 
as honey concentration increased. 
The stimulatory effect on growth of fibroblasts may be by way of the hydrogen peroxide 
produced in honey, as hydrogen peroxide has been found to stimulate the proliferation of 
fibroblasts (Chung et al., 1993). There is a large amount of evidence for hydrogen 
peroxide being involved in many cell types in the body as a stimulus for cell 
multiplication, acting at various points in the mechanisms of the cells that control the 
cycle of cell growth and division (Burdon, 1995), and it has been proposed that low 
concentrations of hydrogen peroxide might be used to stimulate wound healing, in place 
of the expensive cell growth factors used for this purpose (Postmes, 1999; Burdon, 1995). 
However, it has been pointed out that this is only feasible only if the concentration could 
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be carefully controlled to avoid tissue damage (Chung et al., 1993). This is possible with 
the controlled sustained release of hydrogen peroxide that occurs in honey. Extrapolating 
from reported values for the likely concentration of hydrogen peroxide which could be 
produced by honey at 0.25%, 0.05 mM (Bang et al., 2003), hydrogen peroxide would be 
at lower levels than those shown to cause oxidative stress in fibroblasts (0.2 mM) (Wang 
et al., 2001). However, at 0.05 mM levels, hydrogen peroxide would be present at 
concentrations well above the minimum threshold concentration necessary to induce 
fibroblast activation (0.2-0.1 nmol)(Murrell et al., 1990). 
The lack of substantial differences in stimulatory effect between the two honeys, despite 
the likelihood that hydrogen peroxide production would be very different (Molan, 1992b) 
suggests that activity may be due to some factor other than hydrogen peroxide. It was 
established that medium neutralised the acidity of the honey, so that pH differences 
between the honey-treated cells and control cultures could not account for stimulatory 
effects. 
That honey contains proteins which are likely to be modified by sugars was discussed in 
sections 1.4.3 and 2.4.1.1. There is strong evidence that glycated proteins bind to cellular 
receptors in a similar way to lectins and activate a number of cell types to proliferate, 
including fibroblasts (as discussed in Section 2.4.1.1). 
Evidence reported by Pani et al. (2000) that the shifting balance between antioxidant 
concentrations and the availability of exogenous hydrogen peroxide controls thymocyte 
proliferation (discussed in Section 2.4.2.1) is of relevance here. The decrease in 
proliferation reported in the current study as honey concentration increased may reflect 
the higher concentration of an inhibitor or an antioxidant compound which over-rides the 
stimulatory effect. Fractionation of the honeys by dialysis confirmed that the active 
stimulatory components were present in the retentate fraction. No stimulatory activity was 
seen in the low molecular weight diffusate fraction. 
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Incubation of fibroblasts with supematants derived from PBMCs exposed to honey 
induced proliferation. As it was established that low concentrations of honey (less than 
0.1 % concentration) had no direct effect on fibroblast proliferation, factors produced by 
PBMCs must promote fibroblast mitosis. Support for the role of PBMC-derived factors in 
fibroblast proliferation comes from the observation that PBMCs maintained in medium 
alone had no effect on fibroblast activity. However, it was important to note that 
significant activating effects were obtained from the PBMC supematants after they were 
diluted 1 :4 with medium. These results raise questions about the magnitude of cell 
activation which might have been achieved with undiluted supematants and justify future 
in vivo investigation. 
Likely candidates for the fibroblast-activating factors from honey-stimulated PBMC 
include Platelet Derived Growth Factor-a (PDGF-a) a cytokine that causes differentiation 
and proliferation of fibroblasts (Ghahany et al., 1995; Lynch et al., 1989). PDGF-a is 
released from macrophages during wound healing, and acts as a chemoattractant and 
mitogen for fibroblasts. 
The significance of this result is that it provides evidence that honey has activity on many 
different cells in the inflammation pathway and that its actions are perpetuated by cellular 
interactions. That honey induced expression of mRNA for cytokines (specifically IL-113 
and TGF-13) in whole blood cultures (Section 3.3), supports the observation here that 
honey has indirect stimulatory effects on fibroblasts. Both TGF-13 (Cobbold and Sherratt, 
2000), and IL-113 (Ghahany et al., 1995; Lynch et al., 1989), are key cytokines involved 
in the activation of fibroblast activity and re-epithelialisation. 
The present study has characterised the stimulatory agent on fibroblasts as being of high 
molecular weight. While it is known how IL-113 stimulates fibroblast proliferation, it is 
not known how honey has this effect. IL-113 is known to drive fibroblast activity by 
stimulating prostaglandin E2 synthesis, collagenase synthesis, plasminogen activator 
synthesis and breakdown of proteoglycans and fibronectin in extracellular matrix by 
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fibroblasts (Kahari et al., 1987). In particular, IL-1~ is characterised as a potent stimulant 
of free radical formation in fibroblasts (Kahari et al., 1987). 
The growth rate of the cells would be maximal just before confluence, as contact 
inhibition occurs when the monolayers become confluent. The maximum scope for 
proliferation using the 96-well plate format was not determined, and it is not known 
whether greater differences between treatments would have been obtained if confluency 
was not a limiting factor. Therefore, it is not known if the observed differences provide a 
true picture of the full potential of honey to have activity on fibroblast cultures. Future in 
vitro assays could be conducted using beads rather than wells as the adherent surface as 
these would extend the scope for monolayer expansion. 
That honey can reduce IL-1~-driven fibroblast proliferation, and does not augment IL-1~-
stimulation, is an important observation because excessive inflammation is known to 
contribute to a number of fibrotic disorders (Dinarello, 1996), and specifically keloid 
scarring (Ghahany et al., 1995; Lynch et al., 1989). This may suggest that the presence of 
honey in the systemic circulation, as would likely occur when honey is consumed as a 
preventative, may ameliorate excessive inflammatory responses. There is evidence from a 
study by AL-W aili (2003) that routine consumption of honey can modulate the NO 
content in the circulation, and therefore, every likelihood that honey could modulate other 
cytokines when regularly consumed. 
It is also important that honey does not inhibit proliferation as this would prevent wound 
healing from occurring. Artificial honey had no modulatory effect on the cell response to 
IL-1 ~. indicating that sugars were not responsible for the modulatory action observed 
with natural honeys. The present study has characterised the modulatory agent as being of 
high molecular weight. The difference in antioxidant profile and protein content for the 
honeys was introduced in Chapter 2. That Otago pasture honey has a low antioxidant 
content and yet interferes with IL-1~-stimulated proliferation reduces the likelihood that 
antioxidant content alone is responsible for the observed effects. Exposure of fibroblasts 
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to natural honey (0.25-1 %) prior to stimulation with IL-I~ led to a 10-15% reduction in 
proliferation levels as compared to fibroblasts exposed to IL- I~ alone. How this slight 
modulatory effect translates to in vivo fibroblast proliferation is not known, though the 
observation that honey reduces the incidence of hypertrophic scars after bum injury 
(Subrahmanyam, 1998), suggests that it would. One of the consequences of bum injury is 
the production of pro-inflammatory cytokines, including IL-1~ (Tanaka et al., 1995; 
Kaufman et al., 1989), at high levels. 
This study provides evidence that honey stimulates fibroblast proliferation. The findings 
made here are in agreement with clinical observations that honey has an activating effect 
on growth of granulation tissue, and thus contributes to the promotion of tissue healing. 
This clearly indicates that the promotion of formation of granulation tissue by honey may 
be through direct stimulation of growth of fibroblasts rather than (or as well as) 
stimulation of angiogenesis. The observation that manuka honey only had a significant 
stimulatory effect at a single concentration (0.25% v/v), needs to be investigated further. 
While this study has identified the optimal honey concentration for stimulation of 
fibroblast activity in vitro, it is not yet known how this can be transferred to the situation 
in vivo. An attractive possibility is that honey could be used in wound management 
products to stimulate healing. 
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Chapter Nine: General Discussion And Future Experiments 
In the preceding chapters of this thesis, the effect of honey on a variety of cells active 
at different steps in the inflammatory response have been investigated. In this section 
the implications of these results for the effect of honey on the overall inflammatory 
response, and potential benefits for therapeutic application are discussed in light of 
published reports. 
The starting point of this thesis was to repeat some of the key observations described 
in the few published reports on honey in tissue culture systems (Tonks et al., 2001; 
Abuharfeil et al., 1999). This enabled the published reports to be corroborated and 
extended the testing of their observations to both, cells and honeys from different 
origins. Further, only a few concentrations of honey had been tested for cellular 
effects prior to this thesis, and therefore, the range of concentrations tested was 
extended. Far from being a simple repeat of what had previously been shown, this 
study was the first to report that very low concentrations of honey had stimulatory 
effects on T cell proliferation, and the production of TNF-cx. by monocytes, in addition 
to mRNA for key cytokines involved in wound healing. This study was the first to 
report the dual ability for honey to stimulate proliferation in quiescent fibroblasts, and 
to modulate their proliferation in response to a potent proinflammatory cytokine, IL-
1 ~. This study was the first to demonstrate that honey conveys protective effects to 
tight junction integrity. In addition to demonstrating that the sugars in honey increase 
phagocytosis by neutrophils, this study was the first to show that manuka honey has an 
opsonizing effect on bacteria. Further, this study was the first to show in vitro, that 
honey modulates the production of NO by LPS-stimulated mononuclear leukocytes. 
Finally, this study was the first to screen for the effect of honey on a wide range of 
cells involved in the inflammatory response of wound healing, and draws these 
together to suggest several mechanisms by which honey enables tissue repair to 
proceed normally. 
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9.1 JUSTIFICATION FOR CELL TYPES AND ASSAY METHODS 
SELECTED 
The investigations described in the current study were performed using cell-based 
assays in tissue culture systems. Due to the availability of bovine blood and cell lines 
from various origins, along with the constraints of ethical approval and resources for 
human studies, assays were restricted to the use of these cells. Bovine blood was used 
to investigate the effect of honey on T cell activity (Chapter 2) cytokine mRNA 
expression in blood (Chapter 3) nitric oxide production by mononuclear leukocytes 
(Chapter 5) and neutrophil phagocytic activity (Chapter 6). While the activity of 
cytokines on specific cells is known to vary slightly between human and bovine 
systems (Collins et al., 1999), it is assumed that the ability for honey to activate the 
inflammatory pathway would be applicable to both. The use of non-human cell-based 
inflammation models for human application studies is accepted as a viable model in 
several key wound healing studies (Goncalves et al., 2001; Greenwel et al., 2000; 
Klyubin et al., 1996 and Granstein et al., 1990). 
The choice of assay methods described in the current study was influenced by 
research budget, time and the availability of resources, but were considered 
appropriate to address each given hypothesis. Due to the broad scope of this thesis it 
was not possible to examine the effect of honey on all aspects of cell signalling for 
each cell type studied. Therefore the primary objective of this thesis was to use key 
assays to screen for any effects of honey at various steps in the inflammation pathway. 
Assays were planned and implemented according to accepted published methods. 
Immortal cell lines were used to investigate the effect of honey on; TNF-cx production 
by human THP-1 monocytes using human WEHI macrophages as an indicator of 
TNF-cx levels (Chapter 4 ), protection against tight junction disruption in a canine-
derived MOCK cell line after an inflammatory challenge (Chapter 7) and proliferation 
in a mouse-derived 3T3-Ll fibroblast cell line (Chapter 8). 
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9.1.1 Limitations of the in vitro assays used in the current study 
In preceding chapters of the current study, the limitations associated with use of in 
vitro experimentation for their application to the real life situation have been 
mentioned. While testing of honey on purified/semi-purified cell populations in vitro 
was useful to dissect responses at the cellular and molecular level, they provided 
minimal information about the interaction of diverse cells in vivo. Of particular 
relevance to the current study, it has been noted by Yancy et al. (2001) that cellular 
activation observed in vitro will be determined by the populations of cells present, as 
cell signalling is critically dependent on cell-cell interactions. Of additional interest 
here, Collins et al. (1999) have observed that the cellular environment in vivo will 
have profound implications for the activation response of primary cells in vitro. The 
observation that honey has immunogenic activity in cells sourced from different 
species and from different physiological origins (immortal cell lines and primary 
cultures) is encouraging because it indicates that honey has wide applicability to 
various cell types. Therefore, the application of the results obtained in the current 
study to the functioning individual are purely speculative, and further testing would be 
needed to establish whether the results could be realised in vivo. 
9.1.2 Reasons for variation in cellular activation levels of primary cells in vitro 
It has been noted in Section 2.3.4 of the current study, and by deJong (2003) and 
Gauntlett (2004 ), that there was variation between assays in the stimulation effect of 
honey on T cells obtained from primary cultures. There are a number of reports which 
show that cells in primary culture will vary in their cytokine production to the same 
stimulus according to previous exposure to cytokines in vivo (Collins et al., 1999) 
such as an attenuation event (Burleson et al., 2002; Kiecolt-Glaser et al., 1995; 
Collins et al., 1999; Cohen et al., 1998; Herbert and Cohen, 1993; Cohen et al., 1991) 
or psychological stress (Burleson et al., 2002; Iserson, 2000). The observation that 
delays in blood processing led to expression of heat shock proteins (reported by 
Baecheler et al., 2004) may offer some important clues for observed variation between 
assays. Induction of heat shock protein expression in cells due to an oxidative stressor 
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is known to interfere with the subsequent response of the cells to a further stimulus (as 
discussed in Section 2.4 ). 
That different concentrations of honey were found to be optimal for inducing cellular 
effects in different cell types is likely to reflect differences in the physiological 
tolerance of cell types. 
9.2 THE LIKELIHOOD THAT THESE IN VITRO OBSERVATIONS COULD 
BE REALISED IN VIVO 
The observations in the current study that honey stimulates proliferation of 
lymphocytes and fibroblasts, and phagocytosis of bacteria by neutrophils are 
supported by what is reported anecdotally in vivo (Subrahmanyam, 1993;1991) and in 
experimental wound models (Postmes et al. (1997); Kumar et al. (1993); Oryan et al. 
(1998); Gupta et al. (1992) and Church (1954). While there is much evidence for the 
effects of honey on wounds (Cooper et al., 2001; Vardi et al., 1998; Subrahmanyam, 
1998; Wood et al., 1997; Harris, 1994; Subrahmanyam, 1994; Phuapradit and 
Saropola, 1992; Efem, 1988; Bergman et al., 1983), and bums (Subrahmanyam, 1993; 
1991), there is some limited evidence for gastroprotective activity (Ghosh and 
Playford, 2003; Bilsel et al., 2002; Gharzouli et al., 2001; Ali et al., 1997; Haffejee 
and Moosa, 1985; Salem, 1981). The experiments described in the current study were 
designed to best model cellular systems as they exist in vivo. The method by which 
honey would be delivered to damaged and/or inflamed tissues was therefore of prime 
importance in both assay design, and interpretation of the results obtained. With 
regard to the stimulatory effect of honey, it is conceivable that application of honey to 
a non-healing wound may stimulate the activity of neutrophils to debride (Section 
6.4), T cells to proliferate (Section 2.4), leukocytes to produce cytokines (Sections 
3.4; 4.4) and later, fibroblasts to proliferate (Section 8.4). The ability for honey to 
stimulate tissue repair in non-healing recalcitrant wounds (Molan, 2004; Cooper, 
2001), further lends powerful support to the demonstrated ability for honey to act as 
an immunostimulant in the current study. 
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The observations by Al-Waili (2003) that regular consumption of honey induced 
measurable levels of NO metabolites in saliva suggest that oral ingestion of honey 
could have immunogenic effects, even at low concentrations. Gross et al. (2004) 
found a direct link between honey consumption and the level of polyphenols in the 
blood. The regular consumption of honey by some individuals as a prophylactic, made 
it physiologically relevant for investigations to include prior exposure of cells to 
honey before a known activating agent. The four teaspoon per day dose regime 
reported by Al-Waili (2003), and four tablespoon per day dose reported by Gross et al. 
(2004), would have resulted in greatly diluted levels of honey, and therefore the 
effective concentrations of honey reaching the systemic circulation were likely to be 
very low. There are several reports that indicate consumption of honey has significant 
effects on the antioxidant profile of blood (Gross et al., 2004; Schramm et al., 2003) , 
indicating that it is feasible that honey might have anti-inflammatory activity in vivo. 
It is not known how the micromolar concentrations of antioxidants likely to be present 
in the systemic circulation would relate to levels hypothesised to be present in vitro. 
Based on published evidence, it is feasible that honey could exert cellular effects at 
the low concentrations demonstrated to be effective in vitro, and that these low 
concentrations of honey could be achieved in vivo. Certainly, there is no evidence that 
the results obtained in this thesis would not be realised in vivo. 
9.3 THE POSSIBLE MECHANISMS BY WHICH HONEY EXERTS 
™MUNOGENIC EFFECTS 
This thesis did not identify the active component in honey, but it did characterise the 
activity as being of a high molecular weight, and therefore achieved a prime aim of 
this study. In the absence of a clearly identified active compound, any discussion 
about the active agent is purely speculative. Here, the implications for the likely active 
agent are discussed in light of evidence from the current study, and from published 
reports. 
Two key components of honey have been proposed as the most likely agents 
responsible for the observed stimulatory effects on cells, hydrogen peroxide and 
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glycated proteins. Evidence that honey contains both hydrogen peroxide and glycated 
proteins was discussed at length in Chapter 1. It was hypothesised that honey might 
stimulate cell proliferation by activating NF-KB, through the actions of hydrogen 
peroxide or the presence of glycated proteins (Section 2.4, 6.4). This thesis did not 
investigate the effect on cells of hydrogen peroxide content or protein content directly, 
but the observations made in the current study indicate that these agents may indeed 
play a role. Further, there are some indications that antioxidants may play a role in the 
demonstrated activity of honey (also not investigated directly in this thesis). Based on 
the results obtained from the investigations conducted in this thesis, it is hypothesised 
that hydrogen peroxide content alone is unlikely to account for all of the observed 
effects of honey on cells. In particular, where manuka honey has been demonstrated to 
have more potent activity, it is likely that proteins and antioxidants play an important 
role in cellular activation. This is based on the lower levels of hydrogen peroxide 
reported to be delivered by manuka honey compared with Otago pasture honey, and 
yet a higher content of proteins and antioxidants. 
The most reasonable hypothesis which can be proposed based on the evidence 
presented in this thesis, is that a number of components present in honey may act 
separately or in concert to induce irnrnunogenic effects. While such a conclusion 
sheds little light on the true nature of the active component(s), it fits with the inability 
of any studies to date to identify either UMP or the irnrnunogenic agent in honey. 
Such a hypothesis is in agreement with others attempting to identify the active 
component(s) in honey (Gheldof et al., 2002). The biphasic effect of honey, 
stimulatory at low concentrations and modulatory at higher concentrations suggests 
that there are likely to be several irnrnunogenic agents present. 
9.3.1 Evidence that honey is a cell stimulant 
The ability for low concentrations of honey to stimulate proliferation was 
demonstrated for T cells (Section 2.3.1) and fibroblasts (Section 8.3). The results of 
this study mirror numerous reports that low concentrations of hydrogen peroxide 
directly stimulate proliferation in these same cell types (Reth, 2002; Burdon, 1995; 
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Los et al., 1995; Chung et al., 1993; Schmidt et al., 1992; Rao and Berk, 1992; 
Murrell et al., 1990). 
With reference to Figure 9.1, hydrogen peroxide has been demonstrated to induce a 
number of anabolic cellular effects, and these are reconcilable with those seen when 
honey is applied topically (Molan, 1991; Postmes et al., 1997; Subrahmanyam, 1993; 
Harris, 1994; Adesunkanmi and Oyelami, 1994; Subrahmanyam, 1993; Suguna et al., 
1993; Postmes et al., 1993; Ndayisaba et al., 1993; Efem, 1993; Gupta et al., 1992; 
Ankra-Badu, 1992; Subrahmanyam, 1991; Zumla and Lulat, 1989; Farouk et al., 
1988; Efem, 1988; Dumronglert, 1983; Bergman et al., 1983; Bose, 1982; Armon, 
1980; Cavanagh et al., 1970; Bulman, 1955). The observation that micro- and 
nanomolar concentrations of hydrogen peroxide were found to directly stimulate 
fibroblast proliferation in vitro (Schmidt et al., 1992), mean that it is feasible that 
hydrogen peroxide could account for the activating effects obtained with honey. 
Murrell et al. ( 1990) reported that very low levels of oxidant species are needed for 
fibroblast proliferation to be induced (1 µM). These levels fall well within those 
extrapolated from the data reported by Bang et al. (2003) of 0.05 mmol of hydrogen 
peroxide obtained when 0.25% honey is added to cell suspensions. Taking into 
account the results obtained in this thesis and observations reported for the direct 
effects of hydrogen peroxide on cells, a mechanism is proposed by which hydrogen 
peroxide in honey might stimulate wound healing (Figure 9.1). 
Evidence that honey modulates fibroblast activity means that it has potential for a 
topical treatment to optimise tissue repair, and especially while scar formation occurs. 
There is abundant anecdotal evidence that honey has effects on recovery of epithelial 
integrity, both in vitro (D. Adams, Child Health Research Institute, Adelaide) and in 
vivo (Ahmed et al., 2003; Biswal et al., 2003; Misirlioglu et al., 2003; Aysan et al., 
2002; Lusby et al., 2002; Topham, 2002; Agren et al., 1999; Thomas, 1998; Efem, 
1988). The ability of honey to increase fibroblast proliferation has been demonstrated 
using animal wound healing models (Gupta et al., 1992). 
However, the results obtained from this thesis do not entirely support the hypothesis 
that hydrogen peroxide alone could be responsible for stimulatory effects. While it has 
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been reported that progressive dilution of honey increases glucose oxidase activity 
because the enzyme inhibitors are progressively inactivated (Bang et al., 2003; 
Buntting, 2001; White, 1966), activity diminishes as dilution of honey proceeds below 
30% (v/v) (Bang et al., 2003; White, 1966; White et al., 1963), as was the case here. 
Though at 0.25% concentrations the potential levels of hydrogen peroxide delivered 
by honey could conceivably promote fibroblast proliferation, the hundred-fold 
dilutions beyond this, demonstrated to activate T cell proliferation do not appear 
likely. Yet honey is reported to have immunogenic effects even when ingested orally 
(Al-Waili, 2003), and it is highly unlikely that the concentration of honey could 
approximate 30% (v/v) due to the dilution effects of body fluids. With these 
comments in mind, it is very unlikely that sufficient hydrogen peroxide would be 
produced by the high molecular weight fraction of honey to account for stimulation, 
even if the glucose oxidase enzyme had been retained. It was noted that glucose 
oxidase from the honeybee has a molecular weight of 16 kDa (National Honey Board 
USA, 2003; Eichenseer et al., 1999), and the enzyme should have remained in the 
high molecular weight fraction after dialysis. Further, the presence of glucose in the 
cell culture medium would have provided the enzyme with its substrate, meaning that 
hydrogen peroxide could have been generated. To exclude the role of hydrogen 
peroxide completely, future investigations would need to use glucose-free medium, 
though this was not possible with the bovine-derived PBMCs used in this study. 
Further evidence that discounts the probability that hydrogen peroxide could be 
responsible for cellular activation, relate to what is know about hydrogen peroxide 
content of different honey types (Section 1.3.1.5). The level of hydrogen peroxide is 
far greater in the pasture honey than the manuka type, and this is directly attributable 
to the floral source (Molan, 1992b ). Components from floral sources have been 
demonstrated to affect the production and destruction of hydrogen peroxide, among 
these being the levels of catalase, ascorbic acid and iron content affect the rate of its 
breakdown by chemical reactions (Kerkvliet, 1996; Molan, 1992b ). Therefore, it 
would be expected that pasture honey would have stimulatory activity at higher 
dilutions than manuka honey and this was not the case. While there is no dispute that 
honey releases hydrogen peroxide when diluted in cell suspension (Molan, 2001; 
Swellam et al., 2003; Tonks et al., 2003; Weston, 2000), it has not yet been 
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established what the effective concentration of hydrogen peroxide would be in the 
suspension when honey has been diluted a million-fold or more. Of further concern, it 
is unknown how the hydrogen peroxide content is affected by other factors present in 
the suspension. 
There is evidence that the redox status of cells plays an important role in fibroblast 
proliferation, and the supply of bioavailable trace elements, in particular antioxidants 
may be expected to alter the overall redox status of the cells (Lee and Wan, 2002; 
Murley et al., 2001; Burdon, 1995; Los et al., 1995; Halliwell and Gutteridge, 1989). 
The higher antioxidant content of manuka honey as compared with Otago pasture 
honey was discussed in Section 1.3.1.5. This may help to explain why manuka honey 
had mitotic activity on lymphocytes beyond that of pasture honey. 
Based on the established variation in chemical composition between honey types 
according to their floral source, it is reasonable to speculate that chemical interactions 
may affect the final amount of hydrogen peroxide which is released in cell suspension. 
The loss of activity observed for the high molecular weight fractions of manuka honey 
as compared with unfractionated honey is most likely due to disruption of some 
synergy between chemical constituents (Swellam et al., 2003). Honey is a complex 
substance, and the interactions existing between the component molecules responsible 
for observed effects may have altered bioactivity after fractionation. Indeed, natural 
products such as honey remain elusive to chemists because they contain compounds 
with greater structural diversity than is possible via most synthetic chemistry routes 
currently in use (Harvey, 2000). However, some key differences were observed 
between the stimulatory action of honey on T cells and fibroblasts. Fibroblast 
proliferation did not occur at the same low doses which induced T cell proliferation 
with a minimum 0.25% concentration necessary to induce proliferation. On the other 
hand, it was speculated that the increased T cell proliferation which occurred with 
increased honey dilution might be due to the progressive removal of an inhibitor 
(Section 2.4). The importance of different physiological tolerances for the cell types is 
not presently known. The loss of stimulatory effect as honey concentrations exceeded 
0.25% (v/v), and yet could not be due to osmotic effects (as established by viability 
286 
Chaptl.:r Nine General Di~rns~ion and l:'urure Exp1.:rimcnts 
assays), may indicate the presence of an anti-inflammatory agent. Modulatory activity 
was only observed at higher concentrations of honey. 
As blood was obtained from a different animal each time, the possibility that animals 
may respond differently to the stimulant can not be discounted. In a preliminary study 
using a similar T cell proliferation assay protocol, de Jong (2003) reported that blood 
obtained from various bovine differed significantly in cell response to the same honey. 
This needs to be investigated further. The observation that different concentrations of 
honey are required for measurable cellular effects to be obtained in cells from 
different origins may have no relevance in vivo, and can only be proven with in vivo 
testing. 
A further difference observed for the fibroblast stimulation assays was that data 
obtained had less variability. This may be due in part to the observation that 
fibroblasts are more robust to fluctuations in culture conditions than T cells are (Deas 
et al., 1986). However, it should be noted that the fibroblasts were obtained from a 
cell line, whereas T cells were present in PBMC fractions along with various numbers 
of other cell types. The effect of honey on the other cells present in the PBMC 
fraction, along with the potential for these cells to indirectly stimulate T lymphocytes 
after themselves being activated by honey is unknown. It was noted in Section 2.4 
that bystander activation of T cells may be an important factor in perpetuating T cell 
proliferation after initial stimulation by honey has occurred (Los et al., 1995). The role 
of bystander activation of fibroblasts is not known, but fibroblasts release superoxide 
in response to stimulants such as IL-1 and TNF (Burdon, 1995; Datta et al., 1992; 
Larssen and Cerutti, 1989; Treisman, 1986). It was shown in Section 8.3, that honey-
stimulated PBMC activated fibroblast proliferation. Drawing from the observation 
that honey stimulated TNF production by monocytes (Section 4.3), it is feasible that 
honey would have a significant effect on various cell types through indirect activation. 
Release of superoxide from fibroblasts is catalysed by a plasma membrane NADPH-
oxidase, and superoxide dismutates spontaneously to hydrogen peroxide (Burdon, 
1995; Datta et al., 1992). 
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If honey increases the rate at which fibroblasts proliferate (and therefore fill in a 
wound cavity), it is likely that bystander activation would be enhanced as physical 
proximity of fibroblasts to each other perpetuates the stimulus (Pani et al., 2000; 
Burdon, 1995). This suggests that once stimulation has been effected, resulting 
superoxide transmission between cells serves to drive further proliferation in a 
paracrine manner. The extent of this initial activation would then determine the rate at 
which subsequent mitosis will occur, so that cells stimulated with honey would 
rapidly outpace those in medium alone. Further investigation would need to be 
undertaken to examine the role of various stimulants on a paracrine stimulation 
system. 
As discussed in Section 1.4.3, it is highly likely that the proteins in honey would be 
glycated (Tonks et al., 2003) due to both, long-term storage of the proteins with 
monosaccharides and the potential for the Maillard reaction to add sugars onto 
proteins, along with the propensity for invertase to transfer glucose onto other 
functional groups (e.g. proteins). In Sections 1.4.3 and 6.5, the large body of evidence 
for glycated proteins activating a range of cell types was cited. The observation that 
manuka honey has a more potent activating effect on cells than Otago pasture honey 
may reflect its higher protein content than the Otago pasture type (Molan, 1992b). 
Further indications that proteins may exert cellular effects even in low honey 
concentrations come from reports that protein inhibitors may be removed with 
progressive dilution (Radwan et al., 1984). Glucose oxidase is an example of a protein 
which does not exert effects until its inhibitor is removed with progressive dilution 
(Bang et al., 2003; Buntting, 2001; Radwan et al., 1984). 
There is a large body of evidence for glycated proteins activating a diverse range of 
cells. Protein glycation and AGE are associated with increased free radical activity 
(Ahmed, 2005), induced NF-lCB activation and cytokine production (Ahmed, 2005; 
Pullerits et al., 2005; Hein and Franke, 2002), effects on intracellular signalling, gene 
expression, and release of pro-inflammatory molecules (Ahmed, 2005). 
Sustained receptor expression of RAGE has been demonstrated to create a positive 
feedback loop (Pullerits et al., 2005), and it has been demonstrated that AGE-RAGE 
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interaction leads to a more prolonged activation than NF-lCB stimulation through 
cytokines (Hein and Franke, 2002). Cell-bound RAGE function as a counter-receptor 
for leukocytes, resulting in an amplification of the inflammatory response (Pullerits et 
al., 2005. A range of AGE receptors have been identified, including RAGE, AGE-Rl, 
AGE-R2, AGE-R3, sRAGE, and macrophages scavenger receptor) (Ahmed, 2005; 
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Figure 9.1: Concept diagram for the hypothesised mechanism by which hydrogen peroxide in honey 
may act as an immune stimulant The growing body of evidence suggests that hydrogen peroxide 
regulates signal transduction pathways, activates transcription factors and controls the expression of 
several genes concerned with cell anabolism. Observations from this study suggest that the hydrogen 
peroxide content of honey is a likely candidate for its effect on cell growth and immune competency. In 
addition, it is hypothesised that antioxidants in honey would interfere with the feedback amplification 
loop which exists for various inflammatory cytokines and oxidant species. 
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Diabetes studies have established that glycated proteins induce mitosis in fibroblasts 
(Huang et al., 1999; Lapuz, 1997; Sharma and Ziyadeh, 1997; Guh et al., 1996; 
Young et al., 1995), through interaction with specific cell-surface acceptor molecules, 
ultimately activating NF-1d3 (Huang et al., 1999; Yan et al., 1994). Glycated proteins 
can activate the JAK/STAT pathway (Huang et al., 1999; Weiss et al., 1998), 
stimulating production of platelet-derived growth factor (PDGF) by leukocytes 
(Throckmorton et al., 1995), which are potent activating factors for fibroblast 
proliferation (Burgering and Bos, 1995). These reports are reconcilable with the 
observed ability for honey-stimulated PBMC to activate fibroblast proliferation 
(Section 8.3). 
A further possibility may be that tannins in honey (which would likely occur at higher 
concentrations in manuka honey due to its high content of polyphenols) react with 
proteins or sugars forming large complexes which might be antigenic (P. C Molan; 
personal communication). Generally, all proteins are immunogenic due to antibodies 
being directed against sugars present on the surface of glycoprotein moieties, and 
those of greater complexity induce more vigorous responses by leukocytes (Benjamini 
et al., 1996). Binding of glycated proteins have been reported to trigger the release of 
cytokines by monocytes (Brownlee, 1995; Wolff et al., 1991). The observation that 
higher doses of high molecular weight fractions of manuka honey induced greater 
cytokine release by resting cells may be due to increasing protein content. That 
activity could not be identified for the equivalent fractions of pasture honey may be 
evidence that synergy between several compounds in honey is vital for maximal TNF-
a. production by monocytes. This may explain the decrease in total activity which 
occurred when honey was fractionated. 
However, it is unlikely that proteins alone could account for observed stimulatory 
effects as the protein content in full-strength honey is low (Molan, 1992b ), and 
extremely low in Otago pasture honey, also shown to induce cell proliferation. A 
range of honeys were reported to have an average total protein content of 168.6 
mg/lOOg honey (National Honey Board USA, 2003). Extrapolating from a report by 
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White (1975a), the average free amino acid content in an average honey, at a 0.25% 
concentration, would be approximately 1.12 µg/ml. 
Other reports have suggested that the nutrient content of honey may account for its 
promotion of tissue healing (Gupta et al., 1992), but this is unlikely to be of relevance 
in culture systems where conditions are optimal. Likewise, where glucose is available 
at optimal levels in culture medium, the supplementation of sugars to cells provided 
by honey is unlikely to promote an additional growth effect. It was observed in 
Section 6.3 that sugars in honey increased phagocytosis, however, the blood was not 
maintained in medium and this may have explained the small stimulatory effect. 
While others have reported that elevated glucose levels may directly stimulate various 
fibroblast populations, this was not observed in the current study where artificial 
honey had no effect on proliferation beyond culture medium (Huang et al., 1999; 
Trevisan et al., 1997; Ohgi and Johnson, 1996). 
That manuka honey had a more potent stimulatory effect on T cells than Otago pasture 
honey is reconcilable with limited evidence that flavonoids may have a stimulatory 
effect on some cell types (Havsteen, 2002). Flavonoids bound to proteins may be 
taken up by macrophages acting as an antigen (Havsteen, 2002) and stimulate 
production of IFN-~. However, that Otago pasture honey would have a low flavonoid 
content (Molan, 1992b ), and yet stimulates T cell proliferation at hundred-fold 
dilutions means it is very unlikely that flavonoids alone could be responsible for the 
observed stimulatory effects. 
In Section 4.3, the ability for low concentrations of honey to induce TNF-a release by 
monocytes was shown. In addition to inducing the production of functional protein, it 
was reported that honey could induce mRNA expression for key genes involved in 
wound healing in blood cultures (Section 3.3). Taken together with the results from 
Section 4.3, and the indirect stimulation obtained with honey-stimulated PBMC on 
fibroblasts (Section 8.3), it is clear that honey stimulates release of various cytokines. 
These results confirm reports by Blair (2000) and Tonks et al. (2003), that honey 
stimulates the release of IL-1, IL-6 and TNF proteins by monocytic cell lines in vitro. 
Of particular note, the studies by Blair (2000) and Tonks et al. (2003), used different 
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monocytic cell lines and a higher concentration of honey ( 1 % ). This is likely to reflect 
physiological differences between the cell lines. A pilot study by de Jong (2003) 
demonstrated that at 0.025% and 0.25% concentrations, manuka honey induced IL-2 
release from a murine T cell line. If the demonstrated ability for honey to induce 
cytokine mRNA expression for key genes involved in tissue repair (Section 3.3) are 
found to correlate with production of the functional proteins in vivo, this would help 
to explain clinical observations. 
With particular relevance to wound healing, TNF-a induces macrophage activation 
(Leibovich et al., 1987), fibroblast proliferation (Sugarman et al., 1985) and 
angiogenesis (Leibovich et al., 1987). In addition to its role in the early phase of 
inflammation, IL-1 p stimulates the release of growth factors by macrophages and 
fibroblasts for keratinocyte proliferation (Clarke, 1996). The observation that honey 
up regulated mRNA amplicons for some of the pivotal wound healing genes (e.g. IL-
1 P) in the first 6 h is consistent with the rapid effect of honey in stimulating tissue 
repair as reported clinically (Tonks et al., 2003; Phuapradit and Saropala, 1992; Efem, 
1988). It was hypothesised in Section 3.4. that honey may augment mediator release of 
lymphocyte-derived factors (e.g. IL-2) through up regulation of IL-I production. The 
production of mRNA in the early experimental phase (by 6 h) was consistent with 
what had been reported by Tonks et al. (2003) and the observation in the current study 
that TNF-a production by monocytes peaked at 4-6 h incubation (Section 4.3). As 
honey produced maximal levels of TNF-a after 4-6 h, this increases the possibility 
that it is interfering with NF-KB. 
An additional observation in the current study which is deemed to have some 
significance for wound healing is that honey did not upregulate cytokine mRNA or 
TNF protein to the same high levels as induced by the mitogens, Con A or LPS. 
Further, honey did not continue to induce high levels of cytokine mRNA expression 
over the entire incubation period, dampening down expression relative to the mitogens 
by the 24 h time-point. Con A and LPS were used separately to provide models for 
excessive inflammation in the current study, against which to compare the magnitude 
of the cell response to honey. It is hypothesised that the massive, prolonged cell 
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response induced by the mitogens would promote inflammatory conditions such as 
keloid scarring. Therefore, the observation that honey elicited cytokine mRNA 
production at lower levels than the mitogens did was deemed a beneficial action. In 
the absence of measuring the production of functional protein, the feasibility of this 
observed regulation of cytokine mRNA expression to be realised in vivo cannot be 
known. It is recognised that wound healing takes place over a far longer period of time 
(up to two years in some cases, Kanzler et al., 1986) and this would need to be 
investigated further. 
In Section 2.3 it was observed that low concentrations of honey stimulate the 
expression of the IL-2 receptor on T cell membranes, a key activation marker as T 
cells need to receive IL-2 in order to undergo proliferation (Section 2.2). Taken with 
the report that low concentrations of honey stimulate IL-2 production in a murine T 
cell line (de Jong, 2003), this provides further evidence that honey stimulates cytokine 
production in T cells from both primary and immortal cell line origins. It is noted here 
that IL-2 is also known to activate fibroblast proliferation (Plaisance et al., 1994). 
Thus, the observation that supematants obtained from PBMCs incubated with honey 
had a stimulatory effect on fibroblasts (Section 6.3), is in line with the observation 
that low concentrations of honey induce cytokine expression by mononuclear cells. 
Floral source appears to determine the extent of cytokine induction by honey. Manuka 
honey had a more potent inducing effect on mRNA for cytokines than Otago pasture 
honey. The implications of this observation for the production of functional proteins is 
unclear. However, it appears to be consistent with general observations made 
throughout this thesis for the greater potency of the manuka type in exerting 
immunogenic effects. While a high molecular weight fraction of manuka honey was 
found to activate neutrophils in the current study, an equivalent fraction of Otago 
pasture honey did not (Section 6.3). Evidence from studies conducted elsewhere has 
demonstrated that honey derived from wild flowers in Jordan stimulated phagocytic 
activity in neutrophils beyond that by a sugar control (Abuharfeil et al., 1999). While 
the neutrophils studied by Abuharfeil et al. (1999) were from human peripheral blood, 
the neutrophils used in the current study were from a bovine source. Therefore, it is 
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not possible to conclude whether cell type or floral source of the honey could be 
responsible for the observed effects on phagocyte activation. 
While hydrogen peroxide enters the cell by simple diffusion across cell membranes, 
glycated proteins must bind to receptors on the membrane (Benjamini et al., 1996). As 
these two substances have different mechanisms by which they activate lymphocytes, 
it is conceivable they could both have activity on the cells. With regard to the 
implications of cells being stimulated by two different agents, the possibility that 
response to one agent may interfere with cell response to a subsequent stimulus 
(Terstegen et al., 2000) is raised. If this were the case it would be expected that honey 
would not produce an additive effect on cell proliferation when present at the same 
time as a demonstrated mitogenic agent (i.e. IL-1), and this was what was observed for 
fibroblasts in vitro. Because honey is a complex mixture of chemical constituents, the 
specific role of each biomolecule cannot be easily separated from another in the 
absence of extensive isolation procedures (Swellam et al., 2003). 
9.3.2 Evidence that honey modulates cell response to inflammatory agents 
The current study supports the hypothesis that honey modulates cell activity during 
inflammation. In Section 8.3, the ability for honey to modulate fibroblast proliferation 
in response to a mitogen was demonstrated. In Section 3.3, honey was shown to 
modulate production of mRNA in LPS-stimulated blood for proinflammatory 
cytokines. In Section 5.3, honey was demonstrated to modulate NO production by 
LPS-stimulated monocytes. In Section 7 .3, the ability for honey to protect against 
disruption of tight junctions during an inflammatory challenge was shown. The 
observation that pre-incubation with honey prior to IL-I ~-activation suppresses 
fibroblast proliferation suggests honey has a modulatory action on proliferation. This 
may be exploited to reduce the incidence of fibrotic healing disorders such as keloid 
scarring (Section 1.7 .2). It remains to be established whether the antioxidant content 
of honey may interfere with bystander activation or acts on the target cells directly. 
295 
Chapter Nine General Discussion and Future Experiments 
Not all of the investigations undertaken in this study gave support to the hypothesis 
that honey modulates cytokine production by mitogen- or endotoxin-activated cells. 
In Chapter 4, it was shown that honey could not modulate TNF-a production after 
monocytes were exposed to LPS. In Chapter 6 it was shown that honey could not 
modulate the response of neutrophils to an exogenous TNF-a stimulus. In Chapter 8 it 
was demonstrated that honey needed to be present for 2 h prior to addition of an 
exogenous mitogen for any suppression of proliferation to be obtained. This raises 
questions about how realistic it could be for any anti-inflammatory effect of honey to 
be gained when honey is applied topically to a wound, assuming pro-inflammatory 
cytokines (e.g. IL-1~) are already being produced. Yet the observation that honey, 
although in its own right stimulatory, did not augment the effect of the TNF-a 
stimulus on neutrophils, proliferation of IL-1 ~-stimulated fibroblasts, or the 
production of TNF-a by LPS-activated monocytes, is critically important in view of 
its potential role in wound healing. Once again, it is noted that it is possible that one 
agent may interfere with cell response to a subsequent stimulus, thereby overriding the 
activity of one stimulus and leading to sole activation by the other (Terstegen et al., 
2000). Regardless of the possibilities for the mechanisms by which honey may/may 
not have effects in vitro, the wealth of anecdotal observations, reports on experimental 
wound models, and clinical studies (Gharzouli et al., 2002; Mahgoub et al., 2002; 
Oryan and Zaker, 1998; Ali et al., 1997; Gupta et al., 1992; Haffejee and Moosa, 
1985; Salem, 1981; Church, 1954), show that honey does have anti-inflammatory 
activity in wound healing, and mean that it is very realistic to hypothesise that these 
effects would be realised in vivo. 
As this study did not examine the cellular effects of purported anti-inflammatory 
compounds known to be present in honey, indications to the likelihood of the 
modulatory compound are discussed in light of published reports. The most likely 
candidate for observed anti-inflammatory effects of honey is antioxidant content 
(Gharzouli et al., 2002; Mahgoub et al., 2002). As mentioned previously, human in 
vivo studies have shown that there is a direct link between consumption of honey and 
the level of polyphenols in blood (Gross et al., 2004; Schramm et al., 2003). In 
addition to the known antioxidant content of manuka honey (Molan 1992b ), it was 
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observed to convey more potent modulatory effects at higher concentrations (Sections 
5.3; 7.3; 8.3). That the most potent immunomodulatory effects were obtained for an 
ether extract of manuka honey is likely to be the result of a concentrated source of 
phenolic polymers (Gheldof et al., 2002). High molecular weight fractions of the same 
honey obtained by dialysis had less immunomodulatory activity than the ether 
extracted fractions. While the ether extract would have contained all of the 
components which had dissolved in ether, including the phenolics and flavonoids, it 
would have no protein content (P.C Molan; personal communication). This difference 
in potency of the honey fractions may be explained by the established tendency for 
proteins to reduce the scavenging potential of phenolics (Arts et al., 2002). Further, 
the phenolics would have been split by the dialysis process into the two fractions, 
leaving a less concentrated source in the retentate fraction (P.C Molan; personal 
communication). 
Although propolis is known to contain higher concentrations of antioxidant 
substances than honey (Marcucci et al., 2001), there is abundant evidence that this 
antioxidant component of honey has demonstrated bioactivity (Yao et al., 2004; 
Gheldof et al., 2002; Ali et al., 1997; Hannum and Erdman, 2000). Flavonoid 
composition is directly correlated with the botanical source of the propolis and, 
therefore, it is not surprising that different honey types may vary in their ability to 
exert immunomodulatory effects (Section 1.3.1.5). Honey composition closely reflects 
the idiosyncrasies of the hive's geographical location, due to the phenolic compounds 
present in plants from which the honey was derived (Martos et al., 1997). Therefore 
the antioxidant potential of different honey types will be varied, and appears to 
provide a likely reason for the observed differences in immunomodulatory activity of 
the manuka and Otago pasture types. 
There is overwhelming evidence that honey has anti-inflammatory activity, when 
applied to the skin (Oryan and Zaker, 1998; Gupta et al., 1992; Church, 1954), or to 
the gastric mucosa (Gharzouli et al., 2002; Mahgoub et al., 2002; Ali et al., 1997; 
Haffejee and Moosa, 1985 and Salem, 1981). These studies appear to have parallels to 
those where antioxidants are administered directly (Ansorge et al., 2003; Phan et al., 
2003; Havsteen, 2002; Moreno, 2000; Alliangana, 1996; Frankel et al., 1993; Murrell 
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et al., 1990), and especially when applied to bums (Kaufman et al., 1985; Tanaka et 
al., 1995), as has been observed for honey (Subrahmanyam, 1991). 
The established antioxidant content of honey is known to include a range of 
antioxidants which have potent activity at micromolar concentrations (Raneva et al., 
2001; Middleton and Kandaswami, 1992); caffeic acid (Wahdan, 1996), ascorbic acid 
(White, 1975). Of relevance to this thesis, caffeic acid has been reported to reduce T 
cell proliferation (Ansorge et al., 2003). Swellam et al. (2003) reported that honey at 
concentrations beyond 1 %, had strong modulatory activity on bladder cancer cell 
lines, possibly due to the inhibitory effect of caffeic acid and flavonoids on tyrosine 
protein kinase, lipoxygenase and cycloxygenase pathway metabolites. 
In general, antioxidants have been demonstrated to reduce proliferation of fibroblast 
cell lines in response to growth factors (Havsteen, 2002; Moreno, 2000; Frankel et al., 
1993), interfere with the hydrogen peroxide stimulation pathway (Phan et al., 2003; 
Alliangana, 1996; Martinez and Moreno, 1996; Murrell et al., 1990), and reduce 
lymphocyte proliferation in response to mitogenic substances (Ansorge et al., 2003; 
Havsteen, 2002; Pani et al., 2000; Natarajan et al., 1996). It has been shown that the 
unoxidised flavonoids present in honey (Weston, 2000), can act as free radical 
scavengers (Puppo, 1992) through sequestering metal ions, so that they are unable to 
participate in the Fenton reaction (Dailey and Imming, 1999). 
In light of the observation that prior exposure of fibroblasts to honey reduced 
subsequent proliferation in response to IL-1~ (Section 8.3), it would be useful to 
investigate whether this effect was correlated with expression of heat shock proteins. 
The observation that a 6 h incubation of whole blood with 0.25% manuka honey 
upregulated mRNA expression for heat shock protein 70, may be a consequence of 
hydrogen peroxide activity (Section 3.3). Further indications that make it likely that 
hydrogen peroxide might induce heat shock protein expression come from reports that 
a short exposure time is all that is required for hydrogen peroxide to directly activate 
cells (Los et al., 1995). In the current study, a two hour exposure of cells to honey was 
\sufficient to modulate their subsequent response to IL-1 ~-
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However, there are a number of indicators that do not support the hypothesis that 
hydrogen peroxide-induced chaperonins may play a role in modulatory effects. Ether 
extracted fractions of manuka honey gave the most potent suppressive effects and yet 
would be largely devoid of the glucose oxidase enzyme needed to produce hydrogen 
peroxide as it is not ether soluble (P. C Molan; personal communication; Gheldof et 
al., 2002). The known content of antioxidants in manuka honey (Schramm et al., 
2003; Swellam et al., 2003; Weston, 2000), make it unlikely that sufficient oxidative 
stress could be induced for heat shock proteins to be expressed, especially by 0.25% 
concentrations of whole honey. Based on a report by Wang et al. (2001), minimum 
hydrogen peroxide concentrations of 0.2 mM were necessary to induce oxidative 
stress in fibroblasts, much higher than the likely concentration of hydrogen peroxide 
that could accumulate in 30 min with 0.25% honey (0.05 mM) (Bang et al., 2003). 
However, extrapolating from the Bang et al. (2003) study, it is conceivable that the 
minimum 0.2 mM concentrations of hydrogen peroxide would be achieved with 1 % 
concentrations of honey. 
The demonstrated capacity for manuka honey to suppress NO production by LPS-
stimulated monocytes (Section 5.3), along with downregulation of mRNA for iNOS in 
LPS-stimulated whole blood cultures (Section 3.3), raises the possibility that the 
honey modulates NO production through effects on iNOS. Others have shown that 
antioxidants can be used to regulate iNOS expression, and that this can ameliorate 
both NO production (Havsteen, 2002), and inflammatory damage to the intestinal 
mucosa (Kruidenier et al., 2003). The observed ability of honey to convey protective 
effects to TJ integrity during an inflammatory challenge (Section 7.3), indicates that 
there is potential for honey to reduce infiltration of immune cells into the tissues. This 
agrees with the reduction of swelling which is observed when honey is applied to the 
skin (Oryan and Zaker, 1998; Postmes et al., 1997; Gupta et al., 1992; El-Banby et al., 
1989; Kandil et al., 1987; Burlando, 1978), and reduction of vascular permeability 
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Figure 9.2: Concept diagram for the hypothesised mechanism by which honey exerts anti-inflammatory 
effects in inflammatory gut conditions when ingested orally Both honey types had protective effects on 
tight junctions against an inflammatory challenge, and reduced the proliferation response of mitogen-
stimulated fibroblasts. These observations were in agreement with what is observed anecdotally. 
Antioxidants have been demonstrated to have a potent modulating effect on activated immune cells. 
300 
ChaptL:r NinL: GL:nL:ral Disrnssion and FuturL: ExpL:rimL:nts 
antioxidant action (Mahgoub et al., 2002; Ali et al., 1997), or due to enhancing 
epithelial growth (Molan, 2002; Efem, 1988). Subrahmanyam (1991) and Efem 
(1992) demonstrated that honey contains inhibin and catalase, and that these directly 
promote epithelial growth. It would be useful to examine whether honey causes 
cellular changes in the epithelium surrounding the wound, and determine if healing 
may be initiated through this mechanism. 
Though not examined in this thesis, it has been reported that the antioxidant content of 
honey can downregulate superoxide production (Ali et al., 1997), and this would 
potentially reduce superoxide-damage to gastric mucosa characteristic of irritable 
bowel disease (IBO) (Kruidenier et al., 2003). Therefore, if honey can act at all of 
these levels, there is potential for it to ameliorate gastric inflammation. The 
hypothesised role of antioxidants in the observed anti-inflammatory effects of honey 
in inflammatory gut conditions is presented in Figure 9 .2. 
The evidence presented in the current study suggests that honey can both stimulate 
and modulate cell activity. The results presented in the current study show that honey 
interferes with a large number of regulatory steps in the inflammatory pathway, e.g. 
cell division, transcription, tight junction integrity, production of oxidant species. 
While the stimulatory activity was observed at lower concentrations, the modulatory 
effects required higher concentrations of honey. The dual ability for honey to 
stimulate moderate cellular activation in the absence of an immune stimulus, yet not 
augment mitogenic stimulation, and in some cases to modulate cell response to a 
mitogen, indicates that it will promote healing without setting up harmful 
inflammation. Figure 9.3 draws together both observations made in this thesis and a 
wealth of published reports to produce a hypothesised mechanism by which honey 
might optimise wound healing. 
The observations made in this thesis demonstrate that low concentrations of honey 
stimulate: cytokine release, subsequent proliferation and increased phagocytosis by 
resting leukocytes, and dampen down the proliferative response of cells to a mitogen. 
Honey has been demonstrated to convey protective effects to tight junctions during an 
inflammatory challenge, and suppress NO release. These in vitro investigations are in 
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agreement with what is observed anecdotally. There is much evidence to suggest that 
honey is immunogenic due to its content of glycated proteins, complexes of tannins 
bound to proteins, or hydrogen peroxide (as cell stimulants), and that its antioxidant 
content may account for modulatory effects. Further, the role of induction of heat 
shock proteins in the observed modulatory effects cannot be excluded. It is proposed, 
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Figure 9.3 : Schematic diagram summarising the hypothesised mechanisms by which honey optimises 
wound healing as observed in this study 
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on the basis of this study, that honey may provide a neatly controlled therapy for 
optimising tissue repair, with potential for use in inflammatory disorders. It is the 
central thesis of this study that the stimulatory agent in honey induces cytokine 
production necessary for healing to occur, but that the oxidant species produced by 
these cells are effectively regulated by a second agent, thereby creating a feedback-
regulated delivery system. It has been demonstrated in the discussion of fibrosis in 
Section 1.7.2, that excessive inflammation will occur (and therefore disease) if 
cytokine production continues unabated, as changes in cytokine gradients are 
necessary for the following phases of tissue repair to begin. If further experiments 
confirm this to be the case, honey will have potential for therapeutic application. 
9.3.3 Future experiments 
The results obtained from the current study present strong justification to test the 
effect of honey in an animal model. Though the use of cell lines enabled dissecting out 
of complex signalling pathways, it would be desirable to repeat the assays on primary 
cells from human origins (e.g. skin derived fibroblasts). While cell lines have the 
advantage of having very defined characteristics, primary cells cultures show variation 
in their response to immune stimuli, and it has been noted that this occurs for cells in 
vivo as well. It is likely to be the case that the therapeutic potential of various honey 
types may vary among individuals and this needs to be established in vivo. 
As there was not sufficient time to investigate all of the possible effects of honey on 
cell signalling for each cell type, the effect of honey on transcription factors for 
regulatory factors was not explored in the current study. Further, the effect of honey 
on cytokine antagonists was not examined as a possible source of anti-inflammatory 
action. It would have been valuable to examine the effect of honey on cell adhesion 
molecules. This information would be useful to gain a better understanding of the 
mechanism by which honey exerts anti-inflammatory effects. 
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Though the results presented in the current study show that honey has activity on cells 
involved in the inflammatory pathway at low concentrations in vitro they do not 
translate to dose-rates in vivo. Due to time constraints, plans to investigate the effect 
of honey on cellular adhesion molecules and selectin were abandoned. As honey had 
been observed to have direct effects on leukocytes and also on tight junctions, there is 
a strong possibility that it may manipulate the binding interactions which enable 
immune cells to prepare to enter the tissues. A number of compounds derived from 
natural products have been found to interfere with expression of leukocyte adhesion 
molecules (Gupta and Ghosh, 1999). It would be valuable to investigate the effect of 
honey on cellular adhesion molecules in future research. Due to the constraints of time 
and feasible scope of the current study it was not possible to pursue the identification 
of the stimulatory and modulatory fractions beyond the preliminary fractionation 
described here. Chromatographic fractionation would be required to test the activity of 
specific components in honey for their cellular effects, and the enormity of such an 
undertaking would constitute a thesis study in itself. Furthermore, identification of the 
stimulatory and modulatory components of honey lay outside the primary aim of the 
current study, which was to test the effect of honey on a range of cells functioning in 
the inflammatory pathway. 
While this thesis has contributed much to an understanding of the mechanisms by 
which honey optimises wound healing, it raises many further questions which are yet 
to be answered. The reasons for observed variability in individual response to the 
stimulatory component must be further elucidated. Due to the enormity of the 
interactions which exist between cells in the immune system, there are many more 
potential investigations which may (and must) be performed. The experiments 
described in this thesis provide overwhelming support that honey does exert 
immunogenic effects as observed anecdotally. However, in the absence of in vivo 
testing, conclusions drawn will continue to be limited by the inability to demonstrate 
exactly how the human body may interfere with what has been observed in vitro. 
Therefore, it is vital that this research is extended to in vivo testing for further 
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Figure A. la: Standard curves established for MTI absorbance for WEHI cells (570 nm) against TNF-a 
standards. Four representative standard curves have been included for the assays presented in Chapter 4 (each 
assay presented was replicated in time at least twice) . 
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Figure A.2: Calibration curves for the NaN02 standard using the Greiss assay. One calibration curve 
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Figure A.3:Standard curve for the relationship between absorbasnce of MTT (570nm) and cell density 
(3T3-L I fibroblasts). 
